data_1s1n_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1s1n _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.119 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -126.55 161.31 28.3 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 103.537 -2.764 . . . . 0.0 103.537 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -115.1 136.3 53.27 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 116.444 -2.102 . . . . 0.0 112.855 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.422 ' CD1' HG22 ' A' ' 181' ' ' VAL . 6.0 m-85 -124.99 -178.99 4.36 Favored 'General case' 0 C--N 1.299 -1.6 1 N-CA-C 100.068 -4.049 . . . . 0.0 100.068 179.085 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 3.5 pt -125.22 154.6 33.61 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 N-CA-C 101.914 -3.365 . . . . 0.0 101.914 173.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -89.26 150.63 22.54 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 102.02 -3.326 . . . . 0.0 102.02 177.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.2 m -130.09 28.36 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 126.238 2.211 . . . . 0.0 106.545 177.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -142.23 158.94 27.01 Favored Glycine 0 N--CA 1.482 1.754 0 N-CA-C 105.711 -2.956 . . . . 0.0 105.711 174.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -107.68 94.29 5.0 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 118.928 -1.109 . . . . 0.0 108.786 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.448 ' HB3' ' CZ ' ' A' ' 173' ' ' PHE . 47.6 t80 -107.65 154.09 21.96 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.086 -1.046 . . . . 0.0 108.921 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 56.7 m -127.0 163.43 23.72 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 105.442 -2.059 . . . . 0.0 105.442 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -95.25 135.03 37.34 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 177.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 16.6 mp0 -110.74 -29.81 7.84 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -115.63 -178.07 3.3 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 58.5 t -88.95 150.91 3.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 104.822 -2.288 . . . . 0.0 104.822 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 113.51 -51.89 0.68 Allowed Glycine 0 N--CA 1.485 1.929 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 -178.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.423 ' HA ' ' H ' ' A' ' 201' ' ' LEU . 2.9 m-20 -76.99 166.5 23.23 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -178.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.411 ' HG ' ' HA3' ' A' ' 200' ' ' GLY . 16.4 mt -121.26 178.82 4.62 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 113.449 -1.705 . . . . 0.0 109.935 179.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 39.0 m -122.03 100.02 6.75 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.57 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.448 ' CZ ' ' HB3' ' A' ' 163' ' ' PHE . 18.0 p90 -119.21 168.28 11.03 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.531 -0.867 . . . . 0.0 110.88 178.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 57.2 pttt -124.84 142.79 51.2 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 115.882 1.808 . . . . 0.0 115.882 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 49.9 tptt -23.9 77.95 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 109.583 -3.462 . . . . 0.0 115.215 170.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 107.78 50.5 0.79 Allowed Glycine 0 N--CA 1.49 2.281 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.913 176.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -127.95 170.85 12.39 Favored 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 176.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 14.4 mm -99.8 132.76 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 117.98 -1.488 . . . . 0.0 112.11 -177.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 57.9 mt -124.74 167.79 14.09 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 113.561 -1.654 . . . . 0.0 110.077 177.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 22.2 tp -117.47 159.72 22.36 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 102.746 -3.057 . . . . 0.0 102.746 177.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.422 HG22 ' CD1' ' A' ' 157' ' ' TYR . 3.2 t -128.14 136.71 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 CA-C-N 120.915 1.689 . . . . 0.0 109.306 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.437 ' O ' ' CB ' ' A' ' 183' ' ' GLU . 45.8 mt -145.35 86.13 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.093 -176.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . 0.467 ' CB ' HG12 ' A' ' 191' ' ' ILE . 10.1 tm-20 130.56 153.18 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.753 0 C-N-CA 128.109 2.564 . . . . 0.0 107.654 172.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -109.83 123.0 48.81 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 118.426 2.75 . . . . 0.0 118.426 -174.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . 0.436 ' CG ' ' HE1' ' A' ' 190' ' ' TRP . 8.4 tttm -9.79 78.37 0.03 OUTLIER Pre-proline 0 N--CA 1.507 2.413 0 N-CA-C 117.746 2.499 . . . . 0.0 117.746 175.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -69.09 -56.53 0.16 Allowed 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 123.165 2.577 . . . . 0.0 105.96 175.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -125.35 19.28 8.18 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 112.067 -2.333 . . . . 0.0 111.791 -177.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 122.07 -23.84 7.19 Favored Glycine 0 N--CA 1.487 2.074 0 C-N-CA 118.452 -1.832 . . . . 0.0 111.242 -178.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 24.7 m-90 -113.39 154.6 26.67 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 115.842 1.793 . . . . 0.0 115.842 -176.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' TRP . . . . . 0.436 ' HE1' ' CG ' ' A' ' 185' ' ' LYS . 18.3 m95 -122.73 163.91 19.28 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 101.767 -3.42 . . . . 0.0 101.767 -178.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.467 HG12 ' CB ' ' A' ' 183' ' ' GLU . 8.2 mm -102.9 105.57 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 C-N-CA 115.522 -2.471 . . . . 0.0 105.043 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -98.43 -177.88 3.84 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -173.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 199' ' ' GLU . 34.0 ttmt -137.17 164.45 28.44 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 177.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 47.2 p-10 -122.45 -163.23 1.06 Allowed 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.664 -0.814 . . . . 0.0 110.077 178.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -103.36 40.86 1.34 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -126.17 -35.6 2.41 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 113.709 -1.587 . . . . 0.0 107.455 177.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 134.9 -38.96 1.75 Allowed Glycine 0 N--CA 1.487 2.071 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 21.1 p30 -67.8 163.78 21.03 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -178.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 193' ' ' LYS . 0.0 OUTLIER -129.53 149.48 51.28 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 112.121 -2.309 . . . . 0.0 108.609 177.181 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . 0.411 ' HA3' ' HG ' ' A' ' 171' ' ' LEU . . . -139.28 -156.34 6.94 Favored Glycine 0 N--CA 1.482 1.714 0 CA-C-N 114.789 -1.096 . . . . 0.0 113.187 -177.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . 0.423 ' H ' ' HA ' ' A' ' 170' ' ' ASP . 90.3 mt -117.12 101.94 8.89 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 111.622 -2.289 . . . . 0.0 107.56 178.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 4.9 m -120.5 151.44 53.91 Favored Pre-proline 0 N--CA 1.496 1.828 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -82.38 175.85 8.56 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 121.19 1.26 . . . . 0.0 109.05 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.37 -42.89 7.91 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 102.994 -2.965 . . . . 0.0 102.994 178.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 77.3 p -23.44 -53.67 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 O-C-N 125.579 1.799 . . . . 0.0 115.469 178.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -112.34 49.04 0.94 Allowed 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.891 -0.724 . . . . 0.0 110.807 -178.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -131.15 129.49 41.85 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 179.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -121.0 143.68 37.48 Favored Pre-proline 0 N--CA 1.493 1.675 0 C-N-CA 118.729 -1.189 . . . . 0.0 108.198 177.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -58.91 161.21 16.02 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 121.703 1.602 . . . . 0.0 109.798 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 38.7 t80 . . . . . 0 N--CA 1.491 1.599 0 C-N-CA 118.853 -1.139 . . . . 0.0 112.176 -179.06 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.159 0 CA-C-O 121.169 0.316 . . . . 0.0 112.603 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -117.55 162.52 17.86 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 103.195 -2.891 . . . . 0.0 103.195 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 9.3 mp0 -116.31 118.63 33.28 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 117.54 -1.664 . . . . 0.0 110.943 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.45 ' CD1' HG21 ' A' ' 181' ' ' VAL . 41.3 m-85 -126.0 176.46 6.99 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 104.346 -2.464 . . . . 0.0 104.346 178.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.455 ' CG2' ' CD1' ' A' ' 210' ' ' TYR . 1.7 pt -124.87 146.2 30.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 1 N-CA-C 100.155 -4.017 . . . . 0.0 100.155 170.728 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -92.7 155.07 17.95 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 116.849 -1.941 . . . . 0.0 106.246 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.6 m -130.2 25.64 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 125.719 1.887 . . . . 0.0 110.02 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -121.66 146.28 17.09 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 106.687 -2.565 . . . . 0.0 106.687 176.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -104.9 78.06 1.39 Allowed 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -178.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -106.51 155.81 19.21 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.021 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 97.6 m -118.32 161.82 19.3 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -86.41 144.34 27.36 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 117.49 -1.684 . . . . 0.0 107.868 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -113.61 -30.07 6.94 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 113.043 -1.89 . . . . 0.0 106.584 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.427 ' C ' ' H ' ' A' ' 169' ' ' GLY . 56.3 mt-30 -116.88 176.39 5.14 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 19.4 t -96.83 45.42 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 103.925 -2.621 . . . . 0.0 103.925 176.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . 0.427 ' H ' ' C ' ' A' ' 167' ' ' GLN . . . -127.68 -46.02 0.2 Allowed Glycine 0 N--CA 1.484 1.882 0 N-CA-C 106.84 -2.504 . . . . 0.0 106.84 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.41 ' HA ' ' H ' ' A' ' 201' ' ' LEU . 25.3 m-20 -79.89 169.85 17.31 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 112.7 -1.75 . . . . 0.0 111.308 179.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 15.9 mt -121.07 176.73 5.43 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.427 176.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 47.2 m -119.62 99.46 6.67 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 114.354 -1.294 . . . . 0.0 110.994 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.444 ' N ' ' CD1' ' A' ' 173' ' ' PHE . 1.3 p90 -118.67 161.94 19.25 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.021 -1.072 . . . . 0.0 111.282 178.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -118.51 62.98 0.77 Allowed 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 120.047 3.351 . . . . 0.0 120.047 -175.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 70.4 tttt 37.05 76.83 0.05 OUTLIER 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 116.838 2.162 . . . . 0.0 116.838 173.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 119.1 52.4 0.29 Allowed Glycine 0 N--CA 1.495 2.595 0 CA-C-N 113.68 -1.6 . . . . 0.0 111.703 177.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -131.1 173.37 11.09 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 177.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 18.0 mm -97.16 125.06 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 C-N-CA 118.672 -1.211 . . . . 0.0 112.456 -177.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 17.9 mt -118.31 168.25 10.79 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 114.104 -1.407 . . . . 0.0 110.234 177.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 14.5 tp -118.35 157.98 26.11 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 103.826 -2.657 . . . . 0.0 103.826 177.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.45 HG21 ' CD1' ' A' ' 157' ' ' TYR . 43.7 t -120.0 128.3 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-N 120.675 1.579 . . . . 0.0 112.865 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.491 ' O ' ' CB ' ' A' ' 183' ' ' GLU . 56.3 mt -145.61 86.19 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.284 -176.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . 0.491 ' CB ' ' O ' ' A' ' 182' ' ' ILE . 5.0 tm-20 131.08 151.26 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.932 0 C-N-CA 127.672 2.389 . . . . 0.0 109.11 172.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . 0.492 ' HG2' ' CZ3' ' A' ' 190' ' ' TRP . 55.2 mttp -119.37 123.74 44.89 Favored 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 119.69 3.218 . . . . 0.0 119.69 -171.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . 0.532 ' CG ' ' HE1' ' A' ' 190' ' ' TRP . 2.9 tttm -12.43 80.67 0.03 OUTLIER Pre-proline 0 N--CA 1.512 2.664 0 N-CA-C 118.515 2.783 . . . . 0.0 118.515 175.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . 0.413 ' HD3' ' O ' ' A' ' 189' ' ' TRP . 11.4 Cg_exo -78.59 -55.23 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.527 0 N-CA-C 105.143 -2.676 . . . . 0.0 105.143 174.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -121.99 17.96 10.89 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 112.502 -2.135 . . . . 0.0 110.94 -178.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.41 ' HA2' ' HG2' ' A' ' 185' ' ' LYS . . . 114.02 6.81 20.27 Favored Glycine 0 N--CA 1.487 2.057 0 C-N-CA 118.846 -1.645 . . . . 0.0 109.219 -178.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . 0.413 ' O ' ' HD3' ' A' ' 186' ' ' PRO . 1.1 m-90 -121.65 147.26 46.1 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 119.829 3.27 . . . . 0.0 119.829 -177.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' TRP . . . . . 0.532 ' HE1' ' CG ' ' A' ' 185' ' ' LYS . 42.1 m95 -128.66 160.13 33.42 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 101.43 -3.545 . . . . 0.0 101.43 176.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.432 ' HB ' ' O ' ' A' ' 182' ' ' ILE . 7.7 mt -115.9 116.37 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 177.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -105.4 -177.46 3.37 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -171.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 199' ' ' GLU . 3.3 ttmp? -134.83 166.7 22.37 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 175.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -119.67 -159.12 0.76 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -103.47 37.58 1.98 Allowed 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 120.114 -0.634 . . . . 0.0 110.205 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -128.8 -38.21 1.69 Allowed 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 176.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 138.9 -40.69 1.42 Allowed Glycine 0 N--CA 1.485 1.919 0 N-CA-C 109.021 -1.632 . . . . 0.0 109.021 -178.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -56.35 159.67 3.48 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 118.943 -1.103 . . . . 0.0 113.803 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . 0.454 ' HA ' ' HA ' ' A' ' 193' ' ' LYS . 0.0 OUTLIER -129.98 154.26 47.56 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 112.533 -2.121 . . . . 0.0 109.791 179.468 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -135.53 -170.26 12.05 Favored Glycine 0 N--CA 1.482 1.755 0 CA-C-O 122.913 1.285 . . . . 0.0 114.094 -177.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . 0.41 ' H ' ' HA ' ' A' ' 170' ' ' ASP . 13.2 mt -115.41 92.41 3.91 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 110.483 -2.858 . . . . 0.0 105.554 177.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 25.1 m -117.45 158.0 46.06 Favored Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 -177.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -82.86 178.63 5.86 Favored 'Trans proline' 0 C--N 1.302 -1.919 0 N-CA-C 107.945 -1.598 . . . . 0.0 107.945 179.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 13.3 ttt-85 -96.82 -42.69 7.85 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 105.164 -2.162 . . . . 0.0 105.164 179.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 41.6 p -23.21 -46.03 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.987 0 O-C-N 126.544 2.402 . . . . 0.0 115.777 176.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -106.12 51.78 0.74 Allowed 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 119.271 -0.972 . . . . 0.0 111.898 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 73.3 mt -127.9 135.88 50.61 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 176.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -119.41 145.33 38.47 Favored Pre-proline 0 C--N 1.303 -1.422 0 N-CA-C 103.732 -2.692 . . . . 0.0 103.732 177.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -62.93 158.03 45.34 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 121.427 1.418 . . . . 0.0 108.457 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . 0.455 ' CD1' ' CG2' ' A' ' 158' ' ' ILE . 17.6 t80 . . . . . 0 N--CA 1.488 1.448 0 C-N-CA 118.509 -1.276 . . . . 0.0 110.552 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.147 0 CA-C-O 121.348 0.416 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -123.06 170.65 9.96 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 103.873 -2.64 . . . . 0.0 103.873 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -106.75 130.01 54.53 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 117.319 -1.752 . . . . 0.0 112.301 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.41 ' CD1' HG21 ' A' ' 181' ' ' VAL . 6.2 m-85 -122.53 178.95 4.76 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 101.756 -3.424 . . . . 0.0 101.756 177.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.414 ' CG2' ' CD1' ' A' ' 210' ' ' TYR . 6.6 pt -127.76 154.8 38.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 103.519 -2.771 . . . . 0.0 103.519 170.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -88.84 151.22 22.49 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 100.308 -3.96 . . . . 0.0 100.308 176.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 35.9 m -127.2 17.56 3.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 125.845 1.965 . . . . 0.0 107.966 178.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -130.59 159.3 22.83 Favored Glycine 0 N--CA 1.484 1.835 0 N-CA-C 105.895 -2.882 . . . . 0.0 105.895 176.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -107.3 93.05 4.34 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.026 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -106.86 156.95 18.14 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 118.645 -1.222 . . . . 0.0 108.393 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 90.8 m -120.15 162.31 19.55 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 104.677 -2.342 . . . . 0.0 104.677 179.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -88.25 139.76 30.17 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 117.412 -1.715 . . . . 0.0 106.479 178.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -112.05 -33.51 6.24 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -114.4 -178.22 3.32 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 113.428 -1.714 . . . . 0.0 106.581 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 14.4 p -94.37 40.22 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-O 124.261 1.981 . . . . 0.0 108.199 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -118.75 -53.41 0.29 Allowed Glycine 0 N--CA 1.485 1.935 0 CA-C-N 112.18 -2.282 . . . . 0.0 109.181 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.404 ' HA ' ' H ' ' A' ' 201' ' ' LEU . 1.7 m-20 -81.78 174.95 10.85 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 38.8 mt -117.28 177.66 4.65 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 111.92 -2.4 . . . . 0.0 108.202 178.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 42.7 m -116.58 91.48 3.6 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 114.182 -1.372 . . . . 0.0 108.004 177.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 16.8 p90 -118.07 164.57 14.93 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 114.0 -1.455 . . . . 0.0 110.497 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -126.54 142.85 51.4 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 117.638 2.459 . . . . 0.0 117.638 -179.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 71.3 tttt -22.25 76.25 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.726 1 CA-C-N 108.03 -4.168 . . . . 0.0 117.016 171.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 114.92 48.89 0.52 Allowed Glycine 0 N--CA 1.488 2.115 0 CA-C-N 114.225 -1.352 . . . . 0.0 112.998 175.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -131.39 155.71 46.8 Favored 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 176.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.496 ' N ' ' CD1' ' A' ' 178' ' ' ILE . 1.1 mp -85.88 135.01 25.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -179.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -124.3 170.98 10.25 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 112.819 -1.992 . . . . 0.0 105.796 175.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 16.6 tp -117.45 154.49 31.3 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 102.028 -3.323 . . . . 0.0 102.028 176.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.41 HG21 ' CD1' ' A' ' 157' ' ' TYR . 2.9 t -126.22 118.93 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 CA-C-N 120.685 1.584 . . . . 0.0 114.681 -176.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.424 ' N ' HD12 ' A' ' 182' ' ' ILE . 0.0 OUTLIER -135.78 93.13 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-O 123.886 1.803 . . . . 0.0 111.046 -177.962 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . 0.441 ' O ' ' CE3' ' A' ' 190' ' ' TRP . 44.1 tt0 140.1 155.8 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.584 1 CA-C-N 107.649 -4.341 . . . . 0.0 107.347 175.905 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . 0.403 ' N ' ' HG2' ' A' ' 183' ' ' GLU . 97.6 mttt -118.53 97.68 5.87 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 117.246 2.313 . . . . 0.0 117.246 -174.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . 0.557 ' HB2' ' NE1' ' A' ' 190' ' ' TRP . 46.0 tttm -15.52 86.7 0.03 OUTLIER Pre-proline 0 N--CA 1.506 2.345 0 N-CA-C 117.095 2.258 . . . . 0.0 117.095 176.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -70.06 -58.46 0.1 OUTLIER 'Trans proline' 0 C--N 1.304 -1.776 0 N-CA-C 103.548 -3.289 . . . . 0.0 103.548 174.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -126.01 28.97 5.98 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 112.812 -1.995 . . . . 0.0 113.018 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.444 ' CA ' ' HG3' ' A' ' 185' ' ' LYS . . . 115.75 12.04 9.77 Favored Glycine 0 N--CA 1.494 2.527 0 C-N-CA 119.631 -1.271 . . . . 0.0 110.378 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 3.4 m-90 -131.27 122.74 27.0 Favored 'General case' 0 N--CA 1.489 1.517 1 N-CA-C 123.336 4.569 . . . . 0.0 123.336 -178.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' TRP . . . . . 0.557 ' NE1' ' HB2' ' A' ' 185' ' ' LYS . 12.2 m95 -119.09 164.71 15.13 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 100.248 -3.982 . . . . 0.0 100.248 173.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 27.4 mt -115.66 119.91 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 102.185 -3.265 . . . . 0.0 102.185 176.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -112.23 177.39 4.66 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 118.259 -1.376 . . . . 0.0 113.843 -174.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -130.16 165.43 22.34 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 173.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 43.0 p-10 -122.75 -163.76 1.12 Allowed 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.258 -0.977 . . . . 0.0 110.025 177.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -98.87 40.93 1.17 Allowed 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 121.935 0.874 . . . . 0.0 108.787 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -128.56 -37.68 1.77 Allowed 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 113.556 -1.656 . . . . 0.0 107.677 177.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 133.29 -37.97 1.92 Allowed Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 19.9 p30 -64.14 165.65 8.92 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 -178.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.17 154.41 48.4 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 112.723 -2.035 . . . . 0.0 111.443 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -135.47 -173.25 12.97 Favored Glycine 0 N--CA 1.486 2.02 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.587 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . 0.404 ' H ' ' HA ' ' A' ' 170' ' ' ASP . 9.6 mt -116.82 82.38 1.79 Allowed 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 104.636 -2.357 . . . . 0.0 104.636 178.016 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 3.2 m -107.21 156.0 38.35 Favored Pre-proline 0 N--CA 1.498 1.941 0 C-N-CA 119.02 -1.072 . . . . 0.0 109.839 -171.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -88.1 179.26 2.83 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 C-N-CA 123.08 2.52 . . . . 0.0 113.084 -177.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 43.2 ttp180 -96.51 -41.84 8.37 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 103.685 -2.709 . . . . 0.0 103.685 174.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 69.8 p -23.55 -52.73 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 O-C-N 126.067 2.104 . . . . 0.0 115.718 178.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -115.49 46.17 1.54 Allowed 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 120.003 -0.679 . . . . 0.0 112.396 -178.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.43 144.55 51.3 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 114.585 -1.188 . . . . 0.0 107.961 179.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -128.41 154.04 79.2 Favored Pre-proline 0 N--CA 1.493 1.691 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 175.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -64.34 154.98 68.36 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 C-N-CA 121.658 1.572 . . . . 0.0 112.582 -178.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . 0.44 ' CE1' HD11 ' A' ' 178' ' ' ILE . 32.4 t80 . . . . . 0 N--CA 1.492 1.664 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 177.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.203 0 CA-C-O 121.103 0.28 . . . . 0.0 112.918 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -115.96 167.32 11.06 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 103.298 -2.852 . . . . 0.0 103.298 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -101.96 122.15 43.5 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 117.274 -1.77 . . . . 0.0 112.407 -176.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.449 ' CD1' HG22 ' A' ' 181' ' ' VAL . 1.0 OUTLIER -126.95 169.8 12.93 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 102.613 -3.106 . . . . 0.0 102.613 176.485 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.537 HG23 HG12 ' A' ' 178' ' ' ILE . 36.7 pt -125.34 142.14 43.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 C-N-CA 118.058 -1.457 . . . . 0.0 108.524 170.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.462 ' O ' ' N ' ' A' ' 176' ' ' GLY . . . -72.33 152.52 42.04 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 101.631 -3.47 . . . . 0.0 101.631 178.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 26.8 m -118.47 -4.12 10.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 125.892 1.995 . . . . 0.0 108.521 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -137.16 177.01 20.13 Favored Glycine 0 N--CA 1.485 1.962 0 N-CA-C 107.363 -2.295 . . . . 0.0 107.363 178.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -106.51 132.2 52.8 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 118.857 -1.137 . . . . 0.0 109.205 178.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -123.29 153.37 40.31 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 176.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 67.9 m -126.77 156.35 41.36 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -95.79 138.49 33.36 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 178.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -111.82 -34.88 5.88 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 88.0 mm-40 -117.45 -176.01 2.93 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 113.314 -1.767 . . . . 0.0 106.328 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 61.9 t -87.62 154.94 3.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 104.224 -2.51 . . . . 0.0 104.224 178.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 113.28 -48.2 0.96 Allowed Glycine 0 N--CA 1.485 1.948 0 N-CA-C 107.905 -2.078 . . . . 0.0 107.905 -178.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.451 ' HA ' ' H ' ' A' ' 201' ' ' LEU . 3.4 m-20 -83.91 167.42 17.0 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 113.731 -1.235 . . . . 0.0 113.785 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.423 ' CD2' HD21 ' A' ' 198' ' ' ASN . 19.3 mt -121.22 173.68 7.16 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 114.128 -1.396 . . . . 0.0 109.624 178.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 55.0 m -123.94 93.76 4.02 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 114.355 -1.293 . . . . 0.0 110.128 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.425 ' N ' ' CD1' ' A' ' 173' ' ' PHE . 20.1 p90 -126.6 167.92 15.01 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.862 -178.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -118.27 165.93 13.23 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 123.504 1.621 . . . . 0.0 114.338 177.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 52.2 tttm -39.02 154.37 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 110.534 -3.03 . . . . 0.0 117.081 175.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 159' ' ' ALA . . . 33.14 48.75 0.42 Allowed Glycine 0 N--CA 1.493 2.454 0 CA-C-N 112.095 -2.321 . . . . 0.0 111.02 177.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.406 ' O ' ' HA ' ' A' ' 158' ' ' ILE . 5.4 pt-20 -121.39 162.68 19.96 Favored 'General case' 0 N--CA 1.506 2.348 0 CA-C-N 111.722 -2.239 . . . . 0.0 108.372 176.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.537 HG12 HG23 ' A' ' 158' ' ' ILE . 44.7 mt -99.53 120.41 48.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 N-CA-C 118.69 2.848 . . . . 0.0 118.69 -176.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 21.4 mt -118.72 168.59 10.59 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 110.992 -2.822 . . . . 0.0 108.854 178.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -110.74 158.5 18.58 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 177.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.449 HG22 ' CD1' ' A' ' 157' ' ' TYR . 50.5 t -119.38 117.81 55.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 C-N-CA 119.65 -0.82 . . . . 0.0 112.975 -178.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.508 ' O ' ' HB ' ' A' ' 191' ' ' ILE . 3.4 mp -139.55 83.31 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.203 -1.35 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.292 -174.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . 0.471 ' O ' ' CE3' ' A' ' 190' ' ' TRP . 35.8 tt0 136.14 150.59 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.764 0 C-N-CA 127.931 2.493 . . . . 0.0 107.897 173.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -115.94 124.55 50.85 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 -176.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . 0.454 ' CG ' ' HE1' ' A' ' 190' ' ' TRP . 3.6 tttm -10.7 77.4 0.03 OUTLIER Pre-proline 0 N--CA 1.504 2.261 0 O-C-N 126.658 2.473 . . . . 0.0 116.912 177.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -69.39 -57.04 0.13 Allowed 'Trans proline' 0 C--N 1.307 -1.615 0 N-CA-C 105.306 -2.613 . . . . 0.0 105.306 175.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -122.44 17.38 10.53 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 111.406 -2.634 . . . . 0.0 113.176 -177.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 121.19 -25.7 6.96 Favored Glycine 0 N--CA 1.489 2.173 0 C-N-CA 118.359 -1.877 . . . . 0.0 110.596 -178.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 31.3 m-90 -114.84 153.42 30.47 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 122.826 1.298 . . . . 0.0 113.925 -176.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' TRP . . . . . 0.471 ' CE3' ' O ' ' A' ' 183' ' ' GLU . 16.7 m95 -115.9 168.58 9.93 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 100.266 -3.976 . . . . 0.0 100.266 -178.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.508 ' HB ' ' O ' ' A' ' 182' ' ' ILE . 2.1 mm -111.0 109.98 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 103.367 -2.827 . . . . 0.0 103.367 -179.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -106.26 179.99 4.11 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -172.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 199' ' ' GLU . 36.6 ttpt -139.97 163.24 33.2 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 118.748 -1.181 . . . . 0.0 109.549 177.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -121.19 -165.91 1.29 Allowed 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.885 178.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -106.15 40.44 1.59 Allowed 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.897 0.856 . . . . 0.0 109.603 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -118.53 -42.54 2.75 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 177.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 141.94 -48.27 0.8 Allowed Glycine 0 N--CA 1.482 1.718 0 N-CA-C 106.005 -2.838 . . . . 0.0 106.005 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . 0.423 HD21 ' CD2' ' A' ' 171' ' ' LEU . 0.8 OUTLIER -55.15 154.01 6.16 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 179.345 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . 0.437 ' HA ' ' HA ' ' A' ' 193' ' ' LYS . 0.0 OUTLIER -129.17 154.35 46.83 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 112.73 -2.032 . . . . 0.0 107.777 178.13 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -136.03 -161.04 9.04 Favored Glycine 0 N--CA 1.479 1.514 0 C-N-CA 120.009 -1.091 . . . . 0.0 113.161 -176.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . 0.451 ' H ' ' HA ' ' A' ' 170' ' ' ASP . 36.2 mt -118.67 94.08 4.34 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 110.497 -2.852 . . . . 0.0 105.727 179.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 5.3 m -112.81 150.54 42.95 Favored Pre-proline 0 N--CA 1.498 1.932 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 -177.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -75.3 175.35 11.38 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 C-N-CA 121.174 1.25 . . . . 0.0 109.761 -177.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.4 -40.63 8.19 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 103.562 -2.755 . . . . 0.0 103.562 178.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 76.7 p -28.87 -50.97 0.09 Allowed 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 113.3 -1.773 . . . . 0.0 114.602 175.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -113.62 39.12 2.73 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.569 0.7 . . . . 0.0 112.331 -178.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.91 98.56 5.57 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 104.937 -2.246 . . . . 0.0 104.937 178.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -106.62 148.33 36.62 Favored Pre-proline 0 C--N 1.299 -1.621 0 N-CA-C 104.039 -2.578 . . . . 0.0 104.039 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -53.57 165.81 1.52 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.489 2.126 . . . . 0.0 113.18 -177.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . 0.402 ' CE1' HD13 ' A' ' 178' ' ' ILE . 45.4 t80 . . . . . 0 C--N 1.305 -1.361 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.734 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.29 0 N-CA-C 114.681 0.632 . . . . 0.0 114.681 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -128.82 159.5 35.54 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 103.965 -2.606 . . . . 0.0 103.965 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -105.63 134.4 48.8 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 115.968 -2.293 . . . . 0.0 112.967 -177.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.445 ' CD1' HG21 ' A' ' 181' ' ' VAL . 7.1 m-85 -115.49 -178.41 3.38 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 101.397 -3.557 . . . . 0.0 101.397 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.11 152.72 33.68 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 N-CA-C 100.504 -3.887 . . . . 0.0 100.504 175.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -91.88 148.64 22.07 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 102.824 -3.028 . . . . 0.0 102.824 178.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 32.7 m -126.6 9.46 3.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 125.128 1.518 . . . . 0.0 108.773 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -130.03 161.83 23.03 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 104.989 -3.244 . . . . 0.0 104.989 176.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -109.3 97.54 7.12 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 118.95 -1.1 . . . . 0.0 109.107 178.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -104.3 155.1 19.04 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 118.361 -1.336 . . . . 0.0 107.628 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 88.3 m -123.21 165.24 17.24 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 103.862 -2.644 . . . . 0.0 103.862 179.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -91.63 145.25 24.74 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 117.653 -1.619 . . . . 0.0 108.452 179.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -113.7 -38.53 4.26 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -121.45 158.99 27.18 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 113.456 -1.702 . . . . 0.0 106.539 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 83.3 t -41.47 -57.68 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 125.099 1.499 . . . . 0.0 107.472 176.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -27.19 -56.22 0.1 OUTLIER Glycine 0 N--CA 1.486 2.025 0 CA-C-N 112.431 -2.168 . . . . 0.0 114.055 175.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -75.68 161.83 28.75 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -177.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.455 HD12 ' CA ' ' A' ' 200' ' ' GLY . 1.5 tp -116.88 -178.58 3.47 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 112.966 -1.925 . . . . 0.0 109.424 177.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 33.7 m -129.24 98.63 4.95 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 112.394 -2.185 . . . . 0.0 111.805 -178.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -122.17 167.44 13.18 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.785 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -121.53 144.11 48.9 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 116.732 2.123 . . . . 0.0 116.732 179.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -35.07 80.66 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 108.529 -3.941 . . . . 0.0 114.426 172.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 111.33 50.16 0.63 Allowed Glycine 0 N--CA 1.49 2.293 0 CA-C-N 114.726 -1.125 . . . . 0.0 112.125 178.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -126.91 -172.66 2.69 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 177.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 14.4 mm -109.26 137.54 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 123.992 0.807 . . . . 0.0 111.139 177.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 54.2 mt -128.92 169.12 15.01 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 113.588 -1.642 . . . . 0.0 110.008 178.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.481 ' HB2' ' HB2' ' A' ' 193' ' ' LYS . 6.9 mt -121.74 157.82 30.14 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 174.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.445 HG21 ' CD1' ' A' ' 157' ' ' TYR . 92.6 t -119.14 117.48 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 116.714 2.116 . . . . 0.0 116.714 -178.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.43 ' O ' ' CB ' ' A' ' 183' ' ' GLU . 1.7 mm -123.63 70.79 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 105.472 -2.048 . . . . 0.0 105.472 178.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . 0.43 ' CB ' ' O ' ' A' ' 182' ' ' ILE . 10.8 tp10 125.35 141.53 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.296 0 C-N-CA 128.853 2.861 . . . . 0.0 109.756 177.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . 0.43 ' N ' ' HG3' ' A' ' 183' ' ' GLU . 96.2 mttt -120.14 113.54 20.61 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 177.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . 0.52 ' HB2' ' CA ' ' A' ' 188' ' ' GLY . 0.0 OUTLIER -14.37 75.75 0.02 OUTLIER Pre-proline 0 N--CA 1.495 1.781 0 N-CA-C 121.383 3.846 . . . . 0.0 121.383 -171.503 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -43.65 -58.81 1.25 Allowed 'Trans proline' 0 C--N 1.314 -1.289 0 C-N-CA 123.647 2.898 . . . . 0.0 106.221 171.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -124.98 23.17 7.87 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 111.761 -2.472 . . . . 0.0 111.645 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.52 ' CA ' ' HB2' ' A' ' 185' ' ' LYS . . . 113.53 2.16 24.39 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 3.9 m-90 -126.33 119.74 28.11 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 119.621 3.193 . . . . 0.0 119.621 -176.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' TRP . . . . . 0.502 ' NE1' ' HD3' ' A' ' 185' ' ' LYS . 5.7 m0 -103.21 150.61 23.53 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 104.084 -2.562 . . . . 0.0 104.084 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 8.0 mm -113.76 102.19 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 100.341 -3.948 . . . . 0.0 100.341 177.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -106.06 169.4 8.52 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 118.174 -1.411 . . . . 0.0 112.614 -171.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . 0.481 ' HB2' ' HB2' ' A' ' 180' ' ' LEU . 93.7 mttt -117.86 161.93 18.94 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 104.117 -2.549 . . . . 0.0 104.117 176.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -126.35 -162.63 1.15 Allowed 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 118.557 -1.257 . . . . 0.0 110.474 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -98.96 40.85 1.17 Allowed 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.692 -0.803 . . . . 0.0 109.773 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -128.56 -40.75 1.56 Allowed 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 176.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 140.28 -47.39 0.88 Allowed Glycine 0 N--CA 1.487 2.099 0 N-CA-C 107.348 -2.301 . . . . 0.0 107.348 178.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -57.26 161.31 3.34 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 114.965 1.468 . . . . 0.0 114.965 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . 0.406 ' HG3' ' N ' ' A' ' 200' ' ' GLY . 0.0 OUTLIER -130.55 151.42 51.04 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 113.598 -1.637 . . . . 0.0 108.464 176.772 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . 0.455 ' CA ' HD12 ' A' ' 171' ' ' LEU . . . -139.64 -157.05 7.14 Favored Glycine 0 N--CA 1.484 1.877 0 C-N-CA 119.333 -1.413 . . . . 0.0 113.399 -178.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 42.4 mt -112.34 96.15 5.85 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 111.133 -2.533 . . . . 0.0 108.708 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 3.7 m -112.26 154.46 44.41 Favored Pre-proline 0 N--CA 1.49 1.525 0 N-CA-C 105.777 -1.934 . . . . 0.0 105.777 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 0.4 OUTLIER -88.4 -178.24 2.01 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 C-N-CA 123.721 2.947 . . . . 0.0 112.346 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . 0.518 ' HB2' ' CD ' ' A' ' 185' ' ' LYS . 24.8 ttt85 -74.29 -59.65 2.63 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 173.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 69.5 p -18.37 -48.55 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.134 0 CA-C-N 109.876 -3.329 . . . . 0.0 117.187 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -110.45 38.32 2.49 Favored 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 119.192 -1.003 . . . . 0.0 112.243 -178.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -123.53 104.98 9.38 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 124.238 0.961 . . . . 0.0 111.427 -178.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -112.61 155.04 44.46 Favored Pre-proline 0 N--CA 1.496 1.853 0 C-N-CA 117.891 -1.524 . . . . 0.0 107.021 175.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -64.19 164.21 23.43 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 121.809 1.672 . . . . 0.0 111.963 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 21.2 t80 . . . . . 0 N--CA 1.492 1.658 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.594 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.113 0 N-CA-C 113.616 0.207 . . . . 0.0 113.616 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -130.79 170.98 13.64 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.438 ' CD ' ' H ' ' A' ' 156' ' ' GLU . 0.0 OUTLIER -110.79 123.83 50.84 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 116.972 -1.891 . . . . 0.0 112.969 -178.001 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.44 ' CD1' HG23 ' A' ' 181' ' ' VAL . 5.9 m-85 -119.18 178.11 4.64 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 102.649 -3.093 . . . . 0.0 102.649 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 2.9 pt -128.28 145.48 35.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 102.409 -3.182 . . . . 0.0 102.409 172.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -92.26 151.55 20.27 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 115.011 -2.676 . . . . 0.0 103.876 177.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 28.0 m -127.67 32.81 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 125.838 1.961 . . . . 0.0 108.23 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -129.96 158.03 22.14 Favored Glycine 0 N--CA 1.483 1.824 0 N-CA-C 105.762 -2.935 . . . . 0.0 105.762 173.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -106.06 76.14 1.15 Allowed 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -102.21 148.53 25.32 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 118.463 -1.295 . . . . 0.0 108.428 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 87.5 m -120.21 161.49 20.98 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 104.461 -2.422 . . . . 0.0 104.461 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -93.17 135.77 34.05 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 105.744 -1.946 . . . . 0.0 105.744 178.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -110.65 -31.34 7.25 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 -115.71 -178.88 3.49 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 105.091 -2.189 . . . . 0.0 105.091 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 61.8 t -89.94 152.47 3.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 103.317 -2.846 . . . . 0.0 103.317 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 114.54 -47.86 1.0 Allowed Glycine 0 N--CA 1.486 2.02 0 N-CA-C 108.503 -1.839 . . . . 0.0 108.503 -177.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -82.2 168.7 17.4 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 113.964 -1.118 . . . . 0.0 112.622 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 41.8 mt -127.66 178.7 5.95 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.842 176.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 57.3 m -122.13 102.57 8.22 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 114.453 -1.248 . . . . 0.0 113.316 -178.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -118.92 167.96 11.23 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.315 -0.954 . . . . 0.0 111.522 177.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -114.99 62.21 0.68 Allowed 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 121.019 3.711 . . . . 0.0 121.019 -175.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 15.6 tptm 41.02 74.12 0.11 Allowed 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 117.102 2.26 . . . . 0.0 117.102 174.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 116.53 50.99 0.4 Allowed Glycine 0 N--CA 1.495 2.609 0 CA-C-N 114.412 -1.267 . . . . 0.0 113.822 173.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.474 ' CD ' ' N ' ' A' ' 177' ' ' GLU . 0.2 OUTLIER -139.92 163.45 32.63 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 177.837 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.494 ' N ' ' CD1' ' A' ' 178' ' ' ILE . 1.0 OUTLIER -87.99 134.01 29.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 116.361 1.986 . . . . 0.0 116.361 -176.376 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.5 mp -131.42 175.62 8.98 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 112.671 -2.059 . . . . 0.0 108.076 174.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.413 HD11 ' H ' ' A' ' 181' ' ' VAL . 0.5 OUTLIER -112.92 156.18 23.44 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 102.713 -3.069 . . . . 0.0 102.713 -179.449 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.44 HG23 ' CD1' ' A' ' 157' ' ' TYR . 2.8 t -127.15 135.74 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 CA-C-N 120.924 1.693 . . . . 0.0 109.906 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.446 ' O ' ' CB ' ' A' ' 183' ' ' GLU . 4.3 mt -143.49 84.13 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -174.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . 0.446 ' CB ' ' O ' ' A' ' 182' ' ' ILE . 34.2 tt0 142.32 154.13 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.54 0 C-N-CA 126.446 1.898 . . . . 0.0 108.594 176.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -121.34 116.95 25.77 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 115.256 1.576 . . . . 0.0 115.256 -178.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . 0.431 ' CG ' ' HE1' ' A' ' 190' ' ' TRP . 9.3 tttm -7.27 81.18 0.03 OUTLIER Pre-proline 0 N--CA 1.5 2.071 0 CA-C-N 111.757 -2.474 . . . . 0.0 117.378 175.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . 0.418 ' HD2' ' H ' ' A' ' 189' ' ' TRP . 97.1 Cg_endo -78.66 -52.83 0.06 OUTLIER 'Trans proline' 0 C--N 1.302 -1.877 0 C-N-CA 122.797 2.331 . . . . 0.0 106.805 175.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -126.79 14.07 7.45 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.244 -1.343 . . . . 0.0 109.085 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 118.18 7.49 11.26 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . 0.418 ' H ' ' HD2' ' A' ' 186' ' ' PRO . 1.4 m-90 -122.54 142.13 50.94 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 119.767 3.247 . . . . 0.0 119.767 -179.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' TRP . . . . . 0.493 ' NE1' ' HB2' ' A' ' 204' ' ' ARG . 22.7 m95 -124.7 157.7 34.99 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 100.412 -3.921 . . . . 0.0 100.412 177.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.411 ' HB ' ' O ' ' A' ' 182' ' ' ILE . 31.2 mm -97.99 171.06 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.866 1 N-CA-C 99.845 -4.131 . . . . 0.0 99.845 176.671 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 199' ' ' GLU . . . -152.95 176.17 12.14 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 116.683 -2.007 . . . . 0.0 109.893 177.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -134.02 159.58 40.36 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 170.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 58.4 p30 -120.12 -162.78 0.95 Allowed 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 118.594 -1.242 . . . . 0.0 111.426 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -99.54 39.44 1.31 Allowed 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.086 -1.046 . . . . 0.0 109.692 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -121.38 -39.35 2.68 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 176.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 126.98 -1.79 7.29 Favored Glycine 0 N--CA 1.492 2.402 0 CA-C-N 114.803 -1.09 . . . . 0.0 111.224 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 26.3 p30 -100.7 176.68 5.23 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 192' ' ' ALA . 1.5 pt-20 -113.28 166.57 11.34 Favored 'General case' 0 N--CA 1.484 1.27 0 O-C-N 125.859 1.974 . . . . 0.0 109.332 -179.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -144.58 -178.46 20.25 Favored Glycine 0 N--CA 1.481 1.698 0 CA-C-O 122.389 0.994 . . . . 0.0 113.428 -175.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 15.4 mt -125.26 89.18 3.01 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 177.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 3.9 m -111.7 157.16 40.18 Favored Pre-proline 0 N--CA 1.487 1.409 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 -175.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -90.08 179.57 1.98 Allowed 'Trans proline' 0 C--N 1.3 -2.014 0 C-N-CA 122.103 1.869 . . . . 0.0 109.405 178.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . 0.493 ' HB2' ' NE1' ' A' ' 190' ' ' TRP . 10.8 tpt180 -97.54 -43.23 7.33 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 176.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' THR . . . . . 0.458 ' HG1' ' H ' ' A' ' 206' ' ' TYR . 43.0 p -25.56 -51.31 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 126.231 2.207 . . . . 0.0 114.731 177.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . 0.458 ' H ' ' HG1' ' A' ' 205' ' ' THR . 85.7 m-85 -113.88 50.43 0.92 Allowed 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 119.778 -0.769 . . . . 0.0 111.781 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -133.5 135.95 44.77 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 177.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -125.39 154.67 72.32 Favored Pre-proline 0 N--CA 1.489 1.516 0 N-CA-C 105.785 -1.932 . . . . 0.0 105.785 176.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -67.2 165.97 24.83 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 N-CA-C 108.617 -1.34 . . . . 0.0 108.617 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . 0.417 ' CE1' HD13 ' A' ' 178' ' ' ILE . 34.5 t80 . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.496 0 N-CA-C 116.102 1.201 . . . . 0.0 116.102 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.424 ' CD ' ' N ' ' A' ' 155' ' ' GLU . 1.4 pm0 -131.36 169.86 15.43 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 106.02 -1.845 . . . . 0.0 106.02 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -121.78 142.16 50.49 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 117.502 -1.679 . . . . 0.0 114.937 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -128.93 -178.91 4.82 Favored 'General case' 0 C--N 1.301 -1.516 1 N-CA-C 99.664 -4.199 . . . . 0.0 99.664 177.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 4.2 pt -130.54 152.87 38.18 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 101.647 -3.464 . . . . 0.0 101.647 170.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -91.5 156.2 17.86 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 104.325 -2.472 . . . . 0.0 104.325 179.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 20.3 m -125.33 8.61 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 126.045 2.091 . . . . 0.0 107.916 176.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -132.97 168.7 22.83 Favored Glycine 0 N--CA 1.483 1.83 0 N-CA-C 105.746 -2.942 . . . . 0.0 105.746 175.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -107.06 146.6 31.0 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 177.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -124.8 160.53 28.5 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 104.805 -2.295 . . . . 0.0 104.805 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 96.4 m -129.45 151.48 50.03 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 118.864 -1.134 . . . . 0.0 108.333 178.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -98.51 138.67 35.39 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 118.296 -1.362 . . . . 0.0 108.01 178.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -114.42 -32.58 5.88 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 113.213 -1.812 . . . . 0.0 106.708 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -112.9 179.85 3.85 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 114.144 -1.389 . . . . 0.0 107.86 -179.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 16.3 t -95.45 47.21 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -128.76 -53.53 0.11 Allowed Glycine 0 N--CA 1.485 1.944 0 N-CA-C 108.331 -1.907 . . . . 0.0 108.331 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -76.48 163.47 26.9 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 113.542 -1.329 . . . . 0.0 113.788 -178.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.429 HD13 ' HA3' ' A' ' 200' ' ' GLY . 1.1 tp -108.51 -171.61 1.89 Allowed 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 111.954 -2.384 . . . . 0.0 109.078 175.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 53.6 m -120.88 -69.24 0.85 Allowed 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 113.736 -1.575 . . . . 0.0 114.335 -177.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 54.2 p90 37.52 164.33 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.527 0 N-CA-C 117.12 2.267 . . . . 0.0 117.12 -174.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -130.16 151.83 50.26 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 118.391 2.737 . . . . 0.0 118.391 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -21.28 80.41 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.568 1 CA-C-N 108.342 -4.026 . . . . 0.0 118.057 171.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 110.04 47.99 0.8 Allowed Glycine 0 N--CA 1.493 2.473 0 CA-C-N 114.728 -1.124 . . . . 0.0 112.878 174.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -135.84 154.91 51.03 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 117.309 -1.757 . . . . 0.0 108.045 177.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.479 ' N ' ' CD1' ' A' ' 178' ' ' ILE . 1.1 mp -80.6 130.94 35.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -178.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 27.7 mt -120.15 162.59 19.07 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 113.129 -1.851 . . . . 0.0 108.222 176.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.441 HD11 ' N ' ' A' ' 181' ' ' VAL . 1.6 tm? -116.06 151.38 35.65 Favored 'General case' 0 N--CA 1.498 1.93 1 N-CA-C 100.105 -4.035 . . . . 0.0 100.105 179.345 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.441 ' N ' HD11 ' A' ' 180' ' ' LEU . 2.4 t -121.05 139.12 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 CA-C-N 122.041 2.2 . . . . 0.0 111.074 -179.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.416 ' O ' ' CB ' ' A' ' 183' ' ' GLU . 42.9 mt -145.0 87.09 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-O 121.105 0.479 . . . . 0.0 111.004 -176.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . 0.485 ' O ' ' CE3' ' A' ' 190' ' ' TRP . 0.0 OUTLIER 135.96 148.7 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.586 0 C-N-CA 128.359 2.664 . . . . 0.0 107.084 172.59 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -106.24 117.45 34.06 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 118.276 2.695 . . . . 0.0 118.276 -172.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . 0.493 ' CG ' ' HE1' ' A' ' 190' ' ' TRP . 0.8 OUTLIER -11.97 81.38 0.03 OUTLIER Pre-proline 0 N--CA 1.507 2.389 0 N-CA-C 118.124 2.639 . . . . 0.0 118.124 175.24 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -73.06 -56.23 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 123.549 2.833 . . . . 0.0 105.684 175.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 21.3 p-10 -120.97 16.34 11.69 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 112.08 -2.327 . . . . 0.0 113.877 -177.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.418 ' CA ' ' HG2' ' A' ' 185' ' ' LYS . . . 118.09 -15.81 12.1 Favored Glycine 0 N--CA 1.493 2.465 0 C-N-CA 118.712 -1.709 . . . . 0.0 109.002 -178.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 13.5 m-90 -116.61 149.39 39.77 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 116.761 2.134 . . . . 0.0 116.761 -176.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' TRP . . . . . 0.493 ' HE1' ' CG ' ' A' ' 185' ' ' LYS . 20.0 m95 -122.88 169.15 11.41 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 102.396 -3.187 . . . . 0.0 102.396 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.408 ' HB ' ' O ' ' A' ' 182' ' ' ILE . 2.5 mp -113.95 103.58 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 104.652 -2.351 . . . . 0.0 104.652 175.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -94.34 178.35 5.65 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -173.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -124.91 158.58 33.2 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 103.273 -2.862 . . . . 0.0 103.273 175.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 51.6 p-10 -124.69 -167.1 1.61 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.279 -0.968 . . . . 0.0 111.148 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -99.09 43.14 1.07 Allowed 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 122.123 0.963 . . . . 0.0 108.47 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 4.8 tmtm? -126.05 -45.11 1.73 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 104.204 -2.517 . . . . 0.0 104.204 177.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 137.91 -40.17 1.51 Allowed Glycine 0 N--CA 1.485 1.925 0 N-CA-C 108.109 -1.996 . . . . 0.0 108.109 -178.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -69.98 164.15 24.53 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 118.795 -1.162 . . . . 0.0 113.626 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.36 157.68 46.06 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 112.9 -1.955 . . . . 0.0 109.238 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . 0.429 ' HA3' HD13 ' A' ' 171' ' ' LEU . . . 179.58 -173.76 45.54 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 118.248 -1.929 . . . . 0.0 112.418 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 59.2 mt -71.63 96.25 1.54 Allowed 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -176.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 3.2 m -119.54 153.96 54.27 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 103.641 -2.726 . . . . 0.0 103.641 177.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -87.12 174.72 5.2 Favored 'Trans proline' 0 C--N 1.301 -1.945 0 C-N-CA 121.804 1.669 . . . . 0.0 109.197 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 28.9 ttt180 -106.16 -22.81 12.76 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 177.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 53.9 p -34.37 -50.18 0.41 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 113.91 -1.495 . . . . 0.0 114.368 173.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -105.38 34.3 3.31 Favored 'General case' 0 N--CA 1.503 2.198 0 C-N-CA 118.354 -1.338 . . . . 0.0 111.681 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 3.2 mp -119.42 118.78 32.05 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 124.817 1.323 . . . . 0.0 110.65 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . 0.412 ' CD ' ' N ' ' A' ' 208' ' ' GLU . 43.6 mp0 -115.57 150.74 45.21 Favored Pre-proline 0 C--N 1.297 -1.712 0 N-CA-C 105.982 -1.858 . . . . 0.0 105.982 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -55.16 164.43 3.68 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.292 1.995 . . . . 0.0 113.308 -177.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 43.3 t80 . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 179.13 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.061 0 CA-C-O 121.18 0.322 . . . . 0.0 113.549 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -128.9 165.18 21.54 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 104.053 -2.573 . . . . 0.0 104.053 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -107.76 135.59 48.92 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 116.92 -1.912 . . . . 0.0 111.081 -178.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -132.6 176.24 8.62 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 109.503 -3.499 . . . . 0.0 105.285 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.433 HG22 ' CD1' ' A' ' 210' ' ' TYR . 0.4 OUTLIER -126.31 143.05 41.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 1 N-CA-C 99.572 -4.232 . . . . 0.0 99.572 172.273 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -93.1 151.96 19.55 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 115.983 -2.287 . . . . 0.0 105.311 178.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 35.6 m -127.81 24.3 2.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 125.39 1.681 . . . . 0.0 109.054 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -123.55 153.6 17.26 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 106.697 -2.561 . . . . 0.0 106.697 177.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -105.66 82.53 1.81 Allowed 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 120.069 -0.652 . . . . 0.0 109.834 -179.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -108.68 151.88 25.57 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 118.879 -1.129 . . . . 0.0 108.54 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 53.7 m -122.07 159.86 26.21 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -89.15 133.25 34.47 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 178.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -109.83 -29.23 8.39 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 26.8 pt20 -117.64 -176.31 3.0 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 178.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 9.9 p -91.3 157.02 2.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 177.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 111.44 -50.44 0.77 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 -178.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -79.38 169.65 17.76 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 113.806 -1.197 . . . . 0.0 112.116 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 66.4 mt -126.02 178.22 5.89 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 114.223 -1.353 . . . . 0.0 109.744 177.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 53.5 m -120.48 99.28 6.47 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 114.484 -1.235 . . . . 0.0 112.179 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -115.65 165.87 12.56 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 118.82 -1.152 . . . . 0.0 110.172 177.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? -121.13 57.37 1.0 Allowed 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 121.22 3.785 . . . . 0.0 121.22 -174.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 70.9 tttt 46.67 76.78 0.09 Allowed 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 116.554 2.057 . . . . 0.0 116.554 174.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 117.28 52.27 0.34 Allowed Glycine 0 N--CA 1.495 2.632 0 CA-C-N 114.15 -1.386 . . . . 0.0 111.743 175.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.451 ' CD ' ' N ' ' A' ' 177' ' ' GLU . 2.8 pm0 -131.88 -179.12 5.21 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 178.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 7.0 mm -112.58 120.06 61.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 124.513 1.133 . . . . 0.0 113.885 -175.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -123.72 170.3 10.64 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 16.6 tp -111.12 156.24 21.65 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 100.586 -3.857 . . . . 0.0 100.586 175.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.481 ' CG1' ' HB3' ' A' ' 190' ' ' TRP . 2.4 t -126.66 140.33 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 CA-C-N 120.42 1.463 . . . . 0.0 109.243 -178.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.44 ' O ' ' CB ' ' A' ' 183' ' ' GLU . 21.3 mt -143.57 78.07 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 120.251 -0.579 . . . . 0.0 110.779 -174.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . 0.52 ' O ' ' CE3' ' A' ' 190' ' ' TRP . 31.4 tt0 139.85 150.02 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.708 0 C-N-CA 127.005 2.122 . . . . 0.0 108.576 177.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -114.15 100.87 8.7 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -176.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -11.52 77.09 0.02 OUTLIER Pre-proline 0 N--CA 1.496 1.854 0 N-CA-C 121.656 3.947 . . . . 0.0 121.656 -177.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . 0.402 ' HD2' ' O ' ' A' ' 189' ' ' TRP . 11.4 Cg_endo -46.26 -59.95 1.03 Allowed 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 123.341 2.694 . . . . 0.0 106.932 171.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -121.81 21.85 10.61 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 111.922 -2.399 . . . . 0.0 110.431 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 114.21 11.29 12.32 Favored Glycine 0 N--CA 1.488 2.162 0 C-N-CA 119.629 -1.272 . . . . 0.0 110.986 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . 0.441 ' CD1' ' HB3' ' A' ' 201' ' ' LEU . 2.1 m-90 -125.02 136.55 53.82 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 121.433 3.864 . . . . 0.0 121.433 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' TRP . . . . . 0.52 ' CE3' ' O ' ' A' ' 183' ' ' GLU . 32.4 m95 -119.4 154.66 33.3 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 101.519 -3.511 . . . . 0.0 101.519 178.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.429 ' HB ' ' O ' ' A' ' 182' ' ' ILE . 1.7 mp -109.23 114.11 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 104.234 -2.506 . . . . 0.0 104.234 176.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -107.6 177.55 4.8 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 118.859 -1.136 . . . . 0.0 113.898 -170.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -134.24 160.58 37.42 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 174.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 47.4 p-10 -117.67 -160.51 0.78 Allowed 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 118.456 -1.298 . . . . 0.0 110.406 177.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -101.32 42.26 1.14 Allowed 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 122.398 1.094 . . . . 0.0 108.586 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 5.4 tmtm? -127.01 -44.16 1.63 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 177.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 135.78 -41.08 1.46 Allowed Glycine 0 N--CA 1.485 1.936 0 N-CA-C 108.455 -1.858 . . . . 0.0 108.455 -178.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -53.58 163.38 0.66 Allowed 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 116.037 1.866 . . . . 0.0 116.037 -178.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -103.52 157.08 17.29 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 110.835 -2.893 . . . . 0.0 115.422 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -134.61 -179.56 16.6 Favored Glycine 0 N--CA 1.483 1.827 0 CA-C-N 112.671 -2.059 . . . . 0.0 113.978 -175.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . 0.441 ' HB3' ' CD1' ' A' ' 189' ' ' TRP . 32.0 mt -131.97 89.38 2.67 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 111.698 -2.251 . . . . 0.0 105.43 177.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . 0.251 2.3 t -97.13 148.53 34.54 Favored Pre-proline 0 C--N 1.305 -1.343 0 CA-C-N 114.269 -1.332 . . . . 0.0 113.928 -174.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -92.43 155.21 3.03 Favored 'Trans proline' 0 C--N 1.299 -2.032 0 N-CA-C 107.67 -1.704 . . . . 0.0 107.67 172.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . 0.474 ' HB2' ' CE2' ' A' ' 190' ' ' TRP . 8.6 tpt180 -74.59 -51.99 13.04 Favored 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 176.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 65.3 p -22.07 -45.85 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 127.528 3.017 . . . . 0.0 114.912 178.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -112.61 50.0 0.9 Allowed 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.468 -0.893 . . . . 0.0 113.199 -178.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 97.7 mt -131.05 155.96 46.0 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 176.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -130.26 142.19 44.56 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 103.916 -2.624 . . . . 0.0 103.916 174.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -66.32 155.44 69.92 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 N-CA-C 107.271 -1.857 . . . . 0.0 107.271 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . 0.433 ' CD1' HG22 ' A' ' 158' ' ' ILE . 9.7 t80 . . . . . 0 N--CA 1.49 1.564 0 C-N-CA 118.559 -1.256 . . . . 0.0 110.002 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.993 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -121.42 159.15 26.79 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 101.504 -3.517 . . . . 0.0 101.504 178.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -100.64 129.62 46.58 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 116.035 -2.266 . . . . 0.0 111.35 -177.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.527 ' CD1' HG22 ' A' ' 181' ' ' VAL . 4.9 m-85 -118.9 172.17 7.72 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 101.4 -3.556 . . . . 0.0 101.4 177.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.7 pt -126.97 142.53 43.18 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 N-CA-C 103.44 -2.8 . . . . 0.0 103.44 174.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 176' ' ' GLY . . . -80.13 155.3 27.54 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 104.19 -2.522 . . . . 0.0 104.19 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.1 m -131.18 8.73 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 126.764 2.54 . . . . 0.0 108.447 178.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -127.68 159.1 21.5 Favored Glycine 0 N--CA 1.486 1.99 0 N-CA-C 106.018 -2.833 . . . . 0.0 106.018 176.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -108.54 97.34 7.02 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.253 -0.979 . . . . 0.0 113.083 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.423 ' HB3' ' CZ ' ' A' ' 173' ' ' PHE . 58.4 t80 -111.02 151.88 27.48 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 55.4 m -122.43 157.4 32.0 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.31 105.88 15.49 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 178.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -98.61 -17.43 18.64 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 -178.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -120.72 168.19 11.68 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 102.57 -3.122 . . . . 0.0 102.57 177.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 48.7 t -91.39 156.01 3.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 109.56 -41.12 2.32 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 107.502 -2.239 . . . . 0.0 107.502 -178.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.413 ' HA ' ' H ' ' A' ' 201' ' ' LEU . 11.2 m-20 -80.22 167.97 19.65 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 111.532 -2.334 . . . . 0.0 111.637 -179.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 24.5 mt -118.95 175.93 5.53 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.996 177.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 45.2 m -117.57 96.31 5.33 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 114.58 -1.191 . . . . 0.0 109.479 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.423 ' CZ ' ' HB3' ' A' ' 163' ' ' PHE . 8.9 p90 -119.24 164.43 15.64 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 114.488 -1.233 . . . . 0.0 111.63 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 6.6 ptpp? -128.71 160.44 32.5 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 116.384 1.994 . . . . 0.0 116.384 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 42.9 tttm -41.91 76.91 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.766 1 CA-C-N 107.609 -4.36 . . . . 0.0 115.533 173.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 159' ' ' ALA . . . 112.67 50.44 0.56 Allowed Glycine 0 N--CA 1.491 2.306 0 CA-C-N 114.097 -1.411 . . . . 0.0 112.55 176.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -131.4 168.93 16.75 Favored 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 176.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 1.5 mt -112.98 125.89 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 116.545 2.054 . . . . 0.0 116.545 -175.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 17.9 mt -118.41 176.02 5.44 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 112.339 -2.21 . . . . 0.0 110.756 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 33.5 mt -114.61 159.87 19.95 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 174.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.527 HG22 ' CD1' ' A' ' 157' ' ' TYR . 46.2 t -121.6 124.74 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -176.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.46 ' O ' ' CB ' ' A' ' 183' ' ' GLU . 11.7 mt -141.57 77.24 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.972 -174.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . 0.546 ' O ' ' CE3' ' A' ' 190' ' ' TRP . 44.6 tt0 138.15 149.58 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.037 0 C-N-CA 127.177 2.191 . . . . 0.0 108.402 176.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -116.62 100.94 8.17 Favored 'General case' 0 N--CA 1.508 2.436 0 N-CA-C 115.972 1.842 . . . . 0.0 115.972 -175.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . 0.473 ' CG ' ' HE1' ' A' ' 190' ' ' TRP . 21.6 pttp -13.65 78.15 0.02 OUTLIER Pre-proline 0 N--CA 1.5 2.045 1 N-CA-C 122.075 4.102 . . . . 0.0 122.075 -177.79 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . 0.42 ' HD2' ' O ' ' A' ' 189' ' ' TRP . 13.4 Cg_endo -47.68 -59.85 1.1 Allowed 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 123.061 2.508 . . . . 0.0 106.582 171.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -123.6 22.4 9.11 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 112.331 -2.213 . . . . 0.0 110.229 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 113.74 17.68 7.34 Favored Glycine 0 N--CA 1.491 2.354 0 C-N-CA 120.473 -0.87 . . . . 0.0 111.046 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . 0.453 ' N ' ' HA ' ' A' ' 185' ' ' LYS . 1.4 m-90 -125.62 126.05 44.11 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 121.395 3.85 . . . . 0.0 121.395 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' TRP . . . . . 0.546 ' CE3' ' O ' ' A' ' 183' ' ' GLU . 16.3 m95 -118.44 159.86 22.74 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 102.072 -3.307 . . . . 0.0 102.072 176.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.451 ' HB ' ' O ' ' A' ' 182' ' ' ILE . 79.3 mt -114.72 113.67 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 104.372 -2.455 . . . . 0.0 104.372 176.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -108.41 178.5 4.47 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 119.453 -0.899 . . . . 0.0 112.658 -172.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -137.21 169.1 18.35 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 173.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 43.5 p-10 -121.71 -164.79 1.18 Allowed 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.144 -1.022 . . . . 0.0 109.958 177.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -100.2 39.85 1.31 Allowed 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.928 0.871 . . . . 0.0 108.691 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -126.76 -37.13 2.16 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 113.609 -1.632 . . . . 0.0 107.282 177.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 134.96 -37.4 1.94 Allowed Glycine 0 N--CA 1.487 2.05 0 N-CA-C 110.074 -1.211 . . . . 0.0 110.074 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 22.4 p30 -63.94 164.74 9.86 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 118.591 -1.244 . . . . 0.0 114.167 -178.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.8 157.91 36.31 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 111.858 -2.428 . . . . 0.0 109.492 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -136.36 -175.23 13.7 Favored Glycine 0 N--CA 1.48 1.572 0 CA-C-O 122.319 0.955 . . . . 0.0 111.634 -178.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . 0.413 ' H ' ' HA ' ' A' ' 170' ' ' ASP . 13.8 mt -122.04 82.5 1.97 Allowed 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 111.419 -2.391 . . . . 0.0 105.202 177.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 4.5 m -115.57 154.97 47.87 Favored Pre-proline 0 N--CA 1.495 1.806 0 C-N-CA 119.579 -0.848 . . . . 0.0 109.415 -175.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -81.74 179.97 5.29 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 123.121 2.547 . . . . 0.0 112.156 -178.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . 0.544 ' HB2' ' CE2' ' A' ' 190' ' ' TRP . 17.5 ttp85 -91.24 -49.19 6.5 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 103.762 -2.681 . . . . 0.0 103.762 176.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 68.2 p -19.3 -48.53 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 127.146 2.779 . . . . 0.0 117.026 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -108.51 42.57 1.37 Allowed 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 119.063 -1.055 . . . . 0.0 112.614 -177.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 84.9 mt -129.68 158.42 39.41 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 115.063 -0.972 . . . . 0.0 109.007 177.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -132.82 152.44 79.86 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 104.553 -2.388 . . . . 0.0 104.553 170.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -68.66 165.79 28.23 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 N-CA-C 108.064 -1.552 . . . . 0.0 108.064 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 32.2 t80 . . . . . 0 C--N 1.301 -1.542 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 179.489 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.051 0 CA-C-O 120.974 0.208 . . . . 0.0 112.852 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -135.15 -179.98 5.96 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.329 -1.359 . . . . 0.0 107.329 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -109.93 126.52 53.97 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 114.839 1.422 . . . . 0.0 114.839 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.435 ' CD1' HG21 ' A' ' 181' ' ' VAL . 44.8 m-85 -121.88 177.94 5.08 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 101.183 -3.636 . . . . 0.0 101.183 175.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.408 ' HA ' ' HA ' ' A' ' 178' ' ' ILE . 2.9 pt -123.72 153.32 29.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 100.79 -3.781 . . . . 0.0 100.79 170.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -91.83 153.18 19.73 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 100.768 -3.789 . . . . 0.0 100.768 177.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 31.2 m -125.07 17.36 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 125.908 2.005 . . . . 0.0 108.021 176.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -138.53 164.51 25.67 Favored Glycine 0 N--CA 1.483 1.806 0 N-CA-C 105.628 -2.989 . . . . 0.0 105.628 175.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -106.02 144.5 32.65 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 104.837 -2.283 . . . . 0.0 104.837 177.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -124.69 172.64 9.12 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 77.8 m -130.17 152.55 49.49 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.623 -0.831 . . . . 0.0 109.577 178.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -107.89 122.41 46.73 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 177.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -110.24 -19.51 12.98 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.127 -1.397 . . . . 0.0 108.121 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -123.35 176.7 5.99 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 114.057 -1.429 . . . . 0.0 108.339 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 15.2 t -95.53 49.93 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -131.81 -46.93 0.12 Allowed Glycine 0 N--CA 1.485 1.915 0 CA-C-N 113.282 -1.781 . . . . 0.0 108.788 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -87.62 169.2 12.36 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 112.503 -1.849 . . . . 0.0 114.385 -178.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 39.2 mt -117.97 -176.83 3.13 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 112.547 -2.115 . . . . 0.0 105.806 176.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 73.4 m -108.95 -59.4 1.89 Allowed 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.158 -179.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 43.1 p90 37.42 164.43 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.25 0 N-CA-C 117.617 2.451 . . . . 0.0 117.617 -175.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -124.52 143.62 50.57 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 120.173 3.397 . . . . 0.0 120.173 -178.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -26.75 81.29 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.589 1 CA-C-N 107.847 -4.251 . . . . 0.0 115.868 169.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 112.18 46.98 0.73 Allowed Glycine 0 N--CA 1.492 2.427 0 CA-C-N 114.617 -1.174 . . . . 0.0 113.392 176.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -140.75 152.98 45.69 Favored 'General case' 0 N--CA 1.503 2.205 0 C-N-CA 117.092 -1.843 . . . . 0.0 109.485 176.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.45 ' N ' ' CD1' ' A' ' 178' ' ' ILE . 1.3 mp -74.9 131.53 34.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -178.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 44.0 mt -122.66 168.35 12.3 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 112.339 -2.21 . . . . 0.0 107.044 176.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.05 148.02 36.03 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 101.796 -3.409 . . . . 0.0 101.796 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.435 HG21 ' CD1' ' A' ' 157' ' ' TYR . 2.7 t -124.01 138.51 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 CA-C-N 121.458 1.935 . . . . 0.0 111.467 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.455 ' O ' ' CB ' ' A' ' 183' ' ' GLU . 0.5 OUTLIER -146.52 81.28 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 O-C-N 123.169 0.293 . . . . 0.0 110.619 -173.371 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . 0.532 ' O ' ' CE3' ' A' ' 190' ' ' TRP . 34.9 tt0 139.31 153.18 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.96 0 C-N-CA 127.024 2.13 . . . . 0.0 107.748 178.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -117.92 99.95 7.25 Favored 'General case' 0 N--CA 1.508 2.445 0 N-CA-C 116.227 1.936 . . . . 0.0 116.227 -175.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . 0.518 ' CG ' ' HE1' ' A' ' 190' ' ' TRP . 22.1 pttp -13.07 77.16 0.02 OUTLIER Pre-proline 0 N--CA 1.5 2.057 1 N-CA-C 122.183 4.142 . . . . 0.0 122.183 -177.325 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . 0.42 ' HD2' ' O ' ' A' ' 189' ' ' TRP . 12.3 Cg_endo -47.13 -59.34 1.28 Allowed 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 123.096 2.531 . . . . 0.0 106.999 171.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -121.11 19.58 11.55 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 112.285 -2.234 . . . . 0.0 110.563 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 112.94 15.85 8.94 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . 0.42 ' O ' ' HD2' ' A' ' 186' ' ' PRO . 1.3 m-90 -125.51 127.03 45.8 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 120.58 3.548 . . . . 0.0 120.58 179.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' TRP . . . . . 0.558 ' CE2' ' HB2' ' A' ' 204' ' ' ARG . 15.2 m95 -117.84 161.19 20.14 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 101.095 -3.668 . . . . 0.0 101.095 177.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 28.8 mm -98.28 166.77 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.395 1 N-CA-C 99.679 -4.193 . . . . 0.0 99.679 176.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -150.74 -177.8 6.2 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 116.125 -2.23 . . . . 0.0 111.447 178.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -137.69 163.69 30.67 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 174.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 26.0 p-10 -112.7 -160.72 0.73 Allowed 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.373 -0.931 . . . . 0.0 108.567 177.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -108.26 35.7 3.07 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 118.874 -1.13 . . . . 0.0 110.215 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -129.23 -67.72 0.76 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 105.48 -2.045 . . . . 0.0 105.48 175.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -165.58 -67.24 0.03 OUTLIER Glycine 0 N--CA 1.488 2.133 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.208 178.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -34.85 160.78 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 119.65 3.204 . . . . 0.0 119.65 -178.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.65 160.4 21.89 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 111.904 -2.407 . . . . 0.0 109.573 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -135.54 -169.72 11.91 Favored Glycine 0 N--CA 1.487 2.082 0 CA-C-O 122.998 1.332 . . . . 0.0 114.238 -177.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 16.5 mt -130.09 84.89 2.24 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 111.138 -2.531 . . . . 0.0 105.236 178.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 3.0 m -113.04 156.04 43.38 Favored Pre-proline 0 N--CA 1.495 1.816 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 -175.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -90.35 173.24 3.31 Favored 'Trans proline' 0 C--N 1.302 -1.903 0 C-N-CA 122.429 2.086 . . . . 0.0 107.365 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . 0.558 ' HB2' ' CE2' ' A' ' 190' ' ' TRP . 22.7 ttt180 -102.07 -35.62 8.87 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 117.029 -1.869 . . . . 0.0 106.43 175.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 70.2 p -25.05 -46.67 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 126.057 2.098 . . . . 0.0 114.732 174.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -110.98 43.94 1.37 Allowed 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 119.762 -0.775 . . . . 0.0 112.659 -178.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 60.4 mt -127.17 151.53 48.56 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.618 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -123.64 150.03 60.45 Favored Pre-proline 0 C--N 1.301 -1.512 0 N-CA-C 104.148 -2.538 . . . . 0.0 104.148 174.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -68.81 160.13 50.94 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 C-N-CA 121.363 1.376 . . . . 0.0 110.738 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . 0.415 ' CE1' HD12 ' A' ' 178' ' ' ILE . 10.7 t80 . . . . . 0 N--CA 1.494 1.739 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 177.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.059 0 N-CA-C 110.241 -1.143 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -116.32 165.14 13.53 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 104.381 -2.452 . . . . 0.0 104.381 -178.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -99.15 119.51 37.97 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 117.098 -1.841 . . . . 0.0 114.417 -178.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -123.87 174.09 7.77 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 101.145 -3.65 . . . . 0.0 101.145 175.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.501 HG22 ' CD1' ' A' ' 210' ' ' TYR . 3.3 pt -127.49 153.84 37.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 101.943 -3.354 . . . . 0.0 101.943 173.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -84.24 152.66 24.07 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 103.582 -2.747 . . . . 0.0 103.582 178.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 32.9 m -132.8 6.13 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 125.939 2.025 . . . . 0.0 108.734 177.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -131.37 149.68 19.3 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 106.36 -2.696 . . . . 0.0 106.36 177.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -101.77 92.26 4.76 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 118.887 -1.125 . . . . 0.0 108.798 -177.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -107.99 151.18 26.16 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 114.436 -1.256 . . . . 0.0 109.624 -178.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 52.7 m -120.98 158.81 26.93 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -81.29 151.54 28.02 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 118.076 -1.45 . . . . 0.0 109.022 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -112.72 -36.17 5.27 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 112.456 -2.156 . . . . 0.0 105.267 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -120.42 171.89 8.21 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 113.368 -1.742 . . . . 0.0 106.996 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -59.63 -46.8 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 117.489 -1.685 . . . . 0.0 108.693 177.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -29.55 -60.96 0.17 Allowed Glycine 0 N--CA 1.492 2.376 0 O-C-N 125.355 1.66 . . . . 0.0 113.834 177.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -77.23 168.86 19.34 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -176.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 14.2 mt -117.54 176.55 5.12 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 113.715 -1.584 . . . . 0.0 110.478 178.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 42.6 m -120.46 97.07 5.4 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 113.875 -1.512 . . . . 0.0 110.733 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.423 ' CD1' ' N ' ' A' ' 173' ' ' PHE . 8.2 p90 -121.05 171.09 8.92 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.495 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -107.4 -163.35 0.89 Allowed 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 122.691 1.234 . . . . 0.0 113.338 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 42.1 tttm -107.15 89.82 3.11 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 111.002 -2.817 . . . . 0.0 112.146 -175.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 109.16 50.65 0.71 Allowed Glycine 0 N--CA 1.492 2.401 0 CA-C-N 113.228 -1.806 . . . . 0.0 110.695 177.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -128.78 176.59 7.7 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 177.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 21.9 mm -104.0 119.56 52.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 C-N-CA 118.669 -1.213 . . . . 0.0 112.451 -178.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 59.5 mt -121.16 163.62 18.17 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 113.933 -1.485 . . . . 0.0 110.031 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 59.6 mt -110.7 156.67 20.69 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 176.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 2.5 t -126.55 138.67 54.01 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 C-N-CA 117.981 -1.488 . . . . 0.0 110.221 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.417 ' O ' ' CB ' ' A' ' 183' ' ' GLU . 25.6 mt -141.04 82.0 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -174.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . 0.447 ' O ' ' CE3' ' A' ' 190' ' ' TRP . 41.9 tt0 138.02 150.52 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.393 0 C-N-CA 127.042 2.137 . . . . 0.0 108.004 176.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . 0.444 ' N ' ' HG2' ' A' ' 183' ' ' GLU . 97.9 mttt -116.84 115.68 26.0 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 124.628 1.205 . . . . 0.0 111.927 -179.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . 0.504 ' CG ' ' HE1' ' A' ' 190' ' ' TRP . 0.1 OUTLIER -6.96 77.34 0.03 OUTLIER Pre-proline 0 N--CA 1.505 2.291 0 N-CA-C 117.652 2.464 . . . . 0.0 117.652 178.443 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -68.6 -55.95 0.2 Allowed 'Trans proline' 0 C--N 1.307 -1.629 0 N-CA-C 105.516 -2.532 . . . . 0.0 105.516 175.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -125.16 24.53 7.44 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 112.877 -1.965 . . . . 0.0 112.741 -177.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.435 ' CA ' ' HG2' ' A' ' 185' ' ' LYS . . . 116.65 -19.4 12.59 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 118.708 -1.711 . . . . 0.0 109.603 -179.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 16.3 m-90 -115.28 158.71 21.97 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 117.783 2.512 . . . . 0.0 117.783 -176.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' TRP . . . . . 0.504 ' HE1' ' CG ' ' A' ' 185' ' ' LYS . 23.9 m95 -129.97 162.43 28.68 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 100.457 -3.905 . . . . 0.0 100.457 -178.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.433 HG12 ' CB ' ' A' ' 183' ' ' GLU . 10.9 mm -113.33 106.21 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 C-N-CA 116.382 -2.127 . . . . 0.0 106.479 177.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -101.94 175.49 5.52 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -172.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 63.1 mttm -126.51 165.12 19.71 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 174.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -122.82 -158.16 0.78 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 124.467 1.104 . . . . 0.0 110.376 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -100.26 36.95 1.75 Allowed 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 121.693 0.758 . . . . 0.0 110.822 -178.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -125.38 -43.42 1.92 Allowed 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 176.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 138.29 -43.3 1.2 Allowed Glycine 0 N--CA 1.483 1.817 0 N-CA-C 106.477 -2.649 . . . . 0.0 106.477 -178.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -53.57 155.91 2.82 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.89 155.0 44.87 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 112.949 -1.932 . . . . 0.0 110.357 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -145.0 -176.68 19.21 Favored Glycine 0 N--CA 1.485 1.964 0 C-N-CA 119.195 -1.479 . . . . 0.0 112.924 -178.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . 0.416 ' CD2' ' N ' ' A' ' 201' ' ' LEU . 0.8 OUTLIER -92.78 92.05 7.76 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 112.757 -1.722 . . . . 0.0 106.741 176.943 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 5.0 m -113.81 147.85 38.57 Favored Pre-proline 0 N--CA 1.494 1.757 0 C-N-CA 117.43 -1.708 . . . . 0.0 106.739 -179.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -79.22 179.06 6.77 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 C-N-CA 122.291 1.994 . . . . 0.0 112.014 -177.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . 0.431 ' HB2' ' NE1' ' A' ' 190' ' ' TRP . 0.1 OUTLIER -86.25 -46.22 10.55 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 103.552 -2.759 . . . . 0.0 103.552 178.164 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 71.8 p -22.2 -50.62 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 O-C-N 126.013 2.071 . . . . 0.0 116.168 178.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -112.79 43.2 1.71 Allowed 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.587 0.708 . . . . 0.0 111.985 -178.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 12.3 mt -140.25 108.86 5.9 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 113.793 -1.548 . . . . 0.0 109.346 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -110.73 153.37 43.69 Favored Pre-proline 0 N--CA 1.49 1.55 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 178.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -59.6 165.39 9.72 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.093 1.862 . . . . 0.0 111.252 -178.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . 0.501 ' CD1' HG22 ' A' ' 158' ' ' ILE . 9.0 t80 . . . . . 0 N--CA 1.492 1.647 0 C-N-CA 119.024 -1.071 . . . . 0.0 111.99 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 -105.87 167.19 9.95 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 112.681 -1.76 . . . . 0.0 108.436 -178.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -112.71 141.57 46.35 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 124.598 2.142 . . . . 0.0 113.175 -177.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.467 ' CG ' HD22 ' A' ' 207' ' ' LEU . 76.0 m-85 -133.57 -179.73 5.7 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 108.462 -3.972 . . . . 0.0 107.326 -176.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.432 ' CG2' ' CD1' ' A' ' 210' ' ' TYR . 7.5 pt -128.66 162.2 36.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 102.188 -3.264 . . . . 0.0 102.188 168.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.418 ' O ' ' N ' ' A' ' 176' ' ' GLY . . . -90.98 157.47 17.27 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 103.405 -2.813 . . . . 0.0 103.405 -179.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 16.6 m -126.63 -0.24 4.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 125.809 1.943 . . . . 0.0 108.381 175.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -132.11 165.71 23.46 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 107.812 -2.115 . . . . 0.0 107.812 177.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -106.97 122.33 46.22 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -122.05 156.21 34.02 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.085 179.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 75.3 m -124.44 161.65 25.59 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -92.96 144.59 25.1 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 118.012 -1.475 . . . . 0.0 108.389 178.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -113.23 -32.69 6.21 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 112.834 -1.985 . . . . 0.0 106.645 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -112.52 177.59 4.58 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 113.66 -1.609 . . . . 0.0 107.027 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 17.3 t -95.84 49.34 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 104.502 -2.407 . . . . 0.0 104.502 178.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -130.65 -49.36 0.11 Allowed Glycine 0 N--CA 1.485 1.947 0 CA-C-N 112.697 -2.047 . . . . 0.0 109.27 -178.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.419 ' HA ' ' H ' ' A' ' 201' ' ' LEU . 29.2 m-20 -79.43 175.13 10.88 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 113.293 -1.454 . . . . 0.0 111.797 -178.273 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.401 ' HG ' ' HA3' ' A' ' 200' ' ' GLY . 14.1 mt -115.89 174.52 5.99 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 114.394 -1.276 . . . . 0.0 108.466 177.075 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 52.5 m -120.97 91.37 3.51 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 113.796 -1.547 . . . . 0.0 108.078 178.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -121.87 169.45 10.77 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 113.698 -1.592 . . . . 0.0 111.064 -178.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -109.44 -163.67 0.88 Allowed 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 122.78 1.276 . . . . 0.0 111.373 178.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 67.9 tttt -92.87 156.3 17.05 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 110.724 -2.944 . . . . 0.0 110.661 -178.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 159' ' ' ALA . . . 53.61 44.66 68.61 Favored Glycine 0 N--CA 1.485 1.935 0 CA-C-N 112.783 -2.008 . . . . 0.0 108.1 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -130.49 128.25 40.84 Favored 'General case' 0 N--CA 1.504 2.256 0 C-N-CA 116.881 -1.928 . . . . 0.0 113.988 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.416 ' HA ' ' HA ' ' A' ' 158' ' ' ILE . 1.6 mp -58.95 119.27 3.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 -178.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 19.6 mt -118.63 155.45 30.97 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 113.766 -1.561 . . . . 0.0 107.6 175.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 23.7 tp -111.99 158.42 19.54 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 104.575 -2.38 . . . . 0.0 104.575 177.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.599 HG22 ' CZ3' ' A' ' 190' ' ' TRP . 98.5 t -110.39 147.74 14.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 C-N-CA 119.078 -1.049 . . . . 0.0 109.899 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.461 ' O ' ' HB ' ' A' ' 191' ' ' ILE . 8.9 mt -148.69 74.97 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 C-N-CA 118.148 -1.421 . . . . 0.0 108.991 173.081 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . 0.418 ' CB ' ' O ' ' A' ' 182' ' ' ILE . 12.8 tm-20 139.07 165.21 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.224 0 C-N-CA 129.04 2.936 . . . . 0.0 105.314 176.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -113.76 88.69 2.9 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 117.444 2.387 . . . . 0.0 117.444 -175.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . 0.492 ' O ' ' CG ' ' A' ' 185' ' ' LYS . 7.4 pttm -8.69 76.05 0.03 OUTLIER Pre-proline 0 N--CA 1.505 2.319 0 N-CA-C 116.704 2.113 . . . . 0.0 116.704 177.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -44.52 -56.27 2.7 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 123.37 2.713 . . . . 0.0 107.598 176.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -128.8 16.4 6.35 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 111.634 -2.53 . . . . 0.0 110.04 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 111.4 26.01 4.73 Favored Glycine 0 N--CA 1.485 1.917 0 N-CA-C 107.501 -2.24 . . . . 0.0 107.501 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 2.7 m-90 -134.45 97.74 3.9 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 116.72 2.119 . . . . 0.0 116.72 178.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' TRP . . . . . 0.686 ' CD1' ' N ' ' A' ' 190' ' ' TRP . 0.0 OUTLIER -112.68 171.72 7.36 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.597 179.636 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.461 ' HB ' ' O ' ' A' ' 182' ' ' ILE . 1.9 mp -108.9 111.23 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 N-CA-C 104.037 -2.579 . . . . 0.0 104.037 -179.186 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . 0.547 ' HB2' ' CZ3' ' A' ' 190' ' ' TRP . . . -109.91 -178.37 3.51 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -173.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -137.26 166.76 23.01 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 105.38 -2.081 . . . . 0.0 105.38 176.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 53.3 p-10 -121.26 -148.48 0.41 Allowed 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.121 -1.032 . . . . 0.0 111.637 177.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -103.76 19.37 20.04 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -176.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . 0.481 ' NZ ' HD21 ' A' ' 198' ' ' ASN . 8.4 ptmm? -124.07 -26.21 4.06 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 174.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 137.73 -35.11 2.09 Favored Glycine 0 N--CA 1.49 2.259 0 C-N-CA 119.097 -1.525 . . . . 0.0 113.363 178.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . 0.481 HD21 ' NZ ' ' A' ' 196' ' ' LYS . 24.2 p30 -61.56 162.17 8.63 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 117.546 -1.662 . . . . 0.0 113.417 -177.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -128.72 155.01 45.77 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 112.712 -2.04 . . . . 0.0 111.026 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . 0.401 ' HA3' ' HG ' ' A' ' 171' ' ' LEU . . . -144.7 -160.71 8.65 Favored Glycine 0 N--CA 1.489 2.175 0 CA-C-O 122.276 0.931 . . . . 0.0 112.581 -178.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . 0.419 ' H ' ' HA ' ' A' ' 170' ' ' ASP . 20.1 mt -121.94 110.14 15.48 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 111.499 -2.35 . . . . 0.0 105.844 175.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.504 HG21 ' CD2' ' A' ' 190' ' ' TRP . 13.7 m -129.82 163.36 47.65 Favored Pre-proline 0 N--CA 1.498 1.958 0 C-N-CA 117.867 -1.533 . . . . 0.0 111.626 -175.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -100.24 139.28 0.26 Allowed 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 123.661 2.907 . . . . 0.0 109.713 174.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . 0.443 ' N ' ' HE1' ' A' ' 190' ' ' TRP . 0.1 OUTLIER -81.43 -23.57 37.45 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 104.64 -2.355 . . . . 0.0 104.64 179.954 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' THR . . . . . 0.446 ' HG1' ' H ' ' A' ' 206' ' ' TYR . 68.2 p -24.65 -43.75 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.156 0 O-C-N 124.518 1.137 . . . . 0.0 113.602 171.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . 0.446 ' H ' ' HG1' ' A' ' 205' ' ' THR . 31.2 m-85 -114.33 50.23 0.96 Allowed 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 120.098 -0.641 . . . . 0.0 111.977 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.467 HD22 ' CG ' ' A' ' 157' ' ' TYR . 1.0 OUTLIER -133.95 152.73 51.96 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.255 -179.005 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -132.03 153.5 81.38 Favored Pre-proline 0 N--CA 1.491 1.601 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 172.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -64.52 164.91 21.89 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.077 1.851 . . . . 0.0 111.684 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . 0.432 ' CD1' ' CG2' ' A' ' 158' ' ' ILE . 35.1 t80 . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 2.021 0 N-CA-C 111.609 -0.596 . . . . 0.0 111.609 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -115.6 165.76 12.67 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -178.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -94.65 123.04 37.85 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 117.551 -1.66 . . . . 0.0 113.695 -176.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -124.83 172.26 9.49 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 111.071 -2.786 . . . . 0.0 105.138 177.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.511 HG23 ' CD1' ' A' ' 210' ' ' TYR . 2.1 pt -129.98 150.33 34.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 102.959 -2.978 . . . . 0.0 102.959 171.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.407 ' O ' ' N ' ' A' ' 176' ' ' GLY . . . -86.59 150.7 24.04 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 102.435 -3.172 . . . . 0.0 102.435 178.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 33.8 m -132.68 23.18 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 126.189 2.181 . . . . 0.0 107.642 178.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -144.06 160.19 27.76 Favored Glycine 0 N--CA 1.483 1.784 0 N-CA-C 107.86 -2.096 . . . . 0.0 107.86 176.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -106.49 78.73 1.3 Allowed 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.292 -0.963 . . . . 0.0 108.449 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -99.9 149.86 22.98 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 114.36 -1.291 . . . . 0.0 108.163 -178.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 93.6 m -120.81 157.96 28.62 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 114.023 -1.444 . . . . 0.0 108.856 -177.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -79.32 135.27 36.68 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 178.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -114.13 -28.26 7.38 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 113.804 -1.544 . . . . 0.0 107.293 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -114.77 178.61 4.22 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 179.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 58.8 t -90.78 149.9 3.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 104.003 -2.591 . . . . 0.0 104.003 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 110.53 -42.7 1.89 Allowed Glycine 0 N--CA 1.487 2.059 0 C-N-CA 118.407 -1.854 . . . . 0.0 108.703 -178.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -78.28 168.37 19.94 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 113.079 -1.561 . . . . 0.0 113.239 -179.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.503 ' HG ' ' CA ' ' A' ' 200' ' ' GLY . 76.6 mt -123.22 179.05 4.84 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 114.506 -1.225 . . . . 0.0 110.28 178.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 37.0 m -120.78 98.41 6.0 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 113.392 -1.731 . . . . 0.0 108.372 177.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -113.23 165.31 12.54 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 118.73 -1.188 . . . . 0.0 111.379 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -122.59 152.84 40.03 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 117.736 2.495 . . . . 0.0 117.736 -177.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -37.11 76.66 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 108.575 -3.92 . . . . 0.0 114.923 173.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 159' ' ' ALA . . . 106.86 54.69 0.67 Allowed Glycine 0 N--CA 1.491 2.35 0 CA-C-N 114.986 -1.007 . . . . 0.0 112.973 175.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -124.17 175.46 7.01 Favored 'General case' 0 N--CA 1.504 2.273 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 176.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.403 HD13 ' CE2' ' A' ' 210' ' ' TYR . 14.2 mm -112.46 131.9 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 119.068 -1.053 . . . . 0.0 111.607 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . 0.463 ' N ' HD23 ' A' ' 179' ' ' LEU . 0.7 OUTLIER -140.26 174.87 10.08 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 114.653 -1.158 . . . . 0.0 113.69 177.826 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 83.6 mt -114.5 154.1 28.83 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.858 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 57.3 t -116.33 104.94 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 114.83 1.419 . . . . 0.0 114.83 -177.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.424 ' O ' ' HB ' ' A' ' 191' ' ' ILE . 13.3 mt -117.1 77.34 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-O 122.94 1.352 . . . . 0.0 108.178 -176.295 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . 0.465 ' HB3' ' H ' ' A' ' 191' ' ' ILE . 42.4 tt0 146.39 157.15 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.12 0 CA-C-N 109.715 -3.402 . . . . 0.0 108.262 173.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -117.37 102.21 9.05 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 114.655 -1.157 . . . . 0.0 112.233 -177.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . 0.464 ' HB2' ' HE1' ' A' ' 190' ' ' TRP . 38.5 tttm -5.76 76.03 0.03 OUTLIER Pre-proline 0 N--CA 1.507 2.392 0 O-C-N 126.798 2.561 . . . . 0.0 115.005 178.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -66.81 -57.42 0.2 Allowed 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 123.565 2.843 . . . . 0.0 105.88 178.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 27.7 p-10 -121.01 20.36 11.54 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 111.329 -2.669 . . . . 0.0 112.992 -177.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 116.52 -27.49 7.97 Favored Glycine 0 N--CA 1.48 1.578 0 C-N-CA 117.424 -2.322 . . . . 0.0 108.93 -179.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 8.0 m-90 -118.02 148.65 42.04 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 118.332 -1.347 . . . . 0.0 114.474 -177.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' TRP . . . . . 0.464 ' HE1' ' HB2' ' A' ' 185' ' ' LYS . 3.0 m0 -112.39 173.45 6.36 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 102.684 -3.08 . . . . 0.0 102.684 178.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.465 ' H ' ' HB3' ' A' ' 183' ' ' GLU . 12.9 mt -115.58 114.34 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 N-CA-C 103.209 -2.886 . . . . 0.0 103.209 175.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -113.92 173.63 6.34 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 116.249 1.944 . . . . 0.0 116.249 -170.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 26.0 mmmt -121.37 141.1 51.28 Favored 'General case' 0 C--N 1.298 -1.638 1 N-CA-C 99.769 -4.159 . . . . 0.0 99.769 173.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -110.4 -160.1 0.7 Allowed 'General case' 0 N--CA 1.502 2.145 0 C-N-CA 117.433 -1.707 . . . . 0.0 112.089 -177.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -88.87 31.93 0.83 Allowed 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.245 -0.982 . . . . 0.0 111.077 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -123.99 -43.31 2.11 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 175.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 132.43 -40.3 1.64 Allowed Glycine 0 N--CA 1.485 1.939 0 N-CA-C 107.984 -2.046 . . . . 0.0 107.984 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -56.79 167.35 0.78 Allowed 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 115.162 1.541 . . . . 0.0 115.162 -178.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -98.01 150.72 21.08 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 112.737 -2.029 . . . . 0.0 115.746 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . 0.503 ' CA ' ' HG ' ' A' ' 171' ' ' LEU . . . -133.18 -177.16 14.75 Favored Glycine 0 N--CA 1.48 1.568 0 CA-C-N 112.827 -1.988 . . . . 0.0 114.522 -176.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 19.6 mt -131.77 76.82 1.73 Allowed 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 101.492 -3.521 . . . . 0.0 101.492 175.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 5.0 m -107.08 140.14 21.13 Favored Pre-proline 0 N--CA 1.494 1.749 0 C-N-CA 117.997 -1.481 . . . . 0.0 110.207 -172.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 0.4 OUTLIER -90.93 177.77 2.02 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 C-N-CA 122.725 2.283 . . . . 0.0 115.287 -175.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 41.6 ttt-85 -89.16 -35.7 16.1 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 174.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 72.9 p -33.46 -41.31 0.08 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 125.527 1.767 . . . . 0.0 113.3 174.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -113.68 5.12 16.34 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 114.522 1.305 . . . . 0.0 114.522 -178.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.68 161.01 20.8 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 178.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -132.57 157.65 77.76 Favored Pre-proline 0 N--CA 1.487 1.383 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 174.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -69.98 173.32 11.34 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.223 1.949 . . . . 0.0 109.47 178.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . 0.511 ' CD1' HG23 ' A' ' 158' ' ' ILE . 2.4 t80 . . . . . 0 N--CA 1.492 1.657 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 2.021 0 CA-C-O 122.149 0.86 . . . . 0.0 113.67 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -132.16 148.29 52.46 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 103.921 -2.622 . . . . 0.0 103.921 177.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -107.49 142.36 37.48 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 116.82 -1.952 . . . . 0.0 111.577 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -125.29 -179.51 4.63 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 100.91 -3.737 . . . . 0.0 100.91 -179.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.491 HG22 ' CD1' ' A' ' 210' ' ' TYR . 1.5 pt -125.92 147.69 30.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 101.295 -3.594 . . . . 0.0 101.295 174.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.447 ' O ' ' N ' ' A' ' 176' ' ' GLY . . . -86.29 154.44 21.25 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 103.45 -2.796 . . . . 0.0 103.45 178.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.0 m -124.8 -0.93 5.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 126.089 2.118 . . . . 0.0 107.655 177.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -133.2 165.28 24.08 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 177.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -105.27 145.77 30.23 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 178.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -137.77 177.59 7.76 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 117.978 -1.489 . . . . 0.0 109.119 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 87.9 m -132.28 160.7 35.44 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -100.52 130.51 46.61 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 175.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -106.82 -30.51 8.87 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 -178.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -119.44 -177.82 3.46 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 113.253 -1.794 . . . . 0.0 108.22 -179.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 61.1 t -92.77 150.97 3.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 101.899 -3.371 . . . . 0.0 101.899 176.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 110.39 -48.44 0.94 Allowed Glycine 0 N--CA 1.488 2.142 0 N-CA-C 106.057 -2.817 . . . . 0.0 106.057 -176.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.29 169.6 16.77 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 123.879 1.8 . . . . 0.0 114.189 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.403 ' HG ' ' HA3' ' A' ' 200' ' ' GLY . 9.7 mt -121.04 -178.05 3.65 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 109.404 -3.544 . . . . 0.0 110.243 177.203 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 18.4 m -115.09 -65.15 1.22 Allowed 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 113.955 -1.475 . . . . 0.0 107.967 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 21.7 p90 42.64 166.26 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 116.867 2.173 . . . . 0.0 116.867 -178.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -113.82 -166.84 1.13 Allowed 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 113.562 -1.653 . . . . 0.0 112.728 179.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.415 ' CG ' ' N ' ' A' ' 176' ' ' GLY . 37.2 tttp -98.39 161.56 13.62 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 110.924 -2.853 . . . . 0.0 112.826 -178.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 159' ' ' ALA . . . 37.39 46.45 1.44 Allowed Glycine 0 N--CA 1.492 2.399 0 CA-C-N 112.665 -2.061 . . . . 0.0 110.172 179.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -123.35 176.41 6.15 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-N 111.045 -2.578 . . . . 0.0 106.875 177.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 13.9 mm -108.24 125.67 64.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 C-N-CA 119.392 -0.923 . . . . 0.0 111.338 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 24.2 mt -119.78 165.59 14.36 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 114.575 -1.193 . . . . 0.0 108.37 177.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 45.7 tp -118.11 163.24 16.93 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 178.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 69.0 t -113.24 142.25 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 178.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.461 ' O ' ' CB ' ' A' ' 183' ' ' GLU . 3.2 mm -141.86 75.41 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 104.551 -2.389 . . . . 0.0 104.551 173.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . 0.461 ' CB ' ' O ' ' A' ' 182' ' ' ILE . 38.8 tt0 127.47 148.39 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.539 0 C-N-CA 127.255 2.222 . . . . 0.0 108.794 178.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . 0.455 ' N ' ' HG2' ' A' ' 183' ' ' GLU . 92.6 mttt -126.4 133.06 51.38 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.117 -1.033 . . . . 0.0 111.787 177.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . 0.473 ' CG ' ' HE1' ' A' ' 190' ' ' TRP . 3.5 tttm -7.98 80.86 0.03 OUTLIER Pre-proline 0 N--CA 1.501 2.081 0 O-C-N 126.683 2.489 . . . . 0.0 116.972 177.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -72.59 -56.57 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.732 0 N-CA-C 104.136 -3.063 . . . . 0.0 104.136 175.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -134.14 23.2 3.82 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 113.604 -1.635 . . . . 0.0 107.999 178.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 127.65 -21.46 5.64 Favored Glycine 0 N--CA 1.489 2.223 0 CA-C-O 117.902 -1.499 . . . . 0.0 113.258 -178.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -105.05 156.14 18.34 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 118.018 2.599 . . . . 0.0 118.018 -176.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' TRP . . . . . 0.508 ' NE1' ' HB2' ' A' ' 204' ' ' ARG . 20.4 m95 -130.12 147.47 51.86 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 100.344 -3.947 . . . . 0.0 100.344 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.415 ' HB ' ' O ' ' A' ' 182' ' ' ILE . 12.4 mm -109.22 87.27 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 N-CA-C 102.998 -2.964 . . . . 0.0 102.998 178.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -80.02 175.04 10.99 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 113.247 -1.797 . . . . 0.0 113.848 -173.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -130.4 166.45 20.44 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 174.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -126.34 -161.89 1.09 Allowed 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 118.869 -1.132 . . . . 0.0 110.416 178.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -101.44 32.77 3.18 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.711 -178.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -129.1 -33.8 1.94 Allowed 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.092 176.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 138.07 -39.03 1.64 Allowed Glycine 0 N--CA 1.486 1.967 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.525 -179.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 21.3 p30 -56.84 159.84 3.81 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 118.536 -1.266 . . . . 0.0 114.267 -178.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . 0.42 ' HG3' ' N ' ' A' ' 200' ' ' GLY . 0.1 OUTLIER -140.69 166.12 25.62 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 112.008 -2.36 . . . . 0.0 109.573 179.175 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . 0.42 ' N ' ' HG3' ' A' ' 199' ' ' GLU . . . 159.41 174.01 28.59 Favored Glycine 0 N--CA 1.486 2.013 0 C-N-CA 118.148 -1.977 . . . . 0.0 114.684 177.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 9.8 mp -59.45 91.82 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 117.052 2.241 . . . . 0.0 117.052 -179.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 5.5 m -107.41 149.62 39.02 Favored Pre-proline 0 C--N 1.302 -1.495 0 N-CA-C 100.417 -3.92 . . . . 0.0 100.417 174.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -86.17 167.41 9.33 Favored 'Trans proline' 0 C--N 1.299 -2.033 0 N-CA-C 107.437 -1.794 . . . . 0.0 107.437 178.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . 0.508 ' HB2' ' NE1' ' A' ' 190' ' ' TRP . 12.2 ttp85 -80.22 -36.88 34.13 Favored 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 115.856 -2.338 . . . . 0.0 107.458 176.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 40.8 p -23.73 -54.82 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -110.52 47.4 0.97 Allowed 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.539 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -134.33 101.1 4.88 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 179.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -102.52 151.41 38.22 Favored Pre-proline 0 C--N 1.298 -1.654 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -57.61 164.78 6.96 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.176 1.918 . . . . 0.0 111.757 -178.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . 0.491 ' CD1' HG22 ' A' ' 158' ' ' ILE . 9.7 t80 . . . . . 0 N--CA 1.488 1.464 0 C-N-CA 119.544 -0.862 . . . . 0.0 109.592 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.717 0 N-CA-C 116.64 1.416 . . . . 0.0 116.64 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -123.46 168.31 12.73 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 178.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -112.32 135.21 53.29 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 124.216 1.96 . . . . 0.0 110.782 -178.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.44 ' CE1' HG23 ' A' ' 181' ' ' VAL . 16.9 m-85 -133.57 175.12 9.71 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 109.28 -3.6 . . . . 0.0 106.251 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.465 HG21 ' CD1' ' A' ' 210' ' ' TYR . 1.3 pt -132.03 152.54 36.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 101.475 -3.528 . . . . 0.0 101.475 171.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.48 ' O ' ' N ' ' A' ' 176' ' ' GLY . . . -90.33 152.89 20.82 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 102.287 -3.227 . . . . 0.0 102.287 177.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.418 ' C ' ' HB2' ' A' ' 175' ' ' LYS . 29.1 m -129.41 10.96 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 125.864 1.978 . . . . 0.0 107.765 177.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.417 ' N ' ' HB2' ' A' ' 175' ' ' LYS . . . -137.82 161.05 25.43 Favored Glycine 0 N--CA 1.478 1.474 0 N-CA-C 106.751 -2.54 . . . . 0.0 106.751 173.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -101.18 150.2 23.2 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 104.061 -2.57 . . . . 0.0 104.061 176.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -132.7 177.33 7.71 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 117.816 -1.554 . . . . 0.0 109.145 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 96.8 m -128.65 157.95 39.89 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 177.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -100.09 145.03 28.43 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 178.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 55.3 tp60 -111.21 -37.24 5.37 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -125.56 171.66 10.36 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 113.312 -1.767 . . . . 0.0 108.098 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 67.9 t -60.42 -48.63 87.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 103.873 -2.64 . . . . 0.0 103.873 177.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -30.29 -50.73 0.18 Allowed Glycine 0 N--CA 1.491 2.306 0 CA-C-N 112.308 -2.223 . . . . 0.0 113.399 174.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.415 ' HA ' ' H ' ' A' ' 201' ' ' LEU . 28.7 m-20 -79.83 164.15 23.84 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 113.738 -1.231 . . . . 0.0 113.339 -178.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 16.6 mt -114.92 177.95 4.46 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 104.345 -2.465 . . . . 0.0 104.345 175.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 31.4 m -107.66 -57.46 2.09 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 33.1 p90 33.76 164.38 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 118.811 2.893 . . . . 0.0 118.811 -178.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -109.25 -166.55 1.12 Allowed 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 113.749 -1.569 . . . . 0.0 112.476 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.418 ' HB2' ' C ' ' A' ' 160' ' ' VAL . 10.4 ptpt -107.51 176.83 5.02 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 111.222 -2.717 . . . . 0.0 113.73 -176.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 159' ' ' ALA . . . 34.72 44.21 0.45 Allowed Glycine 0 N--CA 1.491 2.351 0 O-C-N 126.327 2.267 . . . . 0.0 109.097 -177.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -130.0 175.6 8.75 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-N 110.758 -2.721 . . . . 0.0 106.555 177.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 17.9 mm -101.6 123.19 54.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -175.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 6.8 mp -116.89 156.27 27.64 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.568 177.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.441 HD11 ' H ' ' A' ' 181' ' ' VAL . 0.6 OUTLIER -114.77 152.05 32.73 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 -177.181 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.441 ' H ' HD11 ' A' ' 180' ' ' LEU . 59.6 t -111.6 132.91 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 -179.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.47 ' O ' ' HB ' ' A' ' 191' ' ' ILE . 9.9 mt -142.59 78.88 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 CA-C-N 114.177 -1.374 . . . . 0.0 108.758 179.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . 0.468 ' CB ' ' O ' ' A' ' 182' ' ' ILE . 33.6 tt0 122.0 165.13 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 C-N-CA 128.081 2.552 . . . . 0.0 109.616 173.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . 0.428 ' N ' ' HG2' ' A' ' 183' ' ' GLU . 98.4 mttt -110.37 167.03 10.51 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.206 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . 0.603 ' N ' ' CD1' ' A' ' 190' ' ' TRP . 17.8 pttp -95.85 68.4 0.03 OUTLIER Pre-proline 0 N--CA 1.508 2.469 0 N-CA-C 120.623 3.564 . . . . 0.0 120.623 -179.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -35.1 -56.5 0.5 Allowed 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 123.288 2.659 . . . . 0.0 108.938 171.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -121.16 23.77 10.39 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 112.95 -1.932 . . . . 0.0 114.069 179.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.52 ' CA ' ' HB2' ' A' ' 185' ' ' LYS . . . 110.7 17.46 9.14 Favored Glycine 0 N--CA 1.5 2.962 0 C-N-CA 119.644 -1.265 . . . . 0.0 112.658 178.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 2.0 m-90 -129.81 111.99 13.16 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 119.41 3.115 . . . . 0.0 119.41 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' TRP . . . . . 0.603 ' CD1' ' N ' ' A' ' 185' ' ' LYS . 28.7 m0 -106.54 160.4 15.45 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 101.856 -3.387 . . . . 0.0 101.856 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.47 ' HB ' ' O ' ' A' ' 182' ' ' ILE . 1.5 mp -115.43 114.21 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 N-CA-C 103.359 -2.83 . . . . 0.0 103.359 173.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -116.26 176.84 4.92 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -171.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -126.84 161.03 29.2 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 173.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 17.9 p30 -120.59 -165.85 1.25 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 124.254 0.971 . . . . 0.0 111.64 178.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -99.9 39.12 1.36 Allowed 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 40.8 mmtm -118.66 -37.37 3.29 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 179.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 134.62 -35.87 2.15 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 120.142 -1.028 . . . . 0.0 111.47 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . 0.4 ' ND2' ' H ' ' A' ' 198' ' ' ASN . 0.1 OUTLIER -90.96 174.78 7.24 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 116.153 1.909 . . . . 0.0 116.153 -178.469 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.74 161.27 19.97 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 111.964 -2.38 . . . . 0.0 110.08 -179.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -144.97 -170.21 13.9 Favored Glycine 0 N--CA 1.477 1.411 0 C-N-CA 119.326 -1.416 . . . . 0.0 111.453 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . 0.415 ' H ' ' HA ' ' A' ' 170' ' ' ASP . 14.4 mt -113.92 88.01 2.75 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 110.645 -2.777 . . . . 0.0 103.914 177.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 4.8 m -115.27 156.65 45.35 Favored Pre-proline 0 N--CA 1.489 1.493 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 -174.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -90.02 -179.82 1.87 Allowed 'Trans proline' 0 C--N 1.298 -2.087 0 C-N-CA 122.299 2.0 . . . . 0.0 106.976 178.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . 0.528 ' HB2' ' CE2' ' A' ' 190' ' ' TRP . 0.7 OUTLIER -102.9 -41.93 5.99 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 102.503 -3.147 . . . . 0.0 102.503 175.849 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 77.9 p -17.76 -46.28 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 O-C-N 126.616 2.447 . . . . 0.0 116.515 176.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . 0.403 ' N ' ' O ' ' A' ' 204' ' ' ARG . 36.4 m-85 -110.27 42.1 1.62 Allowed 'General case' 0 N--CA 1.503 2.205 0 CA-C-N 118.85 0.75 . . . . 0.0 112.643 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 6.1 mp -131.06 162.21 30.32 Favored 'General case' 0 N--CA 1.499 1.979 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.014 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -134.5 156.81 78.49 Favored Pre-proline 0 C--N 1.303 -1.433 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 172.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -72.26 170.69 18.54 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 N-CA-C 106.995 -1.964 . . . . 0.0 106.995 178.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . 0.465 ' CD1' HG21 ' A' ' 158' ' ' ILE . 5.2 t80 . . . . . 0 N--CA 1.491 1.602 0 C-N-CA 118.483 -1.287 . . . . 0.0 110.004 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 N-CA-C 116.377 1.311 . . . . 0.0 116.377 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -122.15 156.07 34.43 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 113.196 -1.502 . . . . 0.0 107.977 -179.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -104.61 128.04 52.52 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 117.897 -1.521 . . . . 0.0 111.373 -178.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.416 ' CE1' HG21 ' A' ' 181' ' ' VAL . 15.9 m-85 -122.1 174.8 6.71 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 104.678 -2.341 . . . . 0.0 104.678 178.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.488 HG22 ' CD1' ' A' ' 210' ' ' TYR . 1.7 pt -125.53 146.32 31.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 102.694 -3.076 . . . . 0.0 102.694 172.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.41 156.47 20.15 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 101.361 -3.57 . . . . 0.0 101.361 176.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 33.2 m -122.52 2.53 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 126.106 2.129 . . . . 0.0 108.274 178.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -125.92 167.73 18.24 Favored Glycine 0 N--CA 1.482 1.76 0 N-CA-C 106.504 -2.638 . . . . 0.0 106.504 177.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -105.53 114.36 28.49 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.271 -0.972 . . . . 0.0 109.913 179.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -112.3 154.63 25.37 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.409 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 99.9 m -130.16 159.78 35.78 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 178.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -96.7 103.54 15.46 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 118.31 -1.356 . . . . 0.0 109.404 178.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -117.75 -0.72 11.72 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.009 -178.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.402 ' O ' ' C ' ' A' ' 168' ' ' VAL . 78.3 mm-40 -121.43 179.14 4.53 Favored 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 118.418 -1.313 . . . . 0.0 109.639 -177.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.402 ' C ' ' O ' ' A' ' 167' ' ' GLN . 96.0 t -25.25 -73.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 126.112 2.132 . . . . 0.0 111.06 179.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -133.55 141.13 12.45 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 107.489 -2.244 . . . . 0.0 107.489 174.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -167.64 -179.24 4.24 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 110.372 -2.914 . . . . 0.0 108.181 -179.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.472 ' HG ' ' CA ' ' A' ' 200' ' ' GLY . 16.5 mt -132.34 175.23 9.46 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 169.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 55.1 m -122.05 96.21 4.96 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.282 178.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -118.6 168.47 10.67 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.944 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -126.1 151.25 47.47 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 116.299 1.963 . . . . 0.0 116.299 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 60.1 tttt -27.11 79.1 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.665 1 CA-C-N 108.337 -4.028 . . . . 0.0 116.14 171.22 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 109.61 48.21 0.81 Allowed Glycine 0 N--CA 1.491 2.309 0 CA-C-N 114.775 -1.102 . . . . 0.0 112.611 176.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -138.49 151.81 47.72 Favored 'General case' 0 N--CA 1.507 2.38 0 C-N-CA 117.35 -1.74 . . . . 0.0 109.135 178.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.462 ' N ' ' CD1' ' A' ' 178' ' ' ILE . 1.3 mp -82.95 137.59 20.74 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 117.765 2.505 . . . . 0.0 117.765 -177.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -125.63 173.37 9.03 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 104.2 -2.518 . . . . 0.0 104.2 175.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.42 ' HB2' ' HB2' ' A' ' 193' ' ' LYS . 9.8 mt -117.75 161.34 19.86 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 176.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.416 HG21 ' CE1' ' A' ' 157' ' ' TYR . 78.1 t -113.49 124.43 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 N-CA-C 117.674 2.472 . . . . 0.0 117.674 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.477 ' O ' ' HB ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -135.45 77.53 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 CA-C-N 111.371 -2.65 . . . . 0.0 108.257 176.406 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . 0.491 ' HG2' ' N ' ' A' ' 184' ' ' LYS . 35.7 tt0 117.13 164.28 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 128.214 2.606 . . . . 0.0 110.129 173.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . 0.491 ' N ' ' HG2' ' A' ' 183' ' ' GLU . 99.5 mttt -108.87 -177.45 3.31 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.368 178.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . 0.616 ' N ' ' CD1' ' A' ' 190' ' ' TRP . 8.2 ptmm? -91.43 73.34 0.01 OUTLIER Pre-proline 0 N--CA 1.515 2.782 0 C-N-CA 130.326 3.45 . . . . 0.0 118.018 -177.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . 0.416 ' CD ' ' O ' ' A' ' 184' ' ' LYS . 9.2 Cg_endo -44.31 -56.57 2.46 Favored 'Trans proline' 0 C--N 1.3 -1.981 0 C-N-CA 123.251 2.634 . . . . 0.0 106.802 174.009 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -126.24 24.2 6.88 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 112.582 -2.099 . . . . 0.0 110.665 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 110.22 15.78 11.19 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -128.13 102.78 6.86 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 119.933 3.309 . . . . 0.0 119.933 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' TRP . . . . . 0.616 ' CD1' ' N ' ' A' ' 185' ' ' LYS . 10.7 m0 -95.93 157.05 16.07 Favored 'General case' 0 N--CA 1.498 1.933 1 N-CA-C 99.685 -4.191 . . . . 0.0 99.685 -177.926 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.477 ' HB ' ' O ' ' A' ' 182' ' ' ILE . 1.4 mp -112.54 140.99 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 1 N-CA-C 99.893 -4.114 . . . . 0.0 99.893 173.698 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -132.87 -177.95 4.73 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 119.319 -0.952 . . . . 0.0 113.542 -174.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . 0.42 ' HB2' ' HB2' ' A' ' 180' ' ' LEU . 62.6 mmtt -128.22 169.25 14.37 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 172.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -125.03 -158.0 0.81 Allowed 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.34 -0.944 . . . . 0.0 109.548 178.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -104.71 39.06 1.76 Allowed 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 121.33 0.586 . . . . 0.0 109.967 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -132.26 -37.39 1.1 Allowed 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.56 177.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 134.72 -22.24 3.69 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 -178.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -78.08 164.6 24.87 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.005 -1.078 . . . . 0.0 112.934 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 193' ' ' LYS . 0.0 OUTLIER -122.76 158.17 30.76 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 112.203 -2.271 . . . . 0.0 109.74 -179.941 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . 0.472 ' CA ' ' HG ' ' A' ' 171' ' ' LEU . . . -135.46 -172.22 12.63 Favored Glycine 0 N--CA 1.479 1.501 0 CA-C-O 123.985 1.881 . . . . 0.0 115.115 -177.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 9.5 mt -126.2 87.06 2.61 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 108.568 -3.816 . . . . 0.0 103.684 177.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 4.9 m -116.79 156.5 47.86 Favored Pre-proline 0 C--N 1.303 -1.45 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 -173.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 0.6 OUTLIER -92.0 174.7 2.18 Favored 'Trans proline' 0 C--N 1.299 -2.061 0 N-CA-C 105.564 -2.514 . . . . 0.0 105.564 178.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . 0.511 ' HB3' ' HD2' ' A' ' 185' ' ' LYS . 0.4 OUTLIER -108.85 -31.06 7.83 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 175.502 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 82.5 p -23.68 -47.16 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.173 0 O-C-N 125.742 1.901 . . . . 0.0 113.875 171.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -112.53 49.49 0.92 Allowed 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 119.745 -0.782 . . . . 0.0 111.77 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -132.68 156.89 46.15 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.332 -179.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -132.02 157.6 77.78 Favored Pre-proline 0 N--CA 1.495 1.791 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 174.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -73.24 158.61 48.56 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 121.283 1.322 . . . . 0.0 108.708 178.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . 0.488 ' CD1' HG22 ' A' ' 158' ' ' ILE . 6.8 t80 . . . . . 0 N--CA 1.49 1.526 0 C-N-CA 119.4 -0.92 . . . . 0.0 109.066 179.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.907 0 CA-C-O 121.67 0.595 . . . . 0.0 113.707 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -119.29 166.59 12.82 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 104.907 -2.257 . . . . 0.0 104.907 -179.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -103.48 117.01 33.47 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 117.704 -1.598 . . . . 0.0 113.492 -178.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -123.59 174.91 7.13 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 102.623 -3.103 . . . . 0.0 102.623 177.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.401 HG22 ' CD1' ' A' ' 210' ' ' TYR . 5.7 pt -131.62 150.76 34.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 103.312 -2.847 . . . . 0.0 103.312 172.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -81.71 151.45 27.51 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 102.848 -3.019 . . . . 0.0 102.848 176.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 26.8 m -129.69 10.72 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 125.866 1.978 . . . . 0.0 107.75 177.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -126.89 164.18 20.55 Favored Glycine 0 N--CA 1.484 1.852 0 N-CA-C 105.17 -3.172 . . . . 0.0 105.17 176.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -105.83 83.91 1.99 Allowed 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 118.709 -1.196 . . . . 0.0 109.277 -179.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -104.43 115.96 31.28 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 122.605 1.193 . . . . 0.0 108.425 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 18.2 m -101.01 154.35 18.77 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 111.944 -2.389 . . . . 0.0 106.379 -179.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.39 129.71 34.75 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 117.168 -1.813 . . . . 0.0 106.447 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -107.42 -29.31 9.32 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 -178.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -119.2 -175.67 2.97 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 113.586 -1.643 . . . . 0.0 106.616 179.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 61.4 t -88.76 151.76 3.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 179.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 114.33 -53.04 0.62 Allowed Glycine 0 N--CA 1.487 2.074 0 N-CA-C 108.644 -1.782 . . . . 0.0 108.644 -178.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -78.58 169.52 18.11 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 113.951 -1.125 . . . . 0.0 111.668 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 15.4 mt -121.01 176.02 5.77 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.182 177.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 31.3 m -116.92 93.09 4.06 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 114.12 -1.4 . . . . 0.0 112.273 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -128.17 166.85 17.73 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 113.512 -1.676 . . . . 0.0 109.274 177.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -125.39 159.82 30.9 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 117.001 2.223 . . . . 0.0 117.001 -178.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 44.4 tttm -35.97 77.45 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.659 1 CA-C-N 108.008 -4.178 . . . . 0.0 116.655 173.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 114.9 47.86 0.55 Allowed Glycine 0 N--CA 1.494 2.504 0 CA-C-N 114.866 -1.061 . . . . 0.0 115.126 174.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -137.51 158.66 43.92 Favored 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 117.472 -1.691 . . . . 0.0 107.576 175.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.495 ' N ' ' CD1' ' A' ' 178' ' ' ILE . 1.1 mp -84.57 134.26 27.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 -176.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.7 mp -135.62 168.83 18.54 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 113.158 -1.837 . . . . 0.0 108.7 175.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 27.9 mt -107.09 154.09 21.66 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 176.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 2.3 t -122.52 132.69 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 118.367 -1.333 . . . . 0.0 108.502 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.473 ' O ' ' CB ' ' A' ' 183' ' ' GLU . 16.6 mt -139.77 79.99 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 120.264 -0.575 . . . . 0.0 111.658 -173.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . 0.506 ' O ' ' CE3' ' A' ' 190' ' ' TRP . 3.7 tm-20 136.34 147.56 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.976 0 C-N-CA 127.63 2.372 . . . . 0.0 108.816 173.249 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . 0.425 ' HG2' ' CZ3' ' A' ' 190' ' ' TRP . 62.0 mttp -105.54 104.19 13.87 Favored 'General case' 0 N--CA 1.509 2.504 0 N-CA-C 119.727 3.232 . . . . 0.0 119.727 -171.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . 0.43 ' CG ' ' HE1' ' A' ' 190' ' ' TRP . 21.8 pttp -15.09 79.25 0.02 OUTLIER Pre-proline 0 N--CA 1.5 2.074 1 N-CA-C 122.407 4.225 . . . . 0.0 122.407 179.249 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -45.35 -59.93 1.01 Allowed 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 123.886 3.057 . . . . 0.0 107.321 171.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -121.86 20.75 10.82 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 111.399 -2.637 . . . . 0.0 110.638 -178.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.419 ' CA ' ' HB2' ' A' ' 185' ' ' LYS . . . 114.71 12.18 10.64 Favored Glycine 0 N--CA 1.488 2.154 0 C-N-CA 119.717 -1.23 . . . . 0.0 110.876 179.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 2.5 m-90 -127.49 134.3 49.82 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 120.318 3.451 . . . . 0.0 120.318 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' TRP . . . . . 0.506 ' CE3' ' O ' ' A' ' 183' ' ' GLU . 10.2 m95 -120.11 163.06 18.27 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 104.824 -2.287 . . . . 0.0 104.824 178.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.408 ' HB ' ' O ' ' A' ' 182' ' ' ILE . 1.7 mp -107.45 113.0 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 104.179 -2.526 . . . . 0.0 104.179 177.048 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -108.2 -179.81 3.99 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -173.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -133.6 165.31 25.21 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 172.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -115.62 -160.0 0.73 Allowed 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 118.822 -1.151 . . . . 0.0 109.658 -179.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -97.18 38.67 1.23 Allowed 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.874 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -133.36 -38.38 0.94 Allowed 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.45 177.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 136.87 -39.71 1.6 Allowed Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -178.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 21.5 p30 -52.78 164.27 0.39 Allowed 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.95 157.69 32.07 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 113.049 -1.887 . . . . 0.0 110.552 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -142.58 -165.48 10.6 Favored Glycine 0 N--CA 1.482 1.709 0 CA-C-O 122.671 1.151 . . . . 0.0 112.387 -177.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 33.7 mt -125.2 89.98 3.15 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 111.242 -2.479 . . . . 0.0 106.547 177.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.1 m -116.74 154.82 49.45 Favored Pre-proline 0 N--CA 1.496 1.871 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -177.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -89.59 176.26 2.99 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 C-N-CA 123.177 2.585 . . . . 0.0 111.391 -177.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . 0.457 ' HB2' ' CE2' ' A' ' 190' ' ' TRP . 29.3 ttm180 -97.97 -40.09 8.64 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 102.637 -3.097 . . . . 0.0 102.637 174.04 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 73.8 p -25.14 -55.24 0.05 OUTLIER 'General case' 0 N--CA 1.503 2.202 0 O-C-N 125.512 1.758 . . . . 0.0 115.54 176.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -113.66 45.65 1.41 Allowed 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 122.62 1.2 . . . . 0.0 109.387 -178.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -135.75 128.73 31.41 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 112.361 -2.2 . . . . 0.0 105.369 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -114.2 156.09 44.71 Favored Pre-proline 0 N--CA 1.494 1.744 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 178.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -63.21 166.11 15.53 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 121.693 1.595 . . . . 0.0 110.122 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . 0.403 ' CE1' HD13 ' A' ' 178' ' ' ILE . 35.6 t80 . . . . . 0 N--CA 1.491 1.616 0 C-N-CA 119.688 -0.805 . . . . 0.0 109.511 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 36.6 m . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 112.08 178.72 19.95 Favored Glycine 0 N--CA 1.488 2.119 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.343 -178.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -126.55 161.31 28.3 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 103.537 -2.764 . . . . 0.0 103.537 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -115.1 136.3 53.27 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 116.444 -2.102 . . . . 0.0 112.855 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.422 ' CD1' HG22 ' A' ' 181' ' ' VAL . 6.0 m-85 -124.99 -178.99 4.36 Favored 'General case' 0 C--N 1.299 -1.6 1 N-CA-C 100.068 -4.049 . . . . 0.0 100.068 179.085 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 3.5 pt -125.22 154.6 33.61 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 N-CA-C 101.914 -3.365 . . . . 0.0 101.914 173.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -89.26 150.63 22.54 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 102.02 -3.326 . . . . 0.0 102.02 177.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.2 m -130.09 28.36 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 126.238 2.211 . . . . 0.0 106.545 177.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -142.23 158.94 27.01 Favored Glycine 0 N--CA 1.482 1.754 0 N-CA-C 105.711 -2.956 . . . . 0.0 105.711 174.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -107.68 94.29 5.0 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 118.928 -1.109 . . . . 0.0 108.786 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.448 ' HB3' ' CZ ' ' A' ' 173' ' ' PHE . 47.6 t80 -107.65 154.09 21.96 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.086 -1.046 . . . . 0.0 108.921 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 56.7 m -127.0 163.43 23.72 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 105.442 -2.059 . . . . 0.0 105.442 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -95.25 135.03 37.34 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 177.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 16.6 mp0 -110.74 -29.81 7.84 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -115.63 -178.07 3.3 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 58.5 t -88.95 150.91 3.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 104.822 -2.288 . . . . 0.0 104.822 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 113.51 -51.89 0.68 Allowed Glycine 0 N--CA 1.485 1.929 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 -178.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.423 ' HA ' ' H ' ' A' ' 201' ' ' LEU . 2.9 m-20 -76.99 166.5 23.23 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -178.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.411 ' HG ' ' HA3' ' A' ' 200' ' ' GLY . 16.4 mt -121.26 178.82 4.62 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 113.449 -1.705 . . . . 0.0 109.935 179.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 39.0 m -122.03 100.02 6.75 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.57 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.448 ' CZ ' ' HB3' ' A' ' 163' ' ' PHE . 18.0 p90 -119.21 168.28 11.03 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.531 -0.867 . . . . 0.0 110.88 178.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 57.2 pttt -124.84 142.79 51.2 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 115.882 1.808 . . . . 0.0 115.882 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 49.9 tptt -23.9 77.95 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 109.583 -3.462 . . . . 0.0 115.215 170.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 107.78 50.5 0.79 Allowed Glycine 0 N--CA 1.49 2.281 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.913 176.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -127.95 170.85 12.39 Favored 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 176.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 14.4 mm -99.8 132.76 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 117.98 -1.488 . . . . 0.0 112.11 -177.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 57.9 mt -124.74 167.79 14.09 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 113.561 -1.654 . . . . 0.0 110.077 177.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 22.2 tp -117.47 159.72 22.36 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 102.746 -3.057 . . . . 0.0 102.746 177.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.422 HG22 ' CD1' ' A' ' 157' ' ' TYR . 3.2 t -128.14 136.71 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 CA-C-N 120.915 1.689 . . . . 0.0 109.306 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.437 ' O ' ' CB ' ' A' ' 183' ' ' GLU . 45.8 mt -145.35 86.13 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.093 -176.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . 0.467 ' CB ' HG12 ' A' ' 191' ' ' ILE . 10.1 tm-20 130.56 153.18 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.753 0 C-N-CA 128.109 2.564 . . . . 0.0 107.654 172.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -109.83 123.0 48.81 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 118.426 2.75 . . . . 0.0 118.426 -174.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.436 ' CG ' ' HE1' ' A' ' 190' ' ' TRP . 8.4 tttm -9.79 78.37 0.03 OUTLIER Pre-proline 0 N--CA 1.507 2.413 0 N-CA-C 117.746 2.499 . . . . 0.0 117.746 175.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -69.09 -56.53 0.16 Allowed 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 123.165 2.577 . . . . 0.0 105.96 175.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -125.35 19.28 8.18 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 112.067 -2.333 . . . . 0.0 111.791 -177.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 122.07 -23.84 7.19 Favored Glycine 0 N--CA 1.487 2.074 0 C-N-CA 118.452 -1.832 . . . . 0.0 111.242 -178.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 24.7 m-90 -113.39 154.6 26.67 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 115.842 1.793 . . . . 0.0 115.842 -176.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' TRP . . . . . 0.436 ' HE1' ' CG ' ' A' ' 185' ' ' LYS . 18.3 m95 -122.73 163.91 19.28 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 101.767 -3.42 . . . . 0.0 101.767 -178.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.467 HG12 ' CB ' ' A' ' 183' ' ' GLU . 8.2 mm -102.9 105.57 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 C-N-CA 115.522 -2.471 . . . . 0.0 105.043 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -98.43 -177.88 3.84 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -173.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 199' ' ' GLU . 34.0 ttmt -137.17 164.45 28.44 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 177.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 47.2 p-10 -122.45 -163.23 1.06 Allowed 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.664 -0.814 . . . . 0.0 110.077 178.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -103.36 40.86 1.34 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -126.17 -35.6 2.41 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 113.709 -1.587 . . . . 0.0 107.455 177.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 134.9 -38.96 1.75 Allowed Glycine 0 N--CA 1.487 2.071 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 21.1 p30 -67.8 163.78 21.03 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -178.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 193' ' ' LYS . 0.0 OUTLIER -129.53 149.48 51.28 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 112.121 -2.309 . . . . 0.0 108.609 177.181 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . 0.411 ' HA3' ' HG ' ' A' ' 171' ' ' LEU . . . -139.28 -156.34 6.94 Favored Glycine 0 N--CA 1.482 1.714 0 CA-C-N 114.789 -1.096 . . . . 0.0 113.187 -177.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.423 ' H ' ' HA ' ' A' ' 170' ' ' ASP . 90.3 mt -117.12 101.94 8.89 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 111.622 -2.289 . . . . 0.0 107.56 178.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 4.9 m -120.5 151.44 53.91 Favored Pre-proline 0 N--CA 1.496 1.828 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -82.38 175.85 8.56 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 121.19 1.26 . . . . 0.0 109.05 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.37 -42.89 7.91 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 102.994 -2.965 . . . . 0.0 102.994 178.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 77.3 p -23.44 -53.67 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 O-C-N 125.579 1.799 . . . . 0.0 115.469 178.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -112.34 49.04 0.94 Allowed 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.891 -0.724 . . . . 0.0 110.807 -178.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -131.15 129.49 41.85 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 179.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -121.0 143.68 37.48 Favored Pre-proline 0 N--CA 1.493 1.675 0 C-N-CA 118.729 -1.189 . . . . 0.0 108.198 177.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -58.91 161.21 16.02 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 121.703 1.602 . . . . 0.0 109.798 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . 0.466 ' CG ' ' N ' ' A' ' 211' ' ' SER . 38.7 t80 -121.24 168.89 11.11 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 118.853 -1.139 . . . . 0.0 112.176 -179.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' SER . . . . . 0.466 ' N ' ' CG ' ' A' ' 210' ' ' TYR . 47.5 t -110.75 73.55 0.83 Allowed 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.825 0 CA-C-N 112.562 -2.108 . . . . 0.0 114.029 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 58.3 m . . . . . 0 N--CA 1.492 1.633 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 70.39 -179.43 29.21 Favored Glycine 0 N--CA 1.488 2.159 0 C-N-CA 119.873 -1.156 . . . . 0.0 112.603 178.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -117.55 162.52 17.86 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 103.195 -2.891 . . . . 0.0 103.195 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 9.3 mp0 -116.31 118.63 33.28 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 117.54 -1.664 . . . . 0.0 110.943 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.45 ' CD1' HG21 ' A' ' 181' ' ' VAL . 41.3 m-85 -126.0 176.46 6.99 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 104.346 -2.464 . . . . 0.0 104.346 178.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.455 ' CG2' ' CD1' ' A' ' 210' ' ' TYR . 1.7 pt -124.87 146.2 30.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 1 N-CA-C 100.155 -4.017 . . . . 0.0 100.155 170.728 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -92.7 155.07 17.95 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 116.849 -1.941 . . . . 0.0 106.246 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.6 m -130.2 25.64 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 125.719 1.887 . . . . 0.0 110.02 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -121.66 146.28 17.09 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 106.687 -2.565 . . . . 0.0 106.687 176.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -104.9 78.06 1.39 Allowed 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -178.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -106.51 155.81 19.21 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.021 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 97.6 m -118.32 161.82 19.3 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -86.41 144.34 27.36 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 117.49 -1.684 . . . . 0.0 107.868 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -113.61 -30.07 6.94 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 113.043 -1.89 . . . . 0.0 106.584 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.427 ' C ' ' H ' ' A' ' 169' ' ' GLY . 56.3 mt-30 -116.88 176.39 5.14 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 19.4 t -96.83 45.42 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 103.925 -2.621 . . . . 0.0 103.925 176.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . 0.427 ' H ' ' C ' ' A' ' 167' ' ' GLN . . . -127.68 -46.02 0.2 Allowed Glycine 0 N--CA 1.484 1.882 0 N-CA-C 106.84 -2.504 . . . . 0.0 106.84 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.41 ' HA ' ' H ' ' A' ' 201' ' ' LEU . 25.3 m-20 -79.89 169.85 17.31 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 112.7 -1.75 . . . . 0.0 111.308 179.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 15.9 mt -121.07 176.73 5.43 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.427 176.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 47.2 m -119.62 99.46 6.67 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 114.354 -1.294 . . . . 0.0 110.994 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.444 ' N ' ' CD1' ' A' ' 173' ' ' PHE . 1.3 p90 -118.67 161.94 19.25 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.021 -1.072 . . . . 0.0 111.282 178.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -118.51 62.98 0.77 Allowed 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 120.047 3.351 . . . . 0.0 120.047 -175.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 70.4 tttt 37.05 76.83 0.05 OUTLIER 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 116.838 2.162 . . . . 0.0 116.838 173.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 119.1 52.4 0.29 Allowed Glycine 0 N--CA 1.495 2.595 0 CA-C-N 113.68 -1.6 . . . . 0.0 111.703 177.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -131.1 173.37 11.09 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 177.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 18.0 mm -97.16 125.06 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 C-N-CA 118.672 -1.211 . . . . 0.0 112.456 -177.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 17.9 mt -118.31 168.25 10.79 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 114.104 -1.407 . . . . 0.0 110.234 177.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 14.5 tp -118.35 157.98 26.11 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 103.826 -2.657 . . . . 0.0 103.826 177.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.45 HG21 ' CD1' ' A' ' 157' ' ' TYR . 43.7 t -120.0 128.3 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-N 120.675 1.579 . . . . 0.0 112.865 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.491 ' O ' ' CB ' ' A' ' 183' ' ' GLU . 56.3 mt -145.61 86.19 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.284 -176.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . 0.491 ' CB ' ' O ' ' A' ' 182' ' ' ILE . 5.0 tm-20 131.08 151.26 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.932 0 C-N-CA 127.672 2.389 . . . . 0.0 109.11 172.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . 0.492 ' HG2' ' CZ3' ' A' ' 190' ' ' TRP . 55.2 mttp -119.37 123.74 44.89 Favored 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 119.69 3.218 . . . . 0.0 119.69 -171.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.532 ' CG ' ' HE1' ' A' ' 190' ' ' TRP . 2.9 tttm -12.43 80.67 0.03 OUTLIER Pre-proline 0 N--CA 1.512 2.664 0 N-CA-C 118.515 2.783 . . . . 0.0 118.515 175.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.413 ' HD3' ' O ' ' A' ' 189' ' ' TRP . 11.4 Cg_exo -78.59 -55.23 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.527 0 N-CA-C 105.143 -2.676 . . . . 0.0 105.143 174.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -121.99 17.96 10.89 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 112.502 -2.135 . . . . 0.0 110.94 -178.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.41 ' HA2' ' HG2' ' A' ' 185' ' ' LYS . . . 114.02 6.81 20.27 Favored Glycine 0 N--CA 1.487 2.057 0 C-N-CA 118.846 -1.645 . . . . 0.0 109.219 -178.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . 0.413 ' O ' ' HD3' ' A' ' 186' ' ' PRO . 1.1 m-90 -121.65 147.26 46.1 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 119.829 3.27 . . . . 0.0 119.829 -177.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' TRP . . . . . 0.532 ' HE1' ' CG ' ' A' ' 185' ' ' LYS . 42.1 m95 -128.66 160.13 33.42 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 101.43 -3.545 . . . . 0.0 101.43 176.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.432 ' HB ' ' O ' ' A' ' 182' ' ' ILE . 7.7 mt -115.9 116.37 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 177.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -105.4 -177.46 3.37 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -171.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 199' ' ' GLU . 3.3 ttmp? -134.83 166.7 22.37 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 175.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -119.67 -159.12 0.76 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -103.47 37.58 1.98 Allowed 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 120.114 -0.634 . . . . 0.0 110.205 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -128.8 -38.21 1.69 Allowed 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 176.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 138.9 -40.69 1.42 Allowed Glycine 0 N--CA 1.485 1.919 0 N-CA-C 109.021 -1.632 . . . . 0.0 109.021 -178.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -56.35 159.67 3.48 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 118.943 -1.103 . . . . 0.0 113.803 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . 0.454 ' HA ' ' HA ' ' A' ' 193' ' ' LYS . 0.0 OUTLIER -129.98 154.26 47.56 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 112.533 -2.121 . . . . 0.0 109.791 179.468 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -135.53 -170.26 12.05 Favored Glycine 0 N--CA 1.482 1.755 0 CA-C-O 122.913 1.285 . . . . 0.0 114.094 -177.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.41 ' H ' ' HA ' ' A' ' 170' ' ' ASP . 13.2 mt -115.41 92.41 3.91 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 110.483 -2.858 . . . . 0.0 105.554 177.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 25.1 m -117.45 158.0 46.06 Favored Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 -177.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -82.86 178.63 5.86 Favored 'Trans proline' 0 C--N 1.302 -1.919 0 N-CA-C 107.945 -1.598 . . . . 0.0 107.945 179.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 13.3 ttt-85 -96.82 -42.69 7.85 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 105.164 -2.162 . . . . 0.0 105.164 179.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 41.6 p -23.21 -46.03 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.987 0 O-C-N 126.544 2.402 . . . . 0.0 115.777 176.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -106.12 51.78 0.74 Allowed 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 119.271 -0.972 . . . . 0.0 111.898 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 73.3 mt -127.9 135.88 50.61 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 176.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -119.41 145.33 38.47 Favored Pre-proline 0 C--N 1.303 -1.422 0 N-CA-C 103.732 -2.692 . . . . 0.0 103.732 177.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -62.93 158.03 45.34 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 121.427 1.418 . . . . 0.0 108.457 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . 0.455 ' CD1' ' CG2' ' A' ' 158' ' ' ILE . 17.6 t80 -129.47 165.67 21.15 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 118.509 -1.276 . . . . 0.0 110.552 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 29.1 t -119.45 52.0 1.12 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 . . . . . 0 N--CA 1.494 1.769 0 CA-C-N 112.805 -1.998 . . . . 0.0 115.142 -179.674 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 4.1 t . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 122.713 1.244 . . . . 0.0 109.357 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -114.5 175.31 16.06 Favored Glycine 0 N--CA 1.488 2.147 0 CA-C-N 114.196 -1.365 . . . . 0.0 112.485 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -123.06 170.65 9.96 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 103.873 -2.64 . . . . 0.0 103.873 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -106.75 130.01 54.53 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 117.319 -1.752 . . . . 0.0 112.301 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.41 ' CD1' HG21 ' A' ' 181' ' ' VAL . 6.2 m-85 -122.53 178.95 4.76 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 101.756 -3.424 . . . . 0.0 101.756 177.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.414 ' CG2' ' CD1' ' A' ' 210' ' ' TYR . 6.6 pt -127.76 154.8 38.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 103.519 -2.771 . . . . 0.0 103.519 170.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -88.84 151.22 22.49 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 100.308 -3.96 . . . . 0.0 100.308 176.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 35.9 m -127.2 17.56 3.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 125.845 1.965 . . . . 0.0 107.966 178.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -130.59 159.3 22.83 Favored Glycine 0 N--CA 1.484 1.835 0 N-CA-C 105.895 -2.882 . . . . 0.0 105.895 176.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -107.3 93.05 4.34 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.026 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -106.86 156.95 18.14 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 118.645 -1.222 . . . . 0.0 108.393 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 90.8 m -120.15 162.31 19.55 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 104.677 -2.342 . . . . 0.0 104.677 179.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -88.25 139.76 30.17 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 117.412 -1.715 . . . . 0.0 106.479 178.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -112.05 -33.51 6.24 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -114.4 -178.22 3.32 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 113.428 -1.714 . . . . 0.0 106.581 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 14.4 p -94.37 40.22 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-O 124.261 1.981 . . . . 0.0 108.199 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -118.75 -53.41 0.29 Allowed Glycine 0 N--CA 1.485 1.935 0 CA-C-N 112.18 -2.282 . . . . 0.0 109.181 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.404 ' HA ' ' H ' ' A' ' 201' ' ' LEU . 1.7 m-20 -81.78 174.95 10.85 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 38.8 mt -117.28 177.66 4.65 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 111.92 -2.4 . . . . 0.0 108.202 178.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 42.7 m -116.58 91.48 3.6 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 114.182 -1.372 . . . . 0.0 108.004 177.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 16.8 p90 -118.07 164.57 14.93 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 114.0 -1.455 . . . . 0.0 110.497 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -126.54 142.85 51.4 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 117.638 2.459 . . . . 0.0 117.638 -179.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 71.3 tttt -22.25 76.25 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.726 1 CA-C-N 108.03 -4.168 . . . . 0.0 117.016 171.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 114.92 48.89 0.52 Allowed Glycine 0 N--CA 1.488 2.115 0 CA-C-N 114.225 -1.352 . . . . 0.0 112.998 175.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -131.39 155.71 46.8 Favored 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 176.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.496 ' N ' ' CD1' ' A' ' 178' ' ' ILE . 1.1 mp -85.88 135.01 25.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -179.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -124.3 170.98 10.25 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 112.819 -1.992 . . . . 0.0 105.796 175.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 16.6 tp -117.45 154.49 31.3 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 102.028 -3.323 . . . . 0.0 102.028 176.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.41 HG21 ' CD1' ' A' ' 157' ' ' TYR . 2.9 t -126.22 118.93 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 CA-C-N 120.685 1.584 . . . . 0.0 114.681 -176.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.424 ' N ' HD12 ' A' ' 182' ' ' ILE . 0.0 OUTLIER -135.78 93.13 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-O 123.886 1.803 . . . . 0.0 111.046 -177.962 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . 0.441 ' O ' ' CE3' ' A' ' 190' ' ' TRP . 44.1 tt0 140.1 155.8 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.584 1 CA-C-N 107.649 -4.341 . . . . 0.0 107.347 175.905 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . 0.403 ' N ' ' HG2' ' A' ' 183' ' ' GLU . 97.6 mttt -118.53 97.68 5.87 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 117.246 2.313 . . . . 0.0 117.246 -174.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.557 ' HB2' ' NE1' ' A' ' 190' ' ' TRP . 46.0 tttm -15.52 86.7 0.03 OUTLIER Pre-proline 0 N--CA 1.506 2.345 0 N-CA-C 117.095 2.258 . . . . 0.0 117.095 176.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -70.06 -58.46 0.1 OUTLIER 'Trans proline' 0 C--N 1.304 -1.776 0 N-CA-C 103.548 -3.289 . . . . 0.0 103.548 174.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -126.01 28.97 5.98 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 112.812 -1.995 . . . . 0.0 113.018 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.444 ' CA ' ' HG3' ' A' ' 185' ' ' LYS . . . 115.75 12.04 9.77 Favored Glycine 0 N--CA 1.494 2.527 0 C-N-CA 119.631 -1.271 . . . . 0.0 110.378 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 3.4 m-90 -131.27 122.74 27.0 Favored 'General case' 0 N--CA 1.489 1.517 1 N-CA-C 123.336 4.569 . . . . 0.0 123.336 -178.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' TRP . . . . . 0.557 ' NE1' ' HB2' ' A' ' 185' ' ' LYS . 12.2 m95 -119.09 164.71 15.13 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 100.248 -3.982 . . . . 0.0 100.248 173.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 27.4 mt -115.66 119.91 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 102.185 -3.265 . . . . 0.0 102.185 176.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -112.23 177.39 4.66 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 118.259 -1.376 . . . . 0.0 113.843 -174.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -130.16 165.43 22.34 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 173.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 43.0 p-10 -122.75 -163.76 1.12 Allowed 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.258 -0.977 . . . . 0.0 110.025 177.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -98.87 40.93 1.17 Allowed 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 121.935 0.874 . . . . 0.0 108.787 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -128.56 -37.68 1.77 Allowed 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 113.556 -1.656 . . . . 0.0 107.677 177.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 133.29 -37.97 1.92 Allowed Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 19.9 p30 -64.14 165.65 8.92 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 -178.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.17 154.41 48.4 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 112.723 -2.035 . . . . 0.0 111.443 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -135.47 -173.25 12.97 Favored Glycine 0 N--CA 1.486 2.02 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.587 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.404 ' H ' ' HA ' ' A' ' 170' ' ' ASP . 9.6 mt -116.82 82.38 1.79 Allowed 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 104.636 -2.357 . . . . 0.0 104.636 178.016 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 3.2 m -107.21 156.0 38.35 Favored Pre-proline 0 N--CA 1.498 1.941 0 C-N-CA 119.02 -1.072 . . . . 0.0 109.839 -171.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -88.1 179.26 2.83 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 C-N-CA 123.08 2.52 . . . . 0.0 113.084 -177.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 43.2 ttp180 -96.51 -41.84 8.37 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 103.685 -2.709 . . . . 0.0 103.685 174.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 69.8 p -23.55 -52.73 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 O-C-N 126.067 2.104 . . . . 0.0 115.718 178.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -115.49 46.17 1.54 Allowed 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 120.003 -0.679 . . . . 0.0 112.396 -178.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.43 144.55 51.3 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 114.585 -1.188 . . . . 0.0 107.961 179.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -128.41 154.04 79.2 Favored Pre-proline 0 N--CA 1.493 1.691 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 175.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -64.34 154.98 68.36 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 C-N-CA 121.658 1.572 . . . . 0.0 112.582 -178.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . 0.44 ' CE1' HD11 ' A' ' 178' ' ' ILE . 32.4 t80 -134.07 51.13 2.15 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 177.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 35.2 t -100.72 63.05 1.04 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 106.606 -1.628 . . . . 0.0 106.606 -178.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.302 -1.489 0 CA-C-N 112.166 -2.288 . . . . 0.0 110.733 -179.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 86.4 m . . . . . 0 N--CA 1.492 1.67 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 108.94 -179.2 21.1 Favored Glycine 0 N--CA 1.489 2.203 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.918 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -115.96 167.32 11.06 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 103.298 -2.852 . . . . 0.0 103.298 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -101.96 122.15 43.5 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 117.274 -1.77 . . . . 0.0 112.407 -176.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.449 ' CD1' HG22 ' A' ' 181' ' ' VAL . 1.0 OUTLIER -126.95 169.8 12.93 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 102.613 -3.106 . . . . 0.0 102.613 176.485 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.537 HG23 HG12 ' A' ' 178' ' ' ILE . 36.7 pt -125.34 142.14 43.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 C-N-CA 118.058 -1.457 . . . . 0.0 108.524 170.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.462 ' O ' ' N ' ' A' ' 176' ' ' GLY . . . -72.33 152.52 42.04 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 101.631 -3.47 . . . . 0.0 101.631 178.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 26.8 m -118.47 -4.12 10.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 125.892 1.995 . . . . 0.0 108.521 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -137.16 177.01 20.13 Favored Glycine 0 N--CA 1.485 1.962 0 N-CA-C 107.363 -2.295 . . . . 0.0 107.363 178.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -106.51 132.2 52.8 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 118.857 -1.137 . . . . 0.0 109.205 178.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -123.29 153.37 40.31 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 176.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 67.9 m -126.77 156.35 41.36 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -95.79 138.49 33.36 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 178.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -111.82 -34.88 5.88 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 88.0 mm-40 -117.45 -176.01 2.93 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 113.314 -1.767 . . . . 0.0 106.328 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 61.9 t -87.62 154.94 3.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 104.224 -2.51 . . . . 0.0 104.224 178.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 113.28 -48.2 0.96 Allowed Glycine 0 N--CA 1.485 1.948 0 N-CA-C 107.905 -2.078 . . . . 0.0 107.905 -178.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.451 ' HA ' ' H ' ' A' ' 201' ' ' LEU . 3.4 m-20 -83.91 167.42 17.0 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 113.731 -1.235 . . . . 0.0 113.785 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.423 ' CD2' HD21 ' A' ' 198' ' ' ASN . 19.3 mt -121.22 173.68 7.16 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 114.128 -1.396 . . . . 0.0 109.624 178.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 55.0 m -123.94 93.76 4.02 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 114.355 -1.293 . . . . 0.0 110.128 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.425 ' N ' ' CD1' ' A' ' 173' ' ' PHE . 20.1 p90 -126.6 167.92 15.01 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.862 -178.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -118.27 165.93 13.23 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 123.504 1.621 . . . . 0.0 114.338 177.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 52.2 tttm -39.02 154.37 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 110.534 -3.03 . . . . 0.0 117.081 175.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 159' ' ' ALA . . . 33.14 48.75 0.42 Allowed Glycine 0 N--CA 1.493 2.454 0 CA-C-N 112.095 -2.321 . . . . 0.0 111.02 177.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.406 ' O ' ' HA ' ' A' ' 158' ' ' ILE . 5.4 pt-20 -121.39 162.68 19.96 Favored 'General case' 0 N--CA 1.506 2.348 0 CA-C-N 111.722 -2.239 . . . . 0.0 108.372 176.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.537 HG12 HG23 ' A' ' 158' ' ' ILE . 44.7 mt -99.53 120.41 48.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 N-CA-C 118.69 2.848 . . . . 0.0 118.69 -176.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 21.4 mt -118.72 168.59 10.59 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 110.992 -2.822 . . . . 0.0 108.854 178.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -110.74 158.5 18.58 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 177.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.449 HG22 ' CD1' ' A' ' 157' ' ' TYR . 50.5 t -119.38 117.81 55.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 C-N-CA 119.65 -0.82 . . . . 0.0 112.975 -178.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.508 ' O ' ' HB ' ' A' ' 191' ' ' ILE . 3.4 mp -139.55 83.31 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.203 -1.35 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.292 -174.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . 0.471 ' O ' ' CE3' ' A' ' 190' ' ' TRP . 35.8 tt0 136.14 150.59 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.764 0 C-N-CA 127.931 2.493 . . . . 0.0 107.897 173.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -115.94 124.55 50.85 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 -176.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.454 ' CG ' ' HE1' ' A' ' 190' ' ' TRP . 3.6 tttm -10.7 77.4 0.03 OUTLIER Pre-proline 0 N--CA 1.504 2.261 0 O-C-N 126.658 2.473 . . . . 0.0 116.912 177.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -69.39 -57.04 0.13 Allowed 'Trans proline' 0 C--N 1.307 -1.615 0 N-CA-C 105.306 -2.613 . . . . 0.0 105.306 175.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -122.44 17.38 10.53 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 111.406 -2.634 . . . . 0.0 113.176 -177.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 121.19 -25.7 6.96 Favored Glycine 0 N--CA 1.489 2.173 0 C-N-CA 118.359 -1.877 . . . . 0.0 110.596 -178.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 31.3 m-90 -114.84 153.42 30.47 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 122.826 1.298 . . . . 0.0 113.925 -176.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' TRP . . . . . 0.471 ' CE3' ' O ' ' A' ' 183' ' ' GLU . 16.7 m95 -115.9 168.58 9.93 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 100.266 -3.976 . . . . 0.0 100.266 -178.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.508 ' HB ' ' O ' ' A' ' 182' ' ' ILE . 2.1 mm -111.0 109.98 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 103.367 -2.827 . . . . 0.0 103.367 -179.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -106.26 179.99 4.11 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -172.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 199' ' ' GLU . 36.6 ttpt -139.97 163.24 33.2 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 118.748 -1.181 . . . . 0.0 109.549 177.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -121.19 -165.91 1.29 Allowed 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.885 178.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -106.15 40.44 1.59 Allowed 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.897 0.856 . . . . 0.0 109.603 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -118.53 -42.54 2.75 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 177.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 141.94 -48.27 0.8 Allowed Glycine 0 N--CA 1.482 1.718 0 N-CA-C 106.005 -2.838 . . . . 0.0 106.005 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . 0.423 HD21 ' CD2' ' A' ' 171' ' ' LEU . 0.8 OUTLIER -55.15 154.01 6.16 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 179.345 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . 0.437 ' HA ' ' HA ' ' A' ' 193' ' ' LYS . 0.0 OUTLIER -129.17 154.35 46.83 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 112.73 -2.032 . . . . 0.0 107.777 178.13 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -136.03 -161.04 9.04 Favored Glycine 0 N--CA 1.479 1.514 0 C-N-CA 120.009 -1.091 . . . . 0.0 113.161 -176.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.451 ' H ' ' HA ' ' A' ' 170' ' ' ASP . 36.2 mt -118.67 94.08 4.34 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 110.497 -2.852 . . . . 0.0 105.727 179.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 5.3 m -112.81 150.54 42.95 Favored Pre-proline 0 N--CA 1.498 1.932 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 -177.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -75.3 175.35 11.38 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 C-N-CA 121.174 1.25 . . . . 0.0 109.761 -177.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.4 -40.63 8.19 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 103.562 -2.755 . . . . 0.0 103.562 178.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 76.7 p -28.87 -50.97 0.09 Allowed 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 113.3 -1.773 . . . . 0.0 114.602 175.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -113.62 39.12 2.73 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.569 0.7 . . . . 0.0 112.331 -178.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.91 98.56 5.57 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 104.937 -2.246 . . . . 0.0 104.937 178.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -106.62 148.33 36.62 Favored Pre-proline 0 C--N 1.299 -1.621 0 N-CA-C 104.039 -2.578 . . . . 0.0 104.039 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -53.57 165.81 1.52 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.489 2.126 . . . . 0.0 113.18 -177.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . 0.412 ' CG ' ' N ' ' A' ' 211' ' ' SER . 45.4 t80 -116.7 -99.27 0.44 Allowed 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.734 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' SER . . . . . 0.412 ' N ' ' CG ' ' A' ' 210' ' ' TYR . 46.6 m -125.69 -52.22 1.58 Allowed 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 123.872 1.796 . . . . 0.0 108.299 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 . . . . . 0 C--N 1.292 -1.922 0 CA-C-N 109.537 -3.483 . . . . 0.0 110.668 -179.429 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 25.7 p . . . . . 0 N--CA 1.488 1.472 0 CA-C-O 121.209 0.528 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 110.39 170.19 19.69 Favored Glycine 0 N--CA 1.49 2.29 0 CA-C-N 114.973 -1.012 . . . . 0.0 114.681 177.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -128.82 159.5 35.54 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 103.965 -2.606 . . . . 0.0 103.965 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -105.63 134.4 48.8 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 115.968 -2.293 . . . . 0.0 112.967 -177.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.445 ' CD1' HG21 ' A' ' 181' ' ' VAL . 7.1 m-85 -115.49 -178.41 3.38 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 101.397 -3.557 . . . . 0.0 101.397 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.11 152.72 33.68 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 N-CA-C 100.504 -3.887 . . . . 0.0 100.504 175.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -91.88 148.64 22.07 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 102.824 -3.028 . . . . 0.0 102.824 178.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 32.7 m -126.6 9.46 3.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 125.128 1.518 . . . . 0.0 108.773 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -130.03 161.83 23.03 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 104.989 -3.244 . . . . 0.0 104.989 176.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -109.3 97.54 7.12 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 118.95 -1.1 . . . . 0.0 109.107 178.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -104.3 155.1 19.04 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 118.361 -1.336 . . . . 0.0 107.628 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 88.3 m -123.21 165.24 17.24 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 103.862 -2.644 . . . . 0.0 103.862 179.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -91.63 145.25 24.74 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 117.653 -1.619 . . . . 0.0 108.452 179.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -113.7 -38.53 4.26 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -121.45 158.99 27.18 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 113.456 -1.702 . . . . 0.0 106.539 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 83.3 t -41.47 -57.68 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 125.099 1.499 . . . . 0.0 107.472 176.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -27.19 -56.22 0.1 OUTLIER Glycine 0 N--CA 1.486 2.025 0 CA-C-N 112.431 -2.168 . . . . 0.0 114.055 175.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -75.68 161.83 28.75 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -177.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.455 HD12 ' CA ' ' A' ' 200' ' ' GLY . 1.5 tp -116.88 -178.58 3.47 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 112.966 -1.925 . . . . 0.0 109.424 177.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 33.7 m -129.24 98.63 4.95 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 112.394 -2.185 . . . . 0.0 111.805 -178.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -122.17 167.44 13.18 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.785 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -121.53 144.11 48.9 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 116.732 2.123 . . . . 0.0 116.732 179.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -35.07 80.66 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 108.529 -3.941 . . . . 0.0 114.426 172.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 111.33 50.16 0.63 Allowed Glycine 0 N--CA 1.49 2.293 0 CA-C-N 114.726 -1.125 . . . . 0.0 112.125 178.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -126.91 -172.66 2.69 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 177.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 14.4 mm -109.26 137.54 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 123.992 0.807 . . . . 0.0 111.139 177.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 54.2 mt -128.92 169.12 15.01 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 113.588 -1.642 . . . . 0.0 110.008 178.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.481 ' HB2' ' HB2' ' A' ' 193' ' ' LYS . 6.9 mt -121.74 157.82 30.14 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 174.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.445 HG21 ' CD1' ' A' ' 157' ' ' TYR . 92.6 t -119.14 117.48 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 116.714 2.116 . . . . 0.0 116.714 -178.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.43 ' O ' ' CB ' ' A' ' 183' ' ' GLU . 1.7 mm -123.63 70.79 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 105.472 -2.048 . . . . 0.0 105.472 178.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . 0.43 ' CB ' ' O ' ' A' ' 182' ' ' ILE . 10.8 tp10 125.35 141.53 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.296 0 C-N-CA 128.853 2.861 . . . . 0.0 109.756 177.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . 0.43 ' N ' ' HG3' ' A' ' 183' ' ' GLU . 96.2 mttt -120.14 113.54 20.61 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 177.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.52 ' HB2' ' CA ' ' A' ' 188' ' ' GLY . 0.0 OUTLIER -14.37 75.75 0.02 OUTLIER Pre-proline 0 N--CA 1.495 1.781 0 N-CA-C 121.383 3.846 . . . . 0.0 121.383 -171.503 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -43.65 -58.81 1.25 Allowed 'Trans proline' 0 C--N 1.314 -1.289 0 C-N-CA 123.647 2.898 . . . . 0.0 106.221 171.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -124.98 23.17 7.87 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 111.761 -2.472 . . . . 0.0 111.645 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.52 ' CA ' ' HB2' ' A' ' 185' ' ' LYS . . . 113.53 2.16 24.39 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 3.9 m-90 -126.33 119.74 28.11 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 119.621 3.193 . . . . 0.0 119.621 -176.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' TRP . . . . . 0.502 ' NE1' ' HD3' ' A' ' 185' ' ' LYS . 5.7 m0 -103.21 150.61 23.53 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 104.084 -2.562 . . . . 0.0 104.084 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 8.0 mm -113.76 102.19 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 100.341 -3.948 . . . . 0.0 100.341 177.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -106.06 169.4 8.52 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 118.174 -1.411 . . . . 0.0 112.614 -171.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . 0.481 ' HB2' ' HB2' ' A' ' 180' ' ' LEU . 93.7 mttt -117.86 161.93 18.94 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 104.117 -2.549 . . . . 0.0 104.117 176.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -126.35 -162.63 1.15 Allowed 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 118.557 -1.257 . . . . 0.0 110.474 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -98.96 40.85 1.17 Allowed 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.692 -0.803 . . . . 0.0 109.773 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -128.56 -40.75 1.56 Allowed 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 176.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 140.28 -47.39 0.88 Allowed Glycine 0 N--CA 1.487 2.099 0 N-CA-C 107.348 -2.301 . . . . 0.0 107.348 178.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -57.26 161.31 3.34 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 114.965 1.468 . . . . 0.0 114.965 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . 0.406 ' HG3' ' N ' ' A' ' 200' ' ' GLY . 0.0 OUTLIER -130.55 151.42 51.04 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 113.598 -1.637 . . . . 0.0 108.464 176.772 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . 0.455 ' CA ' HD12 ' A' ' 171' ' ' LEU . . . -139.64 -157.05 7.14 Favored Glycine 0 N--CA 1.484 1.877 0 C-N-CA 119.333 -1.413 . . . . 0.0 113.399 -178.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 42.4 mt -112.34 96.15 5.85 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 111.133 -2.533 . . . . 0.0 108.708 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 3.7 m -112.26 154.46 44.41 Favored Pre-proline 0 N--CA 1.49 1.525 0 N-CA-C 105.777 -1.934 . . . . 0.0 105.777 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 0.4 OUTLIER -88.4 -178.24 2.01 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 C-N-CA 123.721 2.947 . . . . 0.0 112.346 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . 0.518 ' HB2' ' CD ' ' A' ' 185' ' ' LYS . 24.8 ttt85 -74.29 -59.65 2.63 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 173.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 69.5 p -18.37 -48.55 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.134 0 CA-C-N 109.876 -3.329 . . . . 0.0 117.187 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -110.45 38.32 2.49 Favored 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 119.192 -1.003 . . . . 0.0 112.243 -178.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -123.53 104.98 9.38 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 124.238 0.961 . . . . 0.0 111.427 -178.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -112.61 155.04 44.46 Favored Pre-proline 0 N--CA 1.496 1.853 0 C-N-CA 117.891 -1.524 . . . . 0.0 107.021 175.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -64.19 164.21 23.43 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 121.809 1.672 . . . . 0.0 111.963 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -123.39 -178.81 4.11 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 79.1 p -118.8 32.57 6.06 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.587 -0.845 . . . . 0.0 112.253 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 115.045 -2.407 . . . . 0.0 107.212 176.842 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.441 HG21 ' H ' ' A' ' 154' ' ' GLY . 37.2 m . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.441 ' H ' HG21 ' A' ' 153' ' ' THR . . . -113.49 -178.66 19.36 Favored Glycine 0 N--CA 1.488 2.113 0 C-N-CA 120.561 -0.828 . . . . 0.0 113.616 -179.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -130.79 170.98 13.64 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.438 ' CD ' ' H ' ' A' ' 156' ' ' GLU . 0.0 OUTLIER -110.79 123.83 50.84 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 116.972 -1.891 . . . . 0.0 112.969 -178.001 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.44 ' CD1' HG23 ' A' ' 181' ' ' VAL . 5.9 m-85 -119.18 178.11 4.64 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 102.649 -3.093 . . . . 0.0 102.649 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 2.9 pt -128.28 145.48 35.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 102.409 -3.182 . . . . 0.0 102.409 172.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -92.26 151.55 20.27 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 115.011 -2.676 . . . . 0.0 103.876 177.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 28.0 m -127.67 32.81 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 125.838 1.961 . . . . 0.0 108.23 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -129.96 158.03 22.14 Favored Glycine 0 N--CA 1.483 1.824 0 N-CA-C 105.762 -2.935 . . . . 0.0 105.762 173.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -106.06 76.14 1.15 Allowed 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -102.21 148.53 25.32 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 118.463 -1.295 . . . . 0.0 108.428 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 87.5 m -120.21 161.49 20.98 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 104.461 -2.422 . . . . 0.0 104.461 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -93.17 135.77 34.05 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 105.744 -1.946 . . . . 0.0 105.744 178.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -110.65 -31.34 7.25 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 -115.71 -178.88 3.49 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 105.091 -2.189 . . . . 0.0 105.091 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 61.8 t -89.94 152.47 3.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 103.317 -2.846 . . . . 0.0 103.317 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 114.54 -47.86 1.0 Allowed Glycine 0 N--CA 1.486 2.02 0 N-CA-C 108.503 -1.839 . . . . 0.0 108.503 -177.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -82.2 168.7 17.4 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 113.964 -1.118 . . . . 0.0 112.622 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 41.8 mt -127.66 178.7 5.95 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.842 176.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 57.3 m -122.13 102.57 8.22 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 114.453 -1.248 . . . . 0.0 113.316 -178.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -118.92 167.96 11.23 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.315 -0.954 . . . . 0.0 111.522 177.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -114.99 62.21 0.68 Allowed 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 121.019 3.711 . . . . 0.0 121.019 -175.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 15.6 tptm 41.02 74.12 0.11 Allowed 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 117.102 2.26 . . . . 0.0 117.102 174.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 116.53 50.99 0.4 Allowed Glycine 0 N--CA 1.495 2.609 0 CA-C-N 114.412 -1.267 . . . . 0.0 113.822 173.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.474 ' CD ' ' N ' ' A' ' 177' ' ' GLU . 0.2 OUTLIER -139.92 163.45 32.63 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 177.837 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.494 ' N ' ' CD1' ' A' ' 178' ' ' ILE . 1.0 OUTLIER -87.99 134.01 29.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 116.361 1.986 . . . . 0.0 116.361 -176.376 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.5 mp -131.42 175.62 8.98 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 112.671 -2.059 . . . . 0.0 108.076 174.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.413 HD11 ' H ' ' A' ' 181' ' ' VAL . 0.5 OUTLIER -112.92 156.18 23.44 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 102.713 -3.069 . . . . 0.0 102.713 -179.449 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.44 HG23 ' CD1' ' A' ' 157' ' ' TYR . 2.8 t -127.15 135.74 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 CA-C-N 120.924 1.693 . . . . 0.0 109.906 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.446 ' O ' ' CB ' ' A' ' 183' ' ' GLU . 4.3 mt -143.49 84.13 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -174.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . 0.446 ' CB ' ' O ' ' A' ' 182' ' ' ILE . 34.2 tt0 142.32 154.13 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.54 0 C-N-CA 126.446 1.898 . . . . 0.0 108.594 176.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -121.34 116.95 25.77 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 115.256 1.576 . . . . 0.0 115.256 -178.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.431 ' CG ' ' HE1' ' A' ' 190' ' ' TRP . 9.3 tttm -7.27 81.18 0.03 OUTLIER Pre-proline 0 N--CA 1.5 2.071 0 CA-C-N 111.757 -2.474 . . . . 0.0 117.378 175.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.418 ' HD2' ' H ' ' A' ' 189' ' ' TRP . 97.1 Cg_endo -78.66 -52.83 0.06 OUTLIER 'Trans proline' 0 C--N 1.302 -1.877 0 C-N-CA 122.797 2.331 . . . . 0.0 106.805 175.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -126.79 14.07 7.45 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.244 -1.343 . . . . 0.0 109.085 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 118.18 7.49 11.26 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . 0.418 ' H ' ' HD2' ' A' ' 186' ' ' PRO . 1.4 m-90 -122.54 142.13 50.94 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 119.767 3.247 . . . . 0.0 119.767 -179.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' TRP . . . . . 0.493 ' NE1' ' HB2' ' A' ' 204' ' ' ARG . 22.7 m95 -124.7 157.7 34.99 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 100.412 -3.921 . . . . 0.0 100.412 177.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.411 ' HB ' ' O ' ' A' ' 182' ' ' ILE . 31.2 mm -97.99 171.06 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.866 1 N-CA-C 99.845 -4.131 . . . . 0.0 99.845 176.671 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 199' ' ' GLU . . . -152.95 176.17 12.14 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 116.683 -2.007 . . . . 0.0 109.893 177.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -134.02 159.58 40.36 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 170.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 58.4 p30 -120.12 -162.78 0.95 Allowed 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 118.594 -1.242 . . . . 0.0 111.426 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -99.54 39.44 1.31 Allowed 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.086 -1.046 . . . . 0.0 109.692 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -121.38 -39.35 2.68 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 176.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 126.98 -1.79 7.29 Favored Glycine 0 N--CA 1.492 2.402 0 CA-C-N 114.803 -1.09 . . . . 0.0 111.224 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 26.3 p30 -100.7 176.68 5.23 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 192' ' ' ALA . 1.5 pt-20 -113.28 166.57 11.34 Favored 'General case' 0 N--CA 1.484 1.27 0 O-C-N 125.859 1.974 . . . . 0.0 109.332 -179.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -144.58 -178.46 20.25 Favored Glycine 0 N--CA 1.481 1.698 0 CA-C-O 122.389 0.994 . . . . 0.0 113.428 -175.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 15.4 mt -125.26 89.18 3.01 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 177.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 3.9 m -111.7 157.16 40.18 Favored Pre-proline 0 N--CA 1.487 1.409 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 -175.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -90.08 179.57 1.98 Allowed 'Trans proline' 0 C--N 1.3 -2.014 0 C-N-CA 122.103 1.869 . . . . 0.0 109.405 178.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . 0.493 ' HB2' ' NE1' ' A' ' 190' ' ' TRP . 10.8 tpt180 -97.54 -43.23 7.33 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 176.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' THR . . . . . 0.458 ' HG1' ' H ' ' A' ' 206' ' ' TYR . 43.0 p -25.56 -51.31 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 126.231 2.207 . . . . 0.0 114.731 177.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . 0.458 ' H ' ' HG1' ' A' ' 205' ' ' THR . 85.7 m-85 -113.88 50.43 0.92 Allowed 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 119.778 -0.769 . . . . 0.0 111.781 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -133.5 135.95 44.77 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 177.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -125.39 154.67 72.32 Favored Pre-proline 0 N--CA 1.489 1.516 0 N-CA-C 105.785 -1.932 . . . . 0.0 105.785 176.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -67.2 165.97 24.83 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 N-CA-C 108.617 -1.34 . . . . 0.0 108.617 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . 0.417 ' CE1' HD13 ' A' ' 178' ' ' ILE . 34.5 t80 -123.18 -179.73 4.4 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 179.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 65.5 p -110.43 44.72 1.21 Allowed 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.833 -0.747 . . . . 0.0 111.096 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 114.825 -2.512 . . . . 0.0 107.248 177.589 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 75.1 m . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 47.57 -174.28 0.02 OUTLIER Glycine 0 N--CA 1.493 2.496 0 N-CA-C 116.102 1.201 . . . . 0.0 116.102 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.424 ' CD ' ' N ' ' A' ' 155' ' ' GLU . 1.4 pm0 -131.36 169.86 15.43 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 106.02 -1.845 . . . . 0.0 106.02 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -121.78 142.16 50.49 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 117.502 -1.679 . . . . 0.0 114.937 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -128.93 -178.91 4.82 Favored 'General case' 0 C--N 1.301 -1.516 1 N-CA-C 99.664 -4.199 . . . . 0.0 99.664 177.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 4.2 pt -130.54 152.87 38.18 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 101.647 -3.464 . . . . 0.0 101.647 170.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -91.5 156.2 17.86 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 104.325 -2.472 . . . . 0.0 104.325 179.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 20.3 m -125.33 8.61 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 126.045 2.091 . . . . 0.0 107.916 176.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -132.97 168.7 22.83 Favored Glycine 0 N--CA 1.483 1.83 0 N-CA-C 105.746 -2.942 . . . . 0.0 105.746 175.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -107.06 146.6 31.0 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 177.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -124.8 160.53 28.5 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 104.805 -2.295 . . . . 0.0 104.805 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 96.4 m -129.45 151.48 50.03 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 118.864 -1.134 . . . . 0.0 108.333 178.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -98.51 138.67 35.39 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 118.296 -1.362 . . . . 0.0 108.01 178.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -114.42 -32.58 5.88 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 113.213 -1.812 . . . . 0.0 106.708 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -112.9 179.85 3.85 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 114.144 -1.389 . . . . 0.0 107.86 -179.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 16.3 t -95.45 47.21 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -128.76 -53.53 0.11 Allowed Glycine 0 N--CA 1.485 1.944 0 N-CA-C 108.331 -1.907 . . . . 0.0 108.331 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -76.48 163.47 26.9 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 113.542 -1.329 . . . . 0.0 113.788 -178.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.429 HD13 ' HA3' ' A' ' 200' ' ' GLY . 1.1 tp -108.51 -171.61 1.89 Allowed 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 111.954 -2.384 . . . . 0.0 109.078 175.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 53.6 m -120.88 -69.24 0.85 Allowed 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 113.736 -1.575 . . . . 0.0 114.335 -177.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 54.2 p90 37.52 164.33 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.527 0 N-CA-C 117.12 2.267 . . . . 0.0 117.12 -174.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -130.16 151.83 50.26 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 118.391 2.737 . . . . 0.0 118.391 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -21.28 80.41 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.568 1 CA-C-N 108.342 -4.026 . . . . 0.0 118.057 171.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 110.04 47.99 0.8 Allowed Glycine 0 N--CA 1.493 2.473 0 CA-C-N 114.728 -1.124 . . . . 0.0 112.878 174.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -135.84 154.91 51.03 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 117.309 -1.757 . . . . 0.0 108.045 177.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.479 ' N ' ' CD1' ' A' ' 178' ' ' ILE . 1.1 mp -80.6 130.94 35.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -178.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 27.7 mt -120.15 162.59 19.07 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 113.129 -1.851 . . . . 0.0 108.222 176.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.441 HD11 ' N ' ' A' ' 181' ' ' VAL . 1.6 tm? -116.06 151.38 35.65 Favored 'General case' 0 N--CA 1.498 1.93 1 N-CA-C 100.105 -4.035 . . . . 0.0 100.105 179.345 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.441 ' N ' HD11 ' A' ' 180' ' ' LEU . 2.4 t -121.05 139.12 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 CA-C-N 122.041 2.2 . . . . 0.0 111.074 -179.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.416 ' O ' ' CB ' ' A' ' 183' ' ' GLU . 42.9 mt -145.0 87.09 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-O 121.105 0.479 . . . . 0.0 111.004 -176.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . 0.485 ' O ' ' CE3' ' A' ' 190' ' ' TRP . 0.0 OUTLIER 135.96 148.7 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.586 0 C-N-CA 128.359 2.664 . . . . 0.0 107.084 172.59 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -106.24 117.45 34.06 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 118.276 2.695 . . . . 0.0 118.276 -172.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.493 ' CG ' ' HE1' ' A' ' 190' ' ' TRP . 0.8 OUTLIER -11.97 81.38 0.03 OUTLIER Pre-proline 0 N--CA 1.507 2.389 0 N-CA-C 118.124 2.639 . . . . 0.0 118.124 175.24 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -73.06 -56.23 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 123.549 2.833 . . . . 0.0 105.684 175.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 21.3 p-10 -120.97 16.34 11.69 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 112.08 -2.327 . . . . 0.0 113.877 -177.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.418 ' CA ' ' HG2' ' A' ' 185' ' ' LYS . . . 118.09 -15.81 12.1 Favored Glycine 0 N--CA 1.493 2.465 0 C-N-CA 118.712 -1.709 . . . . 0.0 109.002 -178.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 13.5 m-90 -116.61 149.39 39.77 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 116.761 2.134 . . . . 0.0 116.761 -176.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' TRP . . . . . 0.493 ' HE1' ' CG ' ' A' ' 185' ' ' LYS . 20.0 m95 -122.88 169.15 11.41 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 102.396 -3.187 . . . . 0.0 102.396 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.408 ' HB ' ' O ' ' A' ' 182' ' ' ILE . 2.5 mp -113.95 103.58 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 104.652 -2.351 . . . . 0.0 104.652 175.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -94.34 178.35 5.65 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -173.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -124.91 158.58 33.2 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 103.273 -2.862 . . . . 0.0 103.273 175.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 51.6 p-10 -124.69 -167.1 1.61 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.279 -0.968 . . . . 0.0 111.148 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -99.09 43.14 1.07 Allowed 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 122.123 0.963 . . . . 0.0 108.47 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 4.8 tmtm? -126.05 -45.11 1.73 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 104.204 -2.517 . . . . 0.0 104.204 177.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 137.91 -40.17 1.51 Allowed Glycine 0 N--CA 1.485 1.925 0 N-CA-C 108.109 -1.996 . . . . 0.0 108.109 -178.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -69.98 164.15 24.53 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 118.795 -1.162 . . . . 0.0 113.626 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.36 157.68 46.06 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 112.9 -1.955 . . . . 0.0 109.238 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . 0.429 ' HA3' HD13 ' A' ' 171' ' ' LEU . . . 179.58 -173.76 45.54 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 118.248 -1.929 . . . . 0.0 112.418 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 59.2 mt -71.63 96.25 1.54 Allowed 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -176.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 3.2 m -119.54 153.96 54.27 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 103.641 -2.726 . . . . 0.0 103.641 177.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -87.12 174.72 5.2 Favored 'Trans proline' 0 C--N 1.301 -1.945 0 C-N-CA 121.804 1.669 . . . . 0.0 109.197 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 28.9 ttt180 -106.16 -22.81 12.76 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 177.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 53.9 p -34.37 -50.18 0.41 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 113.91 -1.495 . . . . 0.0 114.368 173.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -105.38 34.3 3.31 Favored 'General case' 0 N--CA 1.503 2.198 0 C-N-CA 118.354 -1.338 . . . . 0.0 111.681 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 3.2 mp -119.42 118.78 32.05 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 124.817 1.323 . . . . 0.0 110.65 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . 0.412 ' CD ' ' N ' ' A' ' 208' ' ' GLU . 43.6 mp0 -115.57 150.74 45.21 Favored Pre-proline 0 C--N 1.297 -1.712 0 N-CA-C 105.982 -1.858 . . . . 0.0 105.982 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -55.16 164.43 3.68 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.292 1.995 . . . . 0.0 113.308 -177.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . 0.471 ' CG ' ' N ' ' A' ' 211' ' ' SER . 43.3 t80 -118.78 -178.72 3.61 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 179.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' SER . . . . . 0.471 ' N ' ' CG ' ' A' ' 210' ' ' TYR . 77.6 p -101.58 33.87 2.81 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 178.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 115.312 -2.28 . . . . 0.0 115.088 178.045 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 43.4 p . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -120.73 -179.19 16.18 Favored Glycine 0 N--CA 1.487 2.061 0 CA-C-N 114.514 -1.221 . . . . 0.0 113.549 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -128.9 165.18 21.54 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 104.053 -2.573 . . . . 0.0 104.053 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -107.76 135.59 48.92 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 116.92 -1.912 . . . . 0.0 111.081 -178.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -132.6 176.24 8.62 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 109.503 -3.499 . . . . 0.0 105.285 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.433 HG22 ' CD1' ' A' ' 210' ' ' TYR . 0.4 OUTLIER -126.31 143.05 41.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 1 N-CA-C 99.572 -4.232 . . . . 0.0 99.572 172.273 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -93.1 151.96 19.55 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 115.983 -2.287 . . . . 0.0 105.311 178.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 35.6 m -127.81 24.3 2.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 125.39 1.681 . . . . 0.0 109.054 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -123.55 153.6 17.26 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 106.697 -2.561 . . . . 0.0 106.697 177.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -105.66 82.53 1.81 Allowed 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 120.069 -0.652 . . . . 0.0 109.834 -179.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -108.68 151.88 25.57 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 118.879 -1.129 . . . . 0.0 108.54 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 53.7 m -122.07 159.86 26.21 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -89.15 133.25 34.47 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 178.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -109.83 -29.23 8.39 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 26.8 pt20 -117.64 -176.31 3.0 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 178.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 9.9 p -91.3 157.02 2.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 177.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 111.44 -50.44 0.77 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 -178.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -79.38 169.65 17.76 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 113.806 -1.197 . . . . 0.0 112.116 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 66.4 mt -126.02 178.22 5.89 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 114.223 -1.353 . . . . 0.0 109.744 177.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 53.5 m -120.48 99.28 6.47 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 114.484 -1.235 . . . . 0.0 112.179 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -115.65 165.87 12.56 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 118.82 -1.152 . . . . 0.0 110.172 177.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? -121.13 57.37 1.0 Allowed 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 121.22 3.785 . . . . 0.0 121.22 -174.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 70.9 tttt 46.67 76.78 0.09 Allowed 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 116.554 2.057 . . . . 0.0 116.554 174.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 117.28 52.27 0.34 Allowed Glycine 0 N--CA 1.495 2.632 0 CA-C-N 114.15 -1.386 . . . . 0.0 111.743 175.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.451 ' CD ' ' N ' ' A' ' 177' ' ' GLU . 2.8 pm0 -131.88 -179.12 5.21 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 178.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 7.0 mm -112.58 120.06 61.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 124.513 1.133 . . . . 0.0 113.885 -175.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -123.72 170.3 10.64 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 16.6 tp -111.12 156.24 21.65 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 100.586 -3.857 . . . . 0.0 100.586 175.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.481 ' CG1' ' HB3' ' A' ' 190' ' ' TRP . 2.4 t -126.66 140.33 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 CA-C-N 120.42 1.463 . . . . 0.0 109.243 -178.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.44 ' O ' ' CB ' ' A' ' 183' ' ' GLU . 21.3 mt -143.57 78.07 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 120.251 -0.579 . . . . 0.0 110.779 -174.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . 0.52 ' O ' ' CE3' ' A' ' 190' ' ' TRP . 31.4 tt0 139.85 150.02 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.708 0 C-N-CA 127.005 2.122 . . . . 0.0 108.576 177.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -114.15 100.87 8.7 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -176.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -11.52 77.09 0.02 OUTLIER Pre-proline 0 N--CA 1.496 1.854 0 N-CA-C 121.656 3.947 . . . . 0.0 121.656 -177.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.402 ' HD2' ' O ' ' A' ' 189' ' ' TRP . 11.4 Cg_endo -46.26 -59.95 1.03 Allowed 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 123.341 2.694 . . . . 0.0 106.932 171.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -121.81 21.85 10.61 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 111.922 -2.399 . . . . 0.0 110.431 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 114.21 11.29 12.32 Favored Glycine 0 N--CA 1.488 2.162 0 C-N-CA 119.629 -1.272 . . . . 0.0 110.986 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . 0.441 ' CD1' ' HB3' ' A' ' 201' ' ' LEU . 2.1 m-90 -125.02 136.55 53.82 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 121.433 3.864 . . . . 0.0 121.433 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' TRP . . . . . 0.52 ' CE3' ' O ' ' A' ' 183' ' ' GLU . 32.4 m95 -119.4 154.66 33.3 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 101.519 -3.511 . . . . 0.0 101.519 178.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.429 ' HB ' ' O ' ' A' ' 182' ' ' ILE . 1.7 mp -109.23 114.11 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 104.234 -2.506 . . . . 0.0 104.234 176.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -107.6 177.55 4.8 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 118.859 -1.136 . . . . 0.0 113.898 -170.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -134.24 160.58 37.42 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 174.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 47.4 p-10 -117.67 -160.51 0.78 Allowed 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 118.456 -1.298 . . . . 0.0 110.406 177.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -101.32 42.26 1.14 Allowed 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 122.398 1.094 . . . . 0.0 108.586 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 5.4 tmtm? -127.01 -44.16 1.63 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 177.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 135.78 -41.08 1.46 Allowed Glycine 0 N--CA 1.485 1.936 0 N-CA-C 108.455 -1.858 . . . . 0.0 108.455 -178.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -53.58 163.38 0.66 Allowed 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 116.037 1.866 . . . . 0.0 116.037 -178.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -103.52 157.08 17.29 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 110.835 -2.893 . . . . 0.0 115.422 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -134.61 -179.56 16.6 Favored Glycine 0 N--CA 1.483 1.827 0 CA-C-N 112.671 -2.059 . . . . 0.0 113.978 -175.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.441 ' HB3' ' CD1' ' A' ' 189' ' ' TRP . 32.0 mt -131.97 89.38 2.67 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 111.698 -2.251 . . . . 0.0 105.43 177.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . 0.251 2.3 t -97.13 148.53 34.54 Favored Pre-proline 0 C--N 1.305 -1.343 0 CA-C-N 114.269 -1.332 . . . . 0.0 113.928 -174.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -92.43 155.21 3.03 Favored 'Trans proline' 0 C--N 1.299 -2.032 0 N-CA-C 107.67 -1.704 . . . . 0.0 107.67 172.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . 0.474 ' HB2' ' CE2' ' A' ' 190' ' ' TRP . 8.6 tpt180 -74.59 -51.99 13.04 Favored 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 176.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 65.3 p -22.07 -45.85 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 127.528 3.017 . . . . 0.0 114.912 178.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -112.61 50.0 0.9 Allowed 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.468 -0.893 . . . . 0.0 113.199 -178.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 97.7 mt -131.05 155.96 46.0 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 176.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -130.26 142.19 44.56 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 103.916 -2.624 . . . . 0.0 103.916 174.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -66.32 155.44 69.92 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 N-CA-C 107.271 -1.857 . . . . 0.0 107.271 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . 0.433 ' CD1' HG22 ' A' ' 158' ' ' ILE . 9.7 t80 -130.38 176.4 8.17 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 118.559 -1.256 . . . . 0.0 110.002 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 22.9 t -121.26 30.89 6.58 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.4 -0.92 . . . . 0.0 110.974 -179.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 114.383 -2.722 . . . . 0.0 105.856 177.494 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 28.2 m . . . . . 0 N--CA 1.489 1.476 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 109.43 179.18 21.19 Favored Glycine 0 N--CA 1.486 1.993 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.966 -178.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -121.42 159.15 26.79 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 101.504 -3.517 . . . . 0.0 101.504 178.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -100.64 129.62 46.58 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 116.035 -2.266 . . . . 0.0 111.35 -177.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.527 ' CD1' HG22 ' A' ' 181' ' ' VAL . 4.9 m-85 -118.9 172.17 7.72 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 101.4 -3.556 . . . . 0.0 101.4 177.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.7 pt -126.97 142.53 43.18 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 N-CA-C 103.44 -2.8 . . . . 0.0 103.44 174.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 176' ' ' GLY . . . -80.13 155.3 27.54 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 104.19 -2.522 . . . . 0.0 104.19 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.1 m -131.18 8.73 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 126.764 2.54 . . . . 0.0 108.447 178.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -127.68 159.1 21.5 Favored Glycine 0 N--CA 1.486 1.99 0 N-CA-C 106.018 -2.833 . . . . 0.0 106.018 176.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -108.54 97.34 7.02 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.253 -0.979 . . . . 0.0 113.083 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.423 ' HB3' ' CZ ' ' A' ' 173' ' ' PHE . 58.4 t80 -111.02 151.88 27.48 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 55.4 m -122.43 157.4 32.0 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.31 105.88 15.49 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 178.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -98.61 -17.43 18.64 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 -178.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -120.72 168.19 11.68 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 102.57 -3.122 . . . . 0.0 102.57 177.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 48.7 t -91.39 156.01 3.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 109.56 -41.12 2.32 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 107.502 -2.239 . . . . 0.0 107.502 -178.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.413 ' HA ' ' H ' ' A' ' 201' ' ' LEU . 11.2 m-20 -80.22 167.97 19.65 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 111.532 -2.334 . . . . 0.0 111.637 -179.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 24.5 mt -118.95 175.93 5.53 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.996 177.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 45.2 m -117.57 96.31 5.33 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 114.58 -1.191 . . . . 0.0 109.479 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.423 ' CZ ' ' HB3' ' A' ' 163' ' ' PHE . 8.9 p90 -119.24 164.43 15.64 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 114.488 -1.233 . . . . 0.0 111.63 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 6.6 ptpp? -128.71 160.44 32.5 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 116.384 1.994 . . . . 0.0 116.384 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 42.9 tttm -41.91 76.91 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.766 1 CA-C-N 107.609 -4.36 . . . . 0.0 115.533 173.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 159' ' ' ALA . . . 112.67 50.44 0.56 Allowed Glycine 0 N--CA 1.491 2.306 0 CA-C-N 114.097 -1.411 . . . . 0.0 112.55 176.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -131.4 168.93 16.75 Favored 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 176.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 1.5 mt -112.98 125.89 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 116.545 2.054 . . . . 0.0 116.545 -175.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 17.9 mt -118.41 176.02 5.44 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 112.339 -2.21 . . . . 0.0 110.756 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 33.5 mt -114.61 159.87 19.95 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 174.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.527 HG22 ' CD1' ' A' ' 157' ' ' TYR . 46.2 t -121.6 124.74 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -176.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.46 ' O ' ' CB ' ' A' ' 183' ' ' GLU . 11.7 mt -141.57 77.24 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.972 -174.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . 0.546 ' O ' ' CE3' ' A' ' 190' ' ' TRP . 44.6 tt0 138.15 149.58 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.037 0 C-N-CA 127.177 2.191 . . . . 0.0 108.402 176.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -116.62 100.94 8.17 Favored 'General case' 0 N--CA 1.508 2.436 0 N-CA-C 115.972 1.842 . . . . 0.0 115.972 -175.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.473 ' CG ' ' HE1' ' A' ' 190' ' ' TRP . 21.6 pttp -13.65 78.15 0.02 OUTLIER Pre-proline 0 N--CA 1.5 2.045 1 N-CA-C 122.075 4.102 . . . . 0.0 122.075 -177.79 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.42 ' HD2' ' O ' ' A' ' 189' ' ' TRP . 13.4 Cg_endo -47.68 -59.85 1.1 Allowed 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 123.061 2.508 . . . . 0.0 106.582 171.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -123.6 22.4 9.11 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 112.331 -2.213 . . . . 0.0 110.229 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 113.74 17.68 7.34 Favored Glycine 0 N--CA 1.491 2.354 0 C-N-CA 120.473 -0.87 . . . . 0.0 111.046 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . 0.453 ' N ' ' HA ' ' A' ' 185' ' ' LYS . 1.4 m-90 -125.62 126.05 44.11 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 121.395 3.85 . . . . 0.0 121.395 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' TRP . . . . . 0.546 ' CE3' ' O ' ' A' ' 183' ' ' GLU . 16.3 m95 -118.44 159.86 22.74 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 102.072 -3.307 . . . . 0.0 102.072 176.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.451 ' HB ' ' O ' ' A' ' 182' ' ' ILE . 79.3 mt -114.72 113.67 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 104.372 -2.455 . . . . 0.0 104.372 176.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -108.41 178.5 4.47 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 119.453 -0.899 . . . . 0.0 112.658 -172.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -137.21 169.1 18.35 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 173.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 43.5 p-10 -121.71 -164.79 1.18 Allowed 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.144 -1.022 . . . . 0.0 109.958 177.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -100.2 39.85 1.31 Allowed 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.928 0.871 . . . . 0.0 108.691 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -126.76 -37.13 2.16 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 113.609 -1.632 . . . . 0.0 107.282 177.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 134.96 -37.4 1.94 Allowed Glycine 0 N--CA 1.487 2.05 0 N-CA-C 110.074 -1.211 . . . . 0.0 110.074 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 22.4 p30 -63.94 164.74 9.86 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 118.591 -1.244 . . . . 0.0 114.167 -178.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.8 157.91 36.31 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 111.858 -2.428 . . . . 0.0 109.492 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -136.36 -175.23 13.7 Favored Glycine 0 N--CA 1.48 1.572 0 CA-C-O 122.319 0.955 . . . . 0.0 111.634 -178.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.413 ' H ' ' HA ' ' A' ' 170' ' ' ASP . 13.8 mt -122.04 82.5 1.97 Allowed 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 111.419 -2.391 . . . . 0.0 105.202 177.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 4.5 m -115.57 154.97 47.87 Favored Pre-proline 0 N--CA 1.495 1.806 0 C-N-CA 119.579 -0.848 . . . . 0.0 109.415 -175.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -81.74 179.97 5.29 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 123.121 2.547 . . . . 0.0 112.156 -178.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . 0.544 ' HB2' ' CE2' ' A' ' 190' ' ' TRP . 17.5 ttp85 -91.24 -49.19 6.5 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 103.762 -2.681 . . . . 0.0 103.762 176.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 68.2 p -19.3 -48.53 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 127.146 2.779 . . . . 0.0 117.026 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -108.51 42.57 1.37 Allowed 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 119.063 -1.055 . . . . 0.0 112.614 -177.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 84.9 mt -129.68 158.42 39.41 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 115.063 -0.972 . . . . 0.0 109.007 177.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -132.82 152.44 79.86 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 104.553 -2.388 . . . . 0.0 104.553 170.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -68.66 165.79 28.23 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 N-CA-C 108.064 -1.552 . . . . 0.0 108.064 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -120.24 -160.41 0.83 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 68.9 p -95.83 45.27 1.08 Allowed 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.02 -1.072 . . . . 0.0 110.429 -178.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 116.416 -1.754 . . . . 0.0 108.282 177.28 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 35.4 m . . . . . 0 N--CA 1.492 1.644 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -116.07 179.44 17.87 Favored Glycine 0 N--CA 1.487 2.051 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.852 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -135.15 -179.98 5.96 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.329 -1.359 . . . . 0.0 107.329 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -109.93 126.52 53.97 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 114.839 1.422 . . . . 0.0 114.839 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.435 ' CD1' HG21 ' A' ' 181' ' ' VAL . 44.8 m-85 -121.88 177.94 5.08 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 101.183 -3.636 . . . . 0.0 101.183 175.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.408 ' HA ' ' HA ' ' A' ' 178' ' ' ILE . 2.9 pt -123.72 153.32 29.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 100.79 -3.781 . . . . 0.0 100.79 170.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -91.83 153.18 19.73 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 100.768 -3.789 . . . . 0.0 100.768 177.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 31.2 m -125.07 17.36 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 125.908 2.005 . . . . 0.0 108.021 176.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -138.53 164.51 25.67 Favored Glycine 0 N--CA 1.483 1.806 0 N-CA-C 105.628 -2.989 . . . . 0.0 105.628 175.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -106.02 144.5 32.65 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 104.837 -2.283 . . . . 0.0 104.837 177.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -124.69 172.64 9.12 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 77.8 m -130.17 152.55 49.49 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.623 -0.831 . . . . 0.0 109.577 178.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -107.89 122.41 46.73 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 177.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -110.24 -19.51 12.98 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.127 -1.397 . . . . 0.0 108.121 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -123.35 176.7 5.99 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 114.057 -1.429 . . . . 0.0 108.339 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 15.2 t -95.53 49.93 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -131.81 -46.93 0.12 Allowed Glycine 0 N--CA 1.485 1.915 0 CA-C-N 113.282 -1.781 . . . . 0.0 108.788 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -87.62 169.2 12.36 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 112.503 -1.849 . . . . 0.0 114.385 -178.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 39.2 mt -117.97 -176.83 3.13 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 112.547 -2.115 . . . . 0.0 105.806 176.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 73.4 m -108.95 -59.4 1.89 Allowed 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.158 -179.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 43.1 p90 37.42 164.43 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.25 0 N-CA-C 117.617 2.451 . . . . 0.0 117.617 -175.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -124.52 143.62 50.57 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 120.173 3.397 . . . . 0.0 120.173 -178.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -26.75 81.29 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.589 1 CA-C-N 107.847 -4.251 . . . . 0.0 115.868 169.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 112.18 46.98 0.73 Allowed Glycine 0 N--CA 1.492 2.427 0 CA-C-N 114.617 -1.174 . . . . 0.0 113.392 176.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -140.75 152.98 45.69 Favored 'General case' 0 N--CA 1.503 2.205 0 C-N-CA 117.092 -1.843 . . . . 0.0 109.485 176.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.45 ' N ' ' CD1' ' A' ' 178' ' ' ILE . 1.3 mp -74.9 131.53 34.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -178.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 44.0 mt -122.66 168.35 12.3 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 112.339 -2.21 . . . . 0.0 107.044 176.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.05 148.02 36.03 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 101.796 -3.409 . . . . 0.0 101.796 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.435 HG21 ' CD1' ' A' ' 157' ' ' TYR . 2.7 t -124.01 138.51 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 CA-C-N 121.458 1.935 . . . . 0.0 111.467 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.455 ' O ' ' CB ' ' A' ' 183' ' ' GLU . 0.5 OUTLIER -146.52 81.28 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 O-C-N 123.169 0.293 . . . . 0.0 110.619 -173.371 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . 0.532 ' O ' ' CE3' ' A' ' 190' ' ' TRP . 34.9 tt0 139.31 153.18 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.96 0 C-N-CA 127.024 2.13 . . . . 0.0 107.748 178.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -117.92 99.95 7.25 Favored 'General case' 0 N--CA 1.508 2.445 0 N-CA-C 116.227 1.936 . . . . 0.0 116.227 -175.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.518 ' CG ' ' HE1' ' A' ' 190' ' ' TRP . 22.1 pttp -13.07 77.16 0.02 OUTLIER Pre-proline 0 N--CA 1.5 2.057 1 N-CA-C 122.183 4.142 . . . . 0.0 122.183 -177.325 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.42 ' HD2' ' O ' ' A' ' 189' ' ' TRP . 12.3 Cg_endo -47.13 -59.34 1.28 Allowed 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 123.096 2.531 . . . . 0.0 106.999 171.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -121.11 19.58 11.55 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 112.285 -2.234 . . . . 0.0 110.563 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 112.94 15.85 8.94 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . 0.42 ' O ' ' HD2' ' A' ' 186' ' ' PRO . 1.3 m-90 -125.51 127.03 45.8 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 120.58 3.548 . . . . 0.0 120.58 179.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' TRP . . . . . 0.558 ' CE2' ' HB2' ' A' ' 204' ' ' ARG . 15.2 m95 -117.84 161.19 20.14 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 101.095 -3.668 . . . . 0.0 101.095 177.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 28.8 mm -98.28 166.77 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.395 1 N-CA-C 99.679 -4.193 . . . . 0.0 99.679 176.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -150.74 -177.8 6.2 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 116.125 -2.23 . . . . 0.0 111.447 178.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -137.69 163.69 30.67 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 174.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 26.0 p-10 -112.7 -160.72 0.73 Allowed 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.373 -0.931 . . . . 0.0 108.567 177.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -108.26 35.7 3.07 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 118.874 -1.13 . . . . 0.0 110.215 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -129.23 -67.72 0.76 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 105.48 -2.045 . . . . 0.0 105.48 175.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -165.58 -67.24 0.03 OUTLIER Glycine 0 N--CA 1.488 2.133 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.208 178.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -34.85 160.78 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 119.65 3.204 . . . . 0.0 119.65 -178.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.65 160.4 21.89 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 111.904 -2.407 . . . . 0.0 109.573 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -135.54 -169.72 11.91 Favored Glycine 0 N--CA 1.487 2.082 0 CA-C-O 122.998 1.332 . . . . 0.0 114.238 -177.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 16.5 mt -130.09 84.89 2.24 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 111.138 -2.531 . . . . 0.0 105.236 178.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 3.0 m -113.04 156.04 43.38 Favored Pre-proline 0 N--CA 1.495 1.816 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 -175.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -90.35 173.24 3.31 Favored 'Trans proline' 0 C--N 1.302 -1.903 0 C-N-CA 122.429 2.086 . . . . 0.0 107.365 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . 0.558 ' HB2' ' CE2' ' A' ' 190' ' ' TRP . 22.7 ttt180 -102.07 -35.62 8.87 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 117.029 -1.869 . . . . 0.0 106.43 175.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 70.2 p -25.05 -46.67 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 126.057 2.098 . . . . 0.0 114.732 174.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -110.98 43.94 1.37 Allowed 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 119.762 -0.775 . . . . 0.0 112.659 -178.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 60.4 mt -127.17 151.53 48.56 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.618 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -123.64 150.03 60.45 Favored Pre-proline 0 C--N 1.301 -1.512 0 N-CA-C 104.148 -2.538 . . . . 0.0 104.148 174.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -68.81 160.13 50.94 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 C-N-CA 121.363 1.376 . . . . 0.0 110.738 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . 0.415 ' CE1' HD12 ' A' ' 178' ' ' ILE . 10.7 t80 -127.84 151.17 49.39 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 177.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.1 t -130.69 49.51 2.3 Favored 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 118.989 -1.085 . . . . 0.0 113.107 -177.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 116.232 -1.842 . . . . 0.0 109.335 177.738 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 10.1 t . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 116.99 179.29 17.75 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 110.241 -1.143 . . . . 0.0 110.241 -178.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -116.32 165.14 13.53 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 104.381 -2.452 . . . . 0.0 104.381 -178.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -99.15 119.51 37.97 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 117.098 -1.841 . . . . 0.0 114.417 -178.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -123.87 174.09 7.77 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 101.145 -3.65 . . . . 0.0 101.145 175.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.501 HG22 ' CD1' ' A' ' 210' ' ' TYR . 3.3 pt -127.49 153.84 37.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 101.943 -3.354 . . . . 0.0 101.943 173.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -84.24 152.66 24.07 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 103.582 -2.747 . . . . 0.0 103.582 178.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 32.9 m -132.8 6.13 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 125.939 2.025 . . . . 0.0 108.734 177.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -131.37 149.68 19.3 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 106.36 -2.696 . . . . 0.0 106.36 177.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -101.77 92.26 4.76 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 118.887 -1.125 . . . . 0.0 108.798 -177.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -107.99 151.18 26.16 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 114.436 -1.256 . . . . 0.0 109.624 -178.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 52.7 m -120.98 158.81 26.93 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -81.29 151.54 28.02 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 118.076 -1.45 . . . . 0.0 109.022 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -112.72 -36.17 5.27 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 112.456 -2.156 . . . . 0.0 105.267 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -120.42 171.89 8.21 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 113.368 -1.742 . . . . 0.0 106.996 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -59.63 -46.8 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 117.489 -1.685 . . . . 0.0 108.693 177.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -29.55 -60.96 0.17 Allowed Glycine 0 N--CA 1.492 2.376 0 O-C-N 125.355 1.66 . . . . 0.0 113.834 177.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -77.23 168.86 19.34 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -176.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 14.2 mt -117.54 176.55 5.12 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 113.715 -1.584 . . . . 0.0 110.478 178.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 42.6 m -120.46 97.07 5.4 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 113.875 -1.512 . . . . 0.0 110.733 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.423 ' CD1' ' N ' ' A' ' 173' ' ' PHE . 8.2 p90 -121.05 171.09 8.92 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.495 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -107.4 -163.35 0.89 Allowed 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 122.691 1.234 . . . . 0.0 113.338 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 42.1 tttm -107.15 89.82 3.11 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 111.002 -2.817 . . . . 0.0 112.146 -175.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 109.16 50.65 0.71 Allowed Glycine 0 N--CA 1.492 2.401 0 CA-C-N 113.228 -1.806 . . . . 0.0 110.695 177.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -128.78 176.59 7.7 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 177.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 21.9 mm -104.0 119.56 52.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 C-N-CA 118.669 -1.213 . . . . 0.0 112.451 -178.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 59.5 mt -121.16 163.62 18.17 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 113.933 -1.485 . . . . 0.0 110.031 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 59.6 mt -110.7 156.67 20.69 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 176.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 2.5 t -126.55 138.67 54.01 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 C-N-CA 117.981 -1.488 . . . . 0.0 110.221 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.417 ' O ' ' CB ' ' A' ' 183' ' ' GLU . 25.6 mt -141.04 82.0 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -174.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . 0.447 ' O ' ' CE3' ' A' ' 190' ' ' TRP . 41.9 tt0 138.02 150.52 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.393 0 C-N-CA 127.042 2.137 . . . . 0.0 108.004 176.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . 0.444 ' N ' ' HG2' ' A' ' 183' ' ' GLU . 97.9 mttt -116.84 115.68 26.0 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 124.628 1.205 . . . . 0.0 111.927 -179.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.504 ' CG ' ' HE1' ' A' ' 190' ' ' TRP . 0.1 OUTLIER -6.96 77.34 0.03 OUTLIER Pre-proline 0 N--CA 1.505 2.291 0 N-CA-C 117.652 2.464 . . . . 0.0 117.652 178.443 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -68.6 -55.95 0.2 Allowed 'Trans proline' 0 C--N 1.307 -1.629 0 N-CA-C 105.516 -2.532 . . . . 0.0 105.516 175.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -125.16 24.53 7.44 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 112.877 -1.965 . . . . 0.0 112.741 -177.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.435 ' CA ' ' HG2' ' A' ' 185' ' ' LYS . . . 116.65 -19.4 12.59 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 118.708 -1.711 . . . . 0.0 109.603 -179.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 16.3 m-90 -115.28 158.71 21.97 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 117.783 2.512 . . . . 0.0 117.783 -176.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' TRP . . . . . 0.504 ' HE1' ' CG ' ' A' ' 185' ' ' LYS . 23.9 m95 -129.97 162.43 28.68 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 100.457 -3.905 . . . . 0.0 100.457 -178.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.433 HG12 ' CB ' ' A' ' 183' ' ' GLU . 10.9 mm -113.33 106.21 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 C-N-CA 116.382 -2.127 . . . . 0.0 106.479 177.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -101.94 175.49 5.52 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -172.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 63.1 mttm -126.51 165.12 19.71 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 174.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -122.82 -158.16 0.78 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 124.467 1.104 . . . . 0.0 110.376 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -100.26 36.95 1.75 Allowed 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 121.693 0.758 . . . . 0.0 110.822 -178.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -125.38 -43.42 1.92 Allowed 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 176.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 138.29 -43.3 1.2 Allowed Glycine 0 N--CA 1.483 1.817 0 N-CA-C 106.477 -2.649 . . . . 0.0 106.477 -178.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -53.57 155.91 2.82 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.89 155.0 44.87 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 112.949 -1.932 . . . . 0.0 110.357 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -145.0 -176.68 19.21 Favored Glycine 0 N--CA 1.485 1.964 0 C-N-CA 119.195 -1.479 . . . . 0.0 112.924 -178.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.416 ' CD2' ' N ' ' A' ' 201' ' ' LEU . 0.8 OUTLIER -92.78 92.05 7.76 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 112.757 -1.722 . . . . 0.0 106.741 176.943 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 5.0 m -113.81 147.85 38.57 Favored Pre-proline 0 N--CA 1.494 1.757 0 C-N-CA 117.43 -1.708 . . . . 0.0 106.739 -179.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -79.22 179.06 6.77 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 C-N-CA 122.291 1.994 . . . . 0.0 112.014 -177.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . 0.431 ' HB2' ' NE1' ' A' ' 190' ' ' TRP . 0.1 OUTLIER -86.25 -46.22 10.55 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 103.552 -2.759 . . . . 0.0 103.552 178.164 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 71.8 p -22.2 -50.62 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 O-C-N 126.013 2.071 . . . . 0.0 116.168 178.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -112.79 43.2 1.71 Allowed 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.587 0.708 . . . . 0.0 111.985 -178.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 12.3 mt -140.25 108.86 5.9 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 113.793 -1.548 . . . . 0.0 109.346 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -110.73 153.37 43.69 Favored Pre-proline 0 N--CA 1.49 1.55 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 178.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -59.6 165.39 9.72 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.093 1.862 . . . . 0.0 111.252 -178.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . 0.501 ' CD1' HG22 ' A' ' 158' ' ' ILE . 9.0 t80 -126.67 169.11 13.48 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 119.024 -1.071 . . . . 0.0 111.99 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' SER . . . . . 0.45 ' N ' ' CG ' ' A' ' 210' ' ' TYR . 42.8 p -121.93 73.19 1.07 Allowed 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 113.824 -1.535 . . . . 0.0 108.486 178.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 116.22 -1.848 . . . . 0.0 109.741 -179.33 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 77.4 p . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.528 0.68 . . . . 0.0 109.902 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -115.62 -156.68 11.09 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 -105.87 167.19 9.95 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 112.681 -1.76 . . . . 0.0 108.436 -178.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -112.71 141.57 46.35 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 124.598 2.142 . . . . 0.0 113.175 -177.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.467 ' CG ' HD22 ' A' ' 207' ' ' LEU . 76.0 m-85 -133.57 -179.73 5.7 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 108.462 -3.972 . . . . 0.0 107.326 -176.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.432 ' CG2' ' CD1' ' A' ' 210' ' ' TYR . 7.5 pt -128.66 162.2 36.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 102.188 -3.264 . . . . 0.0 102.188 168.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.418 ' O ' ' N ' ' A' ' 176' ' ' GLY . . . -90.98 157.47 17.27 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 103.405 -2.813 . . . . 0.0 103.405 -179.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 16.6 m -126.63 -0.24 4.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 125.809 1.943 . . . . 0.0 108.381 175.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -132.11 165.71 23.46 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 107.812 -2.115 . . . . 0.0 107.812 177.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -106.97 122.33 46.22 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -122.05 156.21 34.02 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.085 179.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 75.3 m -124.44 161.65 25.59 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -92.96 144.59 25.1 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 118.012 -1.475 . . . . 0.0 108.389 178.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -113.23 -32.69 6.21 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 112.834 -1.985 . . . . 0.0 106.645 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -112.52 177.59 4.58 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 113.66 -1.609 . . . . 0.0 107.027 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 17.3 t -95.84 49.34 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 104.502 -2.407 . . . . 0.0 104.502 178.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -130.65 -49.36 0.11 Allowed Glycine 0 N--CA 1.485 1.947 0 CA-C-N 112.697 -2.047 . . . . 0.0 109.27 -178.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.419 ' HA ' ' H ' ' A' ' 201' ' ' LEU . 29.2 m-20 -79.43 175.13 10.88 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 113.293 -1.454 . . . . 0.0 111.797 -178.273 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.401 ' HG ' ' HA3' ' A' ' 200' ' ' GLY . 14.1 mt -115.89 174.52 5.99 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 114.394 -1.276 . . . . 0.0 108.466 177.075 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 52.5 m -120.97 91.37 3.51 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 113.796 -1.547 . . . . 0.0 108.078 178.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -121.87 169.45 10.77 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 113.698 -1.592 . . . . 0.0 111.064 -178.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -109.44 -163.67 0.88 Allowed 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 122.78 1.276 . . . . 0.0 111.373 178.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 67.9 tttt -92.87 156.3 17.05 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 110.724 -2.944 . . . . 0.0 110.661 -178.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 159' ' ' ALA . . . 53.61 44.66 68.61 Favored Glycine 0 N--CA 1.485 1.935 0 CA-C-N 112.783 -2.008 . . . . 0.0 108.1 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -130.49 128.25 40.84 Favored 'General case' 0 N--CA 1.504 2.256 0 C-N-CA 116.881 -1.928 . . . . 0.0 113.988 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.416 ' HA ' ' HA ' ' A' ' 158' ' ' ILE . 1.6 mp -58.95 119.27 3.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 -178.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 19.6 mt -118.63 155.45 30.97 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 113.766 -1.561 . . . . 0.0 107.6 175.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 23.7 tp -111.99 158.42 19.54 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 104.575 -2.38 . . . . 0.0 104.575 177.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.599 HG22 ' CZ3' ' A' ' 190' ' ' TRP . 98.5 t -110.39 147.74 14.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 C-N-CA 119.078 -1.049 . . . . 0.0 109.899 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.461 ' O ' ' HB ' ' A' ' 191' ' ' ILE . 8.9 mt -148.69 74.97 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 C-N-CA 118.148 -1.421 . . . . 0.0 108.991 173.081 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . 0.418 ' CB ' ' O ' ' A' ' 182' ' ' ILE . 12.8 tm-20 139.07 165.21 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.224 0 C-N-CA 129.04 2.936 . . . . 0.0 105.314 176.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -113.76 88.69 2.9 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 117.444 2.387 . . . . 0.0 117.444 -175.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.492 ' O ' ' CG ' ' A' ' 185' ' ' LYS . 7.4 pttm -8.69 76.05 0.03 OUTLIER Pre-proline 0 N--CA 1.505 2.319 0 N-CA-C 116.704 2.113 . . . . 0.0 116.704 177.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -44.52 -56.27 2.7 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 123.37 2.713 . . . . 0.0 107.598 176.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -128.8 16.4 6.35 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 111.634 -2.53 . . . . 0.0 110.04 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 111.4 26.01 4.73 Favored Glycine 0 N--CA 1.485 1.917 0 N-CA-C 107.501 -2.24 . . . . 0.0 107.501 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 2.7 m-90 -134.45 97.74 3.9 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 116.72 2.119 . . . . 0.0 116.72 178.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' TRP . . . . . 0.686 ' CD1' ' N ' ' A' ' 190' ' ' TRP . 0.0 OUTLIER -112.68 171.72 7.36 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.597 179.636 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.461 ' HB ' ' O ' ' A' ' 182' ' ' ILE . 1.9 mp -108.9 111.23 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 N-CA-C 104.037 -2.579 . . . . 0.0 104.037 -179.186 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . 0.547 ' HB2' ' CZ3' ' A' ' 190' ' ' TRP . . . -109.91 -178.37 3.51 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -173.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -137.26 166.76 23.01 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 105.38 -2.081 . . . . 0.0 105.38 176.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 53.3 p-10 -121.26 -148.48 0.41 Allowed 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.121 -1.032 . . . . 0.0 111.637 177.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -103.76 19.37 20.04 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -176.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . 0.481 ' NZ ' HD21 ' A' ' 198' ' ' ASN . 8.4 ptmm? -124.07 -26.21 4.06 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 174.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 137.73 -35.11 2.09 Favored Glycine 0 N--CA 1.49 2.259 0 C-N-CA 119.097 -1.525 . . . . 0.0 113.363 178.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . 0.481 HD21 ' NZ ' ' A' ' 196' ' ' LYS . 24.2 p30 -61.56 162.17 8.63 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 117.546 -1.662 . . . . 0.0 113.417 -177.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -128.72 155.01 45.77 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 112.712 -2.04 . . . . 0.0 111.026 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . 0.401 ' HA3' ' HG ' ' A' ' 171' ' ' LEU . . . -144.7 -160.71 8.65 Favored Glycine 0 N--CA 1.489 2.175 0 CA-C-O 122.276 0.931 . . . . 0.0 112.581 -178.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.419 ' H ' ' HA ' ' A' ' 170' ' ' ASP . 20.1 mt -121.94 110.14 15.48 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 111.499 -2.35 . . . . 0.0 105.844 175.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.504 HG21 ' CD2' ' A' ' 190' ' ' TRP . 13.7 m -129.82 163.36 47.65 Favored Pre-proline 0 N--CA 1.498 1.958 0 C-N-CA 117.867 -1.533 . . . . 0.0 111.626 -175.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -100.24 139.28 0.26 Allowed 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 123.661 2.907 . . . . 0.0 109.713 174.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . 0.443 ' N ' ' HE1' ' A' ' 190' ' ' TRP . 0.1 OUTLIER -81.43 -23.57 37.45 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 104.64 -2.355 . . . . 0.0 104.64 179.954 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' THR . . . . . 0.446 ' HG1' ' H ' ' A' ' 206' ' ' TYR . 68.2 p -24.65 -43.75 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.156 0 O-C-N 124.518 1.137 . . . . 0.0 113.602 171.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . 0.446 ' H ' ' HG1' ' A' ' 205' ' ' THR . 31.2 m-85 -114.33 50.23 0.96 Allowed 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 120.098 -0.641 . . . . 0.0 111.977 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.467 HD22 ' CG ' ' A' ' 157' ' ' TYR . 1.0 OUTLIER -133.95 152.73 51.96 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.255 -179.005 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -132.03 153.5 81.38 Favored Pre-proline 0 N--CA 1.491 1.601 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 172.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -64.52 164.91 21.89 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.077 1.851 . . . . 0.0 111.684 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . 0.432 ' CD1' ' CG2' ' A' ' 158' ' ' ILE . 35.1 t80 -127.24 176.78 7.14 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' SER . . . . . 0.417 ' N ' ' CG ' ' A' ' 210' ' ' TYR . 49.8 m -116.04 48.63 1.21 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 178.025 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 . . . . . 0 N--CA 1.497 1.889 0 CA-C-O 115.702 -2.094 . . . . 0.0 112.7 179.321 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 9.7 t . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -120.24 177.66 16.4 Favored Glycine 0 N--CA 1.486 2.021 0 C-N-CA 119.792 -1.194 . . . . 0.0 111.609 179.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -115.6 165.76 12.67 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -178.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -94.65 123.04 37.85 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 117.551 -1.66 . . . . 0.0 113.695 -176.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -124.83 172.26 9.49 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 111.071 -2.786 . . . . 0.0 105.138 177.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.511 HG23 ' CD1' ' A' ' 210' ' ' TYR . 2.1 pt -129.98 150.33 34.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 102.959 -2.978 . . . . 0.0 102.959 171.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.407 ' O ' ' N ' ' A' ' 176' ' ' GLY . . . -86.59 150.7 24.04 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 102.435 -3.172 . . . . 0.0 102.435 178.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 33.8 m -132.68 23.18 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 126.189 2.181 . . . . 0.0 107.642 178.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -144.06 160.19 27.76 Favored Glycine 0 N--CA 1.483 1.784 0 N-CA-C 107.86 -2.096 . . . . 0.0 107.86 176.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -106.49 78.73 1.3 Allowed 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.292 -0.963 . . . . 0.0 108.449 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -99.9 149.86 22.98 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 114.36 -1.291 . . . . 0.0 108.163 -178.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 93.6 m -120.81 157.96 28.62 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 114.023 -1.444 . . . . 0.0 108.856 -177.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -79.32 135.27 36.68 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 178.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -114.13 -28.26 7.38 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 113.804 -1.544 . . . . 0.0 107.293 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -114.77 178.61 4.22 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 179.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 58.8 t -90.78 149.9 3.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 104.003 -2.591 . . . . 0.0 104.003 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 110.53 -42.7 1.89 Allowed Glycine 0 N--CA 1.487 2.059 0 C-N-CA 118.407 -1.854 . . . . 0.0 108.703 -178.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -78.28 168.37 19.94 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 113.079 -1.561 . . . . 0.0 113.239 -179.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.503 ' HG ' ' CA ' ' A' ' 200' ' ' GLY . 76.6 mt -123.22 179.05 4.84 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 114.506 -1.225 . . . . 0.0 110.28 178.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 37.0 m -120.78 98.41 6.0 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 113.392 -1.731 . . . . 0.0 108.372 177.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -113.23 165.31 12.54 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 118.73 -1.188 . . . . 0.0 111.379 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -122.59 152.84 40.03 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 117.736 2.495 . . . . 0.0 117.736 -177.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -37.11 76.66 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 108.575 -3.92 . . . . 0.0 114.923 173.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 159' ' ' ALA . . . 106.86 54.69 0.67 Allowed Glycine 0 N--CA 1.491 2.35 0 CA-C-N 114.986 -1.007 . . . . 0.0 112.973 175.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -124.17 175.46 7.01 Favored 'General case' 0 N--CA 1.504 2.273 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 176.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.403 HD13 ' CE2' ' A' ' 210' ' ' TYR . 14.2 mm -112.46 131.9 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 119.068 -1.053 . . . . 0.0 111.607 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.463 ' N ' HD23 ' A' ' 179' ' ' LEU . 0.7 OUTLIER -140.26 174.87 10.08 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 114.653 -1.158 . . . . 0.0 113.69 177.826 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 83.6 mt -114.5 154.1 28.83 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.858 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 57.3 t -116.33 104.94 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 114.83 1.419 . . . . 0.0 114.83 -177.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.424 ' O ' ' HB ' ' A' ' 191' ' ' ILE . 13.3 mt -117.1 77.34 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-O 122.94 1.352 . . . . 0.0 108.178 -176.295 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . 0.465 ' HB3' ' H ' ' A' ' 191' ' ' ILE . 42.4 tt0 146.39 157.15 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.12 0 CA-C-N 109.715 -3.402 . . . . 0.0 108.262 173.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -117.37 102.21 9.05 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 114.655 -1.157 . . . . 0.0 112.233 -177.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.464 ' HB2' ' HE1' ' A' ' 190' ' ' TRP . 38.5 tttm -5.76 76.03 0.03 OUTLIER Pre-proline 0 N--CA 1.507 2.392 0 O-C-N 126.798 2.561 . . . . 0.0 115.005 178.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -66.81 -57.42 0.2 Allowed 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 123.565 2.843 . . . . 0.0 105.88 178.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 27.7 p-10 -121.01 20.36 11.54 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 111.329 -2.669 . . . . 0.0 112.992 -177.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 116.52 -27.49 7.97 Favored Glycine 0 N--CA 1.48 1.578 0 C-N-CA 117.424 -2.322 . . . . 0.0 108.93 -179.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 8.0 m-90 -118.02 148.65 42.04 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 118.332 -1.347 . . . . 0.0 114.474 -177.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' TRP . . . . . 0.464 ' HE1' ' HB2' ' A' ' 185' ' ' LYS . 3.0 m0 -112.39 173.45 6.36 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 102.684 -3.08 . . . . 0.0 102.684 178.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.465 ' H ' ' HB3' ' A' ' 183' ' ' GLU . 12.9 mt -115.58 114.34 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 N-CA-C 103.209 -2.886 . . . . 0.0 103.209 175.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -113.92 173.63 6.34 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 116.249 1.944 . . . . 0.0 116.249 -170.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 26.0 mmmt -121.37 141.1 51.28 Favored 'General case' 0 C--N 1.298 -1.638 1 N-CA-C 99.769 -4.159 . . . . 0.0 99.769 173.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -110.4 -160.1 0.7 Allowed 'General case' 0 N--CA 1.502 2.145 0 C-N-CA 117.433 -1.707 . . . . 0.0 112.089 -177.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -88.87 31.93 0.83 Allowed 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.245 -0.982 . . . . 0.0 111.077 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -123.99 -43.31 2.11 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 175.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 132.43 -40.3 1.64 Allowed Glycine 0 N--CA 1.485 1.939 0 N-CA-C 107.984 -2.046 . . . . 0.0 107.984 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -56.79 167.35 0.78 Allowed 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 115.162 1.541 . . . . 0.0 115.162 -178.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -98.01 150.72 21.08 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 112.737 -2.029 . . . . 0.0 115.746 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . 0.503 ' CA ' ' HG ' ' A' ' 171' ' ' LEU . . . -133.18 -177.16 14.75 Favored Glycine 0 N--CA 1.48 1.568 0 CA-C-N 112.827 -1.988 . . . . 0.0 114.522 -176.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 19.6 mt -131.77 76.82 1.73 Allowed 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 101.492 -3.521 . . . . 0.0 101.492 175.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 5.0 m -107.08 140.14 21.13 Favored Pre-proline 0 N--CA 1.494 1.749 0 C-N-CA 117.997 -1.481 . . . . 0.0 110.207 -172.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 0.4 OUTLIER -90.93 177.77 2.02 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 C-N-CA 122.725 2.283 . . . . 0.0 115.287 -175.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 41.6 ttt-85 -89.16 -35.7 16.1 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 174.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 72.9 p -33.46 -41.31 0.08 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 125.527 1.767 . . . . 0.0 113.3 174.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -113.68 5.12 16.34 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 114.522 1.305 . . . . 0.0 114.522 -178.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.68 161.01 20.8 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 178.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -132.57 157.65 77.76 Favored Pre-proline 0 N--CA 1.487 1.383 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 174.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -69.98 173.32 11.34 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.223 1.949 . . . . 0.0 109.47 178.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . 0.511 ' CD1' HG23 ' A' ' 158' ' ' ILE . 2.4 t80 -127.66 -177.15 3.99 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 30.5 t -116.85 44.73 1.99 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 178.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 115.052 -2.404 . . . . 0.0 107.491 179.123 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 10.2 t . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 108.8 171.38 21.05 Favored Glycine 0 N--CA 1.486 2.021 0 C-N-CA 120.113 -1.042 . . . . 0.0 113.67 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -132.16 148.29 52.46 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 103.921 -2.622 . . . . 0.0 103.921 177.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -107.49 142.36 37.48 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 116.82 -1.952 . . . . 0.0 111.577 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -125.29 -179.51 4.63 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 100.91 -3.737 . . . . 0.0 100.91 -179.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.491 HG22 ' CD1' ' A' ' 210' ' ' TYR . 1.5 pt -125.92 147.69 30.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 101.295 -3.594 . . . . 0.0 101.295 174.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.447 ' O ' ' N ' ' A' ' 176' ' ' GLY . . . -86.29 154.44 21.25 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 103.45 -2.796 . . . . 0.0 103.45 178.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.0 m -124.8 -0.93 5.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 126.089 2.118 . . . . 0.0 107.655 177.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -133.2 165.28 24.08 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 177.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -105.27 145.77 30.23 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 178.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -137.77 177.59 7.76 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 117.978 -1.489 . . . . 0.0 109.119 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 87.9 m -132.28 160.7 35.44 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -100.52 130.51 46.61 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 175.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -106.82 -30.51 8.87 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 -178.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -119.44 -177.82 3.46 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 113.253 -1.794 . . . . 0.0 108.22 -179.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 61.1 t -92.77 150.97 3.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 101.899 -3.371 . . . . 0.0 101.899 176.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 110.39 -48.44 0.94 Allowed Glycine 0 N--CA 1.488 2.142 0 N-CA-C 106.057 -2.817 . . . . 0.0 106.057 -176.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.29 169.6 16.77 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 123.879 1.8 . . . . 0.0 114.189 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.403 ' HG ' ' HA3' ' A' ' 200' ' ' GLY . 9.7 mt -121.04 -178.05 3.65 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 109.404 -3.544 . . . . 0.0 110.243 177.203 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 18.4 m -115.09 -65.15 1.22 Allowed 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 113.955 -1.475 . . . . 0.0 107.967 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 21.7 p90 42.64 166.26 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 116.867 2.173 . . . . 0.0 116.867 -178.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -113.82 -166.84 1.13 Allowed 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 113.562 -1.653 . . . . 0.0 112.728 179.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.415 ' CG ' ' N ' ' A' ' 176' ' ' GLY . 37.2 tttp -98.39 161.56 13.62 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 110.924 -2.853 . . . . 0.0 112.826 -178.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 159' ' ' ALA . . . 37.39 46.45 1.44 Allowed Glycine 0 N--CA 1.492 2.399 0 CA-C-N 112.665 -2.061 . . . . 0.0 110.172 179.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -123.35 176.41 6.15 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-N 111.045 -2.578 . . . . 0.0 106.875 177.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 13.9 mm -108.24 125.67 64.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 C-N-CA 119.392 -0.923 . . . . 0.0 111.338 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 24.2 mt -119.78 165.59 14.36 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 114.575 -1.193 . . . . 0.0 108.37 177.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 45.7 tp -118.11 163.24 16.93 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 178.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 69.0 t -113.24 142.25 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 178.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.461 ' O ' ' CB ' ' A' ' 183' ' ' GLU . 3.2 mm -141.86 75.41 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 104.551 -2.389 . . . . 0.0 104.551 173.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . 0.461 ' CB ' ' O ' ' A' ' 182' ' ' ILE . 38.8 tt0 127.47 148.39 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.539 0 C-N-CA 127.255 2.222 . . . . 0.0 108.794 178.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . 0.455 ' N ' ' HG2' ' A' ' 183' ' ' GLU . 92.6 mttt -126.4 133.06 51.38 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.117 -1.033 . . . . 0.0 111.787 177.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.473 ' CG ' ' HE1' ' A' ' 190' ' ' TRP . 3.5 tttm -7.98 80.86 0.03 OUTLIER Pre-proline 0 N--CA 1.501 2.081 0 O-C-N 126.683 2.489 . . . . 0.0 116.972 177.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -72.59 -56.57 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.732 0 N-CA-C 104.136 -3.063 . . . . 0.0 104.136 175.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -134.14 23.2 3.82 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 113.604 -1.635 . . . . 0.0 107.999 178.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 127.65 -21.46 5.64 Favored Glycine 0 N--CA 1.489 2.223 0 CA-C-O 117.902 -1.499 . . . . 0.0 113.258 -178.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -105.05 156.14 18.34 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 118.018 2.599 . . . . 0.0 118.018 -176.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' TRP . . . . . 0.508 ' NE1' ' HB2' ' A' ' 204' ' ' ARG . 20.4 m95 -130.12 147.47 51.86 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 100.344 -3.947 . . . . 0.0 100.344 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.415 ' HB ' ' O ' ' A' ' 182' ' ' ILE . 12.4 mm -109.22 87.27 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 N-CA-C 102.998 -2.964 . . . . 0.0 102.998 178.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -80.02 175.04 10.99 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 113.247 -1.797 . . . . 0.0 113.848 -173.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -130.4 166.45 20.44 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 174.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -126.34 -161.89 1.09 Allowed 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 118.869 -1.132 . . . . 0.0 110.416 178.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -101.44 32.77 3.18 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.711 -178.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -129.1 -33.8 1.94 Allowed 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.092 176.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 138.07 -39.03 1.64 Allowed Glycine 0 N--CA 1.486 1.967 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.525 -179.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 21.3 p30 -56.84 159.84 3.81 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 118.536 -1.266 . . . . 0.0 114.267 -178.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . 0.42 ' HG3' ' N ' ' A' ' 200' ' ' GLY . 0.1 OUTLIER -140.69 166.12 25.62 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 112.008 -2.36 . . . . 0.0 109.573 179.175 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . 0.42 ' N ' ' HG3' ' A' ' 199' ' ' GLU . . . 159.41 174.01 28.59 Favored Glycine 0 N--CA 1.486 2.013 0 C-N-CA 118.148 -1.977 . . . . 0.0 114.684 177.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 9.8 mp -59.45 91.82 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 117.052 2.241 . . . . 0.0 117.052 -179.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 5.5 m -107.41 149.62 39.02 Favored Pre-proline 0 C--N 1.302 -1.495 0 N-CA-C 100.417 -3.92 . . . . 0.0 100.417 174.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -86.17 167.41 9.33 Favored 'Trans proline' 0 C--N 1.299 -2.033 0 N-CA-C 107.437 -1.794 . . . . 0.0 107.437 178.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . 0.508 ' HB2' ' NE1' ' A' ' 190' ' ' TRP . 12.2 ttp85 -80.22 -36.88 34.13 Favored 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 115.856 -2.338 . . . . 0.0 107.458 176.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 40.8 p -23.73 -54.82 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -110.52 47.4 0.97 Allowed 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.539 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -134.33 101.1 4.88 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 179.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -102.52 151.41 38.22 Favored Pre-proline 0 C--N 1.298 -1.654 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -57.61 164.78 6.96 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.176 1.918 . . . . 0.0 111.757 -178.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . 0.491 ' CD1' HG22 ' A' ' 158' ' ' ILE . 9.7 t80 -121.69 179.23 4.54 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.544 -0.862 . . . . 0.0 109.592 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 48.8 m -111.77 24.5 12.64 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.596 -0.842 . . . . 0.0 110.277 -179.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 . . . . . 0 N--CA 1.487 1.414 0 CA-C-O 115.103 -2.38 . . . . 0.0 106.256 177.212 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 91.7 m . . . . . 0 N--CA 1.492 1.626 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 40.62 -168.68 0.01 OUTLIER Glycine 0 N--CA 1.497 2.717 0 N-CA-C 116.64 1.416 . . . . 0.0 116.64 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -123.46 168.31 12.73 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 178.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -112.32 135.21 53.29 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 124.216 1.96 . . . . 0.0 110.782 -178.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.44 ' CE1' HG23 ' A' ' 181' ' ' VAL . 16.9 m-85 -133.57 175.12 9.71 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 109.28 -3.6 . . . . 0.0 106.251 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.465 HG21 ' CD1' ' A' ' 210' ' ' TYR . 1.3 pt -132.03 152.54 36.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 101.475 -3.528 . . . . 0.0 101.475 171.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.48 ' O ' ' N ' ' A' ' 176' ' ' GLY . . . -90.33 152.89 20.82 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 102.287 -3.227 . . . . 0.0 102.287 177.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.418 ' C ' ' HB2' ' A' ' 175' ' ' LYS . 29.1 m -129.41 10.96 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 125.864 1.978 . . . . 0.0 107.765 177.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.417 ' N ' ' HB2' ' A' ' 175' ' ' LYS . . . -137.82 161.05 25.43 Favored Glycine 0 N--CA 1.478 1.474 0 N-CA-C 106.751 -2.54 . . . . 0.0 106.751 173.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -101.18 150.2 23.2 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 104.061 -2.57 . . . . 0.0 104.061 176.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -132.7 177.33 7.71 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 117.816 -1.554 . . . . 0.0 109.145 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 96.8 m -128.65 157.95 39.89 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 177.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -100.09 145.03 28.43 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 178.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 55.3 tp60 -111.21 -37.24 5.37 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -125.56 171.66 10.36 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 113.312 -1.767 . . . . 0.0 108.098 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 67.9 t -60.42 -48.63 87.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 103.873 -2.64 . . . . 0.0 103.873 177.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -30.29 -50.73 0.18 Allowed Glycine 0 N--CA 1.491 2.306 0 CA-C-N 112.308 -2.223 . . . . 0.0 113.399 174.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.415 ' HA ' ' H ' ' A' ' 201' ' ' LEU . 28.7 m-20 -79.83 164.15 23.84 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 113.738 -1.231 . . . . 0.0 113.339 -178.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 16.6 mt -114.92 177.95 4.46 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 104.345 -2.465 . . . . 0.0 104.345 175.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 31.4 m -107.66 -57.46 2.09 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 33.1 p90 33.76 164.38 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 118.811 2.893 . . . . 0.0 118.811 -178.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -109.25 -166.55 1.12 Allowed 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 113.749 -1.569 . . . . 0.0 112.476 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.418 ' HB2' ' C ' ' A' ' 160' ' ' VAL . 10.4 ptpt -107.51 176.83 5.02 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 111.222 -2.717 . . . . 0.0 113.73 -176.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 159' ' ' ALA . . . 34.72 44.21 0.45 Allowed Glycine 0 N--CA 1.491 2.351 0 O-C-N 126.327 2.267 . . . . 0.0 109.097 -177.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -130.0 175.6 8.75 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-N 110.758 -2.721 . . . . 0.0 106.555 177.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 17.9 mm -101.6 123.19 54.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -175.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 6.8 mp -116.89 156.27 27.64 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.568 177.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.441 HD11 ' H ' ' A' ' 181' ' ' VAL . 0.6 OUTLIER -114.77 152.05 32.73 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 -177.181 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.441 ' H ' HD11 ' A' ' 180' ' ' LEU . 59.6 t -111.6 132.91 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 -179.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.47 ' O ' ' HB ' ' A' ' 191' ' ' ILE . 9.9 mt -142.59 78.88 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 CA-C-N 114.177 -1.374 . . . . 0.0 108.758 179.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . 0.468 ' CB ' ' O ' ' A' ' 182' ' ' ILE . 33.6 tt0 122.0 165.13 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 C-N-CA 128.081 2.552 . . . . 0.0 109.616 173.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . 0.428 ' N ' ' HG2' ' A' ' 183' ' ' GLU . 98.4 mttt -110.37 167.03 10.51 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.206 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.603 ' N ' ' CD1' ' A' ' 190' ' ' TRP . 17.8 pttp -95.85 68.4 0.03 OUTLIER Pre-proline 0 N--CA 1.508 2.469 0 N-CA-C 120.623 3.564 . . . . 0.0 120.623 -179.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -35.1 -56.5 0.5 Allowed 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 123.288 2.659 . . . . 0.0 108.938 171.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -121.16 23.77 10.39 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 112.95 -1.932 . . . . 0.0 114.069 179.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.52 ' CA ' ' HB2' ' A' ' 185' ' ' LYS . . . 110.7 17.46 9.14 Favored Glycine 0 N--CA 1.5 2.962 0 C-N-CA 119.644 -1.265 . . . . 0.0 112.658 178.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 2.0 m-90 -129.81 111.99 13.16 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 119.41 3.115 . . . . 0.0 119.41 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' TRP . . . . . 0.603 ' CD1' ' N ' ' A' ' 185' ' ' LYS . 28.7 m0 -106.54 160.4 15.45 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 101.856 -3.387 . . . . 0.0 101.856 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.47 ' HB ' ' O ' ' A' ' 182' ' ' ILE . 1.5 mp -115.43 114.21 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 N-CA-C 103.359 -2.83 . . . . 0.0 103.359 173.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -116.26 176.84 4.92 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -171.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -126.84 161.03 29.2 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 173.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 17.9 p30 -120.59 -165.85 1.25 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 124.254 0.971 . . . . 0.0 111.64 178.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -99.9 39.12 1.36 Allowed 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 40.8 mmtm -118.66 -37.37 3.29 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 179.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 134.62 -35.87 2.15 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 120.142 -1.028 . . . . 0.0 111.47 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . 0.4 ' ND2' ' H ' ' A' ' 198' ' ' ASN . 0.1 OUTLIER -90.96 174.78 7.24 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 116.153 1.909 . . . . 0.0 116.153 -178.469 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.74 161.27 19.97 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 111.964 -2.38 . . . . 0.0 110.08 -179.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -144.97 -170.21 13.9 Favored Glycine 0 N--CA 1.477 1.411 0 C-N-CA 119.326 -1.416 . . . . 0.0 111.453 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.415 ' H ' ' HA ' ' A' ' 170' ' ' ASP . 14.4 mt -113.92 88.01 2.75 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 110.645 -2.777 . . . . 0.0 103.914 177.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 4.8 m -115.27 156.65 45.35 Favored Pre-proline 0 N--CA 1.489 1.493 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 -174.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -90.02 -179.82 1.87 Allowed 'Trans proline' 0 C--N 1.298 -2.087 0 C-N-CA 122.299 2.0 . . . . 0.0 106.976 178.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . 0.528 ' HB2' ' CE2' ' A' ' 190' ' ' TRP . 0.7 OUTLIER -102.9 -41.93 5.99 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 102.503 -3.147 . . . . 0.0 102.503 175.849 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 77.9 p -17.76 -46.28 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 O-C-N 126.616 2.447 . . . . 0.0 116.515 176.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . 0.403 ' N ' ' O ' ' A' ' 204' ' ' ARG . 36.4 m-85 -110.27 42.1 1.62 Allowed 'General case' 0 N--CA 1.503 2.205 0 CA-C-N 118.85 0.75 . . . . 0.0 112.643 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 6.1 mp -131.06 162.21 30.32 Favored 'General case' 0 N--CA 1.499 1.979 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.014 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -134.5 156.81 78.49 Favored Pre-proline 0 C--N 1.303 -1.433 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 172.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -72.26 170.69 18.54 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 N-CA-C 106.995 -1.964 . . . . 0.0 106.995 178.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . 0.465 ' CD1' HG21 ' A' ' 158' ' ' ILE . 5.2 t80 -122.91 173.16 7.97 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 118.483 -1.287 . . . . 0.0 110.004 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 32.8 t -123.49 62.19 1.04 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 123.87 0.732 . . . . 0.0 111.448 -179.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 . . . . . 0 N--CA 1.494 1.756 0 CA-C-O 115.68 -2.105 . . . . 0.0 108.861 177.838 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 35.6 m . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -46.22 170.18 0.03 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 116.377 1.311 . . . . 0.0 116.377 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -122.15 156.07 34.43 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 113.196 -1.502 . . . . 0.0 107.977 -179.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -104.61 128.04 52.52 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 117.897 -1.521 . . . . 0.0 111.373 -178.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.416 ' CE1' HG21 ' A' ' 181' ' ' VAL . 15.9 m-85 -122.1 174.8 6.71 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 104.678 -2.341 . . . . 0.0 104.678 178.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.488 HG22 ' CD1' ' A' ' 210' ' ' TYR . 1.7 pt -125.53 146.32 31.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 102.694 -3.076 . . . . 0.0 102.694 172.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.41 156.47 20.15 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 101.361 -3.57 . . . . 0.0 101.361 176.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 33.2 m -122.52 2.53 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 126.106 2.129 . . . . 0.0 108.274 178.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -125.92 167.73 18.24 Favored Glycine 0 N--CA 1.482 1.76 0 N-CA-C 106.504 -2.638 . . . . 0.0 106.504 177.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -105.53 114.36 28.49 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.271 -0.972 . . . . 0.0 109.913 179.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -112.3 154.63 25.37 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.409 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 99.9 m -130.16 159.78 35.78 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 178.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -96.7 103.54 15.46 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 118.31 -1.356 . . . . 0.0 109.404 178.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -117.75 -0.72 11.72 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.009 -178.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.402 ' O ' ' C ' ' A' ' 168' ' ' VAL . 78.3 mm-40 -121.43 179.14 4.53 Favored 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 118.418 -1.313 . . . . 0.0 109.639 -177.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.402 ' C ' ' O ' ' A' ' 167' ' ' GLN . 96.0 t -25.25 -73.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 126.112 2.132 . . . . 0.0 111.06 179.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -133.55 141.13 12.45 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 107.489 -2.244 . . . . 0.0 107.489 174.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -167.64 -179.24 4.24 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 110.372 -2.914 . . . . 0.0 108.181 -179.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.472 ' HG ' ' CA ' ' A' ' 200' ' ' GLY . 16.5 mt -132.34 175.23 9.46 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 169.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 55.1 m -122.05 96.21 4.96 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.282 178.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -118.6 168.47 10.67 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.944 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -126.1 151.25 47.47 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 116.299 1.963 . . . . 0.0 116.299 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 60.1 tttt -27.11 79.1 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.665 1 CA-C-N 108.337 -4.028 . . . . 0.0 116.14 171.22 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 109.61 48.21 0.81 Allowed Glycine 0 N--CA 1.491 2.309 0 CA-C-N 114.775 -1.102 . . . . 0.0 112.611 176.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -138.49 151.81 47.72 Favored 'General case' 0 N--CA 1.507 2.38 0 C-N-CA 117.35 -1.74 . . . . 0.0 109.135 178.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.462 ' N ' ' CD1' ' A' ' 178' ' ' ILE . 1.3 mp -82.95 137.59 20.74 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 117.765 2.505 . . . . 0.0 117.765 -177.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -125.63 173.37 9.03 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 104.2 -2.518 . . . . 0.0 104.2 175.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.42 ' HB2' ' HB2' ' A' ' 193' ' ' LYS . 9.8 mt -117.75 161.34 19.86 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 176.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.416 HG21 ' CE1' ' A' ' 157' ' ' TYR . 78.1 t -113.49 124.43 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 N-CA-C 117.674 2.472 . . . . 0.0 117.674 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.477 ' O ' ' HB ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -135.45 77.53 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 CA-C-N 111.371 -2.65 . . . . 0.0 108.257 176.406 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . 0.491 ' HG2' ' N ' ' A' ' 184' ' ' LYS . 35.7 tt0 117.13 164.28 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 128.214 2.606 . . . . 0.0 110.129 173.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . 0.491 ' N ' ' HG2' ' A' ' 183' ' ' GLU . 99.5 mttt -108.87 -177.45 3.31 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.368 178.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.616 ' N ' ' CD1' ' A' ' 190' ' ' TRP . 8.2 ptmm? -91.43 73.34 0.01 OUTLIER Pre-proline 0 N--CA 1.515 2.782 0 C-N-CA 130.326 3.45 . . . . 0.0 118.018 -177.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.416 ' CD ' ' O ' ' A' ' 184' ' ' LYS . 9.2 Cg_endo -44.31 -56.57 2.46 Favored 'Trans proline' 0 C--N 1.3 -1.981 0 C-N-CA 123.251 2.634 . . . . 0.0 106.802 174.009 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -126.24 24.2 6.88 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 112.582 -2.099 . . . . 0.0 110.665 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 110.22 15.78 11.19 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -128.13 102.78 6.86 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 119.933 3.309 . . . . 0.0 119.933 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' TRP . . . . . 0.616 ' CD1' ' N ' ' A' ' 185' ' ' LYS . 10.7 m0 -95.93 157.05 16.07 Favored 'General case' 0 N--CA 1.498 1.933 1 N-CA-C 99.685 -4.191 . . . . 0.0 99.685 -177.926 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.477 ' HB ' ' O ' ' A' ' 182' ' ' ILE . 1.4 mp -112.54 140.99 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 1 N-CA-C 99.893 -4.114 . . . . 0.0 99.893 173.698 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -132.87 -177.95 4.73 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 119.319 -0.952 . . . . 0.0 113.542 -174.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . 0.42 ' HB2' ' HB2' ' A' ' 180' ' ' LEU . 62.6 mmtt -128.22 169.25 14.37 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 172.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -125.03 -158.0 0.81 Allowed 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.34 -0.944 . . . . 0.0 109.548 178.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -104.71 39.06 1.76 Allowed 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 121.33 0.586 . . . . 0.0 109.967 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -132.26 -37.39 1.1 Allowed 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.56 177.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 134.72 -22.24 3.69 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 -178.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -78.08 164.6 24.87 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.005 -1.078 . . . . 0.0 112.934 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 193' ' ' LYS . 0.0 OUTLIER -122.76 158.17 30.76 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 112.203 -2.271 . . . . 0.0 109.74 -179.941 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . 0.472 ' CA ' ' HG ' ' A' ' 171' ' ' LEU . . . -135.46 -172.22 12.63 Favored Glycine 0 N--CA 1.479 1.501 0 CA-C-O 123.985 1.881 . . . . 0.0 115.115 -177.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 9.5 mt -126.2 87.06 2.61 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 108.568 -3.816 . . . . 0.0 103.684 177.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 4.9 m -116.79 156.5 47.86 Favored Pre-proline 0 C--N 1.303 -1.45 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 -173.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 0.6 OUTLIER -92.0 174.7 2.18 Favored 'Trans proline' 0 C--N 1.299 -2.061 0 N-CA-C 105.564 -2.514 . . . . 0.0 105.564 178.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . 0.511 ' HB3' ' HD2' ' A' ' 185' ' ' LYS . 0.4 OUTLIER -108.85 -31.06 7.83 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 175.502 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 82.5 p -23.68 -47.16 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.173 0 O-C-N 125.742 1.901 . . . . 0.0 113.875 171.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -112.53 49.49 0.92 Allowed 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 119.745 -0.782 . . . . 0.0 111.77 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -132.68 156.89 46.15 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.332 -179.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -132.02 157.6 77.78 Favored Pre-proline 0 N--CA 1.495 1.791 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 174.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -73.24 158.61 48.56 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 121.283 1.322 . . . . 0.0 108.708 178.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . 0.488 ' CD1' HG22 ' A' ' 158' ' ' ILE . 6.8 t80 -137.18 58.79 1.7 Allowed 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.4 -0.92 . . . . 0.0 109.066 179.148 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 49.2 m -100.51 61.51 1.03 Allowed 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 -178.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.303 -1.455 0 CA-C-N 112.297 -2.229 . . . . 0.0 109.952 -179.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 10.1 t . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -115.73 -175.22 18.09 Favored Glycine 0 N--CA 1.485 1.907 0 C-N-CA 120.399 -0.905 . . . . 0.0 113.707 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -119.29 166.59 12.82 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 104.907 -2.257 . . . . 0.0 104.907 -179.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -103.48 117.01 33.47 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 117.704 -1.598 . . . . 0.0 113.492 -178.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -123.59 174.91 7.13 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 102.623 -3.103 . . . . 0.0 102.623 177.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.401 HG22 ' CD1' ' A' ' 210' ' ' TYR . 5.7 pt -131.62 150.76 34.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 103.312 -2.847 . . . . 0.0 103.312 172.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -81.71 151.45 27.51 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 102.848 -3.019 . . . . 0.0 102.848 176.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 26.8 m -129.69 10.72 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 125.866 1.978 . . . . 0.0 107.75 177.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -126.89 164.18 20.55 Favored Glycine 0 N--CA 1.484 1.852 0 N-CA-C 105.17 -3.172 . . . . 0.0 105.17 176.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -105.83 83.91 1.99 Allowed 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 118.709 -1.196 . . . . 0.0 109.277 -179.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -104.43 115.96 31.28 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 122.605 1.193 . . . . 0.0 108.425 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 18.2 m -101.01 154.35 18.77 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 111.944 -2.389 . . . . 0.0 106.379 -179.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.39 129.71 34.75 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 117.168 -1.813 . . . . 0.0 106.447 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -107.42 -29.31 9.32 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 -178.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -119.2 -175.67 2.97 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 113.586 -1.643 . . . . 0.0 106.616 179.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 61.4 t -88.76 151.76 3.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 179.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 114.33 -53.04 0.62 Allowed Glycine 0 N--CA 1.487 2.074 0 N-CA-C 108.644 -1.782 . . . . 0.0 108.644 -178.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -78.58 169.52 18.11 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 113.951 -1.125 . . . . 0.0 111.668 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 15.4 mt -121.01 176.02 5.77 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.182 177.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 31.3 m -116.92 93.09 4.06 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 114.12 -1.4 . . . . 0.0 112.273 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -128.17 166.85 17.73 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 113.512 -1.676 . . . . 0.0 109.274 177.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -125.39 159.82 30.9 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 117.001 2.223 . . . . 0.0 117.001 -178.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 44.4 tttm -35.97 77.45 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.659 1 CA-C-N 108.008 -4.178 . . . . 0.0 116.655 173.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 114.9 47.86 0.55 Allowed Glycine 0 N--CA 1.494 2.504 0 CA-C-N 114.866 -1.061 . . . . 0.0 115.126 174.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -137.51 158.66 43.92 Favored 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 117.472 -1.691 . . . . 0.0 107.576 175.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.495 ' N ' ' CD1' ' A' ' 178' ' ' ILE . 1.1 mp -84.57 134.26 27.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 -176.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.7 mp -135.62 168.83 18.54 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 113.158 -1.837 . . . . 0.0 108.7 175.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 27.9 mt -107.09 154.09 21.66 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 176.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 2.3 t -122.52 132.69 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 118.367 -1.333 . . . . 0.0 108.502 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.473 ' O ' ' CB ' ' A' ' 183' ' ' GLU . 16.6 mt -139.77 79.99 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 120.264 -0.575 . . . . 0.0 111.658 -173.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . 0.506 ' O ' ' CE3' ' A' ' 190' ' ' TRP . 3.7 tm-20 136.34 147.56 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.976 0 C-N-CA 127.63 2.372 . . . . 0.0 108.816 173.249 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . 0.425 ' HG2' ' CZ3' ' A' ' 190' ' ' TRP . 62.0 mttp -105.54 104.19 13.87 Favored 'General case' 0 N--CA 1.509 2.504 0 N-CA-C 119.727 3.232 . . . . 0.0 119.727 -171.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.43 ' CG ' ' HE1' ' A' ' 190' ' ' TRP . 21.8 pttp -15.09 79.25 0.02 OUTLIER Pre-proline 0 N--CA 1.5 2.074 1 N-CA-C 122.407 4.225 . . . . 0.0 122.407 179.249 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -45.35 -59.93 1.01 Allowed 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 123.886 3.057 . . . . 0.0 107.321 171.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -121.86 20.75 10.82 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 111.399 -2.637 . . . . 0.0 110.638 -178.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.419 ' CA ' ' HB2' ' A' ' 185' ' ' LYS . . . 114.71 12.18 10.64 Favored Glycine 0 N--CA 1.488 2.154 0 C-N-CA 119.717 -1.23 . . . . 0.0 110.876 179.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 2.5 m-90 -127.49 134.3 49.82 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 120.318 3.451 . . . . 0.0 120.318 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' TRP . . . . . 0.506 ' CE3' ' O ' ' A' ' 183' ' ' GLU . 10.2 m95 -120.11 163.06 18.27 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 104.824 -2.287 . . . . 0.0 104.824 178.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.408 ' HB ' ' O ' ' A' ' 182' ' ' ILE . 1.7 mp -107.45 113.0 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 104.179 -2.526 . . . . 0.0 104.179 177.048 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -108.2 -179.81 3.99 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -173.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -133.6 165.31 25.21 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 172.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -115.62 -160.0 0.73 Allowed 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 118.822 -1.151 . . . . 0.0 109.658 -179.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -97.18 38.67 1.23 Allowed 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.874 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -133.36 -38.38 0.94 Allowed 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.45 177.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 136.87 -39.71 1.6 Allowed Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -178.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 21.5 p30 -52.78 164.27 0.39 Allowed 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.95 157.69 32.07 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 113.049 -1.887 . . . . 0.0 110.552 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -142.58 -165.48 10.6 Favored Glycine 0 N--CA 1.482 1.709 0 CA-C-O 122.671 1.151 . . . . 0.0 112.387 -177.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 33.7 mt -125.2 89.98 3.15 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 111.242 -2.479 . . . . 0.0 106.547 177.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.1 m -116.74 154.82 49.45 Favored Pre-proline 0 N--CA 1.496 1.871 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -177.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -89.59 176.26 2.99 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 C-N-CA 123.177 2.585 . . . . 0.0 111.391 -177.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . 0.457 ' HB2' ' CE2' ' A' ' 190' ' ' TRP . 29.3 ttm180 -97.97 -40.09 8.64 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 102.637 -3.097 . . . . 0.0 102.637 174.04 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 73.8 p -25.14 -55.24 0.05 OUTLIER 'General case' 0 N--CA 1.503 2.202 0 O-C-N 125.512 1.758 . . . . 0.0 115.54 176.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -113.66 45.65 1.41 Allowed 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 122.62 1.2 . . . . 0.0 109.387 -178.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -135.75 128.73 31.41 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 112.361 -2.2 . . . . 0.0 105.369 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -114.2 156.09 44.71 Favored Pre-proline 0 N--CA 1.494 1.744 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 178.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -63.21 166.11 15.53 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 121.693 1.595 . . . . 0.0 110.122 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . 0.428 ' CG ' ' N ' ' A' ' 211' ' ' SER . 35.6 t80 -124.33 172.69 8.92 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.688 -0.805 . . . . 0.0 109.511 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' SER . . . . . 0.428 ' N ' ' CG ' ' A' ' 210' ' ' TYR . 56.1 m -116.11 50.52 1.03 Allowed 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.004 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 . . . . . 0 N--CA 1.494 1.753 0 CA-C-O 115.121 -2.371 . . . . 0.0 115.495 178.9 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.119 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -126.55 161.31 28.3 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 103.537 -2.764 . . . . 0.0 103.537 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -115.1 136.3 53.27 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 116.444 -2.102 . . . . 0.0 112.855 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.484 ' CD1' HG21 ' A' ' 181' ' ' VAL . 6.0 m-85 -124.99 -178.99 4.36 Favored 'General case' 0 C--N 1.299 -1.6 1 N-CA-C 100.068 -4.049 . . . . 0.0 100.068 179.085 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.408 HD13 HG21 ' A' ' 158' ' ' ILE . 3.5 pt -125.22 154.6 33.61 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 N-CA-C 101.914 -3.365 . . . . 0.0 101.914 173.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -89.26 150.63 22.54 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 102.02 -3.326 . . . . 0.0 102.02 177.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.2 m -130.09 28.36 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 126.238 2.211 . . . . 0.0 106.545 177.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -142.23 158.94 27.01 Favored Glycine 0 N--CA 1.482 1.754 0 N-CA-C 105.711 -2.956 . . . . 0.0 105.711 174.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.438 ' HA ' ' HA ' ' A' ' 174' ' ' LYS . 9.9 t70 -107.68 94.29 5.0 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 118.928 -1.109 . . . . 0.0 108.786 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.498 ' HB3' ' CZ ' ' A' ' 173' ' ' PHE . 47.6 t80 -107.65 154.09 21.96 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.086 -1.046 . . . . 0.0 108.921 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 56.7 m -127.0 163.43 23.72 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 105.442 -2.059 . . . . 0.0 105.442 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -95.25 135.03 37.34 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 177.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -110.74 -29.81 7.84 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -115.63 -178.07 3.3 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 58.5 t -88.95 150.91 3.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 104.822 -2.288 . . . . 0.0 104.822 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 113.51 -51.89 0.68 Allowed Glycine 0 N--CA 1.485 1.929 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 -178.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.591 ' HA ' ' H ' ' A' ' 201' ' ' LEU . 2.9 m-20 -76.99 166.5 23.23 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -178.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.508 ' HG ' ' HA3' ' A' ' 200' ' ' GLY . 16.4 mt -121.26 178.82 4.62 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 113.449 -1.705 . . . . 0.0 109.935 179.005 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 39.0 m -122.03 100.02 6.75 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.57 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.498 ' CZ ' ' HB3' ' A' ' 163' ' ' PHE . 18.0 p90 -119.21 168.28 11.03 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.531 -0.867 . . . . 0.0 110.88 178.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 162' ' ' ASP . 57.2 pttt -124.84 142.79 51.2 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 115.882 1.808 . . . . 0.0 115.882 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 49.9 tptt -23.9 77.95 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 109.583 -3.462 . . . . 0.0 115.215 170.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 107.78 50.5 0.79 Allowed Glycine 0 N--CA 1.49 2.281 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.913 176.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.402 ' O ' ' HA ' ' A' ' 158' ' ' ILE . 8.0 pt-20 -127.95 170.85 12.39 Favored 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 176.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.405 ' HA ' ' HA ' ' A' ' 158' ' ' ILE . 14.4 mm -99.8 132.76 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 117.98 -1.488 . . . . 0.0 112.11 -177.044 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 57.9 mt -124.74 167.79 14.09 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 113.561 -1.654 . . . . 0.0 110.077 177.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.402 ' O ' ' HB1' ' A' ' 192' ' ' ALA . 22.2 tp -117.47 159.72 22.36 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 102.746 -3.057 . . . . 0.0 102.746 177.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.484 HG21 ' CD1' ' A' ' 157' ' ' TYR . 3.2 t -128.14 136.71 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 CA-C-N 120.915 1.689 . . . . 0.0 109.306 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.505 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 45.8 mt -145.35 86.13 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.093 -176.457 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' GLU . . . . . 0.505 ' HB2' ' O ' ' A' ' 182' ' ' ILE . 10.1 tm-20 130.56 153.18 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.753 0 C-N-CA 128.109 2.564 . . . . 0.0 107.654 172.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -109.83 123.0 48.81 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 118.426 2.75 . . . . 0.0 118.426 -174.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.459 ' CG ' ' HE1' ' A' ' 190' ' ' TRP . 8.4 tttm -9.79 78.37 0.03 OUTLIER Pre-proline 0 N--CA 1.507 2.413 0 N-CA-C 117.746 2.499 . . . . 0.0 117.746 175.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -69.09 -56.53 0.16 Allowed 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 123.165 2.577 . . . . 0.0 105.96 175.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -125.35 19.28 8.18 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 112.067 -2.333 . . . . 0.0 111.791 -177.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.403 ' HA2' ' NZ ' ' A' ' 185' ' ' LYS . . . 122.07 -23.84 7.19 Favored Glycine 0 N--CA 1.487 2.074 0 C-N-CA 118.452 -1.832 . . . . 0.0 111.242 -178.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 24.7 m-90 -113.39 154.6 26.67 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 115.842 1.793 . . . . 0.0 115.842 -176.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' TRP . . . . . 0.459 ' HE1' ' CG ' ' A' ' 185' ' ' LYS . 18.3 m95 -122.73 163.91 19.28 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 101.767 -3.42 . . . . 0.0 101.767 -178.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.493 HG12 ' CB ' ' A' ' 183' ' ' GLU . 8.2 mm -102.9 105.57 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 C-N-CA 115.522 -2.471 . . . . 0.0 105.043 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 192' ' ' ALA . . . . . 0.425 ' HB2' HG22 ' A' ' 202' ' ' VAL . . . -98.43 -177.88 3.84 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -173.027 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 193' ' ' LYS . . . . . 0.465 ' HA ' ' HA ' ' A' ' 199' ' ' GLU . 34.0 ttmt -137.17 164.45 28.44 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 177.105 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 47.2 p-10 -122.45 -163.23 1.06 Allowed 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.664 -0.814 . . . . 0.0 110.077 178.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -103.36 40.86 1.34 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -126.17 -35.6 2.41 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 113.709 -1.587 . . . . 0.0 107.455 177.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 134.9 -38.96 1.75 Allowed Glycine 0 N--CA 1.487 2.071 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 21.1 p30 -67.8 163.78 21.03 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -178.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' GLU . . . . . 0.465 ' HA ' ' HA ' ' A' ' 193' ' ' LYS . 0.0 OUTLIER -129.53 149.48 51.28 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 112.121 -2.309 . . . . 0.0 108.609 177.181 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 200' ' ' GLY . . . . . 0.508 ' HA3' ' HG ' ' A' ' 171' ' ' LEU . . . -139.28 -156.34 6.94 Favored Glycine 0 N--CA 1.482 1.714 0 CA-C-N 114.789 -1.096 . . . . 0.0 113.187 -177.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.591 ' H ' ' HA ' ' A' ' 170' ' ' ASP . 90.3 mt -117.12 101.94 8.89 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 111.622 -2.289 . . . . 0.0 107.56 178.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.425 HG22 ' HB2' ' A' ' 192' ' ' ALA . 4.9 m -120.5 151.44 53.91 Favored Pre-proline 0 N--CA 1.496 1.828 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -82.38 175.85 8.56 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 121.19 1.26 . . . . 0.0 109.05 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' ARG . . . . . 0.411 ' HB2' ' NE1' ' A' ' 190' ' ' TRP . 0.0 OUTLIER -96.37 -42.89 7.91 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 102.994 -2.965 . . . . 0.0 102.994 178.273 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 77.3 p -23.44 -53.67 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 O-C-N 125.579 1.799 . . . . 0.0 115.469 178.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -112.34 49.04 0.94 Allowed 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.891 -0.724 . . . . 0.0 110.807 -178.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -131.15 129.49 41.85 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 179.151 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -121.0 143.68 37.48 Favored Pre-proline 0 N--CA 1.493 1.675 0 C-N-CA 118.729 -1.189 . . . . 0.0 108.198 177.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -58.91 161.21 16.02 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 121.703 1.602 . . . . 0.0 109.798 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 38.7 t80 . . . . . 0 N--CA 1.491 1.599 0 C-N-CA 118.853 -1.139 . . . . 0.0 112.176 -179.06 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.159 0 CA-C-O 121.169 0.316 . . . . 0.0 112.603 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -117.55 162.52 17.86 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 103.195 -2.891 . . . . 0.0 103.195 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 9.3 mp0 -116.31 118.63 33.28 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 117.54 -1.664 . . . . 0.0 110.943 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.515 ' CD1' HG21 ' A' ' 181' ' ' VAL . 41.3 m-85 -126.0 176.46 6.99 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 104.346 -2.464 . . . . 0.0 104.346 178.107 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.455 ' CG2' ' CD1' ' A' ' 210' ' ' TYR . 1.7 pt -124.87 146.2 30.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 1 N-CA-C 100.155 -4.017 . . . . 0.0 100.155 170.728 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -92.7 155.07 17.95 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 116.849 -1.941 . . . . 0.0 106.246 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.6 m -130.2 25.64 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 125.719 1.887 . . . . 0.0 110.02 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -121.66 146.28 17.09 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 106.687 -2.565 . . . . 0.0 106.687 176.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -104.9 78.06 1.39 Allowed 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -178.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -106.51 155.81 19.21 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.021 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 97.6 m -118.32 161.82 19.3 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -86.41 144.34 27.36 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 117.49 -1.684 . . . . 0.0 107.868 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -113.61 -30.07 6.94 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 113.043 -1.89 . . . . 0.0 106.584 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -116.88 176.39 5.14 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 19.4 t -96.83 45.42 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 103.925 -2.621 . . . . 0.0 103.925 176.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -127.68 -46.02 0.2 Allowed Glycine 0 N--CA 1.484 1.882 0 N-CA-C 106.84 -2.504 . . . . 0.0 106.84 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.522 ' HA ' ' H ' ' A' ' 201' ' ' LEU . 25.3 m-20 -79.89 169.85 17.31 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 112.7 -1.75 . . . . 0.0 111.308 179.215 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.457 ' HG ' ' HA3' ' A' ' 200' ' ' GLY . 15.9 mt -121.07 176.73 5.43 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.427 176.272 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 47.2 m -119.62 99.46 6.67 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 114.354 -1.294 . . . . 0.0 110.994 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.444 ' N ' ' CD1' ' A' ' 173' ' ' PHE . 1.3 p90 -118.67 161.94 19.25 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.021 -1.072 . . . . 0.0 111.282 178.383 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -118.51 62.98 0.77 Allowed 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 120.047 3.351 . . . . 0.0 120.047 -175.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 70.4 tttt 37.05 76.83 0.05 OUTLIER 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 116.838 2.162 . . . . 0.0 116.838 173.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 119.1 52.4 0.29 Allowed Glycine 0 N--CA 1.495 2.595 0 CA-C-N 113.68 -1.6 . . . . 0.0 111.703 177.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -131.1 173.37 11.09 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 177.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.444 ' HA ' ' HA ' ' A' ' 158' ' ' ILE . 18.0 mm -97.16 125.06 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 C-N-CA 118.672 -1.211 . . . . 0.0 112.456 -177.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 17.9 mt -118.31 168.25 10.79 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 114.104 -1.407 . . . . 0.0 110.234 177.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 14.5 tp -118.35 157.98 26.11 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 103.826 -2.657 . . . . 0.0 103.826 177.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.515 HG21 ' CD1' ' A' ' 157' ' ' TYR . 43.7 t -120.0 128.3 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-N 120.675 1.579 . . . . 0.0 112.865 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.514 ' O ' ' HB ' ' A' ' 191' ' ' ILE . 56.3 mt -145.61 86.19 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.284 -176.069 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' GLU . . . . . 0.491 ' CB ' ' O ' ' A' ' 182' ' ' ILE . 5.0 tm-20 131.08 151.26 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.932 0 C-N-CA 127.672 2.389 . . . . 0.0 109.11 172.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' LYS . . . . . 0.499 ' HG2' ' CZ3' ' A' ' 190' ' ' TRP . 55.2 mttp -119.37 123.74 44.89 Favored 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 119.69 3.218 . . . . 0.0 119.69 -171.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.559 ' CG ' ' HE1' ' A' ' 190' ' ' TRP . 2.9 tttm -12.43 80.67 0.03 OUTLIER Pre-proline 0 N--CA 1.512 2.664 0 N-CA-C 118.515 2.783 . . . . 0.0 118.515 175.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 189' ' ' TRP . 11.4 Cg_exo -78.59 -55.23 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.527 0 N-CA-C 105.143 -2.676 . . . . 0.0 105.143 174.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' ASP . . . . . 0.403 ' H ' ' HD2' ' A' ' 186' ' ' PRO . 4.6 p-10 -121.99 17.96 10.89 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 112.502 -2.135 . . . . 0.0 110.94 -178.167 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.504 ' HA2' ' HG2' ' A' ' 185' ' ' LYS . . . 114.02 6.81 20.27 Favored Glycine 0 N--CA 1.487 2.057 0 C-N-CA 118.846 -1.645 . . . . 0.0 109.219 -178.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' TRP . . . . . 0.488 ' O ' ' HD3' ' A' ' 186' ' ' PRO . 1.1 m-90 -121.65 147.26 46.1 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 119.829 3.27 . . . . 0.0 119.829 -177.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 190' ' ' TRP . . . . . 0.559 ' HE1' ' CG ' ' A' ' 185' ' ' LYS . 42.1 m95 -128.66 160.13 33.42 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 101.43 -3.545 . . . . 0.0 101.43 176.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.514 ' HB ' ' O ' ' A' ' 182' ' ' ILE . 7.7 mt -115.9 116.37 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 177.118 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -105.4 -177.46 3.37 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -171.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' LYS . . . . . 0.458 ' HA ' ' HA ' ' A' ' 199' ' ' GLU . 3.3 ttmp? -134.83 166.7 22.37 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 175.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.406 ' H ' ' HG2' ' A' ' 193' ' ' LYS . 6.1 p-10 -119.67 -159.12 0.76 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -103.47 37.58 1.98 Allowed 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 120.114 -0.634 . . . . 0.0 110.205 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -128.8 -38.21 1.69 Allowed 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 176.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 138.9 -40.69 1.42 Allowed Glycine 0 N--CA 1.485 1.919 0 N-CA-C 109.021 -1.632 . . . . 0.0 109.021 -178.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -56.35 159.67 3.48 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 118.943 -1.103 . . . . 0.0 113.803 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' GLU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 193' ' ' LYS . 0.0 OUTLIER -129.98 154.26 47.56 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 112.533 -2.121 . . . . 0.0 109.791 179.468 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 200' ' ' GLY . . . . . 0.457 ' HA3' ' HG ' ' A' ' 171' ' ' LEU . . . -135.53 -170.26 12.05 Favored Glycine 0 N--CA 1.482 1.755 0 CA-C-O 122.913 1.285 . . . . 0.0 114.094 -177.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.522 ' H ' ' HA ' ' A' ' 170' ' ' ASP . 13.2 mt -115.41 92.41 3.91 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 110.483 -2.858 . . . . 0.0 105.554 177.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 25.1 m -117.45 158.0 46.06 Favored Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 -177.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -82.86 178.63 5.86 Favored 'Trans proline' 0 C--N 1.302 -1.919 0 N-CA-C 107.945 -1.598 . . . . 0.0 107.945 179.029 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' ARG . . . . . 0.413 ' HB2' ' NE1' ' A' ' 190' ' ' TRP . 13.3 ttt-85 -96.82 -42.69 7.85 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 105.164 -2.162 . . . . 0.0 105.164 179.25 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 41.6 p -23.21 -46.03 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.987 0 O-C-N 126.544 2.402 . . . . 0.0 115.777 176.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -106.12 51.78 0.74 Allowed 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 119.271 -0.972 . . . . 0.0 111.898 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 73.3 mt -127.9 135.88 50.61 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 176.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -119.41 145.33 38.47 Favored Pre-proline 0 C--N 1.303 -1.422 0 N-CA-C 103.732 -2.692 . . . . 0.0 103.732 177.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -62.93 158.03 45.34 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 121.427 1.418 . . . . 0.0 108.457 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' TYR . . . . . 0.455 ' CD1' ' CG2' ' A' ' 158' ' ' ILE . 17.6 t80 . . . . . 0 N--CA 1.488 1.448 0 C-N-CA 118.509 -1.276 . . . . 0.0 110.552 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.147 0 CA-C-O 121.348 0.416 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -123.06 170.65 9.96 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 103.873 -2.64 . . . . 0.0 103.873 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -106.75 130.01 54.53 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 117.319 -1.752 . . . . 0.0 112.301 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.483 ' CD1' HG21 ' A' ' 181' ' ' VAL . 6.2 m-85 -122.53 178.95 4.76 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 101.756 -3.424 . . . . 0.0 101.756 177.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.452 HG22 HG13 ' A' ' 178' ' ' ILE . 6.6 pt -127.76 154.8 38.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 103.519 -2.771 . . . . 0.0 103.519 170.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -88.84 151.22 22.49 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 100.308 -3.96 . . . . 0.0 100.308 176.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 35.9 m -127.2 17.56 3.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 125.845 1.965 . . . . 0.0 107.966 178.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -130.59 159.3 22.83 Favored Glycine 0 N--CA 1.484 1.835 0 N-CA-C 105.895 -2.882 . . . . 0.0 105.895 176.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.408 ' HA ' ' HA ' ' A' ' 174' ' ' LYS . 31.0 t70 -107.3 93.05 4.34 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.026 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -106.86 156.95 18.14 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 118.645 -1.222 . . . . 0.0 108.393 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 90.8 m -120.15 162.31 19.55 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 104.677 -2.342 . . . . 0.0 104.677 179.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -88.25 139.76 30.17 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 117.412 -1.715 . . . . 0.0 106.479 178.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -112.05 -33.51 6.24 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -114.4 -178.22 3.32 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 113.428 -1.714 . . . . 0.0 106.581 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 14.4 p -94.37 40.22 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-O 124.261 1.981 . . . . 0.0 108.199 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -118.75 -53.41 0.29 Allowed Glycine 0 N--CA 1.485 1.935 0 CA-C-N 112.18 -2.282 . . . . 0.0 109.181 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.528 ' HA ' ' H ' ' A' ' 201' ' ' LEU . 1.7 m-20 -81.78 174.95 10.85 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.433 ' HG ' ' HA3' ' A' ' 200' ' ' GLY . 38.8 mt -117.28 177.66 4.65 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 111.92 -2.4 . . . . 0.0 108.202 178.217 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 42.7 m -116.58 91.48 3.6 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 114.182 -1.372 . . . . 0.0 108.004 177.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 16.8 p90 -118.07 164.57 14.93 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 114.0 -1.455 . . . . 0.0 110.497 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 162' ' ' ASP . 17.8 ptpt -126.54 142.85 51.4 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 117.638 2.459 . . . . 0.0 117.638 -179.001 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 71.3 tttt -22.25 76.25 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.726 1 CA-C-N 108.03 -4.168 . . . . 0.0 117.016 171.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 114.92 48.89 0.52 Allowed Glycine 0 N--CA 1.488 2.115 0 CA-C-N 114.225 -1.352 . . . . 0.0 112.998 175.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.415 ' O ' ' HA ' ' A' ' 158' ' ' ILE . 8.5 pt-20 -131.39 155.71 46.8 Favored 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 176.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.496 ' CD1' ' N ' ' A' ' 178' ' ' ILE . 1.1 mp -85.88 135.01 25.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -179.002 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.401 ' N ' HD22 ' A' ' 179' ' ' LEU . 2.7 mm? -124.3 170.98 10.25 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 112.819 -1.992 . . . . 0.0 105.796 175.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 16.6 tp -117.45 154.49 31.3 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 102.028 -3.323 . . . . 0.0 102.028 176.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.483 HG21 ' CD1' ' A' ' 157' ' ' TYR . 2.9 t -126.22 118.93 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 CA-C-N 120.685 1.584 . . . . 0.0 114.681 -176.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.489 ' N ' HD13 ' A' ' 182' ' ' ILE . 0.0 OUTLIER -135.78 93.13 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-O 123.886 1.803 . . . . 0.0 111.046 -177.962 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 183' ' ' GLU . . . . . 0.45 ' HG2' ' N ' ' A' ' 184' ' ' LYS . 44.1 tt0 140.1 155.8 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.584 1 CA-C-N 107.649 -4.341 . . . . 0.0 107.347 175.905 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 184' ' ' LYS . . . . . 0.45 ' N ' ' HG2' ' A' ' 183' ' ' GLU . 97.6 mttt -118.53 97.68 5.87 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 117.246 2.313 . . . . 0.0 117.246 -174.483 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.74 ' HB2' ' NE1' ' A' ' 190' ' ' TRP . 46.0 tttm -15.52 86.7 0.03 OUTLIER Pre-proline 0 N--CA 1.506 2.345 0 N-CA-C 117.095 2.258 . . . . 0.0 117.095 176.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -70.06 -58.46 0.1 OUTLIER 'Trans proline' 0 C--N 1.304 -1.776 0 N-CA-C 103.548 -3.289 . . . . 0.0 103.548 174.027 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -126.01 28.97 5.98 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 112.812 -1.995 . . . . 0.0 113.018 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.471 ' H ' ' HG3' ' A' ' 185' ' ' LYS . . . 115.75 12.04 9.77 Favored Glycine 0 N--CA 1.494 2.527 0 C-N-CA 119.631 -1.271 . . . . 0.0 110.378 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 3.4 m-90 -131.27 122.74 27.0 Favored 'General case' 0 N--CA 1.489 1.517 1 N-CA-C 123.336 4.569 . . . . 0.0 123.336 -178.01 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 190' ' ' TRP . . . . . 0.74 ' NE1' ' HB2' ' A' ' 185' ' ' LYS . 12.2 m95 -119.09 164.71 15.13 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 100.248 -3.982 . . . . 0.0 100.248 173.283 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 27.4 mt -115.66 119.91 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 102.185 -3.265 . . . . 0.0 102.185 176.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -112.23 177.39 4.66 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 118.259 -1.376 . . . . 0.0 113.843 -174.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -130.16 165.43 22.34 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 173.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 43.0 p-10 -122.75 -163.76 1.12 Allowed 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.258 -0.977 . . . . 0.0 110.025 177.288 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -98.87 40.93 1.17 Allowed 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 121.935 0.874 . . . . 0.0 108.787 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -128.56 -37.68 1.77 Allowed 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 113.556 -1.656 . . . . 0.0 107.677 177.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 133.29 -37.97 1.92 Allowed Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 19.9 p30 -64.14 165.65 8.92 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 -178.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.17 154.41 48.4 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 112.723 -2.035 . . . . 0.0 111.443 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' GLY . . . . . 0.433 ' HA3' ' HG ' ' A' ' 171' ' ' LEU . . . -135.47 -173.25 12.97 Favored Glycine 0 N--CA 1.486 2.02 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.587 -178.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.528 ' H ' ' HA ' ' A' ' 170' ' ' ASP . 9.6 mt -116.82 82.38 1.79 Allowed 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 104.636 -2.357 . . . . 0.0 104.636 178.016 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 3.2 m -107.21 156.0 38.35 Favored Pre-proline 0 N--CA 1.498 1.941 0 C-N-CA 119.02 -1.072 . . . . 0.0 109.839 -171.288 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -88.1 179.26 2.83 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 C-N-CA 123.08 2.52 . . . . 0.0 113.084 -177.485 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 204' ' ' ARG . . . . . 0.413 ' HB2' ' NE1' ' A' ' 190' ' ' TRP . 43.2 ttp180 -96.51 -41.84 8.37 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 103.685 -2.709 . . . . 0.0 103.685 174.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 69.8 p -23.55 -52.73 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 O-C-N 126.067 2.104 . . . . 0.0 115.718 178.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -115.49 46.17 1.54 Allowed 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 120.003 -0.679 . . . . 0.0 112.396 -178.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.43 144.55 51.3 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 114.585 -1.188 . . . . 0.0 107.961 179.124 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -128.41 154.04 79.2 Favored Pre-proline 0 N--CA 1.493 1.691 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 175.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -64.34 154.98 68.36 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 C-N-CA 121.658 1.572 . . . . 0.0 112.582 -178.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' TYR . . . . . 0.43 ' CE1' HD11 ' A' ' 178' ' ' ILE . 32.4 t80 . . . . . 0 N--CA 1.492 1.664 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 177.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' GLY . . . . . 0.403 ' HA2' ' O ' ' A' ' 181' ' ' VAL . . . . . . . . 0 N--CA 1.489 2.203 0 CA-C-O 121.103 0.28 . . . . 0.0 112.918 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -115.96 167.32 11.06 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 103.298 -2.852 . . . . 0.0 103.298 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -101.96 122.15 43.5 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 117.274 -1.77 . . . . 0.0 112.407 -176.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.559 ' CD1' HG21 ' A' ' 181' ' ' VAL . 1.0 OUTLIER -126.95 169.8 12.93 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 102.613 -3.106 . . . . 0.0 102.613 176.485 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.971 HG22 HG12 ' A' ' 178' ' ' ILE . 36.7 pt -125.34 142.14 43.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 C-N-CA 118.058 -1.457 . . . . 0.0 108.524 170.077 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.462 ' O ' ' N ' ' A' ' 176' ' ' GLY . . . -72.33 152.52 42.04 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 101.631 -3.47 . . . . 0.0 101.631 178.534 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 26.8 m -118.47 -4.12 10.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 125.892 1.995 . . . . 0.0 108.521 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -137.16 177.01 20.13 Favored Glycine 0 N--CA 1.485 1.962 0 N-CA-C 107.363 -2.295 . . . . 0.0 107.363 178.043 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.408 ' HA ' ' HA ' ' A' ' 174' ' ' LYS . 8.5 t70 -106.51 132.2 52.8 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 118.857 -1.137 . . . . 0.0 109.205 178.49 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.421 ' HB3' ' CZ ' ' A' ' 173' ' ' PHE . 60.8 t80 -123.29 153.37 40.31 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 176.444 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 67.9 m -126.77 156.35 41.36 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -95.79 138.49 33.36 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 178.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 23.6 mm100 -111.82 -34.88 5.88 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 88.0 mm-40 -117.45 -176.01 2.93 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 113.314 -1.767 . . . . 0.0 106.328 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 61.9 t -87.62 154.94 3.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 104.224 -2.51 . . . . 0.0 104.224 178.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 113.28 -48.2 0.96 Allowed Glycine 0 N--CA 1.485 1.948 0 N-CA-C 107.905 -2.078 . . . . 0.0 107.905 -178.019 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.611 ' HA ' ' H ' ' A' ' 201' ' ' LEU . 3.4 m-20 -83.91 167.42 17.0 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 113.731 -1.235 . . . . 0.0 113.785 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.462 ' CD2' HD22 ' A' ' 198' ' ' ASN . 19.3 mt -121.22 173.68 7.16 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 114.128 -1.396 . . . . 0.0 109.624 178.34 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 55.0 m -123.94 93.76 4.02 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 114.355 -1.293 . . . . 0.0 110.128 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.425 ' CD1' ' N ' ' A' ' 173' ' ' PHE . 20.1 p90 -126.6 167.92 15.01 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.862 -178.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 162' ' ' ASP . 63.7 pttt -118.27 165.93 13.23 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 123.504 1.621 . . . . 0.0 114.338 177.497 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 52.2 tttm -39.02 154.37 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 110.534 -3.03 . . . . 0.0 117.081 175.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 159' ' ' ALA . . . 33.14 48.75 0.42 Allowed Glycine 0 N--CA 1.493 2.454 0 CA-C-N 112.095 -2.321 . . . . 0.0 111.02 177.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' A' ' 158' ' ' ILE . 5.4 pt-20 -121.39 162.68 19.96 Favored 'General case' 0 N--CA 1.506 2.348 0 CA-C-N 111.722 -2.239 . . . . 0.0 108.372 176.556 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.971 HG12 HG22 ' A' ' 158' ' ' ILE . 44.7 mt -99.53 120.41 48.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 N-CA-C 118.69 2.848 . . . . 0.0 118.69 -176.119 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 21.4 mt -118.72 168.59 10.59 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 110.992 -2.822 . . . . 0.0 108.854 178.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.401 HD13 ' HA ' ' A' ' 180' ' ' LEU . 4.1 mm? -110.74 158.5 18.58 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 177.302 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.559 HG21 ' CD1' ' A' ' 157' ' ' TYR . 50.5 t -119.38 117.81 55.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 C-N-CA 119.65 -0.82 . . . . 0.0 112.975 -178.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.605 ' O ' ' HB ' ' A' ' 191' ' ' ILE . 3.4 mp -139.55 83.31 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.203 -1.35 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.292 -174.232 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' GLU . . . . . 0.49 ' HB3' ' H ' ' A' ' 191' ' ' ILE . 35.8 tt0 136.14 150.59 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.764 0 C-N-CA 127.931 2.493 . . . . 0.0 107.897 173.469 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' LYS . . . . . 0.414 ' N ' ' HG2' ' A' ' 183' ' ' GLU . 67.0 mttm -115.94 124.55 50.85 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 -176.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.481 ' CG ' ' HE1' ' A' ' 190' ' ' TRP . 3.6 tttm -10.7 77.4 0.03 OUTLIER Pre-proline 0 N--CA 1.504 2.261 0 O-C-N 126.658 2.473 . . . . 0.0 116.912 177.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -69.39 -57.04 0.13 Allowed 'Trans proline' 0 C--N 1.307 -1.615 0 N-CA-C 105.306 -2.613 . . . . 0.0 105.306 175.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -122.44 17.38 10.53 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 111.406 -2.634 . . . . 0.0 113.176 -177.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.412 ' HA2' ' NZ ' ' A' ' 185' ' ' LYS . . . 121.19 -25.7 6.96 Favored Glycine 0 N--CA 1.489 2.173 0 C-N-CA 118.359 -1.877 . . . . 0.0 110.596 -178.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 31.3 m-90 -114.84 153.42 30.47 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 122.826 1.298 . . . . 0.0 113.925 -176.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' TRP . . . . . 0.481 ' HE1' ' CG ' ' A' ' 185' ' ' LYS . 16.7 m95 -115.9 168.58 9.93 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 100.266 -3.976 . . . . 0.0 100.266 -178.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.605 ' HB ' ' O ' ' A' ' 182' ' ' ILE . 2.1 mm -111.0 109.98 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 103.367 -2.827 . . . . 0.0 103.367 -179.298 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -106.26 179.99 4.11 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -172.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' LYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 199' ' ' GLU . 36.6 ttpt -139.97 163.24 33.2 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 118.748 -1.181 . . . . 0.0 109.549 177.233 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -121.19 -165.91 1.29 Allowed 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.885 178.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -106.15 40.44 1.59 Allowed 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.897 0.856 . . . . 0.0 109.603 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -118.53 -42.54 2.75 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 177.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 141.94 -48.27 0.8 Allowed Glycine 0 N--CA 1.482 1.718 0 N-CA-C 106.005 -2.838 . . . . 0.0 106.005 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' ASN . . . . . 0.462 HD22 ' CD2' ' A' ' 171' ' ' LEU . 0.8 OUTLIER -55.15 154.01 6.16 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 179.345 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 199' ' ' GLU . . . . . 0.49 ' HA ' ' HA ' ' A' ' 193' ' ' LYS . 0.0 OUTLIER -129.17 154.35 46.83 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 112.73 -2.032 . . . . 0.0 107.777 178.13 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 200' ' ' GLY . . . . . 0.446 ' O ' ' HA ' ' A' ' 191' ' ' ILE . . . -136.03 -161.04 9.04 Favored Glycine 0 N--CA 1.479 1.514 0 C-N-CA 120.009 -1.091 . . . . 0.0 113.161 -176.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.611 ' H ' ' HA ' ' A' ' 170' ' ' ASP . 36.2 mt -118.67 94.08 4.34 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 110.497 -2.852 . . . . 0.0 105.727 179.162 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 5.3 m -112.81 150.54 42.95 Favored Pre-proline 0 N--CA 1.498 1.932 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 -177.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -75.3 175.35 11.38 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 C-N-CA 121.174 1.25 . . . . 0.0 109.761 -177.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.4 -40.63 8.19 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 103.562 -2.755 . . . . 0.0 103.562 178.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 76.7 p -28.87 -50.97 0.09 Allowed 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 113.3 -1.773 . . . . 0.0 114.602 175.034 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -113.62 39.12 2.73 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.569 0.7 . . . . 0.0 112.331 -178.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.91 98.56 5.57 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 104.937 -2.246 . . . . 0.0 104.937 178.08 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -106.62 148.33 36.62 Favored Pre-proline 0 C--N 1.299 -1.621 0 N-CA-C 104.039 -2.578 . . . . 0.0 104.039 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -53.57 165.81 1.52 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.489 2.126 . . . . 0.0 113.18 -177.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' TYR . . . . . 0.474 ' CE1' HD11 ' A' ' 178' ' ' ILE . 45.4 t80 . . . . . 0 C--N 1.305 -1.361 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.734 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' GLY . . . . . 0.403 ' HA2' ' O ' ' A' ' 181' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.29 0 N-CA-C 114.681 0.632 . . . . 0.0 114.681 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -128.82 159.5 35.54 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 103.965 -2.606 . . . . 0.0 103.965 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -105.63 134.4 48.8 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 115.968 -2.293 . . . . 0.0 112.967 -177.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.504 ' CD1' HG21 ' A' ' 181' ' ' VAL . 7.1 m-85 -115.49 -178.41 3.38 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 101.397 -3.557 . . . . 0.0 101.397 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.492 ' HA ' ' O ' ' A' ' 177' ' ' GLU . 0.1 OUTLIER -126.11 152.72 33.68 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 N-CA-C 100.504 -3.887 . . . . 0.0 100.504 175.15 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -91.88 148.64 22.07 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 102.824 -3.028 . . . . 0.0 102.824 178.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 32.7 m -126.6 9.46 3.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 125.128 1.518 . . . . 0.0 108.773 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -130.03 161.83 23.03 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 104.989 -3.244 . . . . 0.0 104.989 176.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.428 ' HA ' ' HA ' ' A' ' 174' ' ' LYS . 9.9 t70 -109.3 97.54 7.12 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 118.95 -1.1 . . . . 0.0 109.107 178.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.4 ' HB3' ' CZ ' ' A' ' 173' ' ' PHE . 13.7 t80 -104.3 155.1 19.04 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 118.361 -1.336 . . . . 0.0 107.628 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 88.3 m -123.21 165.24 17.24 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 103.862 -2.644 . . . . 0.0 103.862 179.068 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -91.63 145.25 24.74 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 117.653 -1.619 . . . . 0.0 108.452 179.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -113.7 -38.53 4.26 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -121.45 158.99 27.18 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 113.456 -1.702 . . . . 0.0 106.539 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 83.3 t -41.47 -57.68 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 125.099 1.499 . . . . 0.0 107.472 176.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -27.19 -56.22 0.1 OUTLIER Glycine 0 N--CA 1.486 2.025 0 CA-C-N 112.431 -2.168 . . . . 0.0 114.055 175.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.543 ' HA ' ' H ' ' A' ' 201' ' ' LEU . 18.2 m-20 -75.68 161.83 28.75 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -177.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.478 HD13 ' CA ' ' A' ' 200' ' ' GLY . 1.5 tp -116.88 -178.58 3.47 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 112.966 -1.925 . . . . 0.0 109.424 177.1 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 33.7 m -129.24 98.63 4.95 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 112.394 -2.185 . . . . 0.0 111.805 -178.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.4 ' CZ ' ' HB3' ' A' ' 163' ' ' PHE . 25.1 p90 -122.17 167.44 13.18 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.785 178.38 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 162' ' ' ASP . 18.8 ptpt -121.53 144.11 48.9 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 116.732 2.123 . . . . 0.0 116.732 179.035 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -35.07 80.66 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 108.529 -3.941 . . . . 0.0 114.426 172.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 111.33 50.16 0.63 Allowed Glycine 0 N--CA 1.49 2.293 0 CA-C-N 114.726 -1.125 . . . . 0.0 112.125 178.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.492 ' O ' ' HA ' ' A' ' 158' ' ' ILE . 5.9 pt-20 -126.91 -172.66 2.69 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 177.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 14.4 mm -109.26 137.54 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 123.992 0.807 . . . . 0.0 111.139 177.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 54.2 mt -128.92 169.12 15.01 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 113.588 -1.642 . . . . 0.0 110.008 178.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.63 ' HB2' ' HB2' ' A' ' 193' ' ' LYS . 6.9 mt -121.74 157.82 30.14 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 174.359 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.504 HG21 ' CD1' ' A' ' 157' ' ' TYR . 92.6 t -119.14 117.48 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 116.714 2.116 . . . . 0.0 116.714 -178.421 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.507 ' O ' ' HB ' ' A' ' 191' ' ' ILE . 1.7 mm -123.63 70.79 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 105.472 -2.048 . . . . 0.0 105.472 178.075 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' A' ' 182' ' ' ILE . 10.8 tp10 125.35 141.53 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.296 0 C-N-CA 128.853 2.861 . . . . 0.0 109.756 177.634 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -120.14 113.54 20.61 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 177.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.634 ' HB2' ' CA ' ' A' ' 188' ' ' GLY . 0.0 OUTLIER -14.37 75.75 0.02 OUTLIER Pre-proline 0 N--CA 1.495 1.781 0 N-CA-C 121.383 3.846 . . . . 0.0 121.383 -171.503 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.449 ' HD2' ' HA ' ' A' ' 185' ' ' LYS . 9.9 Cg_endo -43.65 -58.81 1.25 Allowed 'Trans proline' 0 C--N 1.314 -1.289 0 C-N-CA 123.647 2.898 . . . . 0.0 106.221 171.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -124.98 23.17 7.87 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 111.761 -2.472 . . . . 0.0 111.645 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.634 ' CA ' ' HB2' ' A' ' 185' ' ' LYS . . . 113.53 2.16 24.39 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 189' ' ' TRP . . . . . 0.428 ' O ' ' HD2' ' A' ' 186' ' ' PRO . 3.9 m-90 -126.33 119.74 28.11 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 119.621 3.193 . . . . 0.0 119.621 -176.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 190' ' ' TRP . . . . . 0.55 ' CD1' ' HB3' ' A' ' 185' ' ' LYS . 5.7 m0 -103.21 150.61 23.53 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 104.084 -2.562 . . . . 0.0 104.084 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.507 ' HB ' ' O ' ' A' ' 182' ' ' ILE . 8.0 mm -113.76 102.19 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 100.341 -3.948 . . . . 0.0 100.341 177.5 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -106.06 169.4 8.52 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 118.174 -1.411 . . . . 0.0 112.614 -171.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' LYS . . . . . 0.63 ' HB2' ' HB2' ' A' ' 180' ' ' LEU . 93.7 mttt -117.86 161.93 18.94 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 104.117 -2.549 . . . . 0.0 104.117 176.513 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -126.35 -162.63 1.15 Allowed 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 118.557 -1.257 . . . . 0.0 110.474 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -98.96 40.85 1.17 Allowed 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.692 -0.803 . . . . 0.0 109.773 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -128.56 -40.75 1.56 Allowed 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 176.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 140.28 -47.39 0.88 Allowed Glycine 0 N--CA 1.487 2.099 0 N-CA-C 107.348 -2.301 . . . . 0.0 107.348 178.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -57.26 161.31 3.34 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 114.965 1.468 . . . . 0.0 114.965 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' GLU . . . . . 0.448 ' HG3' ' N ' ' A' ' 200' ' ' GLY . 0.0 OUTLIER -130.55 151.42 51.04 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 113.598 -1.637 . . . . 0.0 108.464 176.772 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 200' ' ' GLY . . . . . 0.478 ' CA ' HD13 ' A' ' 171' ' ' LEU . . . -139.64 -157.05 7.14 Favored Glycine 0 N--CA 1.484 1.877 0 C-N-CA 119.333 -1.413 . . . . 0.0 113.399 -178.04 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.543 ' H ' ' HA ' ' A' ' 170' ' ' ASP . 42.4 mt -112.34 96.15 5.85 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 111.133 -2.533 . . . . 0.0 108.708 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 3.7 m -112.26 154.46 44.41 Favored Pre-proline 0 N--CA 1.49 1.525 0 N-CA-C 105.777 -1.934 . . . . 0.0 105.777 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 0.4 OUTLIER -88.4 -178.24 2.01 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 C-N-CA 123.721 2.947 . . . . 0.0 112.346 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 204' ' ' ARG . . . . . 0.55 ' HB2' ' CD ' ' A' ' 185' ' ' LYS . 24.8 ttt85 -74.29 -59.65 2.63 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 173.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 69.5 p -18.37 -48.55 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.134 0 CA-C-N 109.876 -3.329 . . . . 0.0 117.187 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -110.45 38.32 2.49 Favored 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 119.192 -1.003 . . . . 0.0 112.243 -178.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -123.53 104.98 9.38 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 124.238 0.961 . . . . 0.0 111.427 -178.325 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -112.61 155.04 44.46 Favored Pre-proline 0 N--CA 1.496 1.853 0 C-N-CA 117.891 -1.524 . . . . 0.0 107.021 175.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -64.19 164.21 23.43 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 121.809 1.672 . . . . 0.0 111.963 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 21.2 t80 . . . . . 0 N--CA 1.492 1.658 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.594 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 154' ' ' GLY . . . . . 0.409 ' HA3' ' O ' ' A' ' 181' ' ' VAL . . . . . . . . 0 N--CA 1.488 2.113 0 N-CA-C 113.616 0.207 . . . . 0.0 113.616 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -130.79 170.98 13.64 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.531 ' CD ' ' H ' ' A' ' 156' ' ' GLU . 0.0 OUTLIER -110.79 123.83 50.84 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 116.972 -1.891 . . . . 0.0 112.969 -178.001 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.52 ' CD1' HG21 ' A' ' 181' ' ' VAL . 5.9 m-85 -119.18 178.11 4.64 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 102.649 -3.093 . . . . 0.0 102.649 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.504 HG22 HG13 ' A' ' 178' ' ' ILE . 2.9 pt -128.28 145.48 35.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 102.409 -3.182 . . . . 0.0 102.409 172.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -92.26 151.55 20.27 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 115.011 -2.676 . . . . 0.0 103.876 177.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 28.0 m -127.67 32.81 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 125.838 1.961 . . . . 0.0 108.23 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -129.96 158.03 22.14 Favored Glycine 0 N--CA 1.483 1.824 0 N-CA-C 105.762 -2.935 . . . . 0.0 105.762 173.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -106.06 76.14 1.15 Allowed 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -102.21 148.53 25.32 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 118.463 -1.295 . . . . 0.0 108.428 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 87.5 m -120.21 161.49 20.98 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 104.461 -2.422 . . . . 0.0 104.461 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -93.17 135.77 34.05 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 105.744 -1.946 . . . . 0.0 105.744 178.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -110.65 -31.34 7.25 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 -115.71 -178.88 3.49 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 105.091 -2.189 . . . . 0.0 105.091 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 61.8 t -89.94 152.47 3.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 103.317 -2.846 . . . . 0.0 103.317 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 114.54 -47.86 1.0 Allowed Glycine 0 N--CA 1.486 2.02 0 N-CA-C 108.503 -1.839 . . . . 0.0 108.503 -177.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.489 ' HA ' ' H ' ' A' ' 201' ' ' LEU . 26.4 m-20 -82.2 168.7 17.4 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 113.964 -1.118 . . . . 0.0 112.622 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.441 HD11 ' C ' ' A' ' 199' ' ' GLU . 41.8 mt -127.66 178.7 5.95 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.842 176.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 57.3 m -122.13 102.57 8.22 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 114.453 -1.248 . . . . 0.0 113.316 -178.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -118.92 167.96 11.23 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.315 -0.954 . . . . 0.0 111.522 177.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -114.99 62.21 0.68 Allowed 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 121.019 3.711 . . . . 0.0 121.019 -175.052 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.439 ' O ' ' HG3' ' A' ' 175' ' ' LYS . 15.6 tptm 41.02 74.12 0.11 Allowed 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 117.102 2.26 . . . . 0.0 117.102 174.323 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 116.53 50.99 0.4 Allowed Glycine 0 N--CA 1.495 2.609 0 CA-C-N 114.412 -1.267 . . . . 0.0 113.822 173.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.474 ' N ' ' CD ' ' A' ' 177' ' ' GLU . 0.2 OUTLIER -139.92 163.45 32.63 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 177.837 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.504 HG13 HG22 ' A' ' 158' ' ' ILE . 1.0 OUTLIER -87.99 134.01 29.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 116.361 1.986 . . . . 0.0 116.361 -176.376 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.5 mp -131.42 175.62 8.98 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 112.671 -2.059 . . . . 0.0 108.076 174.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.472 HD13 ' H ' ' A' ' 181' ' ' VAL . 0.5 OUTLIER -112.92 156.18 23.44 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 102.713 -3.069 . . . . 0.0 102.713 -179.449 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.52 HG21 ' CD1' ' A' ' 157' ' ' TYR . 2.8 t -127.15 135.74 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 CA-C-N 120.924 1.693 . . . . 0.0 109.906 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.464 ' O ' ' HB ' ' A' ' 191' ' ' ILE . 4.3 mt -143.49 84.13 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -174.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' GLU . . . . . 0.446 ' CB ' ' O ' ' A' ' 182' ' ' ILE . 34.2 tt0 142.32 154.13 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.54 0 C-N-CA 126.446 1.898 . . . . 0.0 108.594 176.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' LYS . . . . . 0.442 ' N ' ' HG2' ' A' ' 183' ' ' GLU . 97.9 mttt -121.34 116.95 25.77 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 115.256 1.576 . . . . 0.0 115.256 -178.058 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.481 ' HB2' ' NE1' ' A' ' 190' ' ' TRP . 9.3 tttm -7.27 81.18 0.03 OUTLIER Pre-proline 0 N--CA 1.5 2.071 0 CA-C-N 111.757 -2.474 . . . . 0.0 117.378 175.367 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.468 ' HD2' ' H ' ' A' ' 189' ' ' TRP . 97.1 Cg_endo -78.66 -52.83 0.06 OUTLIER 'Trans proline' 0 C--N 1.302 -1.877 0 C-N-CA 122.797 2.331 . . . . 0.0 106.805 175.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -126.79 14.07 7.45 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.244 -1.343 . . . . 0.0 109.085 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.432 ' HA2' ' HG2' ' A' ' 185' ' ' LYS . . . 118.18 7.49 11.26 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 -178.297 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' TRP . . . . . 0.468 ' H ' ' HD2' ' A' ' 186' ' ' PRO . 1.4 m-90 -122.54 142.13 50.94 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 119.767 3.247 . . . . 0.0 119.767 -179.003 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' TRP . . . . . 0.514 ' NE1' ' HB2' ' A' ' 204' ' ' ARG . 22.7 m95 -124.7 157.7 34.99 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 100.412 -3.921 . . . . 0.0 100.412 177.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.464 ' HB ' ' O ' ' A' ' 182' ' ' ILE . 31.2 mm -97.99 171.06 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.866 1 N-CA-C 99.845 -4.131 . . . . 0.0 99.845 176.671 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 192' ' ' ALA . . . . . 0.436 ' O ' ' HA ' ' A' ' 199' ' ' GLU . . . -152.95 176.17 12.14 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 116.683 -2.007 . . . . 0.0 109.893 177.442 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -134.02 159.58 40.36 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 170.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 58.4 p30 -120.12 -162.78 0.95 Allowed 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 118.594 -1.242 . . . . 0.0 111.426 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -99.54 39.44 1.31 Allowed 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.086 -1.046 . . . . 0.0 109.692 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -121.38 -39.35 2.68 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 176.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 126.98 -1.79 7.29 Favored Glycine 0 N--CA 1.492 2.402 0 CA-C-N 114.803 -1.09 . . . . 0.0 111.224 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 26.3 p30 -100.7 176.68 5.23 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' GLU . . . . . 0.441 ' C ' HD11 ' A' ' 171' ' ' LEU . 1.5 pt-20 -113.28 166.57 11.34 Favored 'General case' 0 N--CA 1.484 1.27 0 O-C-N 125.859 1.974 . . . . 0.0 109.332 -179.156 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' GLY . . . . . 0.415 ' CA ' ' HG ' ' A' ' 171' ' ' LEU . . . -144.58 -178.46 20.25 Favored Glycine 0 N--CA 1.481 1.698 0 CA-C-O 122.389 0.994 . . . . 0.0 113.428 -175.152 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.489 ' H ' ' HA ' ' A' ' 170' ' ' ASP . 15.4 mt -125.26 89.18 3.01 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 177.089 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 3.9 m -111.7 157.16 40.18 Favored Pre-proline 0 N--CA 1.487 1.409 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 -175.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -90.08 179.57 1.98 Allowed 'Trans proline' 0 C--N 1.3 -2.014 0 C-N-CA 122.103 1.869 . . . . 0.0 109.405 178.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' ARG . . . . . 0.514 ' HB2' ' NE1' ' A' ' 190' ' ' TRP . 10.8 tpt180 -97.54 -43.23 7.33 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 176.433 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.442 ' HG1' ' HD1' ' A' ' 206' ' ' TYR . 43.0 p -25.56 -51.31 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 126.231 2.207 . . . . 0.0 114.731 177.257 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 206' ' ' TYR . . . . . 0.442 ' HD1' ' HG1' ' A' ' 205' ' ' THR . 85.7 m-85 -113.88 50.43 0.92 Allowed 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 119.778 -0.769 . . . . 0.0 111.781 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -133.5 135.95 44.77 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 177.648 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -125.39 154.67 72.32 Favored Pre-proline 0 N--CA 1.489 1.516 0 N-CA-C 105.785 -1.932 . . . . 0.0 105.785 176.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -67.2 165.97 24.83 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 N-CA-C 108.617 -1.34 . . . . 0.0 108.617 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' TYR . . . . . 0.41 ' CE1' HD11 ' A' ' 178' ' ' ILE . 34.5 t80 . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.496 0 N-CA-C 116.102 1.201 . . . . 0.0 116.102 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.424 ' CD ' ' N ' ' A' ' 155' ' ' GLU . 1.4 pm0 -131.36 169.86 15.43 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 106.02 -1.845 . . . . 0.0 106.02 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -121.78 142.16 50.49 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 117.502 -1.679 . . . . 0.0 114.937 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -128.93 -178.91 4.82 Favored 'General case' 0 C--N 1.301 -1.516 1 N-CA-C 99.664 -4.199 . . . . 0.0 99.664 177.329 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.508 HG22 HG13 ' A' ' 178' ' ' ILE . 4.2 pt -130.54 152.87 38.18 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 101.647 -3.464 . . . . 0.0 101.647 170.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -91.5 156.2 17.86 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 104.325 -2.472 . . . . 0.0 104.325 179.259 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 20.3 m -125.33 8.61 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 126.045 2.091 . . . . 0.0 107.916 176.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -132.97 168.7 22.83 Favored Glycine 0 N--CA 1.483 1.83 0 N-CA-C 105.746 -2.942 . . . . 0.0 105.746 175.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -107.06 146.6 31.0 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 177.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -124.8 160.53 28.5 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 104.805 -2.295 . . . . 0.0 104.805 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 96.4 m -129.45 151.48 50.03 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 118.864 -1.134 . . . . 0.0 108.333 178.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -98.51 138.67 35.39 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 118.296 -1.362 . . . . 0.0 108.01 178.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 25.1 mm100 -114.42 -32.58 5.88 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 113.213 -1.812 . . . . 0.0 106.708 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -112.9 179.85 3.85 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 114.144 -1.389 . . . . 0.0 107.86 -179.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 16.3 t -95.45 47.21 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -128.76 -53.53 0.11 Allowed Glycine 0 N--CA 1.485 1.944 0 N-CA-C 108.331 -1.907 . . . . 0.0 108.331 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -76.48 163.47 26.9 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 113.542 -1.329 . . . . 0.0 113.788 -178.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.449 HD13 ' HA3' ' A' ' 200' ' ' GLY . 1.1 tp -108.51 -171.61 1.89 Allowed 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 111.954 -2.384 . . . . 0.0 109.078 175.43 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 53.6 m -120.88 -69.24 0.85 Allowed 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 113.736 -1.575 . . . . 0.0 114.335 -177.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 54.2 p90 37.52 164.33 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.527 0 N-CA-C 117.12 2.267 . . . . 0.0 117.12 -174.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -130.16 151.83 50.26 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 118.391 2.737 . . . . 0.0 118.391 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -21.28 80.41 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.568 1 CA-C-N 108.342 -4.026 . . . . 0.0 118.057 171.174 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 110.04 47.99 0.8 Allowed Glycine 0 N--CA 1.493 2.473 0 CA-C-N 114.728 -1.124 . . . . 0.0 112.878 174.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -135.84 154.91 51.03 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 117.309 -1.757 . . . . 0.0 108.045 177.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.508 HG13 HG22 ' A' ' 158' ' ' ILE . 1.1 mp -80.6 130.94 35.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -178.231 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 27.7 mt -120.15 162.59 19.07 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 113.129 -1.851 . . . . 0.0 108.222 176.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.529 HD13 ' N ' ' A' ' 181' ' ' VAL . 1.6 tm? -116.06 151.38 35.65 Favored 'General case' 0 N--CA 1.498 1.93 1 N-CA-C 100.105 -4.035 . . . . 0.0 100.105 179.345 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.529 ' N ' HD13 ' A' ' 180' ' ' LEU . 2.4 t -121.05 139.12 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 CA-C-N 122.041 2.2 . . . . 0.0 111.074 -179.175 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.484 ' O ' ' HB ' ' A' ' 191' ' ' ILE . 42.9 mt -145.0 87.09 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-O 121.105 0.479 . . . . 0.0 111.004 -176.607 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' GLU . . . . . 0.485 ' O ' ' CE3' ' A' ' 190' ' ' TRP . 0.0 OUTLIER 135.96 148.7 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.586 0 C-N-CA 128.359 2.664 . . . . 0.0 107.084 172.59 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -106.24 117.45 34.06 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 118.276 2.695 . . . . 0.0 118.276 -172.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.544 ' HE2' ' HE1' ' A' ' 190' ' ' TRP . 0.8 OUTLIER -11.97 81.38 0.03 OUTLIER Pre-proline 0 N--CA 1.507 2.389 0 N-CA-C 118.124 2.639 . . . . 0.0 118.124 175.24 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -73.06 -56.23 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 123.549 2.833 . . . . 0.0 105.684 175.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 21.3 p-10 -120.97 16.34 11.69 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 112.08 -2.327 . . . . 0.0 113.877 -177.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.491 ' CA ' ' HG2' ' A' ' 185' ' ' LYS . . . 118.09 -15.81 12.1 Favored Glycine 0 N--CA 1.493 2.465 0 C-N-CA 118.712 -1.709 . . . . 0.0 109.002 -178.037 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 13.5 m-90 -116.61 149.39 39.77 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 116.761 2.134 . . . . 0.0 116.761 -176.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' TRP . . . . . 0.544 ' HE1' ' HE2' ' A' ' 185' ' ' LYS . 20.0 m95 -122.88 169.15 11.41 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 102.396 -3.187 . . . . 0.0 102.396 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.484 ' HB ' ' O ' ' A' ' 182' ' ' ILE . 2.5 mp -113.95 103.58 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 104.652 -2.351 . . . . 0.0 104.652 175.044 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 192' ' ' ALA . . . . . 0.437 ' HB1' ' O ' ' A' ' 180' ' ' LEU . . . -94.34 178.35 5.65 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -173.137 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -124.91 158.58 33.2 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 103.273 -2.862 . . . . 0.0 103.273 175.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 51.6 p-10 -124.69 -167.1 1.61 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.279 -0.968 . . . . 0.0 111.148 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -99.09 43.14 1.07 Allowed 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 122.123 0.963 . . . . 0.0 108.47 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 4.8 tmtm? -126.05 -45.11 1.73 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 104.204 -2.517 . . . . 0.0 104.204 177.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 137.91 -40.17 1.51 Allowed Glycine 0 N--CA 1.485 1.925 0 N-CA-C 108.109 -1.996 . . . . 0.0 108.109 -178.229 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -69.98 164.15 24.53 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 118.795 -1.162 . . . . 0.0 113.626 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' GLU . . . . . 0.439 ' C ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -137.36 157.68 46.06 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 112.9 -1.955 . . . . 0.0 109.238 -179.915 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 200' ' ' GLY . . . . . 0.449 ' HA3' HD13 ' A' ' 171' ' ' LEU . . . 179.58 -173.76 45.54 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 118.248 -1.929 . . . . 0.0 112.418 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 59.2 mt -71.63 96.25 1.54 Allowed 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -176.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 3.2 m -119.54 153.96 54.27 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 103.641 -2.726 . . . . 0.0 103.641 177.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -87.12 174.72 5.2 Favored 'Trans proline' 0 C--N 1.301 -1.945 0 C-N-CA 121.804 1.669 . . . . 0.0 109.197 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 28.9 ttt180 -106.16 -22.81 12.76 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 177.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 53.9 p -34.37 -50.18 0.41 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 113.91 -1.495 . . . . 0.0 114.368 173.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -105.38 34.3 3.31 Favored 'General case' 0 N--CA 1.503 2.198 0 C-N-CA 118.354 -1.338 . . . . 0.0 111.681 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 3.2 mp -119.42 118.78 32.05 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 124.817 1.323 . . . . 0.0 110.65 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' GLU . . . . . 0.412 ' N ' ' CD ' ' A' ' 208' ' ' GLU . 43.6 mp0 -115.57 150.74 45.21 Favored Pre-proline 0 C--N 1.297 -1.712 0 N-CA-C 105.982 -1.858 . . . . 0.0 105.982 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -55.16 164.43 3.68 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.292 1.995 . . . . 0.0 113.308 -177.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 43.3 t80 . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 179.13 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.061 0 CA-C-O 121.18 0.322 . . . . 0.0 113.549 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -128.9 165.18 21.54 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 104.053 -2.573 . . . . 0.0 104.053 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -107.76 135.59 48.92 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 116.92 -1.912 . . . . 0.0 111.081 -178.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.463 ' CD1' HG21 ' A' ' 181' ' ' VAL . 28.2 m-85 -132.6 176.24 8.62 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 109.503 -3.499 . . . . 0.0 105.285 179.509 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.449 ' HA ' ' O ' ' A' ' 177' ' ' GLU . 0.4 OUTLIER -126.31 143.05 41.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 1 N-CA-C 99.572 -4.232 . . . . 0.0 99.572 172.273 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -93.1 151.96 19.55 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 115.983 -2.287 . . . . 0.0 105.311 178.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 35.6 m -127.81 24.3 2.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 125.39 1.681 . . . . 0.0 109.054 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -123.55 153.6 17.26 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 106.697 -2.561 . . . . 0.0 106.697 177.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -105.66 82.53 1.81 Allowed 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 120.069 -0.652 . . . . 0.0 109.834 -179.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -108.68 151.88 25.57 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 118.879 -1.129 . . . . 0.0 108.54 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 53.7 m -122.07 159.86 26.21 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -89.15 133.25 34.47 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 178.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -109.83 -29.23 8.39 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 26.8 pt20 -117.64 -176.31 3.0 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 178.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 9.9 p -91.3 157.02 2.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 177.196 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 111.44 -50.44 0.77 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 -178.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -79.38 169.65 17.76 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 113.806 -1.197 . . . . 0.0 112.116 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 66.4 mt -126.02 178.22 5.89 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 114.223 -1.353 . . . . 0.0 109.744 177.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 53.5 m -120.48 99.28 6.47 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 114.484 -1.235 . . . . 0.0 112.179 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -115.65 165.87 12.56 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 118.82 -1.152 . . . . 0.0 110.172 177.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? -121.13 57.37 1.0 Allowed 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 121.22 3.785 . . . . 0.0 121.22 -174.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 70.9 tttt 46.67 76.78 0.09 Allowed 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 116.554 2.057 . . . . 0.0 116.554 174.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 117.28 52.27 0.34 Allowed Glycine 0 N--CA 1.495 2.632 0 CA-C-N 114.15 -1.386 . . . . 0.0 111.743 175.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.451 ' N ' ' CD ' ' A' ' 177' ' ' GLU . 2.8 pm0 -131.88 -179.12 5.21 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 178.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 7.0 mm -112.58 120.06 61.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 124.513 1.133 . . . . 0.0 113.885 -175.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.452 HD22 ' N ' ' A' ' 179' ' ' LEU . 2.0 mm? -123.72 170.3 10.64 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.304 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 16.6 tp -111.12 156.24 21.65 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 100.586 -3.857 . . . . 0.0 100.586 175.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.506 ' CG1' ' HB3' ' A' ' 190' ' ' TRP . 2.4 t -126.66 140.33 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 CA-C-N 120.42 1.463 . . . . 0.0 109.243 -178.538 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.474 ' O ' ' HB ' ' A' ' 191' ' ' ILE . 21.3 mt -143.57 78.07 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 120.251 -0.579 . . . . 0.0 110.779 -174.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' GLU . . . . . 0.52 ' O ' ' CE3' ' A' ' 190' ' ' TRP . 31.4 tt0 139.85 150.02 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.708 0 C-N-CA 127.005 2.122 . . . . 0.0 108.576 177.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' LYS . . . . . 0.441 ' NZ ' ' HB3' ' A' ' 184' ' ' LYS . 8.1 mtpm? -114.15 100.87 8.7 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -176.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.503 ' HA ' ' HD2' ' A' ' 186' ' ' PRO . 19.9 pttp -11.52 77.09 0.02 OUTLIER Pre-proline 0 N--CA 1.496 1.854 0 N-CA-C 121.656 3.947 . . . . 0.0 121.656 -177.017 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.503 ' HD2' ' HA ' ' A' ' 185' ' ' LYS . 11.4 Cg_endo -46.26 -59.95 1.03 Allowed 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 123.341 2.694 . . . . 0.0 106.932 171.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -121.81 21.85 10.61 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 111.922 -2.399 . . . . 0.0 110.431 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.488 ' CA ' ' HB2' ' A' ' 185' ' ' LYS . . . 114.21 11.29 12.32 Favored Glycine 0 N--CA 1.488 2.162 0 C-N-CA 119.629 -1.272 . . . . 0.0 110.986 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' TRP . . . . . 0.475 ' CD1' ' HB3' ' A' ' 201' ' ' LEU . 2.1 m-90 -125.02 136.55 53.82 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 121.433 3.864 . . . . 0.0 121.433 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 190' ' ' TRP . . . . . 0.52 ' CE3' ' O ' ' A' ' 183' ' ' GLU . 32.4 m95 -119.4 154.66 33.3 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 101.519 -3.511 . . . . 0.0 101.519 178.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.474 ' HB ' ' O ' ' A' ' 182' ' ' ILE . 1.7 mp -109.23 114.11 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 104.234 -2.506 . . . . 0.0 104.234 176.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -107.6 177.55 4.8 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 118.859 -1.136 . . . . 0.0 113.898 -170.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -134.24 160.58 37.42 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 174.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 47.4 p-10 -117.67 -160.51 0.78 Allowed 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 118.456 -1.298 . . . . 0.0 110.406 177.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -101.32 42.26 1.14 Allowed 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 122.398 1.094 . . . . 0.0 108.586 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 5.4 tmtm? -127.01 -44.16 1.63 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 177.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 135.78 -41.08 1.46 Allowed Glycine 0 N--CA 1.485 1.936 0 N-CA-C 108.455 -1.858 . . . . 0.0 108.455 -178.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -53.58 163.38 0.66 Allowed 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 116.037 1.866 . . . . 0.0 116.037 -178.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -103.52 157.08 17.29 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 110.835 -2.893 . . . . 0.0 115.422 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 191' ' ' ILE . . . -134.61 -179.56 16.6 Favored Glycine 0 N--CA 1.483 1.827 0 CA-C-N 112.671 -2.059 . . . . 0.0 113.978 -175.433 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.475 ' HB3' ' CD1' ' A' ' 189' ' ' TRP . 32.0 mt -131.97 89.38 2.67 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 111.698 -2.251 . . . . 0.0 105.43 177.443 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . 0.251 2.3 t -97.13 148.53 34.54 Favored Pre-proline 0 C--N 1.305 -1.343 0 CA-C-N 114.269 -1.332 . . . . 0.0 113.928 -174.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -92.43 155.21 3.03 Favored 'Trans proline' 0 C--N 1.299 -2.032 0 N-CA-C 107.67 -1.704 . . . . 0.0 107.67 172.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' ARG . . . . . 0.516 ' HB2' ' CE2' ' A' ' 190' ' ' TRP . 8.6 tpt180 -74.59 -51.99 13.04 Favored 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 176.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 65.3 p -22.07 -45.85 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 127.528 3.017 . . . . 0.0 114.912 178.151 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -112.61 50.0 0.9 Allowed 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.468 -0.893 . . . . 0.0 113.199 -178.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 97.7 mt -131.05 155.96 46.0 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 176.132 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -130.26 142.19 44.56 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 103.916 -2.624 . . . . 0.0 103.916 174.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -66.32 155.44 69.92 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 N-CA-C 107.271 -1.857 . . . . 0.0 107.271 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' TYR . . . . . 0.413 ' CD1' HG21 ' A' ' 158' ' ' ILE . 9.7 t80 . . . . . 0 N--CA 1.49 1.564 0 C-N-CA 118.559 -1.256 . . . . 0.0 110.002 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.993 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -121.42 159.15 26.79 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 101.504 -3.517 . . . . 0.0 101.504 178.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -100.64 129.62 46.58 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 116.035 -2.266 . . . . 0.0 111.35 -177.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.631 ' CD1' HG21 ' A' ' 181' ' ' VAL . 4.9 m-85 -118.9 172.17 7.72 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 101.4 -3.556 . . . . 0.0 101.4 177.29 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.48 ' HA ' ' O ' ' A' ' 177' ' ' GLU . 1.7 pt -126.97 142.53 43.18 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 N-CA-C 103.44 -2.8 . . . . 0.0 103.44 174.252 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 176' ' ' GLY . . . -80.13 155.3 27.54 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 104.19 -2.522 . . . . 0.0 104.19 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.1 m -131.18 8.73 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 126.764 2.54 . . . . 0.0 108.447 178.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -127.68 159.1 21.5 Favored Glycine 0 N--CA 1.486 1.99 0 N-CA-C 106.018 -2.833 . . . . 0.0 106.018 176.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.408 ' HA ' ' HA ' ' A' ' 174' ' ' LYS . 33.1 t70 -108.54 97.34 7.02 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.253 -0.979 . . . . 0.0 113.083 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.44 ' HB3' ' CZ ' ' A' ' 173' ' ' PHE . 58.4 t80 -111.02 151.88 27.48 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 55.4 m -122.43 157.4 32.0 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.31 105.88 15.49 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 178.065 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -98.61 -17.43 18.64 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 -178.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -120.72 168.19 11.68 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 102.57 -3.122 . . . . 0.0 102.57 177.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 48.7 t -91.39 156.01 3.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 109.56 -41.12 2.32 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 107.502 -2.239 . . . . 0.0 107.502 -178.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.538 ' HA ' ' H ' ' A' ' 201' ' ' LEU . 11.2 m-20 -80.22 167.97 19.65 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 111.532 -2.334 . . . . 0.0 111.637 -179.144 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 24.5 mt -118.95 175.93 5.53 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.996 177.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 45.2 m -117.57 96.31 5.33 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 114.58 -1.191 . . . . 0.0 109.479 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.44 ' CZ ' ' HB3' ' A' ' 163' ' ' PHE . 8.9 p90 -119.24 164.43 15.64 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 114.488 -1.233 . . . . 0.0 111.63 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 162' ' ' ASP . 6.6 ptpp? -128.71 160.44 32.5 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 116.384 1.994 . . . . 0.0 116.384 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 42.9 tttm -41.91 76.91 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.766 1 CA-C-N 107.609 -4.36 . . . . 0.0 115.533 173.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 159' ' ' ALA . . . 112.67 50.44 0.56 Allowed Glycine 0 N--CA 1.491 2.306 0 CA-C-N 114.097 -1.411 . . . . 0.0 112.55 176.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.48 ' O ' ' HA ' ' A' ' 158' ' ' ILE . 15.4 pt-20 -131.4 168.93 16.75 Favored 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 176.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.428 ' HA ' ' HA ' ' A' ' 158' ' ' ILE . 1.5 mt -112.98 125.89 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 116.545 2.054 . . . . 0.0 116.545 -175.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 17.9 mt -118.41 176.02 5.44 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 112.339 -2.21 . . . . 0.0 110.756 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 33.5 mt -114.61 159.87 19.95 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 174.203 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.631 HG21 ' CD1' ' A' ' 157' ' ' TYR . 46.2 t -121.6 124.74 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -176.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.486 ' O ' ' HB ' ' A' ' 191' ' ' ILE . 11.7 mt -141.57 77.24 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.972 -174.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' GLU . . . . . 0.546 ' O ' ' CE3' ' A' ' 190' ' ' TRP . 44.6 tt0 138.15 149.58 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.037 0 C-N-CA 127.177 2.191 . . . . 0.0 108.402 176.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -116.62 100.94 8.17 Favored 'General case' 0 N--CA 1.508 2.436 0 N-CA-C 115.972 1.842 . . . . 0.0 115.972 -175.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.506 ' CG ' ' HE1' ' A' ' 190' ' ' TRP . 21.6 pttp -13.65 78.15 0.02 OUTLIER Pre-proline 0 N--CA 1.5 2.045 1 N-CA-C 122.075 4.102 . . . . 0.0 122.075 -177.79 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.45 ' HD2' ' O ' ' A' ' 189' ' ' TRP . 13.4 Cg_endo -47.68 -59.85 1.1 Allowed 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 123.061 2.508 . . . . 0.0 106.582 171.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -123.6 22.4 9.11 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 112.331 -2.213 . . . . 0.0 110.229 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.448 ' CA ' ' HB2' ' A' ' 185' ' ' LYS . . . 113.74 17.68 7.34 Favored Glycine 0 N--CA 1.491 2.354 0 C-N-CA 120.473 -0.87 . . . . 0.0 111.046 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' TRP . . . . . 0.45 ' O ' ' HD2' ' A' ' 186' ' ' PRO . 1.4 m-90 -125.62 126.05 44.11 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 121.395 3.85 . . . . 0.0 121.395 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 190' ' ' TRP . . . . . 0.594 ' CE2' ' HB2' ' A' ' 204' ' ' ARG . 16.3 m95 -118.44 159.86 22.74 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 102.072 -3.307 . . . . 0.0 102.072 176.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.486 ' HB ' ' O ' ' A' ' 182' ' ' ILE . 79.3 mt -114.72 113.67 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 104.372 -2.455 . . . . 0.0 104.372 176.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -108.41 178.5 4.47 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 119.453 -0.899 . . . . 0.0 112.658 -172.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' LYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 199' ' ' GLU . 64.9 mttm -137.21 169.1 18.35 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 173.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 43.5 p-10 -121.71 -164.79 1.18 Allowed 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.144 -1.022 . . . . 0.0 109.958 177.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -100.2 39.85 1.31 Allowed 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.928 0.871 . . . . 0.0 108.691 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -126.76 -37.13 2.16 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 113.609 -1.632 . . . . 0.0 107.282 177.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 134.96 -37.4 1.94 Allowed Glycine 0 N--CA 1.487 2.05 0 N-CA-C 110.074 -1.211 . . . . 0.0 110.074 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 22.4 p30 -63.94 164.74 9.86 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 118.591 -1.244 . . . . 0.0 114.167 -178.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' GLU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 193' ' ' LYS . 0.0 OUTLIER -125.8 157.91 36.31 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 111.858 -2.428 . . . . 0.0 109.492 179.405 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 200' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 191' ' ' ILE . . . -136.36 -175.23 13.7 Favored Glycine 0 N--CA 1.48 1.572 0 CA-C-O 122.319 0.955 . . . . 0.0 111.634 -178.424 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.538 ' H ' ' HA ' ' A' ' 170' ' ' ASP . 13.8 mt -122.04 82.5 1.97 Allowed 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 111.419 -2.391 . . . . 0.0 105.202 177.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 4.5 m -115.57 154.97 47.87 Favored Pre-proline 0 N--CA 1.495 1.806 0 C-N-CA 119.579 -0.848 . . . . 0.0 109.415 -175.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -81.74 179.97 5.29 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 123.121 2.547 . . . . 0.0 112.156 -178.136 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' ARG . . . . . 0.594 ' HB2' ' CE2' ' A' ' 190' ' ' TRP . 17.5 ttp85 -91.24 -49.19 6.5 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 103.762 -2.681 . . . . 0.0 103.762 176.404 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.406 HG23 ' H ' ' A' ' 205' ' ' THR . 68.2 p -19.3 -48.53 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 127.146 2.779 . . . . 0.0 117.026 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -108.51 42.57 1.37 Allowed 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 119.063 -1.055 . . . . 0.0 112.614 -177.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 84.9 mt -129.68 158.42 39.41 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 115.063 -0.972 . . . . 0.0 109.007 177.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -132.82 152.44 79.86 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 104.553 -2.388 . . . . 0.0 104.553 170.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -68.66 165.79 28.23 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 N-CA-C 108.064 -1.552 . . . . 0.0 108.064 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 32.2 t80 . . . . . 0 C--N 1.301 -1.542 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 179.489 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.051 0 CA-C-O 120.974 0.208 . . . . 0.0 112.852 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -135.15 -179.98 5.96 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.329 -1.359 . . . . 0.0 107.329 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -109.93 126.52 53.97 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 114.839 1.422 . . . . 0.0 114.839 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.527 ' CD1' HG21 ' A' ' 181' ' ' VAL . 44.8 m-85 -121.88 177.94 5.08 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 101.183 -3.636 . . . . 0.0 101.183 175.054 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.511 ' HA ' ' HA ' ' A' ' 178' ' ' ILE . 2.9 pt -123.72 153.32 29.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 100.79 -3.781 . . . . 0.0 100.79 170.139 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -91.83 153.18 19.73 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 100.768 -3.789 . . . . 0.0 100.768 177.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 31.2 m -125.07 17.36 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 125.908 2.005 . . . . 0.0 108.021 176.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -138.53 164.51 25.67 Favored Glycine 0 N--CA 1.483 1.806 0 N-CA-C 105.628 -2.989 . . . . 0.0 105.628 175.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -106.02 144.5 32.65 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 104.837 -2.283 . . . . 0.0 104.837 177.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -124.69 172.64 9.12 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 77.8 m -130.17 152.55 49.49 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.623 -0.831 . . . . 0.0 109.577 178.066 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -107.89 122.41 46.73 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 177.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -110.24 -19.51 12.98 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.127 -1.397 . . . . 0.0 108.121 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -123.35 176.7 5.99 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 114.057 -1.429 . . . . 0.0 108.339 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 15.2 t -95.53 49.93 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -131.81 -46.93 0.12 Allowed Glycine 0 N--CA 1.485 1.915 0 CA-C-N 113.282 -1.781 . . . . 0.0 108.788 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.419 ' HA ' ' H ' ' A' ' 201' ' ' LEU . 1.8 m-20 -87.62 169.2 12.36 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 112.503 -1.849 . . . . 0.0 114.385 -178.46 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.422 ' HG ' ' CA ' ' A' ' 200' ' ' GLY . 39.2 mt -117.97 -176.83 3.13 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 112.547 -2.115 . . . . 0.0 105.806 176.532 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 73.4 m -108.95 -59.4 1.89 Allowed 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.158 -179.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 43.1 p90 37.42 164.43 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.25 0 N-CA-C 117.617 2.451 . . . . 0.0 117.617 -175.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -124.52 143.62 50.57 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 120.173 3.397 . . . . 0.0 120.173 -178.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -26.75 81.29 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.589 1 CA-C-N 107.847 -4.251 . . . . 0.0 115.868 169.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 112.18 46.98 0.73 Allowed Glycine 0 N--CA 1.492 2.427 0 CA-C-N 114.617 -1.174 . . . . 0.0 113.392 176.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.418 ' O ' ' HA ' ' A' ' 158' ' ' ILE . 7.0 pt-20 -140.75 152.98 45.69 Favored 'General case' 0 N--CA 1.503 2.205 0 C-N-CA 117.092 -1.843 . . . . 0.0 109.485 176.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.511 ' HA ' ' HA ' ' A' ' 158' ' ' ILE . 1.3 mp -74.9 131.53 34.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -178.504 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 44.0 mt -122.66 168.35 12.3 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 112.339 -2.21 . . . . 0.0 107.044 176.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.408 HD13 ' H ' ' A' ' 181' ' ' VAL . 0.4 OUTLIER -113.05 148.02 36.03 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 101.796 -3.409 . . . . 0.0 101.796 179.591 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.527 HG21 ' CD1' ' A' ' 157' ' ' TYR . 2.7 t -124.01 138.51 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 CA-C-N 121.458 1.935 . . . . 0.0 111.467 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.455 ' O ' ' CB ' ' A' ' 183' ' ' GLU . 0.5 OUTLIER -146.52 81.28 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 O-C-N 123.169 0.293 . . . . 0.0 110.619 -173.371 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 183' ' ' GLU . . . . . 0.532 ' O ' ' CE3' ' A' ' 190' ' ' TRP . 34.9 tt0 139.31 153.18 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.96 0 C-N-CA 127.024 2.13 . . . . 0.0 107.748 178.375 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -117.92 99.95 7.25 Favored 'General case' 0 N--CA 1.508 2.445 0 N-CA-C 116.227 1.936 . . . . 0.0 116.227 -175.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.551 ' CG ' ' HE1' ' A' ' 190' ' ' TRP . 22.1 pttp -13.07 77.16 0.02 OUTLIER Pre-proline 0 N--CA 1.5 2.057 1 N-CA-C 122.183 4.142 . . . . 0.0 122.183 -177.325 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.492 ' HD2' ' HA ' ' A' ' 185' ' ' LYS . 12.3 Cg_endo -47.13 -59.34 1.28 Allowed 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 123.096 2.531 . . . . 0.0 106.999 171.097 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -121.11 19.58 11.55 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 112.285 -2.234 . . . . 0.0 110.563 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.498 ' CA ' ' HB2' ' A' ' 185' ' ' LYS . . . 112.94 15.85 8.94 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 189' ' ' TRP . . . . . 0.448 ' O ' ' HD2' ' A' ' 186' ' ' PRO . 1.3 m-90 -125.51 127.03 45.8 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 120.58 3.548 . . . . 0.0 120.58 179.025 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 190' ' ' TRP . . . . . 0.659 ' CE2' ' HB2' ' A' ' 204' ' ' ARG . 15.2 m95 -117.84 161.19 20.14 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 101.095 -3.668 . . . . 0.0 101.095 177.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.411 ' HB ' ' O ' ' A' ' 182' ' ' ILE . 28.8 mm -98.28 166.77 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.395 1 N-CA-C 99.679 -4.193 . . . . 0.0 99.679 176.963 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 192' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 199' ' ' GLU . . . -150.74 -177.8 6.2 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 116.125 -2.23 . . . . 0.0 111.447 178.219 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -137.69 163.69 30.67 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 174.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 26.0 p-10 -112.7 -160.72 0.73 Allowed 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.373 -0.931 . . . . 0.0 108.567 177.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -108.26 35.7 3.07 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 118.874 -1.13 . . . . 0.0 110.215 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -129.23 -67.72 0.76 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 105.48 -2.045 . . . . 0.0 105.48 175.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -165.58 -67.24 0.03 OUTLIER Glycine 0 N--CA 1.488 2.133 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.208 178.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -34.85 160.78 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 119.65 3.204 . . . . 0.0 119.65 -178.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' GLU . . . . . 0.419 ' HG3' ' N ' ' A' ' 200' ' ' GLY . 0.0 OUTLIER -118.65 160.4 21.89 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 111.904 -2.407 . . . . 0.0 109.573 179.251 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 200' ' ' GLY . . . . . 0.422 ' CA ' ' HG ' ' A' ' 171' ' ' LEU . . . -135.54 -169.72 11.91 Favored Glycine 0 N--CA 1.487 2.082 0 CA-C-O 122.998 1.332 . . . . 0.0 114.238 -177.556 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.419 ' H ' ' HA ' ' A' ' 170' ' ' ASP . 16.5 mt -130.09 84.89 2.24 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 111.138 -2.531 . . . . 0.0 105.236 178.048 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 3.0 m -113.04 156.04 43.38 Favored Pre-proline 0 N--CA 1.495 1.816 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 -175.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -90.35 173.24 3.31 Favored 'Trans proline' 0 C--N 1.302 -1.903 0 C-N-CA 122.429 2.086 . . . . 0.0 107.365 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' ARG . . . . . 0.659 ' HB2' ' CE2' ' A' ' 190' ' ' TRP . 22.7 ttt180 -102.07 -35.62 8.87 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 117.029 -1.869 . . . . 0.0 106.43 175.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 70.2 p -25.05 -46.67 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 126.057 2.098 . . . . 0.0 114.732 174.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -110.98 43.94 1.37 Allowed 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 119.762 -0.775 . . . . 0.0 112.659 -178.262 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 60.4 mt -127.17 151.53 48.56 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.618 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -123.64 150.03 60.45 Favored Pre-proline 0 C--N 1.301 -1.512 0 N-CA-C 104.148 -2.538 . . . . 0.0 104.148 174.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -68.81 160.13 50.94 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 C-N-CA 121.363 1.376 . . . . 0.0 110.738 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' TYR . . . . . 0.411 ' CE1' HD11 ' A' ' 178' ' ' ILE . 10.7 t80 . . . . . 0 N--CA 1.494 1.739 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 177.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.059 0 N-CA-C 110.241 -1.143 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -116.32 165.14 13.53 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 104.381 -2.452 . . . . 0.0 104.381 -178.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -99.15 119.51 37.97 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 117.098 -1.841 . . . . 0.0 114.417 -178.014 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.481 ' CD1' HG21 ' A' ' 181' ' ' VAL . 2.2 m-85 -123.87 174.09 7.77 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 101.145 -3.65 . . . . 0.0 101.145 175.256 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.513 HG21 ' CD1' ' A' ' 210' ' ' TYR . 3.3 pt -127.49 153.84 37.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 101.943 -3.354 . . . . 0.0 101.943 173.465 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -84.24 152.66 24.07 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 103.582 -2.747 . . . . 0.0 103.582 178.271 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 32.9 m -132.8 6.13 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 125.939 2.025 . . . . 0.0 108.734 177.007 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -131.37 149.68 19.3 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 106.36 -2.696 . . . . 0.0 106.36 177.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -101.77 92.26 4.76 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 118.887 -1.125 . . . . 0.0 108.798 -177.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -107.99 151.18 26.16 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 114.436 -1.256 . . . . 0.0 109.624 -178.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 52.7 m -120.98 158.81 26.93 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -81.29 151.54 28.02 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 118.076 -1.45 . . . . 0.0 109.022 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -112.72 -36.17 5.27 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 112.456 -2.156 . . . . 0.0 105.267 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -120.42 171.89 8.21 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 113.368 -1.742 . . . . 0.0 106.996 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.454 HG12 ' H ' ' A' ' 168' ' ' VAL . 0.1 OUTLIER -59.63 -46.8 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 117.489 -1.685 . . . . 0.0 108.693 177.766 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -29.55 -60.96 0.17 Allowed Glycine 0 N--CA 1.492 2.376 0 O-C-N 125.355 1.66 . . . . 0.0 113.834 177.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.504 ' HA ' ' H ' ' A' ' 201' ' ' LEU . 1.1 m-20 -77.23 168.86 19.34 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -176.409 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.436 ' CD2' HD22 ' A' ' 198' ' ' ASN . 14.2 mt -117.54 176.55 5.12 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 113.715 -1.584 . . . . 0.0 110.478 178.499 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 42.6 m -120.46 97.07 5.4 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 113.875 -1.512 . . . . 0.0 110.733 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.423 ' CD1' ' N ' ' A' ' 173' ' ' PHE . 8.2 p90 -121.05 171.09 8.92 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.495 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -107.4 -163.35 0.89 Allowed 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 122.691 1.234 . . . . 0.0 113.338 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 42.1 tttm -107.15 89.82 3.11 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 111.002 -2.817 . . . . 0.0 112.146 -175.191 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 109.16 50.65 0.71 Allowed Glycine 0 N--CA 1.492 2.401 0 CA-C-N 113.228 -1.806 . . . . 0.0 110.695 177.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.413 ' O ' ' HB ' ' A' ' 158' ' ' ILE . 6.0 pt-20 -128.78 176.59 7.7 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 177.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 21.9 mm -104.0 119.56 52.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 C-N-CA 118.669 -1.213 . . . . 0.0 112.451 -178.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 59.5 mt -121.16 163.62 18.17 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 113.933 -1.485 . . . . 0.0 110.031 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 59.6 mt -110.7 156.67 20.69 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 176.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.481 HG21 ' CD1' ' A' ' 157' ' ' TYR . 2.5 t -126.55 138.67 54.01 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 C-N-CA 117.981 -1.488 . . . . 0.0 110.221 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.453 ' O ' ' HB ' ' A' ' 191' ' ' ILE . 25.6 mt -141.04 82.0 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -174.158 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 183' ' ' GLU . . . . . 0.478 ' HG2' ' N ' ' A' ' 184' ' ' LYS . 41.9 tt0 138.02 150.52 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.393 0 C-N-CA 127.042 2.137 . . . . 0.0 108.004 176.72 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 184' ' ' LYS . . . . . 0.478 ' N ' ' HG2' ' A' ' 183' ' ' GLU . 97.9 mttt -116.84 115.68 26.0 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 124.628 1.205 . . . . 0.0 111.927 -179.279 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.537 ' CG ' ' HE1' ' A' ' 190' ' ' TRP . 0.1 OUTLIER -6.96 77.34 0.03 OUTLIER Pre-proline 0 N--CA 1.505 2.291 0 N-CA-C 117.652 2.464 . . . . 0.0 117.652 178.443 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -68.6 -55.95 0.2 Allowed 'Trans proline' 0 C--N 1.307 -1.629 0 N-CA-C 105.516 -2.532 . . . . 0.0 105.516 175.166 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -125.16 24.53 7.44 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 112.877 -1.965 . . . . 0.0 112.741 -177.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.511 ' CA ' ' HG2' ' A' ' 185' ' ' LYS . . . 116.65 -19.4 12.59 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 118.708 -1.711 . . . . 0.0 109.603 -179.199 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 16.3 m-90 -115.28 158.71 21.97 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 117.783 2.512 . . . . 0.0 117.783 -176.482 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' TRP . . . . . 0.537 ' HE1' ' CG ' ' A' ' 185' ' ' LYS . 23.9 m95 -129.97 162.43 28.68 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 100.457 -3.905 . . . . 0.0 100.457 -178.08 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.456 HG12 ' CB ' ' A' ' 183' ' ' GLU . 10.9 mm -113.33 106.21 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 C-N-CA 116.382 -2.127 . . . . 0.0 106.479 177.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -101.94 175.49 5.52 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -172.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' LYS . . . . . 0.462 ' HG2' ' HB2' ' A' ' 199' ' ' GLU . 63.1 mttm -126.51 165.12 19.71 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 174.113 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -122.82 -158.16 0.78 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 124.467 1.104 . . . . 0.0 110.376 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -100.26 36.95 1.75 Allowed 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 121.693 0.758 . . . . 0.0 110.822 -178.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -125.38 -43.42 1.92 Allowed 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 176.202 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 138.29 -43.3 1.2 Allowed Glycine 0 N--CA 1.483 1.817 0 N-CA-C 106.477 -2.649 . . . . 0.0 106.477 -178.501 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 198' ' ' ASN . . . . . 0.436 HD22 ' CD2' ' A' ' 171' ' ' LEU . 0.9 OUTLIER -53.57 155.91 2.82 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 179.361 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 199' ' ' GLU . . . . . 0.462 ' HB2' ' HG2' ' A' ' 193' ' ' LYS . 0.0 OUTLIER -127.89 155.0 44.87 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 112.949 -1.932 . . . . 0.0 110.357 -179.936 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 200' ' ' GLY . . . . . 0.416 ' HA3' ' HG ' ' A' ' 171' ' ' LEU . . . -145.0 -176.68 19.21 Favored Glycine 0 N--CA 1.485 1.964 0 C-N-CA 119.195 -1.479 . . . . 0.0 112.924 -178.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.504 ' H ' ' HA ' ' A' ' 170' ' ' ASP . 0.8 OUTLIER -92.78 92.05 7.76 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 112.757 -1.722 . . . . 0.0 106.741 176.943 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 5.0 m -113.81 147.85 38.57 Favored Pre-proline 0 N--CA 1.494 1.757 0 C-N-CA 117.43 -1.708 . . . . 0.0 106.739 -179.155 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -79.22 179.06 6.77 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 C-N-CA 122.291 1.994 . . . . 0.0 112.014 -177.083 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 204' ' ' ARG . . . . . 0.473 ' HB2' ' HE1' ' A' ' 190' ' ' TRP . 0.1 OUTLIER -86.25 -46.22 10.55 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 103.552 -2.759 . . . . 0.0 103.552 178.164 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 71.8 p -22.2 -50.62 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 O-C-N 126.013 2.071 . . . . 0.0 116.168 178.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -112.79 43.2 1.71 Allowed 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.587 0.708 . . . . 0.0 111.985 -178.302 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 12.3 mt -140.25 108.86 5.9 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 113.793 -1.548 . . . . 0.0 109.346 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -110.73 153.37 43.69 Favored Pre-proline 0 N--CA 1.49 1.55 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 178.276 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -59.6 165.39 9.72 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.093 1.862 . . . . 0.0 111.252 -178.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 210' ' ' TYR . . . . . 0.513 ' CD1' HG21 ' A' ' 158' ' ' ILE . 9.0 t80 . . . . . 0 N--CA 1.492 1.647 0 C-N-CA 119.024 -1.071 . . . . 0.0 111.99 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' GLY . . . . . 0.402 ' HA3' ' O ' ' A' ' 181' ' ' VAL . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 -105.87 167.19 9.95 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 112.681 -1.76 . . . . 0.0 108.436 -178.152 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -112.71 141.57 46.35 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 124.598 2.142 . . . . 0.0 113.175 -177.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.513 ' CG ' HD23 ' A' ' 207' ' ' LEU . 76.0 m-85 -133.57 -179.73 5.7 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 108.462 -3.972 . . . . 0.0 107.326 -176.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.535 ' HA ' ' HA ' ' A' ' 178' ' ' ILE . 7.5 pt -128.66 162.2 36.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 102.188 -3.264 . . . . 0.0 102.188 168.128 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.418 ' O ' ' N ' ' A' ' 176' ' ' GLY . . . -90.98 157.47 17.27 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 103.405 -2.813 . . . . 0.0 103.405 -179.206 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 16.6 m -126.63 -0.24 4.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 125.809 1.943 . . . . 0.0 108.381 175.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -132.11 165.71 23.46 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 107.812 -2.115 . . . . 0.0 107.812 177.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -106.97 122.33 46.22 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 173' ' ' PHE . 36.6 t80 -122.05 156.21 34.02 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.085 179.014 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 75.3 m -124.44 161.65 25.59 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -92.96 144.59 25.1 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 118.012 -1.475 . . . . 0.0 108.389 178.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -113.23 -32.69 6.21 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 112.834 -1.985 . . . . 0.0 106.645 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -112.52 177.59 4.58 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 113.66 -1.609 . . . . 0.0 107.027 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 17.3 t -95.84 49.34 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 104.502 -2.407 . . . . 0.0 104.502 178.236 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -130.65 -49.36 0.11 Allowed Glycine 0 N--CA 1.485 1.947 0 CA-C-N 112.697 -2.047 . . . . 0.0 109.27 -178.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.548 ' HA ' ' H ' ' A' ' 201' ' ' LEU . 29.2 m-20 -79.43 175.13 10.88 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 113.293 -1.454 . . . . 0.0 111.797 -178.273 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.51 ' HG ' ' HA3' ' A' ' 200' ' ' GLY . 14.1 mt -115.89 174.52 5.99 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 114.394 -1.276 . . . . 0.0 108.466 177.075 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 52.5 m -120.97 91.37 3.51 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 113.796 -1.547 . . . . 0.0 108.078 178.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.425 ' CZ ' ' HB3' ' A' ' 163' ' ' PHE . 9.9 p90 -121.87 169.45 10.77 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 113.698 -1.592 . . . . 0.0 111.064 -178.349 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -109.44 -163.67 0.88 Allowed 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 122.78 1.276 . . . . 0.0 111.373 178.37 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 67.9 tttt -92.87 156.3 17.05 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 110.724 -2.944 . . . . 0.0 110.661 -178.106 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 159' ' ' ALA . . . 53.61 44.66 68.61 Favored Glycine 0 N--CA 1.485 1.935 0 CA-C-N 112.783 -2.008 . . . . 0.0 108.1 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -130.49 128.25 40.84 Favored 'General case' 0 N--CA 1.504 2.256 0 C-N-CA 116.881 -1.928 . . . . 0.0 113.988 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.535 ' HA ' ' HA ' ' A' ' 158' ' ' ILE . 1.6 mp -58.95 119.27 3.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 -178.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 19.6 mt -118.63 155.45 30.97 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 113.766 -1.561 . . . . 0.0 107.6 175.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 23.7 tp -111.99 158.42 19.54 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 104.575 -2.38 . . . . 0.0 104.575 177.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.613 HG22 ' CZ3' ' A' ' 190' ' ' TRP . 98.5 t -110.39 147.74 14.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 C-N-CA 119.078 -1.049 . . . . 0.0 109.899 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.56 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 8.9 mt -148.69 74.97 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 C-N-CA 118.148 -1.421 . . . . 0.0 108.991 173.081 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 183' ' ' GLU . . . . . 0.56 ' HB2' ' O ' ' A' ' 182' ' ' ILE . 12.8 tm-20 139.07 165.21 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.224 0 C-N-CA 129.04 2.936 . . . . 0.0 105.314 176.072 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -113.76 88.69 2.9 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 117.444 2.387 . . . . 0.0 117.444 -175.256 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.542 ' HB3' ' CD1' ' A' ' 190' ' ' TRP . 7.4 pttm -8.69 76.05 0.03 OUTLIER Pre-proline 0 N--CA 1.505 2.319 0 N-CA-C 116.704 2.113 . . . . 0.0 116.704 177.275 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.467 ' HD2' ' HA ' ' A' ' 185' ' ' LYS . 11.8 Cg_endo -44.52 -56.27 2.7 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 123.37 2.713 . . . . 0.0 107.598 176.705 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -128.8 16.4 6.35 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 111.634 -2.53 . . . . 0.0 110.04 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 111.4 26.01 4.73 Favored Glycine 0 N--CA 1.485 1.917 0 N-CA-C 107.501 -2.24 . . . . 0.0 107.501 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 2.7 m-90 -134.45 97.74 3.9 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 116.72 2.119 . . . . 0.0 116.72 178.314 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 190' ' ' TRP . . . . . 0.686 ' CD1' ' N ' ' A' ' 190' ' ' TRP . 0.0 OUTLIER -112.68 171.72 7.36 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.597 179.636 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.512 ' HB ' ' O ' ' A' ' 182' ' ' ILE . 1.9 mp -108.9 111.23 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 N-CA-C 104.037 -2.579 . . . . 0.0 104.037 -179.186 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 192' ' ' ALA . . . . . 0.572 ' HB2' ' CZ3' ' A' ' 190' ' ' TRP . . . -109.91 -178.37 3.51 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -173.35 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -137.26 166.76 23.01 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 105.38 -2.081 . . . . 0.0 105.38 176.511 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 53.3 p-10 -121.26 -148.48 0.41 Allowed 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.121 -1.032 . . . . 0.0 111.637 177.34 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -103.76 19.37 20.04 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -176.073 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 8.4 ptmm? -124.07 -26.21 4.06 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 174.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 137.73 -35.11 2.09 Favored Glycine 0 N--CA 1.49 2.259 0 C-N-CA 119.097 -1.525 . . . . 0.0 113.363 178.222 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 198' ' ' ASN . . . . . 0.498 ' C ' HD21 ' A' ' 198' ' ' ASN . 0.4 OUTLIER -61.56 162.17 8.63 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 117.546 -1.662 . . . . 0.0 113.417 -177.677 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -128.72 155.01 45.77 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 112.712 -2.04 . . . . 0.0 111.026 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 200' ' ' GLY . . . . . 0.51 ' HA3' ' HG ' ' A' ' 171' ' ' LEU . . . -144.7 -160.71 8.65 Favored Glycine 0 N--CA 1.489 2.175 0 CA-C-O 122.276 0.931 . . . . 0.0 112.581 -178.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.548 ' H ' ' HA ' ' A' ' 170' ' ' ASP . 20.1 mt -121.94 110.14 15.48 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 111.499 -2.35 . . . . 0.0 105.844 175.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.54 HG23 ' CD2' ' A' ' 190' ' ' TRP . 13.7 m -129.82 163.36 47.65 Favored Pre-proline 0 N--CA 1.498 1.958 0 C-N-CA 117.867 -1.533 . . . . 0.0 111.626 -175.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -100.24 139.28 0.26 Allowed 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 123.661 2.907 . . . . 0.0 109.713 174.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 204' ' ' ARG . . . . . 0.504 ' N ' ' HE1' ' A' ' 190' ' ' TRP . 0.1 OUTLIER -81.43 -23.57 37.45 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 104.64 -2.355 . . . . 0.0 104.64 179.954 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.44 ' C ' ' O ' ' A' ' 204' ' ' ARG . 68.2 p -24.65 -43.75 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.156 0 O-C-N 124.518 1.137 . . . . 0.0 113.602 171.696 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -114.33 50.23 0.96 Allowed 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 120.098 -0.641 . . . . 0.0 111.977 179.201 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.513 HD23 ' CG ' ' A' ' 157' ' ' TYR . 1.0 OUTLIER -133.95 152.73 51.96 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.255 -179.005 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -132.03 153.5 81.38 Favored Pre-proline 0 N--CA 1.491 1.601 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 172.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -64.52 164.91 21.89 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.077 1.851 . . . . 0.0 111.684 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 210' ' ' TYR . . . . . 0.432 ' CD1' ' CG2' ' A' ' 158' ' ' ILE . 35.1 t80 . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' GLY . . . . . 0.439 ' HA2' ' O ' ' A' ' 181' ' ' VAL . . . . . . . . 0 N--CA 1.486 2.021 0 N-CA-C 111.609 -0.596 . . . . 0.0 111.609 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -115.6 165.76 12.67 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -178.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -94.65 123.04 37.85 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 117.551 -1.66 . . . . 0.0 113.695 -176.227 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.507 ' CD1' HG21 ' A' ' 181' ' ' VAL . 4.0 m-85 -124.83 172.26 9.49 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 111.071 -2.786 . . . . 0.0 105.138 177.576 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.526 HG21 ' CD1' ' A' ' 210' ' ' TYR . 2.1 pt -129.98 150.33 34.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 102.959 -2.978 . . . . 0.0 102.959 171.59 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.407 ' O ' ' N ' ' A' ' 176' ' ' GLY . . . -86.59 150.7 24.04 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 102.435 -3.172 . . . . 0.0 102.435 178.17 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 33.8 m -132.68 23.18 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 126.189 2.181 . . . . 0.0 107.642 178.356 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -144.06 160.19 27.76 Favored Glycine 0 N--CA 1.483 1.784 0 N-CA-C 107.86 -2.096 . . . . 0.0 107.86 176.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -106.49 78.73 1.3 Allowed 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.292 -0.963 . . . . 0.0 108.449 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.421 ' HB3' ' CZ ' ' A' ' 173' ' ' PHE . 68.5 t80 -99.9 149.86 22.98 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 114.36 -1.291 . . . . 0.0 108.163 -178.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 93.6 m -120.81 157.96 28.62 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 114.023 -1.444 . . . . 0.0 108.856 -177.441 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -79.32 135.27 36.68 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 178.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -114.13 -28.26 7.38 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 113.804 -1.544 . . . . 0.0 107.293 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -114.77 178.61 4.22 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 179.077 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 58.8 t -90.78 149.9 3.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 104.003 -2.591 . . . . 0.0 104.003 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 110.53 -42.7 1.89 Allowed Glycine 0 N--CA 1.487 2.059 0 C-N-CA 118.407 -1.854 . . . . 0.0 108.703 -178.303 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.464 ' HA ' ' H ' ' A' ' 201' ' ' LEU . 3.0 m-20 -78.28 168.37 19.94 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 113.079 -1.561 . . . . 0.0 113.239 -179.006 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.539 ' HG ' ' CA ' ' A' ' 200' ' ' GLY . 76.6 mt -123.22 179.05 4.84 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 114.506 -1.225 . . . . 0.0 110.28 178.451 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 37.0 m -120.78 98.41 6.0 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 113.392 -1.731 . . . . 0.0 108.372 177.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.421 ' CZ ' ' HB3' ' A' ' 163' ' ' PHE . 17.4 p90 -113.23 165.31 12.54 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 118.73 -1.188 . . . . 0.0 111.379 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -122.59 152.84 40.03 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 117.736 2.495 . . . . 0.0 117.736 -177.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -37.11 76.66 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 108.575 -3.92 . . . . 0.0 114.923 173.227 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 159' ' ' ALA . . . 106.86 54.69 0.67 Allowed Glycine 0 N--CA 1.491 2.35 0 CA-C-N 114.986 -1.007 . . . . 0.0 112.973 175.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.47 ' O ' ' HA ' ' A' ' 158' ' ' ILE . 5.0 pt-20 -124.17 175.46 7.01 Favored 'General case' 0 N--CA 1.504 2.273 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 176.15 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.434 HD12 ' CE2' ' A' ' 210' ' ' TYR . 14.2 mm -112.46 131.9 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 119.068 -1.053 . . . . 0.0 111.607 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.507 ' N ' HD23 ' A' ' 179' ' ' LEU . 0.7 OUTLIER -140.26 174.87 10.08 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 114.653 -1.158 . . . . 0.0 113.69 177.826 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 83.6 mt -114.5 154.1 28.83 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.858 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.507 HG21 ' CD1' ' A' ' 157' ' ' TYR . 57.3 t -116.33 104.94 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 114.83 1.419 . . . . 0.0 114.83 -177.468 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.475 ' O ' ' HB ' ' A' ' 191' ' ' ILE . 13.3 mt -117.1 77.34 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-O 122.94 1.352 . . . . 0.0 108.178 -176.295 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 183' ' ' GLU . . . . . 0.462 ' HB3' ' H ' ' A' ' 191' ' ' ILE . 42.4 tt0 146.39 157.15 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.12 0 CA-C-N 109.715 -3.402 . . . . 0.0 108.262 173.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 184' ' ' LYS . . . . . 0.438 ' N ' ' HG2' ' A' ' 183' ' ' GLU . 64.1 mttp -117.37 102.21 9.05 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 114.655 -1.157 . . . . 0.0 112.233 -177.613 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.524 ' HB2' ' HE1' ' A' ' 190' ' ' TRP . 38.5 tttm -5.76 76.03 0.03 OUTLIER Pre-proline 0 N--CA 1.507 2.392 0 O-C-N 126.798 2.561 . . . . 0.0 115.005 178.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -66.81 -57.42 0.2 Allowed 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 123.565 2.843 . . . . 0.0 105.88 178.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 27.7 p-10 -121.01 20.36 11.54 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 111.329 -2.669 . . . . 0.0 112.992 -177.249 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 116.52 -27.49 7.97 Favored Glycine 0 N--CA 1.48 1.578 0 C-N-CA 117.424 -2.322 . . . . 0.0 108.93 -179.185 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 8.0 m-90 -118.02 148.65 42.04 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 118.332 -1.347 . . . . 0.0 114.474 -177.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 190' ' ' TRP . . . . . 0.524 ' HE1' ' HB2' ' A' ' 185' ' ' LYS . 3.0 m0 -112.39 173.45 6.36 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 102.684 -3.08 . . . . 0.0 102.684 178.385 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.511 ' HA ' ' O ' ' A' ' 200' ' ' GLY . 12.9 mt -115.58 114.34 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 N-CA-C 103.209 -2.886 . . . . 0.0 103.209 175.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -113.92 173.63 6.34 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 116.249 1.944 . . . . 0.0 116.249 -170.442 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 26.0 mmmt -121.37 141.1 51.28 Favored 'General case' 0 C--N 1.298 -1.638 1 N-CA-C 99.769 -4.159 . . . . 0.0 99.769 173.459 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -110.4 -160.1 0.7 Allowed 'General case' 0 N--CA 1.502 2.145 0 C-N-CA 117.433 -1.707 . . . . 0.0 112.089 -177.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -88.87 31.93 0.83 Allowed 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.245 -0.982 . . . . 0.0 111.077 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -123.99 -43.31 2.11 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 175.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 132.43 -40.3 1.64 Allowed Glycine 0 N--CA 1.485 1.939 0 N-CA-C 107.984 -2.046 . . . . 0.0 107.984 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 198' ' ' ASN . . . . . 0.428 ' OD1' HD22 ' A' ' 171' ' ' LEU . 15.1 p30 -56.79 167.35 0.78 Allowed 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 115.162 1.541 . . . . 0.0 115.162 -178.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -98.01 150.72 21.08 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 112.737 -2.029 . . . . 0.0 115.746 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 200' ' ' GLY . . . . . 0.539 ' CA ' ' HG ' ' A' ' 171' ' ' LEU . . . -133.18 -177.16 14.75 Favored Glycine 0 N--CA 1.48 1.568 0 CA-C-N 112.827 -1.988 . . . . 0.0 114.522 -176.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.464 ' H ' ' HA ' ' A' ' 170' ' ' ASP . 19.6 mt -131.77 76.82 1.73 Allowed 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 101.492 -3.521 . . . . 0.0 101.492 175.272 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 5.0 m -107.08 140.14 21.13 Favored Pre-proline 0 N--CA 1.494 1.749 0 C-N-CA 117.997 -1.481 . . . . 0.0 110.207 -172.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 0.4 OUTLIER -90.93 177.77 2.02 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 C-N-CA 122.725 2.283 . . . . 0.0 115.287 -175.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 204' ' ' ARG . . . . . 0.481 ' HB2' ' HD2' ' A' ' 185' ' ' LYS . 41.6 ttt-85 -89.16 -35.7 16.1 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 174.477 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 72.9 p -33.46 -41.31 0.08 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 125.527 1.767 . . . . 0.0 113.3 174.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -113.68 5.12 16.34 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 114.522 1.305 . . . . 0.0 114.522 -178.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.411 HD23 ' HB3' ' A' ' 157' ' ' TYR . 0.3 OUTLIER -118.68 161.01 20.8 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 178.374 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -132.57 157.65 77.76 Favored Pre-proline 0 N--CA 1.487 1.383 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 174.552 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -69.98 173.32 11.34 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.223 1.949 . . . . 0.0 109.47 178.389 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 210' ' ' TYR . . . . . 0.526 ' CD1' HG21 ' A' ' 158' ' ' ILE . 2.4 t80 . . . . . 0 N--CA 1.492 1.657 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 2.021 0 CA-C-O 122.149 0.86 . . . . 0.0 113.67 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -132.16 148.29 52.46 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 103.921 -2.622 . . . . 0.0 103.921 177.031 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -107.49 142.36 37.48 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 116.82 -1.952 . . . . 0.0 111.577 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.408 ' CE1' HG21 ' A' ' 181' ' ' VAL . 11.2 m-85 -125.29 -179.51 4.63 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 100.91 -3.737 . . . . 0.0 100.91 -179.265 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.479 HG21 ' CD1' ' A' ' 210' ' ' TYR . 1.5 pt -125.92 147.69 30.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 101.295 -3.594 . . . . 0.0 101.295 174.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.447 ' O ' ' N ' ' A' ' 176' ' ' GLY . . . -86.29 154.44 21.25 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 103.45 -2.796 . . . . 0.0 103.45 178.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.0 m -124.8 -0.93 5.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 126.089 2.118 . . . . 0.0 107.655 177.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -133.2 165.28 24.08 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 177.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -105.27 145.77 30.23 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 178.069 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -137.77 177.59 7.76 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 117.978 -1.489 . . . . 0.0 109.119 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 87.9 m -132.28 160.7 35.44 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.101 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -100.52 130.51 46.61 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 175.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -106.82 -30.51 8.87 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 -178.46 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -119.44 -177.82 3.46 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 113.253 -1.794 . . . . 0.0 108.22 -179.224 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 61.1 t -92.77 150.97 3.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 101.899 -3.371 . . . . 0.0 101.899 176.311 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 110.39 -48.44 0.94 Allowed Glycine 0 N--CA 1.488 2.142 0 N-CA-C 106.057 -2.817 . . . . 0.0 106.057 -176.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.434 ' HA ' ' HB2' ' A' ' 201' ' ' LEU . 0.3 OUTLIER -73.29 169.6 16.77 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 123.879 1.8 . . . . 0.0 114.189 179.911 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.452 ' HG ' ' HA3' ' A' ' 200' ' ' GLY . 9.7 mt -121.04 -178.05 3.65 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 109.404 -3.544 . . . . 0.0 110.243 177.203 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 18.4 m -115.09 -65.15 1.22 Allowed 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 113.955 -1.475 . . . . 0.0 107.967 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 21.7 p90 42.64 166.26 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 116.867 2.173 . . . . 0.0 116.867 -178.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -113.82 -166.84 1.13 Allowed 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 113.562 -1.653 . . . . 0.0 112.728 179.217 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.415 ' CG ' ' N ' ' A' ' 176' ' ' GLY . 37.2 tttp -98.39 161.56 13.62 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 110.924 -2.853 . . . . 0.0 112.826 -178.548 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 159' ' ' ALA . . . 37.39 46.45 1.44 Allowed Glycine 0 N--CA 1.492 2.399 0 CA-C-N 112.665 -2.061 . . . . 0.0 110.172 179.297 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.451 ' O ' ' HA ' ' A' ' 158' ' ' ILE . 5.0 pt-20 -123.35 176.41 6.15 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-N 111.045 -2.578 . . . . 0.0 106.875 177.313 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 13.9 mm -108.24 125.67 64.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 C-N-CA 119.392 -0.923 . . . . 0.0 111.338 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 24.2 mt -119.78 165.59 14.36 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 114.575 -1.193 . . . . 0.0 108.37 177.008 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.403 ' HG ' ' N ' ' A' ' 181' ' ' VAL . 45.7 tp -118.11 163.24 16.93 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 178.553 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.408 HG21 ' CE1' ' A' ' 157' ' ' TYR . 69.0 t -113.24 142.25 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 178.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.554 ' O ' ' HB ' ' A' ' 191' ' ' ILE . 3.2 mm -141.86 75.41 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 104.551 -2.389 . . . . 0.0 104.551 173.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 183' ' ' GLU . . . . . 0.51 ' HG2' ' N ' ' A' ' 184' ' ' LYS . 38.8 tt0 127.47 148.39 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.539 0 C-N-CA 127.255 2.222 . . . . 0.0 108.794 178.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 184' ' ' LYS . . . . . 0.51 ' N ' ' HG2' ' A' ' 183' ' ' GLU . 92.6 mttt -126.4 133.06 51.38 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.117 -1.033 . . . . 0.0 111.787 177.418 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.51 ' CG ' ' HE1' ' A' ' 190' ' ' TRP . 3.5 tttm -7.98 80.86 0.03 OUTLIER Pre-proline 0 N--CA 1.501 2.081 0 O-C-N 126.683 2.489 . . . . 0.0 116.972 177.279 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 185' ' ' LYS . 58.3 Cg_endo -72.59 -56.57 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.732 0 N-CA-C 104.136 -3.063 . . . . 0.0 104.136 175.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -134.14 23.2 3.82 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 113.604 -1.635 . . . . 0.0 107.999 178.383 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.474 ' HA2' ' HG2' ' A' ' 185' ' ' LYS . . . 127.65 -21.46 5.64 Favored Glycine 0 N--CA 1.489 2.223 0 CA-C-O 117.902 -1.499 . . . . 0.0 113.258 -178.644 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -105.05 156.14 18.34 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 118.018 2.599 . . . . 0.0 118.018 -176.129 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' TRP . . . . . 0.524 ' NE1' ' HB2' ' A' ' 204' ' ' ARG . 20.4 m95 -130.12 147.47 51.86 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 100.344 -3.947 . . . . 0.0 100.344 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.554 ' HB ' ' O ' ' A' ' 182' ' ' ILE . 12.4 mm -109.22 87.27 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 N-CA-C 102.998 -2.964 . . . . 0.0 102.998 178.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -80.02 175.04 10.99 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 113.247 -1.797 . . . . 0.0 113.848 -173.27 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -130.4 166.45 20.44 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 174.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -126.34 -161.89 1.09 Allowed 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 118.869 -1.132 . . . . 0.0 110.416 178.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -101.44 32.77 3.18 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.711 -178.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -129.1 -33.8 1.94 Allowed 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.092 176.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 138.07 -39.03 1.64 Allowed Glycine 0 N--CA 1.486 1.967 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.525 -179.06 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 21.3 p30 -56.84 159.84 3.81 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 118.536 -1.266 . . . . 0.0 114.267 -178.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 199' ' ' GLU . . . . . 0.457 ' HG3' ' N ' ' A' ' 200' ' ' GLY . 0.1 OUTLIER -140.69 166.12 25.62 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 112.008 -2.36 . . . . 0.0 109.573 179.175 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 200' ' ' GLY . . . . . 0.457 ' N ' ' HG3' ' A' ' 199' ' ' GLU . . . 159.41 174.01 28.59 Favored Glycine 0 N--CA 1.486 2.013 0 C-N-CA 118.148 -1.977 . . . . 0.0 114.684 177.576 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.434 ' HB2' ' HA ' ' A' ' 170' ' ' ASP . 9.8 mp -59.45 91.82 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 117.052 2.241 . . . . 0.0 117.052 -179.078 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 5.5 m -107.41 149.62 39.02 Favored Pre-proline 0 C--N 1.302 -1.495 0 N-CA-C 100.417 -3.92 . . . . 0.0 100.417 174.47 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -86.17 167.41 9.33 Favored 'Trans proline' 0 C--N 1.299 -2.033 0 N-CA-C 107.437 -1.794 . . . . 0.0 107.437 178.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 204' ' ' ARG . . . . . 0.524 ' HB2' ' NE1' ' A' ' 190' ' ' TRP . 12.2 ttp85 -80.22 -36.88 34.13 Favored 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 115.856 -2.338 . . . . 0.0 107.458 176.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 40.8 p -23.73 -54.82 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -110.52 47.4 0.97 Allowed 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.539 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -134.33 101.1 4.88 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 179.361 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -102.52 151.41 38.22 Favored Pre-proline 0 C--N 1.298 -1.654 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -57.61 164.78 6.96 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.176 1.918 . . . . 0.0 111.757 -178.112 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 210' ' ' TYR . . . . . 0.479 ' CD1' HG21 ' A' ' 158' ' ' ILE . 9.7 t80 . . . . . 0 N--CA 1.488 1.464 0 C-N-CA 119.544 -0.862 . . . . 0.0 109.592 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.717 0 N-CA-C 116.64 1.416 . . . . 0.0 116.64 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -123.46 168.31 12.73 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 178.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -112.32 135.21 53.29 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 124.216 1.96 . . . . 0.0 110.782 -178.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.485 ' CE1' HG21 ' A' ' 181' ' ' VAL . 16.9 m-85 -133.57 175.12 9.71 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 109.28 -3.6 . . . . 0.0 106.251 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.485 ' HA ' ' HA ' ' A' ' 178' ' ' ILE . 1.3 pt -132.03 152.54 36.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 101.475 -3.528 . . . . 0.0 101.475 171.522 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.48 ' O ' ' N ' ' A' ' 176' ' ' GLY . . . -90.33 152.89 20.82 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 102.287 -3.227 . . . . 0.0 102.287 177.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.444 ' C ' ' HB2' ' A' ' 175' ' ' LYS . 29.1 m -129.41 10.96 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 125.864 1.978 . . . . 0.0 107.765 177.386 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.401 ' N ' ' HB2' ' A' ' 175' ' ' LYS . . . -137.82 161.05 25.43 Favored Glycine 0 N--CA 1.478 1.474 0 N-CA-C 106.751 -2.54 . . . . 0.0 106.751 173.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -101.18 150.2 23.2 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 104.061 -2.57 . . . . 0.0 104.061 176.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -132.7 177.33 7.71 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 117.816 -1.554 . . . . 0.0 109.145 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 96.8 m -128.65 157.95 39.89 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 177.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -100.09 145.03 28.43 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 178.105 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 55.3 tp60 -111.21 -37.24 5.37 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -125.56 171.66 10.36 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 113.312 -1.767 . . . . 0.0 108.098 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 67.9 t -60.42 -48.63 87.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 103.873 -2.64 . . . . 0.0 103.873 177.1 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -30.29 -50.73 0.18 Allowed Glycine 0 N--CA 1.491 2.306 0 CA-C-N 112.308 -2.223 . . . . 0.0 113.399 174.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.536 ' HA ' ' H ' ' A' ' 201' ' ' LEU . 28.7 m-20 -79.83 164.15 23.84 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 113.738 -1.231 . . . . 0.0 113.339 -178.676 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.434 HD11 ' C ' ' A' ' 199' ' ' GLU . 16.6 mt -114.92 177.95 4.46 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 104.345 -2.465 . . . . 0.0 104.345 175.27 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 31.4 m -107.66 -57.46 2.09 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 33.1 p90 33.76 164.38 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 118.811 2.893 . . . . 0.0 118.811 -178.411 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -109.25 -166.55 1.12 Allowed 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 113.749 -1.569 . . . . 0.0 112.476 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.444 ' HB2' ' C ' ' A' ' 160' ' ' VAL . 10.4 ptpt -107.51 176.83 5.02 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 111.222 -2.717 . . . . 0.0 113.73 -176.506 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 159' ' ' ALA . . . 34.72 44.21 0.45 Allowed Glycine 0 N--CA 1.491 2.351 0 O-C-N 126.327 2.267 . . . . 0.0 109.097 -177.56 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.421 ' O ' ' HA ' ' A' ' 158' ' ' ILE . 16.7 pt-20 -130.0 175.6 8.75 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-N 110.758 -2.721 . . . . 0.0 106.555 177.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.485 ' HA ' ' HA ' ' A' ' 158' ' ' ILE . 17.9 mm -101.6 123.19 54.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -175.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 6.8 mp -116.89 156.27 27.64 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.568 177.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.496 HD13 ' H ' ' A' ' 181' ' ' VAL . 0.6 OUTLIER -114.77 152.05 32.73 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 -177.181 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.496 ' H ' HD13 ' A' ' 180' ' ' LEU . 59.6 t -111.6 132.91 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 -179.273 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.569 ' O ' ' HB ' ' A' ' 191' ' ' ILE . 9.9 mt -142.59 78.88 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 CA-C-N 114.177 -1.374 . . . . 0.0 108.758 179.262 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 183' ' ' GLU . . . . . 0.484 ' HG2' ' N ' ' A' ' 184' ' ' LYS . 33.6 tt0 122.0 165.13 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 C-N-CA 128.081 2.552 . . . . 0.0 109.616 173.564 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 184' ' ' LYS . . . . . 0.484 ' N ' ' HG2' ' A' ' 183' ' ' GLU . 98.4 mttt -110.37 167.03 10.51 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.206 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.708 ' HB3' ' CD1' ' A' ' 190' ' ' TRP . 17.8 pttp -95.85 68.4 0.03 OUTLIER Pre-proline 0 N--CA 1.508 2.469 0 N-CA-C 120.623 3.564 . . . . 0.0 120.623 -179.014 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -35.1 -56.5 0.5 Allowed 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 123.288 2.659 . . . . 0.0 108.938 171.137 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -121.16 23.77 10.39 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 112.95 -1.932 . . . . 0.0 114.069 179.255 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.602 ' CA ' ' HB2' ' A' ' 185' ' ' LYS . . . 110.7 17.46 9.14 Favored Glycine 0 N--CA 1.5 2.962 0 C-N-CA 119.644 -1.265 . . . . 0.0 112.658 178.235 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 2.0 m-90 -129.81 111.99 13.16 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 119.41 3.115 . . . . 0.0 119.41 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 190' ' ' TRP . . . . . 0.708 ' CD1' ' HB3' ' A' ' 185' ' ' LYS . 28.7 m0 -106.54 160.4 15.45 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 101.856 -3.387 . . . . 0.0 101.856 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.569 ' HB ' ' O ' ' A' ' 182' ' ' ILE . 1.5 mp -115.43 114.21 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 N-CA-C 103.359 -2.83 . . . . 0.0 103.359 173.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -116.26 176.84 4.92 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -171.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 193' ' ' LYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 199' ' ' GLU . 27.3 mtpp -126.84 161.03 29.2 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 173.041 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 17.9 p30 -120.59 -165.85 1.25 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 124.254 0.971 . . . . 0.0 111.64 178.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -99.9 39.12 1.36 Allowed 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 40.8 mmtm -118.66 -37.37 3.29 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 179.139 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 134.62 -35.87 2.15 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 120.142 -1.028 . . . . 0.0 111.47 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 38.2 p30 -90.96 174.78 7.24 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 116.153 1.909 . . . . 0.0 116.153 -178.469 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 199' ' ' GLU . . . . . 0.434 ' C ' HD11 ' A' ' 171' ' ' LEU . 0.3 OUTLIER -117.74 161.27 19.97 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 111.964 -2.38 . . . . 0.0 110.08 -179.383 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 200' ' ' GLY . . . . . 0.423 ' N ' ' HG3' ' A' ' 199' ' ' GLU . . . -144.97 -170.21 13.9 Favored Glycine 0 N--CA 1.477 1.411 0 C-N-CA 119.326 -1.416 . . . . 0.0 111.453 -179.433 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.536 ' H ' ' HA ' ' A' ' 170' ' ' ASP . 14.4 mt -113.92 88.01 2.75 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 110.645 -2.777 . . . . 0.0 103.914 177.044 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 4.8 m -115.27 156.65 45.35 Favored Pre-proline 0 N--CA 1.489 1.493 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 -174.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -90.02 -179.82 1.87 Allowed 'Trans proline' 0 C--N 1.298 -2.087 0 C-N-CA 122.299 2.0 . . . . 0.0 106.976 178.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 204' ' ' ARG . . . . . 0.554 ' HB2' ' CE2' ' A' ' 190' ' ' TRP . 0.7 OUTLIER -102.9 -41.93 5.99 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 102.503 -3.147 . . . . 0.0 102.503 175.849 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 77.9 p -17.76 -46.28 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 O-C-N 126.616 2.447 . . . . 0.0 116.515 176.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 206' ' ' TYR . . . . . 0.403 ' N ' ' O ' ' A' ' 204' ' ' ARG . 36.4 m-85 -110.27 42.1 1.62 Allowed 'General case' 0 N--CA 1.503 2.205 0 CA-C-N 118.85 0.75 . . . . 0.0 112.643 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 6.1 mp -131.06 162.21 30.32 Favored 'General case' 0 N--CA 1.499 1.979 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.014 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -134.5 156.81 78.49 Favored Pre-proline 0 C--N 1.303 -1.433 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 172.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -72.26 170.69 18.54 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 N-CA-C 106.995 -1.964 . . . . 0.0 106.995 178.125 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 210' ' ' TYR . . . . . 0.451 ' CD1' HG21 ' A' ' 158' ' ' ILE . 5.2 t80 . . . . . 0 N--CA 1.491 1.602 0 C-N-CA 118.483 -1.287 . . . . 0.0 110.004 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 N-CA-C 116.377 1.311 . . . . 0.0 116.377 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -122.15 156.07 34.43 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 113.196 -1.502 . . . . 0.0 107.977 -179.217 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -104.61 128.04 52.52 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 117.897 -1.521 . . . . 0.0 111.373 -178.255 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.461 ' CE1' HG21 ' A' ' 181' ' ' VAL . 15.9 m-85 -122.1 174.8 6.71 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 104.678 -2.341 . . . . 0.0 104.678 178.315 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.48 HG21 ' CD1' ' A' ' 210' ' ' TYR . 1.7 pt -125.53 146.32 31.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 102.694 -3.076 . . . . 0.0 102.694 172.472 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.41 156.47 20.15 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 101.361 -3.57 . . . . 0.0 101.361 176.379 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 33.2 m -122.52 2.53 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 126.106 2.129 . . . . 0.0 108.274 178.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -125.92 167.73 18.24 Favored Glycine 0 N--CA 1.482 1.76 0 N-CA-C 106.504 -2.638 . . . . 0.0 106.504 177.089 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.413 ' HA ' ' HA ' ' A' ' 174' ' ' LYS . 23.2 t70 -105.53 114.36 28.49 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.271 -0.972 . . . . 0.0 109.913 179.201 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.445 ' HB3' ' CZ ' ' A' ' 173' ' ' PHE . 46.2 t80 -112.3 154.63 25.37 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.409 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 99.9 m -130.16 159.78 35.78 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 178.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -96.7 103.54 15.46 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 118.31 -1.356 . . . . 0.0 109.404 178.027 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -117.75 -0.72 11.72 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.009 -178.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.402 ' O ' ' C ' ' A' ' 168' ' ' VAL . 22.0 mm100 -121.43 179.14 4.53 Favored 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 118.418 -1.313 . . . . 0.0 109.639 -177.618 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.402 ' C ' ' O ' ' A' ' 167' ' ' GLN . 96.0 t -25.25 -73.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 126.112 2.132 . . . . 0.0 111.06 179.533 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -133.55 141.13 12.45 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 107.489 -2.244 . . . . 0.0 107.489 174.152 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -167.64 -179.24 4.24 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 110.372 -2.914 . . . . 0.0 108.181 -179.263 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.499 ' HG ' ' CA ' ' A' ' 200' ' ' GLY . 16.5 mt -132.34 175.23 9.46 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 169.692 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 55.1 m -122.05 96.21 4.96 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.282 178.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.445 ' CZ ' ' HB3' ' A' ' 163' ' ' PHE . 17.6 p90 -118.6 168.47 10.67 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.944 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 162' ' ' ASP . 13.2 ptpt -126.1 151.25 47.47 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 116.299 1.963 . . . . 0.0 116.299 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 60.1 tttt -27.11 79.1 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.665 1 CA-C-N 108.337 -4.028 . . . . 0.0 116.14 171.22 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 109.61 48.21 0.81 Allowed Glycine 0 N--CA 1.491 2.309 0 CA-C-N 114.775 -1.102 . . . . 0.0 112.611 176.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' A' ' 158' ' ' ILE . 9.5 pt-20 -138.49 151.81 47.72 Favored 'General case' 0 N--CA 1.507 2.38 0 C-N-CA 117.35 -1.74 . . . . 0.0 109.135 178.184 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.465 HD12 ' N ' ' A' ' 178' ' ' ILE . 1.3 mp -82.95 137.59 20.74 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 117.765 2.505 . . . . 0.0 117.765 -177.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.413 HD22 ' N ' ' A' ' 179' ' ' LEU . 2.4 mm? -125.63 173.37 9.03 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 104.2 -2.518 . . . . 0.0 104.2 175.466 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.5 ' HB2' ' HB2' ' A' ' 193' ' ' LYS . 9.8 mt -117.75 161.34 19.86 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 176.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.461 HG21 ' CE1' ' A' ' 157' ' ' TYR . 78.1 t -113.49 124.43 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 N-CA-C 117.674 2.472 . . . . 0.0 117.674 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.566 ' O ' ' HB ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -135.45 77.53 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 CA-C-N 111.371 -2.65 . . . . 0.0 108.257 176.406 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 183' ' ' GLU . . . . . 0.55 ' HG2' ' N ' ' A' ' 184' ' ' LYS . 35.7 tt0 117.13 164.28 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 128.214 2.606 . . . . 0.0 110.129 173.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 184' ' ' LYS . . . . . 0.55 ' N ' ' HG2' ' A' ' 183' ' ' GLU . 99.5 mttt -108.87 -177.45 3.31 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.368 178.53 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.69 ' HD2' ' HB3' ' A' ' 204' ' ' ARG . 8.2 ptmm? -91.43 73.34 0.01 OUTLIER Pre-proline 0 N--CA 1.515 2.782 0 C-N-CA 130.326 3.45 . . . . 0.0 118.018 -177.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.505 ' HD2' ' O ' ' A' ' 184' ' ' LYS . 9.2 Cg_endo -44.31 -56.57 2.46 Favored 'Trans proline' 0 C--N 1.3 -1.981 0 C-N-CA 123.251 2.634 . . . . 0.0 106.802 174.009 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -126.24 24.2 6.88 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 112.582 -2.099 . . . . 0.0 110.665 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.498 ' CA ' ' HB2' ' A' ' 185' ' ' LYS . . . 110.22 15.78 11.19 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -128.13 102.78 6.86 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 119.933 3.309 . . . . 0.0 119.933 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 190' ' ' TRP . . . . . 0.675 ' CD1' ' HB3' ' A' ' 185' ' ' LYS . 10.7 m0 -95.93 157.05 16.07 Favored 'General case' 0 N--CA 1.498 1.933 1 N-CA-C 99.685 -4.191 . . . . 0.0 99.685 -177.926 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.566 ' HB ' ' O ' ' A' ' 182' ' ' ILE . 1.4 mp -112.54 140.99 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 1 N-CA-C 99.893 -4.114 . . . . 0.0 99.893 173.698 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -132.87 -177.95 4.73 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 119.319 -0.952 . . . . 0.0 113.542 -174.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 193' ' ' LYS . . . . . 0.5 ' HB2' ' HB2' ' A' ' 180' ' ' LEU . 62.6 mmtt -128.22 169.25 14.37 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 172.537 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -125.03 -158.0 0.81 Allowed 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.34 -0.944 . . . . 0.0 109.548 178.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -104.71 39.06 1.76 Allowed 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 121.33 0.586 . . . . 0.0 109.967 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -132.26 -37.39 1.1 Allowed 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.56 177.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 134.72 -22.24 3.69 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 -178.311 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -78.08 164.6 24.87 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.005 -1.078 . . . . 0.0 112.934 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.76 158.17 30.76 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 112.203 -2.271 . . . . 0.0 109.74 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 200' ' ' GLY . . . . . 0.499 ' CA ' ' HG ' ' A' ' 171' ' ' LEU . . . -135.46 -172.22 12.63 Favored Glycine 0 N--CA 1.479 1.501 0 CA-C-O 123.985 1.881 . . . . 0.0 115.115 -177.211 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.455 HD23 ' HA ' ' A' ' 201' ' ' LEU . 9.5 mt -126.2 87.06 2.61 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 108.568 -3.816 . . . . 0.0 103.684 177.007 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 4.9 m -116.79 156.5 47.86 Favored Pre-proline 0 C--N 1.303 -1.45 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 -173.061 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 0.6 OUTLIER -92.0 174.7 2.18 Favored 'Trans proline' 0 C--N 1.299 -2.061 0 N-CA-C 105.564 -2.514 . . . . 0.0 105.564 178.181 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 204' ' ' ARG . . . . . 0.69 ' HB3' ' HD2' ' A' ' 185' ' ' LYS . 0.4 OUTLIER -108.85 -31.06 7.83 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 175.502 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 82.5 p -23.68 -47.16 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.173 0 O-C-N 125.742 1.901 . . . . 0.0 113.875 171.53 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -112.53 49.49 0.92 Allowed 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 119.745 -0.782 . . . . 0.0 111.77 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -132.68 156.89 46.15 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.332 -179.449 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -132.02 157.6 77.78 Favored Pre-proline 0 N--CA 1.495 1.791 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 174.13 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -73.24 158.61 48.56 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 121.283 1.322 . . . . 0.0 108.708 178.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 210' ' ' TYR . . . . . 0.48 ' CD1' HG21 ' A' ' 158' ' ' ILE . 6.8 t80 . . . . . 0 N--CA 1.49 1.526 0 C-N-CA 119.4 -0.92 . . . . 0.0 109.066 179.148 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.907 0 CA-C-O 121.67 0.595 . . . . 0.0 113.707 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -119.29 166.59 12.82 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 104.907 -2.257 . . . . 0.0 104.907 -179.265 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -103.48 117.01 33.47 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 117.704 -1.598 . . . . 0.0 113.492 -178.057 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.462 ' CD1' HG21 ' A' ' 181' ' ' VAL . 5.5 m-85 -123.59 174.91 7.13 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 102.623 -3.103 . . . . 0.0 102.623 177.013 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.511 HG22 HG13 ' A' ' 178' ' ' ILE . 5.7 pt -131.62 150.76 34.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 103.312 -2.847 . . . . 0.0 103.312 172.698 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -81.71 151.45 27.51 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 102.848 -3.019 . . . . 0.0 102.848 176.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 26.8 m -129.69 10.72 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 125.866 1.978 . . . . 0.0 107.75 177.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -126.89 164.18 20.55 Favored Glycine 0 N--CA 1.484 1.852 0 N-CA-C 105.17 -3.172 . . . . 0.0 105.17 176.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -105.83 83.91 1.99 Allowed 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 118.709 -1.196 . . . . 0.0 109.277 -179.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -104.43 115.96 31.28 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 122.605 1.193 . . . . 0.0 108.425 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 18.2 m -101.01 154.35 18.77 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 111.944 -2.389 . . . . 0.0 106.379 -179.077 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.39 129.71 34.75 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 117.168 -1.813 . . . . 0.0 106.447 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -107.42 -29.31 9.32 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 -178.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -119.2 -175.67 2.97 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 113.586 -1.643 . . . . 0.0 106.616 179.149 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 61.4 t -88.76 151.76 3.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 179.172 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 114.33 -53.04 0.62 Allowed Glycine 0 N--CA 1.487 2.074 0 N-CA-C 108.644 -1.782 . . . . 0.0 108.644 -178.303 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.5 ' HA ' ' H ' ' A' ' 201' ' ' LEU . 39.8 m-20 -78.58 169.52 18.11 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 113.951 -1.125 . . . . 0.0 111.668 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.428 ' HG ' ' HA3' ' A' ' 200' ' ' GLY . 15.4 mt -121.01 176.02 5.77 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.182 177.319 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 31.3 m -116.92 93.09 4.06 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 114.12 -1.4 . . . . 0.0 112.273 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -128.17 166.85 17.73 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 113.512 -1.676 . . . . 0.0 109.274 177.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -125.39 159.82 30.9 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 117.001 2.223 . . . . 0.0 117.001 -178.342 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 44.4 tttm -35.97 77.45 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.659 1 CA-C-N 108.008 -4.178 . . . . 0.0 116.655 173.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 114.9 47.86 0.55 Allowed Glycine 0 N--CA 1.494 2.504 0 CA-C-N 114.866 -1.061 . . . . 0.0 115.126 174.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -137.51 158.66 43.92 Favored 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 117.472 -1.691 . . . . 0.0 107.576 175.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.511 HG13 HG22 ' A' ' 158' ' ' ILE . 1.1 mp -84.57 134.26 27.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 -176.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.7 mp -135.62 168.83 18.54 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 113.158 -1.837 . . . . 0.0 108.7 175.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.429 ' O ' ' HB1' ' A' ' 192' ' ' ALA . 27.9 mt -107.09 154.09 21.66 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 176.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.465 HG12 ' HB3' ' A' ' 190' ' ' TRP . 2.3 t -122.52 132.69 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 118.367 -1.333 . . . . 0.0 108.502 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.473 ' O ' ' CB ' ' A' ' 183' ' ' GLU . 16.6 mt -139.77 79.99 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 120.264 -0.575 . . . . 0.0 111.658 -173.602 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 183' ' ' GLU . . . . . 0.506 ' O ' ' CE3' ' A' ' 190' ' ' TRP . 3.7 tm-20 136.34 147.56 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.976 0 C-N-CA 127.63 2.372 . . . . 0.0 108.816 173.249 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 184' ' ' LYS . . . . . 0.439 ' HG2' ' CZ3' ' A' ' 190' ' ' TRP . 62.0 mttp -105.54 104.19 13.87 Favored 'General case' 0 N--CA 1.509 2.504 0 N-CA-C 119.727 3.232 . . . . 0.0 119.727 -171.509 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.523 ' HA ' ' HD2' ' A' ' 186' ' ' PRO . 21.8 pttp -15.09 79.25 0.02 OUTLIER Pre-proline 0 N--CA 1.5 2.074 1 N-CA-C 122.407 4.225 . . . . 0.0 122.407 179.249 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.523 ' HD2' ' HA ' ' A' ' 185' ' ' LYS . 11.0 Cg_endo -45.35 -59.93 1.01 Allowed 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 123.886 3.057 . . . . 0.0 107.321 171.562 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -121.86 20.75 10.82 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 111.399 -2.637 . . . . 0.0 110.638 -178.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.513 ' CA ' ' HB2' ' A' ' 185' ' ' LYS . . . 114.71 12.18 10.64 Favored Glycine 0 N--CA 1.488 2.154 0 C-N-CA 119.717 -1.23 . . . . 0.0 110.876 179.591 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 189' ' ' TRP . . . . . 0.402 ' O ' ' HD2' ' A' ' 186' ' ' PRO . 2.5 m-90 -127.49 134.3 49.82 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 120.318 3.451 . . . . 0.0 120.318 179.344 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 190' ' ' TRP . . . . . 0.506 ' CE3' ' O ' ' A' ' 183' ' ' GLU . 10.2 m95 -120.11 163.06 18.27 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 104.824 -2.287 . . . . 0.0 104.824 178.617 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.457 ' HB ' ' O ' ' A' ' 182' ' ' ILE . 1.7 mp -107.45 113.0 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 104.179 -2.526 . . . . 0.0 104.179 177.048 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 192' ' ' ALA . . . . . 0.442 ' HB2' HG22 ' A' ' 202' ' ' VAL . . . -108.2 -179.81 3.99 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -173.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 193' ' ' LYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 199' ' ' GLU . 96.5 mttt -133.6 165.31 25.21 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 172.454 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -115.62 -160.0 0.73 Allowed 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 118.822 -1.151 . . . . 0.0 109.658 -179.045 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -97.18 38.67 1.23 Allowed 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.874 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -133.36 -38.38 0.94 Allowed 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.45 177.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 136.87 -39.71 1.6 Allowed Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -178.42 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 21.5 p30 -52.78 164.27 0.39 Allowed 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 199' ' ' GLU . . . . . 0.411 ' C ' HD11 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -122.95 157.69 32.07 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 113.049 -1.887 . . . . 0.0 110.552 179.83 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 200' ' ' GLY . . . . . 0.428 ' HA3' ' HG ' ' A' ' 171' ' ' LEU . . . -142.58 -165.48 10.6 Favored Glycine 0 N--CA 1.482 1.709 0 CA-C-O 122.671 1.151 . . . . 0.0 112.387 -177.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.5 ' H ' ' HA ' ' A' ' 170' ' ' ASP . 33.7 mt -125.2 89.98 3.15 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 111.242 -2.479 . . . . 0.0 106.547 177.22 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.442 HG22 ' HB2' ' A' ' 192' ' ' ALA . 2.1 m -116.74 154.82 49.45 Favored Pre-proline 0 N--CA 1.496 1.871 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -177.313 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -89.59 176.26 2.99 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 C-N-CA 123.177 2.585 . . . . 0.0 111.391 -177.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 204' ' ' ARG . . . . . 0.476 ' HB2' ' CE2' ' A' ' 190' ' ' TRP . 29.3 ttm180 -97.97 -40.09 8.64 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 102.637 -3.097 . . . . 0.0 102.637 174.04 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 73.8 p -25.14 -55.24 0.05 OUTLIER 'General case' 0 N--CA 1.503 2.202 0 O-C-N 125.512 1.758 . . . . 0.0 115.54 176.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -113.66 45.65 1.41 Allowed 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 122.62 1.2 . . . . 0.0 109.387 -178.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -135.75 128.73 31.41 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 112.361 -2.2 . . . . 0.0 105.369 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -114.2 156.09 44.71 Favored Pre-proline 0 N--CA 1.494 1.744 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 178.383 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -63.21 166.11 15.53 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 121.693 1.595 . . . . 0.0 110.122 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 210' ' ' TYR . . . . . 0.406 ' CD1' HG21 ' A' ' 158' ' ' ILE . 35.6 t80 . . . . . 0 N--CA 1.491 1.616 0 C-N-CA 119.688 -0.805 . . . . 0.0 109.511 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 36.6 m . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 112.08 178.72 19.95 Favored Glycine 0 N--CA 1.488 2.119 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.343 -178.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -126.55 161.31 28.3 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 103.537 -2.764 . . . . 0.0 103.537 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -115.1 136.3 53.27 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 116.444 -2.102 . . . . 0.0 112.855 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.484 ' CD1' HG21 ' A' ' 181' ' ' VAL . 6.0 m-85 -124.99 -178.99 4.36 Favored 'General case' 0 C--N 1.299 -1.6 1 N-CA-C 100.068 -4.049 . . . . 0.0 100.068 179.085 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.408 HD13 HG21 ' A' ' 158' ' ' ILE . 3.5 pt -125.22 154.6 33.61 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 N-CA-C 101.914 -3.365 . . . . 0.0 101.914 173.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -89.26 150.63 22.54 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 102.02 -3.326 . . . . 0.0 102.02 177.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.2 m -130.09 28.36 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 126.238 2.211 . . . . 0.0 106.545 177.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -142.23 158.94 27.01 Favored Glycine 0 N--CA 1.482 1.754 0 N-CA-C 105.711 -2.956 . . . . 0.0 105.711 174.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.438 ' HA ' ' HA ' ' A' ' 174' ' ' LYS . 9.9 t70 -107.68 94.29 5.0 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 118.928 -1.109 . . . . 0.0 108.786 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.498 ' HB3' ' CZ ' ' A' ' 173' ' ' PHE . 47.6 t80 -107.65 154.09 21.96 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.086 -1.046 . . . . 0.0 108.921 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 56.7 m -127.0 163.43 23.72 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 105.442 -2.059 . . . . 0.0 105.442 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -95.25 135.03 37.34 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 177.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -110.74 -29.81 7.84 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -115.63 -178.07 3.3 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 58.5 t -88.95 150.91 3.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 104.822 -2.288 . . . . 0.0 104.822 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 113.51 -51.89 0.68 Allowed Glycine 0 N--CA 1.485 1.929 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 -178.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.591 ' HA ' ' H ' ' A' ' 201' ' ' LEU . 2.9 m-20 -76.99 166.5 23.23 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -178.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.508 ' HG ' ' HA3' ' A' ' 200' ' ' GLY . 16.4 mt -121.26 178.82 4.62 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 113.449 -1.705 . . . . 0.0 109.935 179.005 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 39.0 m -122.03 100.02 6.75 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.57 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.498 ' CZ ' ' HB3' ' A' ' 163' ' ' PHE . 18.0 p90 -119.21 168.28 11.03 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.531 -0.867 . . . . 0.0 110.88 178.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 162' ' ' ASP . 57.2 pttt -124.84 142.79 51.2 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 115.882 1.808 . . . . 0.0 115.882 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 49.9 tptt -23.9 77.95 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 109.583 -3.462 . . . . 0.0 115.215 170.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 107.78 50.5 0.79 Allowed Glycine 0 N--CA 1.49 2.281 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.913 176.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.402 ' O ' ' HA ' ' A' ' 158' ' ' ILE . 8.0 pt-20 -127.95 170.85 12.39 Favored 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 176.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.405 ' HA ' ' HA ' ' A' ' 158' ' ' ILE . 14.4 mm -99.8 132.76 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 117.98 -1.488 . . . . 0.0 112.11 -177.044 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 57.9 mt -124.74 167.79 14.09 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 113.561 -1.654 . . . . 0.0 110.077 177.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.402 ' O ' ' HB1' ' A' ' 192' ' ' ALA . 22.2 tp -117.47 159.72 22.36 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 102.746 -3.057 . . . . 0.0 102.746 177.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.484 HG21 ' CD1' ' A' ' 157' ' ' TYR . 3.2 t -128.14 136.71 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 CA-C-N 120.915 1.689 . . . . 0.0 109.306 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.505 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 45.8 mt -145.35 86.13 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.093 -176.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' GLU . . . . . 0.505 ' HB2' ' O ' ' A' ' 182' ' ' ILE . 10.1 tm-20 130.56 153.18 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.753 0 C-N-CA 128.109 2.564 . . . . 0.0 107.654 172.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -109.83 123.0 48.81 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 118.426 2.75 . . . . 0.0 118.426 -174.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.459 ' CG ' ' HE1' ' A' ' 190' ' ' TRP . 8.4 tttm -9.79 78.37 0.03 OUTLIER Pre-proline 0 N--CA 1.507 2.413 0 N-CA-C 117.746 2.499 . . . . 0.0 117.746 175.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -69.09 -56.53 0.16 Allowed 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 123.165 2.577 . . . . 0.0 105.96 175.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -125.35 19.28 8.18 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 112.067 -2.333 . . . . 0.0 111.791 -177.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.403 ' HA2' ' NZ ' ' A' ' 185' ' ' LYS . . . 122.07 -23.84 7.19 Favored Glycine 0 N--CA 1.487 2.074 0 C-N-CA 118.452 -1.832 . . . . 0.0 111.242 -178.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 24.7 m-90 -113.39 154.6 26.67 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 115.842 1.793 . . . . 0.0 115.842 -176.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' TRP . . . . . 0.459 ' HE1' ' CG ' ' A' ' 185' ' ' LYS . 18.3 m95 -122.73 163.91 19.28 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 101.767 -3.42 . . . . 0.0 101.767 -178.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.493 HG12 ' CB ' ' A' ' 183' ' ' GLU . 8.2 mm -102.9 105.57 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 C-N-CA 115.522 -2.471 . . . . 0.0 105.043 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ALA . . . . . 0.425 ' HB2' HG22 ' A' ' 202' ' ' VAL . . . -98.43 -177.88 3.84 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -173.027 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.465 ' HA ' ' HA ' ' A' ' 199' ' ' GLU . 34.0 ttmt -137.17 164.45 28.44 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 177.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 47.2 p-10 -122.45 -163.23 1.06 Allowed 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.664 -0.814 . . . . 0.0 110.077 178.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -103.36 40.86 1.34 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -126.17 -35.6 2.41 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 113.709 -1.587 . . . . 0.0 107.455 177.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 134.9 -38.96 1.75 Allowed Glycine 0 N--CA 1.487 2.071 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 21.1 p30 -67.8 163.78 21.03 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -178.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.465 ' HA ' ' HA ' ' A' ' 193' ' ' LYS . 0.0 OUTLIER -129.53 149.48 51.28 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 112.121 -2.309 . . . . 0.0 108.609 177.181 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 200' ' ' GLY . . . . . 0.508 ' HA3' ' HG ' ' A' ' 171' ' ' LEU . . . -139.28 -156.34 6.94 Favored Glycine 0 N--CA 1.482 1.714 0 CA-C-N 114.789 -1.096 . . . . 0.0 113.187 -177.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.591 ' H ' ' HA ' ' A' ' 170' ' ' ASP . 90.3 mt -117.12 101.94 8.89 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 111.622 -2.289 . . . . 0.0 107.56 178.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.425 HG22 ' HB2' ' A' ' 192' ' ' ALA . 4.9 m -120.5 151.44 53.91 Favored Pre-proline 0 N--CA 1.496 1.828 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -82.38 175.85 8.56 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 121.19 1.26 . . . . 0.0 109.05 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' ARG . . . . . 0.411 ' HB2' ' NE1' ' A' ' 190' ' ' TRP . 0.0 OUTLIER -96.37 -42.89 7.91 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 102.994 -2.965 . . . . 0.0 102.994 178.273 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 77.3 p -23.44 -53.67 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 O-C-N 125.579 1.799 . . . . 0.0 115.469 178.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -112.34 49.04 0.94 Allowed 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.891 -0.724 . . . . 0.0 110.807 -178.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -131.15 129.49 41.85 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 179.151 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -121.0 143.68 37.48 Favored Pre-proline 0 N--CA 1.493 1.675 0 C-N-CA 118.729 -1.189 . . . . 0.0 108.198 177.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -58.91 161.21 16.02 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 121.703 1.602 . . . . 0.0 109.798 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' TYR . . . . . 0.466 ' CG ' ' N ' ' A' ' 211' ' ' SER . 38.7 t80 -121.24 168.89 11.11 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 118.853 -1.139 . . . . 0.0 112.176 -179.06 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' SER . . . . . 0.466 ' N ' ' CG ' ' A' ' 210' ' ' TYR . 47.5 t -110.75 73.55 0.83 Allowed 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.428 ' CD ' ' H ' ' A' ' 212' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.825 0 CA-C-N 112.562 -2.108 . . . . 0.0 114.029 -179.281 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 58.3 m . . . . . 0 N--CA 1.492 1.633 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 70.39 -179.43 29.21 Favored Glycine 0 N--CA 1.488 2.159 0 C-N-CA 119.873 -1.156 . . . . 0.0 112.603 178.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -117.55 162.52 17.86 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 103.195 -2.891 . . . . 0.0 103.195 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 9.3 mp0 -116.31 118.63 33.28 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 117.54 -1.664 . . . . 0.0 110.943 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.515 ' CD1' HG21 ' A' ' 181' ' ' VAL . 41.3 m-85 -126.0 176.46 6.99 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 104.346 -2.464 . . . . 0.0 104.346 178.107 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.455 ' CG2' ' CD1' ' A' ' 210' ' ' TYR . 1.7 pt -124.87 146.2 30.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 1 N-CA-C 100.155 -4.017 . . . . 0.0 100.155 170.728 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -92.7 155.07 17.95 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 116.849 -1.941 . . . . 0.0 106.246 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.6 m -130.2 25.64 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 125.719 1.887 . . . . 0.0 110.02 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -121.66 146.28 17.09 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 106.687 -2.565 . . . . 0.0 106.687 176.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -104.9 78.06 1.39 Allowed 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -178.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -106.51 155.81 19.21 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.021 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 97.6 m -118.32 161.82 19.3 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -86.41 144.34 27.36 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 117.49 -1.684 . . . . 0.0 107.868 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -113.61 -30.07 6.94 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 113.043 -1.89 . . . . 0.0 106.584 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -116.88 176.39 5.14 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 19.4 t -96.83 45.42 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 103.925 -2.621 . . . . 0.0 103.925 176.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -127.68 -46.02 0.2 Allowed Glycine 0 N--CA 1.484 1.882 0 N-CA-C 106.84 -2.504 . . . . 0.0 106.84 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.522 ' HA ' ' H ' ' A' ' 201' ' ' LEU . 25.3 m-20 -79.89 169.85 17.31 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 112.7 -1.75 . . . . 0.0 111.308 179.215 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.457 ' HG ' ' HA3' ' A' ' 200' ' ' GLY . 15.9 mt -121.07 176.73 5.43 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.427 176.272 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 47.2 m -119.62 99.46 6.67 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 114.354 -1.294 . . . . 0.0 110.994 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.444 ' N ' ' CD1' ' A' ' 173' ' ' PHE . 1.3 p90 -118.67 161.94 19.25 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.021 -1.072 . . . . 0.0 111.282 178.383 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -118.51 62.98 0.77 Allowed 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 120.047 3.351 . . . . 0.0 120.047 -175.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 70.4 tttt 37.05 76.83 0.05 OUTLIER 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 116.838 2.162 . . . . 0.0 116.838 173.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 119.1 52.4 0.29 Allowed Glycine 0 N--CA 1.495 2.595 0 CA-C-N 113.68 -1.6 . . . . 0.0 111.703 177.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -131.1 173.37 11.09 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 177.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.444 ' HA ' ' HA ' ' A' ' 158' ' ' ILE . 18.0 mm -97.16 125.06 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 C-N-CA 118.672 -1.211 . . . . 0.0 112.456 -177.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 17.9 mt -118.31 168.25 10.79 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 114.104 -1.407 . . . . 0.0 110.234 177.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 14.5 tp -118.35 157.98 26.11 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 103.826 -2.657 . . . . 0.0 103.826 177.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.515 HG21 ' CD1' ' A' ' 157' ' ' TYR . 43.7 t -120.0 128.3 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-N 120.675 1.579 . . . . 0.0 112.865 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.514 ' O ' ' HB ' ' A' ' 191' ' ' ILE . 56.3 mt -145.61 86.19 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.284 -176.069 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' GLU . . . . . 0.491 ' CB ' ' O ' ' A' ' 182' ' ' ILE . 5.0 tm-20 131.08 151.26 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.932 0 C-N-CA 127.672 2.389 . . . . 0.0 109.11 172.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' LYS . . . . . 0.499 ' HG2' ' CZ3' ' A' ' 190' ' ' TRP . 55.2 mttp -119.37 123.74 44.89 Favored 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 119.69 3.218 . . . . 0.0 119.69 -171.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.559 ' CG ' ' HE1' ' A' ' 190' ' ' TRP . 2.9 tttm -12.43 80.67 0.03 OUTLIER Pre-proline 0 N--CA 1.512 2.664 0 N-CA-C 118.515 2.783 . . . . 0.0 118.515 175.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 189' ' ' TRP . 11.4 Cg_exo -78.59 -55.23 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.527 0 N-CA-C 105.143 -2.676 . . . . 0.0 105.143 174.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.403 ' H ' ' HD2' ' A' ' 186' ' ' PRO . 4.6 p-10 -121.99 17.96 10.89 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 112.502 -2.135 . . . . 0.0 110.94 -178.167 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.504 ' HA2' ' HG2' ' A' ' 185' ' ' LYS . . . 114.02 6.81 20.27 Favored Glycine 0 N--CA 1.487 2.057 0 C-N-CA 118.846 -1.645 . . . . 0.0 109.219 -178.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' TRP . . . . . 0.488 ' O ' ' HD3' ' A' ' 186' ' ' PRO . 1.1 m-90 -121.65 147.26 46.1 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 119.829 3.27 . . . . 0.0 119.829 -177.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' TRP . . . . . 0.559 ' HE1' ' CG ' ' A' ' 185' ' ' LYS . 42.1 m95 -128.66 160.13 33.42 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 101.43 -3.545 . . . . 0.0 101.43 176.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.514 ' HB ' ' O ' ' A' ' 182' ' ' ILE . 7.7 mt -115.9 116.37 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 177.118 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -105.4 -177.46 3.37 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -171.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.458 ' HA ' ' HA ' ' A' ' 199' ' ' GLU . 3.3 ttmp? -134.83 166.7 22.37 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 175.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.406 ' H ' ' HG2' ' A' ' 193' ' ' LYS . 6.1 p-10 -119.67 -159.12 0.76 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -103.47 37.58 1.98 Allowed 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 120.114 -0.634 . . . . 0.0 110.205 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -128.8 -38.21 1.69 Allowed 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 176.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 138.9 -40.69 1.42 Allowed Glycine 0 N--CA 1.485 1.919 0 N-CA-C 109.021 -1.632 . . . . 0.0 109.021 -178.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -56.35 159.67 3.48 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 118.943 -1.103 . . . . 0.0 113.803 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 193' ' ' LYS . 0.0 OUTLIER -129.98 154.26 47.56 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 112.533 -2.121 . . . . 0.0 109.791 179.468 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 200' ' ' GLY . . . . . 0.457 ' HA3' ' HG ' ' A' ' 171' ' ' LEU . . . -135.53 -170.26 12.05 Favored Glycine 0 N--CA 1.482 1.755 0 CA-C-O 122.913 1.285 . . . . 0.0 114.094 -177.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.522 ' H ' ' HA ' ' A' ' 170' ' ' ASP . 13.2 mt -115.41 92.41 3.91 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 110.483 -2.858 . . . . 0.0 105.554 177.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 25.1 m -117.45 158.0 46.06 Favored Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 -177.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -82.86 178.63 5.86 Favored 'Trans proline' 0 C--N 1.302 -1.919 0 N-CA-C 107.945 -1.598 . . . . 0.0 107.945 179.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' ARG . . . . . 0.413 ' HB2' ' NE1' ' A' ' 190' ' ' TRP . 13.3 ttt-85 -96.82 -42.69 7.85 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 105.164 -2.162 . . . . 0.0 105.164 179.25 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 41.6 p -23.21 -46.03 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.987 0 O-C-N 126.544 2.402 . . . . 0.0 115.777 176.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -106.12 51.78 0.74 Allowed 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 119.271 -0.972 . . . . 0.0 111.898 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 73.3 mt -127.9 135.88 50.61 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 176.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -119.41 145.33 38.47 Favored Pre-proline 0 C--N 1.303 -1.422 0 N-CA-C 103.732 -2.692 . . . . 0.0 103.732 177.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -62.93 158.03 45.34 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 121.427 1.418 . . . . 0.0 108.457 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' TYR . . . . . 0.455 ' CD1' ' CG2' ' A' ' 158' ' ' ILE . 17.6 t80 -129.47 165.67 21.15 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 118.509 -1.276 . . . . 0.0 110.552 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 29.1 t -119.45 52.0 1.12 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 . . . . . 0 N--CA 1.494 1.769 0 CA-C-N 112.805 -1.998 . . . . 0.0 115.142 -179.674 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 4.1 t . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 122.713 1.244 . . . . 0.0 109.357 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -114.5 175.31 16.06 Favored Glycine 0 N--CA 1.488 2.147 0 CA-C-N 114.196 -1.365 . . . . 0.0 112.485 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -123.06 170.65 9.96 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 103.873 -2.64 . . . . 0.0 103.873 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -106.75 130.01 54.53 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 117.319 -1.752 . . . . 0.0 112.301 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.483 ' CD1' HG21 ' A' ' 181' ' ' VAL . 6.2 m-85 -122.53 178.95 4.76 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 101.756 -3.424 . . . . 0.0 101.756 177.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.452 HG22 HG13 ' A' ' 178' ' ' ILE . 6.6 pt -127.76 154.8 38.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 103.519 -2.771 . . . . 0.0 103.519 170.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -88.84 151.22 22.49 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 100.308 -3.96 . . . . 0.0 100.308 176.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 35.9 m -127.2 17.56 3.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 125.845 1.965 . . . . 0.0 107.966 178.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -130.59 159.3 22.83 Favored Glycine 0 N--CA 1.484 1.835 0 N-CA-C 105.895 -2.882 . . . . 0.0 105.895 176.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.408 ' HA ' ' HA ' ' A' ' 174' ' ' LYS . 31.0 t70 -107.3 93.05 4.34 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.026 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -106.86 156.95 18.14 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 118.645 -1.222 . . . . 0.0 108.393 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 90.8 m -120.15 162.31 19.55 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 104.677 -2.342 . . . . 0.0 104.677 179.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -88.25 139.76 30.17 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 117.412 -1.715 . . . . 0.0 106.479 178.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -112.05 -33.51 6.24 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -114.4 -178.22 3.32 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 113.428 -1.714 . . . . 0.0 106.581 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 14.4 p -94.37 40.22 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-O 124.261 1.981 . . . . 0.0 108.199 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -118.75 -53.41 0.29 Allowed Glycine 0 N--CA 1.485 1.935 0 CA-C-N 112.18 -2.282 . . . . 0.0 109.181 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.528 ' HA ' ' H ' ' A' ' 201' ' ' LEU . 1.7 m-20 -81.78 174.95 10.85 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.433 ' HG ' ' HA3' ' A' ' 200' ' ' GLY . 38.8 mt -117.28 177.66 4.65 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 111.92 -2.4 . . . . 0.0 108.202 178.217 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 42.7 m -116.58 91.48 3.6 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 114.182 -1.372 . . . . 0.0 108.004 177.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 16.8 p90 -118.07 164.57 14.93 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 114.0 -1.455 . . . . 0.0 110.497 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 162' ' ' ASP . 17.8 ptpt -126.54 142.85 51.4 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 117.638 2.459 . . . . 0.0 117.638 -179.001 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 71.3 tttt -22.25 76.25 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.726 1 CA-C-N 108.03 -4.168 . . . . 0.0 117.016 171.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 114.92 48.89 0.52 Allowed Glycine 0 N--CA 1.488 2.115 0 CA-C-N 114.225 -1.352 . . . . 0.0 112.998 175.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.415 ' O ' ' HA ' ' A' ' 158' ' ' ILE . 8.5 pt-20 -131.39 155.71 46.8 Favored 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 176.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.496 ' CD1' ' N ' ' A' ' 178' ' ' ILE . 1.1 mp -85.88 135.01 25.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -179.002 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.401 ' N ' HD22 ' A' ' 179' ' ' LEU . 2.7 mm? -124.3 170.98 10.25 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 112.819 -1.992 . . . . 0.0 105.796 175.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 16.6 tp -117.45 154.49 31.3 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 102.028 -3.323 . . . . 0.0 102.028 176.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.483 HG21 ' CD1' ' A' ' 157' ' ' TYR . 2.9 t -126.22 118.93 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 CA-C-N 120.685 1.584 . . . . 0.0 114.681 -176.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.489 ' N ' HD13 ' A' ' 182' ' ' ILE . 0.0 OUTLIER -135.78 93.13 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-O 123.886 1.803 . . . . 0.0 111.046 -177.962 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 183' ' ' GLU . . . . . 0.45 ' HG2' ' N ' ' A' ' 184' ' ' LYS . 44.1 tt0 140.1 155.8 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.584 1 CA-C-N 107.649 -4.341 . . . . 0.0 107.347 175.905 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 184' ' ' LYS . . . . . 0.45 ' N ' ' HG2' ' A' ' 183' ' ' GLU . 97.6 mttt -118.53 97.68 5.87 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 117.246 2.313 . . . . 0.0 117.246 -174.483 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.74 ' HB2' ' NE1' ' A' ' 190' ' ' TRP . 46.0 tttm -15.52 86.7 0.03 OUTLIER Pre-proline 0 N--CA 1.506 2.345 0 N-CA-C 117.095 2.258 . . . . 0.0 117.095 176.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -70.06 -58.46 0.1 OUTLIER 'Trans proline' 0 C--N 1.304 -1.776 0 N-CA-C 103.548 -3.289 . . . . 0.0 103.548 174.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -126.01 28.97 5.98 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 112.812 -1.995 . . . . 0.0 113.018 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.471 ' H ' ' HG3' ' A' ' 185' ' ' LYS . . . 115.75 12.04 9.77 Favored Glycine 0 N--CA 1.494 2.527 0 C-N-CA 119.631 -1.271 . . . . 0.0 110.378 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 3.4 m-90 -131.27 122.74 27.0 Favored 'General case' 0 N--CA 1.489 1.517 1 N-CA-C 123.336 4.569 . . . . 0.0 123.336 -178.01 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' TRP . . . . . 0.74 ' NE1' ' HB2' ' A' ' 185' ' ' LYS . 12.2 m95 -119.09 164.71 15.13 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 100.248 -3.982 . . . . 0.0 100.248 173.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 27.4 mt -115.66 119.91 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 102.185 -3.265 . . . . 0.0 102.185 176.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -112.23 177.39 4.66 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 118.259 -1.376 . . . . 0.0 113.843 -174.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -130.16 165.43 22.34 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 173.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 43.0 p-10 -122.75 -163.76 1.12 Allowed 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.258 -0.977 . . . . 0.0 110.025 177.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -98.87 40.93 1.17 Allowed 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 121.935 0.874 . . . . 0.0 108.787 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -128.56 -37.68 1.77 Allowed 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 113.556 -1.656 . . . . 0.0 107.677 177.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 133.29 -37.97 1.92 Allowed Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 19.9 p30 -64.14 165.65 8.92 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 -178.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.17 154.41 48.4 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 112.723 -2.035 . . . . 0.0 111.443 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' GLY . . . . . 0.433 ' HA3' ' HG ' ' A' ' 171' ' ' LEU . . . -135.47 -173.25 12.97 Favored Glycine 0 N--CA 1.486 2.02 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.587 -178.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.528 ' H ' ' HA ' ' A' ' 170' ' ' ASP . 9.6 mt -116.82 82.38 1.79 Allowed 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 104.636 -2.357 . . . . 0.0 104.636 178.016 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 3.2 m -107.21 156.0 38.35 Favored Pre-proline 0 N--CA 1.498 1.941 0 C-N-CA 119.02 -1.072 . . . . 0.0 109.839 -171.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -88.1 179.26 2.83 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 C-N-CA 123.08 2.52 . . . . 0.0 113.084 -177.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' ARG . . . . . 0.413 ' HB2' ' NE1' ' A' ' 190' ' ' TRP . 43.2 ttp180 -96.51 -41.84 8.37 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 103.685 -2.709 . . . . 0.0 103.685 174.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 69.8 p -23.55 -52.73 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 O-C-N 126.067 2.104 . . . . 0.0 115.718 178.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -115.49 46.17 1.54 Allowed 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 120.003 -0.679 . . . . 0.0 112.396 -178.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.43 144.55 51.3 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 114.585 -1.188 . . . . 0.0 107.961 179.124 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -128.41 154.04 79.2 Favored Pre-proline 0 N--CA 1.493 1.691 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 175.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -64.34 154.98 68.36 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 C-N-CA 121.658 1.572 . . . . 0.0 112.582 -178.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' TYR . . . . . 0.43 ' CE1' HD11 ' A' ' 178' ' ' ILE . 32.4 t80 -134.07 51.13 2.15 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 177.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 35.2 t -100.72 63.05 1.04 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 106.606 -1.628 . . . . 0.0 106.606 -178.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.302 -1.489 0 CA-C-N 112.166 -2.288 . . . . 0.0 110.733 -179.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 86.4 m . . . . . 0 N--CA 1.492 1.67 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.403 ' HA2' ' O ' ' A' ' 181' ' ' VAL . . . 108.94 -179.2 21.1 Favored Glycine 0 N--CA 1.489 2.203 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.918 179.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -115.96 167.32 11.06 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 103.298 -2.852 . . . . 0.0 103.298 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -101.96 122.15 43.5 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 117.274 -1.77 . . . . 0.0 112.407 -176.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.559 ' CD1' HG21 ' A' ' 181' ' ' VAL . 1.0 OUTLIER -126.95 169.8 12.93 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 102.613 -3.106 . . . . 0.0 102.613 176.485 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.971 HG22 HG12 ' A' ' 178' ' ' ILE . 36.7 pt -125.34 142.14 43.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 C-N-CA 118.058 -1.457 . . . . 0.0 108.524 170.077 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.462 ' O ' ' N ' ' A' ' 176' ' ' GLY . . . -72.33 152.52 42.04 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 101.631 -3.47 . . . . 0.0 101.631 178.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 26.8 m -118.47 -4.12 10.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 125.892 1.995 . . . . 0.0 108.521 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -137.16 177.01 20.13 Favored Glycine 0 N--CA 1.485 1.962 0 N-CA-C 107.363 -2.295 . . . . 0.0 107.363 178.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.408 ' HA ' ' HA ' ' A' ' 174' ' ' LYS . 8.5 t70 -106.51 132.2 52.8 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 118.857 -1.137 . . . . 0.0 109.205 178.49 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.421 ' HB3' ' CZ ' ' A' ' 173' ' ' PHE . 60.8 t80 -123.29 153.37 40.31 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 176.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 67.9 m -126.77 156.35 41.36 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -95.79 138.49 33.36 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 178.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 23.6 mm100 -111.82 -34.88 5.88 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 88.0 mm-40 -117.45 -176.01 2.93 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 113.314 -1.767 . . . . 0.0 106.328 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 61.9 t -87.62 154.94 3.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 104.224 -2.51 . . . . 0.0 104.224 178.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 113.28 -48.2 0.96 Allowed Glycine 0 N--CA 1.485 1.948 0 N-CA-C 107.905 -2.078 . . . . 0.0 107.905 -178.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.611 ' HA ' ' H ' ' A' ' 201' ' ' LEU . 3.4 m-20 -83.91 167.42 17.0 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 113.731 -1.235 . . . . 0.0 113.785 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.462 ' CD2' HD22 ' A' ' 198' ' ' ASN . 19.3 mt -121.22 173.68 7.16 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 114.128 -1.396 . . . . 0.0 109.624 178.34 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 55.0 m -123.94 93.76 4.02 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 114.355 -1.293 . . . . 0.0 110.128 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.425 ' CD1' ' N ' ' A' ' 173' ' ' PHE . 20.1 p90 -126.6 167.92 15.01 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.862 -178.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 162' ' ' ASP . 63.7 pttt -118.27 165.93 13.23 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 123.504 1.621 . . . . 0.0 114.338 177.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 52.2 tttm -39.02 154.37 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 110.534 -3.03 . . . . 0.0 117.081 175.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 159' ' ' ALA . . . 33.14 48.75 0.42 Allowed Glycine 0 N--CA 1.493 2.454 0 CA-C-N 112.095 -2.321 . . . . 0.0 111.02 177.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' A' ' 158' ' ' ILE . 5.4 pt-20 -121.39 162.68 19.96 Favored 'General case' 0 N--CA 1.506 2.348 0 CA-C-N 111.722 -2.239 . . . . 0.0 108.372 176.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.971 HG12 HG22 ' A' ' 158' ' ' ILE . 44.7 mt -99.53 120.41 48.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 N-CA-C 118.69 2.848 . . . . 0.0 118.69 -176.119 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 21.4 mt -118.72 168.59 10.59 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 110.992 -2.822 . . . . 0.0 108.854 178.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.401 HD13 ' HA ' ' A' ' 180' ' ' LEU . 4.1 mm? -110.74 158.5 18.58 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 177.302 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.559 HG21 ' CD1' ' A' ' 157' ' ' TYR . 50.5 t -119.38 117.81 55.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 C-N-CA 119.65 -0.82 . . . . 0.0 112.975 -178.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.605 ' O ' ' HB ' ' A' ' 191' ' ' ILE . 3.4 mp -139.55 83.31 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.203 -1.35 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.292 -174.232 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' GLU . . . . . 0.49 ' HB3' ' H ' ' A' ' 191' ' ' ILE . 35.8 tt0 136.14 150.59 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.764 0 C-N-CA 127.931 2.493 . . . . 0.0 107.897 173.469 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' LYS . . . . . 0.414 ' N ' ' HG2' ' A' ' 183' ' ' GLU . 67.0 mttm -115.94 124.55 50.85 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 -176.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.481 ' CG ' ' HE1' ' A' ' 190' ' ' TRP . 3.6 tttm -10.7 77.4 0.03 OUTLIER Pre-proline 0 N--CA 1.504 2.261 0 O-C-N 126.658 2.473 . . . . 0.0 116.912 177.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -69.39 -57.04 0.13 Allowed 'Trans proline' 0 C--N 1.307 -1.615 0 N-CA-C 105.306 -2.613 . . . . 0.0 105.306 175.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -122.44 17.38 10.53 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 111.406 -2.634 . . . . 0.0 113.176 -177.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.412 ' HA2' ' NZ ' ' A' ' 185' ' ' LYS . . . 121.19 -25.7 6.96 Favored Glycine 0 N--CA 1.489 2.173 0 C-N-CA 118.359 -1.877 . . . . 0.0 110.596 -178.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 31.3 m-90 -114.84 153.42 30.47 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 122.826 1.298 . . . . 0.0 113.925 -176.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' TRP . . . . . 0.481 ' HE1' ' CG ' ' A' ' 185' ' ' LYS . 16.7 m95 -115.9 168.58 9.93 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 100.266 -3.976 . . . . 0.0 100.266 -178.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.605 ' HB ' ' O ' ' A' ' 182' ' ' ILE . 2.1 mm -111.0 109.98 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 103.367 -2.827 . . . . 0.0 103.367 -179.298 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -106.26 179.99 4.11 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -172.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 199' ' ' GLU . 36.6 ttpt -139.97 163.24 33.2 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 118.748 -1.181 . . . . 0.0 109.549 177.233 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -121.19 -165.91 1.29 Allowed 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.885 178.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -106.15 40.44 1.59 Allowed 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.897 0.856 . . . . 0.0 109.603 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -118.53 -42.54 2.75 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 177.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 141.94 -48.27 0.8 Allowed Glycine 0 N--CA 1.482 1.718 0 N-CA-C 106.005 -2.838 . . . . 0.0 106.005 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ASN . . . . . 0.462 HD22 ' CD2' ' A' ' 171' ' ' LEU . 0.8 OUTLIER -55.15 154.01 6.16 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 179.345 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.49 ' HA ' ' HA ' ' A' ' 193' ' ' LYS . 0.0 OUTLIER -129.17 154.35 46.83 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 112.73 -2.032 . . . . 0.0 107.777 178.13 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 200' ' ' GLY . . . . . 0.446 ' O ' ' HA ' ' A' ' 191' ' ' ILE . . . -136.03 -161.04 9.04 Favored Glycine 0 N--CA 1.479 1.514 0 C-N-CA 120.009 -1.091 . . . . 0.0 113.161 -176.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.611 ' H ' ' HA ' ' A' ' 170' ' ' ASP . 36.2 mt -118.67 94.08 4.34 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 110.497 -2.852 . . . . 0.0 105.727 179.162 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 5.3 m -112.81 150.54 42.95 Favored Pre-proline 0 N--CA 1.498 1.932 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 -177.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -75.3 175.35 11.38 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 C-N-CA 121.174 1.25 . . . . 0.0 109.761 -177.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.4 -40.63 8.19 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 103.562 -2.755 . . . . 0.0 103.562 178.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 76.7 p -28.87 -50.97 0.09 Allowed 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 113.3 -1.773 . . . . 0.0 114.602 175.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -113.62 39.12 2.73 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.569 0.7 . . . . 0.0 112.331 -178.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.91 98.56 5.57 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 104.937 -2.246 . . . . 0.0 104.937 178.08 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -106.62 148.33 36.62 Favored Pre-proline 0 C--N 1.299 -1.621 0 N-CA-C 104.039 -2.578 . . . . 0.0 104.039 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -53.57 165.81 1.52 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.489 2.126 . . . . 0.0 113.18 -177.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' TYR . . . . . 0.474 ' CE1' HD11 ' A' ' 178' ' ' ILE . 45.4 t80 -116.7 -99.27 0.44 Allowed 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.734 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 211' ' ' SER . . . . . 0.412 ' N ' ' CG ' ' A' ' 210' ' ' TYR . 46.6 m -125.69 -52.22 1.58 Allowed 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 123.872 1.796 . . . . 0.0 108.299 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 . . . . . 0 C--N 1.292 -1.922 0 CA-C-N 109.537 -3.483 . . . . 0.0 110.668 -179.429 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 25.7 p . . . . . 0 N--CA 1.488 1.472 0 CA-C-O 121.209 0.528 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.403 ' HA2' ' O ' ' A' ' 181' ' ' VAL . . . 110.39 170.19 19.69 Favored Glycine 0 N--CA 1.49 2.29 0 CA-C-N 114.973 -1.012 . . . . 0.0 114.681 177.264 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -128.82 159.5 35.54 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 103.965 -2.606 . . . . 0.0 103.965 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -105.63 134.4 48.8 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 115.968 -2.293 . . . . 0.0 112.967 -177.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.504 ' CD1' HG21 ' A' ' 181' ' ' VAL . 7.1 m-85 -115.49 -178.41 3.38 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 101.397 -3.557 . . . . 0.0 101.397 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.492 ' HA ' ' O ' ' A' ' 177' ' ' GLU . 0.1 OUTLIER -126.11 152.72 33.68 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 N-CA-C 100.504 -3.887 . . . . 0.0 100.504 175.15 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -91.88 148.64 22.07 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 102.824 -3.028 . . . . 0.0 102.824 178.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 32.7 m -126.6 9.46 3.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 125.128 1.518 . . . . 0.0 108.773 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -130.03 161.83 23.03 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 104.989 -3.244 . . . . 0.0 104.989 176.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.428 ' HA ' ' HA ' ' A' ' 174' ' ' LYS . 9.9 t70 -109.3 97.54 7.12 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 118.95 -1.1 . . . . 0.0 109.107 178.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.4 ' HB3' ' CZ ' ' A' ' 173' ' ' PHE . 13.7 t80 -104.3 155.1 19.04 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 118.361 -1.336 . . . . 0.0 107.628 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 88.3 m -123.21 165.24 17.24 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 103.862 -2.644 . . . . 0.0 103.862 179.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -91.63 145.25 24.74 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 117.653 -1.619 . . . . 0.0 108.452 179.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -113.7 -38.53 4.26 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -121.45 158.99 27.18 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 113.456 -1.702 . . . . 0.0 106.539 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 83.3 t -41.47 -57.68 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 125.099 1.499 . . . . 0.0 107.472 176.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -27.19 -56.22 0.1 OUTLIER Glycine 0 N--CA 1.486 2.025 0 CA-C-N 112.431 -2.168 . . . . 0.0 114.055 175.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.543 ' HA ' ' H ' ' A' ' 201' ' ' LEU . 18.2 m-20 -75.68 161.83 28.75 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -177.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.478 HD13 ' CA ' ' A' ' 200' ' ' GLY . 1.5 tp -116.88 -178.58 3.47 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 112.966 -1.925 . . . . 0.0 109.424 177.1 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 33.7 m -129.24 98.63 4.95 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 112.394 -2.185 . . . . 0.0 111.805 -178.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.4 ' CZ ' ' HB3' ' A' ' 163' ' ' PHE . 25.1 p90 -122.17 167.44 13.18 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.785 178.38 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 162' ' ' ASP . 18.8 ptpt -121.53 144.11 48.9 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 116.732 2.123 . . . . 0.0 116.732 179.035 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -35.07 80.66 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 108.529 -3.941 . . . . 0.0 114.426 172.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 111.33 50.16 0.63 Allowed Glycine 0 N--CA 1.49 2.293 0 CA-C-N 114.726 -1.125 . . . . 0.0 112.125 178.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.492 ' O ' ' HA ' ' A' ' 158' ' ' ILE . 5.9 pt-20 -126.91 -172.66 2.69 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 177.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 14.4 mm -109.26 137.54 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 123.992 0.807 . . . . 0.0 111.139 177.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 54.2 mt -128.92 169.12 15.01 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 113.588 -1.642 . . . . 0.0 110.008 178.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.63 ' HB2' ' HB2' ' A' ' 193' ' ' LYS . 6.9 mt -121.74 157.82 30.14 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 174.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.504 HG21 ' CD1' ' A' ' 157' ' ' TYR . 92.6 t -119.14 117.48 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 116.714 2.116 . . . . 0.0 116.714 -178.421 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.507 ' O ' ' HB ' ' A' ' 191' ' ' ILE . 1.7 mm -123.63 70.79 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 105.472 -2.048 . . . . 0.0 105.472 178.075 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' A' ' 182' ' ' ILE . 10.8 tp10 125.35 141.53 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.296 0 C-N-CA 128.853 2.861 . . . . 0.0 109.756 177.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -120.14 113.54 20.61 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 177.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.634 ' HB2' ' CA ' ' A' ' 188' ' ' GLY . 0.0 OUTLIER -14.37 75.75 0.02 OUTLIER Pre-proline 0 N--CA 1.495 1.781 0 N-CA-C 121.383 3.846 . . . . 0.0 121.383 -171.503 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.449 ' HD2' ' HA ' ' A' ' 185' ' ' LYS . 9.9 Cg_endo -43.65 -58.81 1.25 Allowed 'Trans proline' 0 C--N 1.314 -1.289 0 C-N-CA 123.647 2.898 . . . . 0.0 106.221 171.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -124.98 23.17 7.87 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 111.761 -2.472 . . . . 0.0 111.645 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.634 ' CA ' ' HB2' ' A' ' 185' ' ' LYS . . . 113.53 2.16 24.39 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' TRP . . . . . 0.428 ' O ' ' HD2' ' A' ' 186' ' ' PRO . 3.9 m-90 -126.33 119.74 28.11 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 119.621 3.193 . . . . 0.0 119.621 -176.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' TRP . . . . . 0.55 ' CD1' ' HB3' ' A' ' 185' ' ' LYS . 5.7 m0 -103.21 150.61 23.53 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 104.084 -2.562 . . . . 0.0 104.084 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.507 ' HB ' ' O ' ' A' ' 182' ' ' ILE . 8.0 mm -113.76 102.19 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 100.341 -3.948 . . . . 0.0 100.341 177.5 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -106.06 169.4 8.52 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 118.174 -1.411 . . . . 0.0 112.614 -171.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.63 ' HB2' ' HB2' ' A' ' 180' ' ' LEU . 93.7 mttt -117.86 161.93 18.94 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 104.117 -2.549 . . . . 0.0 104.117 176.513 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -126.35 -162.63 1.15 Allowed 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 118.557 -1.257 . . . . 0.0 110.474 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -98.96 40.85 1.17 Allowed 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.692 -0.803 . . . . 0.0 109.773 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -128.56 -40.75 1.56 Allowed 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 176.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 140.28 -47.39 0.88 Allowed Glycine 0 N--CA 1.487 2.099 0 N-CA-C 107.348 -2.301 . . . . 0.0 107.348 178.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -57.26 161.31 3.34 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 114.965 1.468 . . . . 0.0 114.965 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.448 ' HG3' ' N ' ' A' ' 200' ' ' GLY . 0.0 OUTLIER -130.55 151.42 51.04 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 113.598 -1.637 . . . . 0.0 108.464 176.772 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 200' ' ' GLY . . . . . 0.478 ' CA ' HD13 ' A' ' 171' ' ' LEU . . . -139.64 -157.05 7.14 Favored Glycine 0 N--CA 1.484 1.877 0 C-N-CA 119.333 -1.413 . . . . 0.0 113.399 -178.04 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.543 ' H ' ' HA ' ' A' ' 170' ' ' ASP . 42.4 mt -112.34 96.15 5.85 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 111.133 -2.533 . . . . 0.0 108.708 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 3.7 m -112.26 154.46 44.41 Favored Pre-proline 0 N--CA 1.49 1.525 0 N-CA-C 105.777 -1.934 . . . . 0.0 105.777 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 0.4 OUTLIER -88.4 -178.24 2.01 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 C-N-CA 123.721 2.947 . . . . 0.0 112.346 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' ARG . . . . . 0.55 ' HB2' ' CD ' ' A' ' 185' ' ' LYS . 24.8 ttt85 -74.29 -59.65 2.63 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 173.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 69.5 p -18.37 -48.55 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.134 0 CA-C-N 109.876 -3.329 . . . . 0.0 117.187 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -110.45 38.32 2.49 Favored 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 119.192 -1.003 . . . . 0.0 112.243 -178.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -123.53 104.98 9.38 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 124.238 0.961 . . . . 0.0 111.427 -178.325 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -112.61 155.04 44.46 Favored Pre-proline 0 N--CA 1.496 1.853 0 C-N-CA 117.891 -1.524 . . . . 0.0 107.021 175.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -64.19 164.21 23.43 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 121.809 1.672 . . . . 0.0 111.963 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -123.39 -178.81 4.11 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 79.1 p -118.8 32.57 6.06 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.587 -0.845 . . . . 0.0 112.253 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 115.045 -2.407 . . . . 0.0 107.212 176.842 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.483 HG22 ' H ' ' A' ' 154' ' ' GLY . 37.2 m . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.483 ' H ' HG22 ' A' ' 153' ' ' THR . . . -113.49 -178.66 19.36 Favored Glycine 0 N--CA 1.488 2.113 0 C-N-CA 120.561 -0.828 . . . . 0.0 113.616 -179.073 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -130.79 170.98 13.64 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.531 ' CD ' ' H ' ' A' ' 156' ' ' GLU . 0.0 OUTLIER -110.79 123.83 50.84 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 116.972 -1.891 . . . . 0.0 112.969 -178.001 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.52 ' CD1' HG21 ' A' ' 181' ' ' VAL . 5.9 m-85 -119.18 178.11 4.64 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 102.649 -3.093 . . . . 0.0 102.649 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.504 HG22 HG13 ' A' ' 178' ' ' ILE . 2.9 pt -128.28 145.48 35.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 102.409 -3.182 . . . . 0.0 102.409 172.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -92.26 151.55 20.27 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 115.011 -2.676 . . . . 0.0 103.876 177.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 28.0 m -127.67 32.81 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 125.838 1.961 . . . . 0.0 108.23 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -129.96 158.03 22.14 Favored Glycine 0 N--CA 1.483 1.824 0 N-CA-C 105.762 -2.935 . . . . 0.0 105.762 173.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -106.06 76.14 1.15 Allowed 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -102.21 148.53 25.32 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 118.463 -1.295 . . . . 0.0 108.428 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 87.5 m -120.21 161.49 20.98 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 104.461 -2.422 . . . . 0.0 104.461 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -93.17 135.77 34.05 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 105.744 -1.946 . . . . 0.0 105.744 178.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -110.65 -31.34 7.25 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 -115.71 -178.88 3.49 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 105.091 -2.189 . . . . 0.0 105.091 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 61.8 t -89.94 152.47 3.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 103.317 -2.846 . . . . 0.0 103.317 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 114.54 -47.86 1.0 Allowed Glycine 0 N--CA 1.486 2.02 0 N-CA-C 108.503 -1.839 . . . . 0.0 108.503 -177.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.489 ' HA ' ' H ' ' A' ' 201' ' ' LEU . 26.4 m-20 -82.2 168.7 17.4 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 113.964 -1.118 . . . . 0.0 112.622 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.441 HD11 ' C ' ' A' ' 199' ' ' GLU . 41.8 mt -127.66 178.7 5.95 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.842 176.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 57.3 m -122.13 102.57 8.22 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 114.453 -1.248 . . . . 0.0 113.316 -178.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -118.92 167.96 11.23 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.315 -0.954 . . . . 0.0 111.522 177.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -114.99 62.21 0.68 Allowed 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 121.019 3.711 . . . . 0.0 121.019 -175.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.439 ' O ' ' HG3' ' A' ' 175' ' ' LYS . 15.6 tptm 41.02 74.12 0.11 Allowed 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 117.102 2.26 . . . . 0.0 117.102 174.323 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 116.53 50.99 0.4 Allowed Glycine 0 N--CA 1.495 2.609 0 CA-C-N 114.412 -1.267 . . . . 0.0 113.822 173.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.474 ' N ' ' CD ' ' A' ' 177' ' ' GLU . 0.2 OUTLIER -139.92 163.45 32.63 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 177.837 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.504 HG13 HG22 ' A' ' 158' ' ' ILE . 1.0 OUTLIER -87.99 134.01 29.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 116.361 1.986 . . . . 0.0 116.361 -176.376 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.5 mp -131.42 175.62 8.98 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 112.671 -2.059 . . . . 0.0 108.076 174.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.472 HD13 ' H ' ' A' ' 181' ' ' VAL . 0.5 OUTLIER -112.92 156.18 23.44 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 102.713 -3.069 . . . . 0.0 102.713 -179.449 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.52 HG21 ' CD1' ' A' ' 157' ' ' TYR . 2.8 t -127.15 135.74 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 CA-C-N 120.924 1.693 . . . . 0.0 109.906 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.464 ' O ' ' HB ' ' A' ' 191' ' ' ILE . 4.3 mt -143.49 84.13 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -174.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' GLU . . . . . 0.446 ' CB ' ' O ' ' A' ' 182' ' ' ILE . 34.2 tt0 142.32 154.13 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.54 0 C-N-CA 126.446 1.898 . . . . 0.0 108.594 176.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' LYS . . . . . 0.442 ' N ' ' HG2' ' A' ' 183' ' ' GLU . 97.9 mttt -121.34 116.95 25.77 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 115.256 1.576 . . . . 0.0 115.256 -178.058 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.481 ' HB2' ' NE1' ' A' ' 190' ' ' TRP . 9.3 tttm -7.27 81.18 0.03 OUTLIER Pre-proline 0 N--CA 1.5 2.071 0 CA-C-N 111.757 -2.474 . . . . 0.0 117.378 175.367 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.468 ' HD2' ' H ' ' A' ' 189' ' ' TRP . 97.1 Cg_endo -78.66 -52.83 0.06 OUTLIER 'Trans proline' 0 C--N 1.302 -1.877 0 C-N-CA 122.797 2.331 . . . . 0.0 106.805 175.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -126.79 14.07 7.45 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.244 -1.343 . . . . 0.0 109.085 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.432 ' HA2' ' HG2' ' A' ' 185' ' ' LYS . . . 118.18 7.49 11.26 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 -178.297 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' TRP . . . . . 0.468 ' H ' ' HD2' ' A' ' 186' ' ' PRO . 1.4 m-90 -122.54 142.13 50.94 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 119.767 3.247 . . . . 0.0 119.767 -179.003 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' TRP . . . . . 0.514 ' NE1' ' HB2' ' A' ' 204' ' ' ARG . 22.7 m95 -124.7 157.7 34.99 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 100.412 -3.921 . . . . 0.0 100.412 177.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.464 ' HB ' ' O ' ' A' ' 182' ' ' ILE . 31.2 mm -97.99 171.06 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.866 1 N-CA-C 99.845 -4.131 . . . . 0.0 99.845 176.671 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 192' ' ' ALA . . . . . 0.436 ' O ' ' HA ' ' A' ' 199' ' ' GLU . . . -152.95 176.17 12.14 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 116.683 -2.007 . . . . 0.0 109.893 177.442 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -134.02 159.58 40.36 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 170.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 58.4 p30 -120.12 -162.78 0.95 Allowed 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 118.594 -1.242 . . . . 0.0 111.426 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -99.54 39.44 1.31 Allowed 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.086 -1.046 . . . . 0.0 109.692 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -121.38 -39.35 2.68 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 176.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 126.98 -1.79 7.29 Favored Glycine 0 N--CA 1.492 2.402 0 CA-C-N 114.803 -1.09 . . . . 0.0 111.224 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 26.3 p30 -100.7 176.68 5.23 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.441 ' C ' HD11 ' A' ' 171' ' ' LEU . 1.5 pt-20 -113.28 166.57 11.34 Favored 'General case' 0 N--CA 1.484 1.27 0 O-C-N 125.859 1.974 . . . . 0.0 109.332 -179.156 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' GLY . . . . . 0.415 ' CA ' ' HG ' ' A' ' 171' ' ' LEU . . . -144.58 -178.46 20.25 Favored Glycine 0 N--CA 1.481 1.698 0 CA-C-O 122.389 0.994 . . . . 0.0 113.428 -175.152 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.489 ' H ' ' HA ' ' A' ' 170' ' ' ASP . 15.4 mt -125.26 89.18 3.01 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 177.089 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 3.9 m -111.7 157.16 40.18 Favored Pre-proline 0 N--CA 1.487 1.409 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 -175.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -90.08 179.57 1.98 Allowed 'Trans proline' 0 C--N 1.3 -2.014 0 C-N-CA 122.103 1.869 . . . . 0.0 109.405 178.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' ARG . . . . . 0.514 ' HB2' ' NE1' ' A' ' 190' ' ' TRP . 10.8 tpt180 -97.54 -43.23 7.33 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 176.433 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.442 ' HG1' ' HD1' ' A' ' 206' ' ' TYR . 43.0 p -25.56 -51.31 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 126.231 2.207 . . . . 0.0 114.731 177.257 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 206' ' ' TYR . . . . . 0.442 ' HD1' ' HG1' ' A' ' 205' ' ' THR . 85.7 m-85 -113.88 50.43 0.92 Allowed 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 119.778 -0.769 . . . . 0.0 111.781 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -133.5 135.95 44.77 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 177.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -125.39 154.67 72.32 Favored Pre-proline 0 N--CA 1.489 1.516 0 N-CA-C 105.785 -1.932 . . . . 0.0 105.785 176.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -67.2 165.97 24.83 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 N-CA-C 108.617 -1.34 . . . . 0.0 108.617 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' TYR . . . . . 0.41 ' CE1' HD11 ' A' ' 178' ' ' ILE . 34.5 t80 -123.18 -179.73 4.4 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 179.043 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 65.5 p -110.43 44.72 1.21 Allowed 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.833 -0.747 . . . . 0.0 111.096 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 114.825 -2.512 . . . . 0.0 107.248 177.589 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 75.1 m . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 47.57 -174.28 0.02 OUTLIER Glycine 0 N--CA 1.493 2.496 0 N-CA-C 116.102 1.201 . . . . 0.0 116.102 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.424 ' CD ' ' N ' ' A' ' 155' ' ' GLU . 1.4 pm0 -131.36 169.86 15.43 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 106.02 -1.845 . . . . 0.0 106.02 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -121.78 142.16 50.49 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 117.502 -1.679 . . . . 0.0 114.937 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -128.93 -178.91 4.82 Favored 'General case' 0 C--N 1.301 -1.516 1 N-CA-C 99.664 -4.199 . . . . 0.0 99.664 177.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.508 HG22 HG13 ' A' ' 178' ' ' ILE . 4.2 pt -130.54 152.87 38.18 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 101.647 -3.464 . . . . 0.0 101.647 170.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -91.5 156.2 17.86 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 104.325 -2.472 . . . . 0.0 104.325 179.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 20.3 m -125.33 8.61 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 126.045 2.091 . . . . 0.0 107.916 176.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -132.97 168.7 22.83 Favored Glycine 0 N--CA 1.483 1.83 0 N-CA-C 105.746 -2.942 . . . . 0.0 105.746 175.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -107.06 146.6 31.0 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 177.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -124.8 160.53 28.5 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 104.805 -2.295 . . . . 0.0 104.805 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 96.4 m -129.45 151.48 50.03 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 118.864 -1.134 . . . . 0.0 108.333 178.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -98.51 138.67 35.39 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 118.296 -1.362 . . . . 0.0 108.01 178.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 25.1 mm100 -114.42 -32.58 5.88 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 113.213 -1.812 . . . . 0.0 106.708 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -112.9 179.85 3.85 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 114.144 -1.389 . . . . 0.0 107.86 -179.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 16.3 t -95.45 47.21 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -128.76 -53.53 0.11 Allowed Glycine 0 N--CA 1.485 1.944 0 N-CA-C 108.331 -1.907 . . . . 0.0 108.331 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -76.48 163.47 26.9 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 113.542 -1.329 . . . . 0.0 113.788 -178.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.449 HD13 ' HA3' ' A' ' 200' ' ' GLY . 1.1 tp -108.51 -171.61 1.89 Allowed 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 111.954 -2.384 . . . . 0.0 109.078 175.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 53.6 m -120.88 -69.24 0.85 Allowed 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 113.736 -1.575 . . . . 0.0 114.335 -177.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 54.2 p90 37.52 164.33 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.527 0 N-CA-C 117.12 2.267 . . . . 0.0 117.12 -174.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -130.16 151.83 50.26 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 118.391 2.737 . . . . 0.0 118.391 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -21.28 80.41 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.568 1 CA-C-N 108.342 -4.026 . . . . 0.0 118.057 171.174 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 110.04 47.99 0.8 Allowed Glycine 0 N--CA 1.493 2.473 0 CA-C-N 114.728 -1.124 . . . . 0.0 112.878 174.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -135.84 154.91 51.03 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 117.309 -1.757 . . . . 0.0 108.045 177.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.508 HG13 HG22 ' A' ' 158' ' ' ILE . 1.1 mp -80.6 130.94 35.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -178.231 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 27.7 mt -120.15 162.59 19.07 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 113.129 -1.851 . . . . 0.0 108.222 176.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.529 HD13 ' N ' ' A' ' 181' ' ' VAL . 1.6 tm? -116.06 151.38 35.65 Favored 'General case' 0 N--CA 1.498 1.93 1 N-CA-C 100.105 -4.035 . . . . 0.0 100.105 179.345 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.529 ' N ' HD13 ' A' ' 180' ' ' LEU . 2.4 t -121.05 139.12 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 CA-C-N 122.041 2.2 . . . . 0.0 111.074 -179.175 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.484 ' O ' ' HB ' ' A' ' 191' ' ' ILE . 42.9 mt -145.0 87.09 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-O 121.105 0.479 . . . . 0.0 111.004 -176.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' GLU . . . . . 0.485 ' O ' ' CE3' ' A' ' 190' ' ' TRP . 0.0 OUTLIER 135.96 148.7 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.586 0 C-N-CA 128.359 2.664 . . . . 0.0 107.084 172.59 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -106.24 117.45 34.06 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 118.276 2.695 . . . . 0.0 118.276 -172.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.544 ' HE2' ' HE1' ' A' ' 190' ' ' TRP . 0.8 OUTLIER -11.97 81.38 0.03 OUTLIER Pre-proline 0 N--CA 1.507 2.389 0 N-CA-C 118.124 2.639 . . . . 0.0 118.124 175.24 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -73.06 -56.23 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 123.549 2.833 . . . . 0.0 105.684 175.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 21.3 p-10 -120.97 16.34 11.69 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 112.08 -2.327 . . . . 0.0 113.877 -177.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.491 ' CA ' ' HG2' ' A' ' 185' ' ' LYS . . . 118.09 -15.81 12.1 Favored Glycine 0 N--CA 1.493 2.465 0 C-N-CA 118.712 -1.709 . . . . 0.0 109.002 -178.037 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 13.5 m-90 -116.61 149.39 39.77 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 116.761 2.134 . . . . 0.0 116.761 -176.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' TRP . . . . . 0.544 ' HE1' ' HE2' ' A' ' 185' ' ' LYS . 20.0 m95 -122.88 169.15 11.41 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 102.396 -3.187 . . . . 0.0 102.396 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.484 ' HB ' ' O ' ' A' ' 182' ' ' ILE . 2.5 mp -113.95 103.58 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 104.652 -2.351 . . . . 0.0 104.652 175.044 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' ALA . . . . . 0.437 ' HB1' ' O ' ' A' ' 180' ' ' LEU . . . -94.34 178.35 5.65 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -173.137 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -124.91 158.58 33.2 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 103.273 -2.862 . . . . 0.0 103.273 175.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 51.6 p-10 -124.69 -167.1 1.61 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.279 -0.968 . . . . 0.0 111.148 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -99.09 43.14 1.07 Allowed 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 122.123 0.963 . . . . 0.0 108.47 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 4.8 tmtm? -126.05 -45.11 1.73 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 104.204 -2.517 . . . . 0.0 104.204 177.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 137.91 -40.17 1.51 Allowed Glycine 0 N--CA 1.485 1.925 0 N-CA-C 108.109 -1.996 . . . . 0.0 108.109 -178.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -69.98 164.15 24.53 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 118.795 -1.162 . . . . 0.0 113.626 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.439 ' C ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -137.36 157.68 46.06 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 112.9 -1.955 . . . . 0.0 109.238 -179.915 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 200' ' ' GLY . . . . . 0.449 ' HA3' HD13 ' A' ' 171' ' ' LEU . . . 179.58 -173.76 45.54 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 118.248 -1.929 . . . . 0.0 112.418 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 59.2 mt -71.63 96.25 1.54 Allowed 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -176.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 3.2 m -119.54 153.96 54.27 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 103.641 -2.726 . . . . 0.0 103.641 177.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -87.12 174.72 5.2 Favored 'Trans proline' 0 C--N 1.301 -1.945 0 C-N-CA 121.804 1.669 . . . . 0.0 109.197 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 28.9 ttt180 -106.16 -22.81 12.76 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 177.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 53.9 p -34.37 -50.18 0.41 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 113.91 -1.495 . . . . 0.0 114.368 173.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -105.38 34.3 3.31 Favored 'General case' 0 N--CA 1.503 2.198 0 C-N-CA 118.354 -1.338 . . . . 0.0 111.681 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 3.2 mp -119.42 118.78 32.05 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 124.817 1.323 . . . . 0.0 110.65 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' GLU . . . . . 0.412 ' N ' ' CD ' ' A' ' 208' ' ' GLU . 43.6 mp0 -115.57 150.74 45.21 Favored Pre-proline 0 C--N 1.297 -1.712 0 N-CA-C 105.982 -1.858 . . . . 0.0 105.982 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -55.16 164.43 3.68 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.292 1.995 . . . . 0.0 113.308 -177.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' TYR . . . . . 0.471 ' CG ' ' N ' ' A' ' 211' ' ' SER . 43.3 t80 -118.78 -178.72 3.61 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 179.13 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 211' ' ' SER . . . . . 0.471 ' N ' ' CG ' ' A' ' 210' ' ' TYR . 77.6 p -101.58 33.87 2.81 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 178.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 115.312 -2.28 . . . . 0.0 115.088 178.045 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 43.4 p . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -120.73 -179.19 16.18 Favored Glycine 0 N--CA 1.487 2.061 0 CA-C-N 114.514 -1.221 . . . . 0.0 113.549 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -128.9 165.18 21.54 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 104.053 -2.573 . . . . 0.0 104.053 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -107.76 135.59 48.92 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 116.92 -1.912 . . . . 0.0 111.081 -178.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.463 ' CD1' HG21 ' A' ' 181' ' ' VAL . 28.2 m-85 -132.6 176.24 8.62 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 109.503 -3.499 . . . . 0.0 105.285 179.509 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.449 ' HA ' ' O ' ' A' ' 177' ' ' GLU . 0.4 OUTLIER -126.31 143.05 41.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 1 N-CA-C 99.572 -4.232 . . . . 0.0 99.572 172.273 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -93.1 151.96 19.55 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 115.983 -2.287 . . . . 0.0 105.311 178.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 35.6 m -127.81 24.3 2.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 125.39 1.681 . . . . 0.0 109.054 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -123.55 153.6 17.26 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 106.697 -2.561 . . . . 0.0 106.697 177.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -105.66 82.53 1.81 Allowed 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 120.069 -0.652 . . . . 0.0 109.834 -179.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -108.68 151.88 25.57 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 118.879 -1.129 . . . . 0.0 108.54 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 53.7 m -122.07 159.86 26.21 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -89.15 133.25 34.47 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 178.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -109.83 -29.23 8.39 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 26.8 pt20 -117.64 -176.31 3.0 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 178.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 9.9 p -91.3 157.02 2.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 177.196 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 111.44 -50.44 0.77 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 -178.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -79.38 169.65 17.76 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 113.806 -1.197 . . . . 0.0 112.116 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 66.4 mt -126.02 178.22 5.89 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 114.223 -1.353 . . . . 0.0 109.744 177.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 53.5 m -120.48 99.28 6.47 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 114.484 -1.235 . . . . 0.0 112.179 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -115.65 165.87 12.56 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 118.82 -1.152 . . . . 0.0 110.172 177.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? -121.13 57.37 1.0 Allowed 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 121.22 3.785 . . . . 0.0 121.22 -174.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 70.9 tttt 46.67 76.78 0.09 Allowed 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 116.554 2.057 . . . . 0.0 116.554 174.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 117.28 52.27 0.34 Allowed Glycine 0 N--CA 1.495 2.632 0 CA-C-N 114.15 -1.386 . . . . 0.0 111.743 175.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.451 ' N ' ' CD ' ' A' ' 177' ' ' GLU . 2.8 pm0 -131.88 -179.12 5.21 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 178.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 7.0 mm -112.58 120.06 61.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 124.513 1.133 . . . . 0.0 113.885 -175.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.452 HD22 ' N ' ' A' ' 179' ' ' LEU . 2.0 mm? -123.72 170.3 10.64 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.304 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 16.6 tp -111.12 156.24 21.65 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 100.586 -3.857 . . . . 0.0 100.586 175.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.506 ' CG1' ' HB3' ' A' ' 190' ' ' TRP . 2.4 t -126.66 140.33 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 CA-C-N 120.42 1.463 . . . . 0.0 109.243 -178.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.474 ' O ' ' HB ' ' A' ' 191' ' ' ILE . 21.3 mt -143.57 78.07 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 120.251 -0.579 . . . . 0.0 110.779 -174.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' GLU . . . . . 0.52 ' O ' ' CE3' ' A' ' 190' ' ' TRP . 31.4 tt0 139.85 150.02 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.708 0 C-N-CA 127.005 2.122 . . . . 0.0 108.576 177.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' LYS . . . . . 0.441 ' NZ ' ' HB3' ' A' ' 184' ' ' LYS . 8.1 mtpm? -114.15 100.87 8.7 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -176.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.503 ' HA ' ' HD2' ' A' ' 186' ' ' PRO . 19.9 pttp -11.52 77.09 0.02 OUTLIER Pre-proline 0 N--CA 1.496 1.854 0 N-CA-C 121.656 3.947 . . . . 0.0 121.656 -177.017 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.503 ' HD2' ' HA ' ' A' ' 185' ' ' LYS . 11.4 Cg_endo -46.26 -59.95 1.03 Allowed 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 123.341 2.694 . . . . 0.0 106.932 171.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -121.81 21.85 10.61 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 111.922 -2.399 . . . . 0.0 110.431 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.488 ' CA ' ' HB2' ' A' ' 185' ' ' LYS . . . 114.21 11.29 12.32 Favored Glycine 0 N--CA 1.488 2.162 0 C-N-CA 119.629 -1.272 . . . . 0.0 110.986 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' TRP . . . . . 0.475 ' CD1' ' HB3' ' A' ' 201' ' ' LEU . 2.1 m-90 -125.02 136.55 53.82 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 121.433 3.864 . . . . 0.0 121.433 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' TRP . . . . . 0.52 ' CE3' ' O ' ' A' ' 183' ' ' GLU . 32.4 m95 -119.4 154.66 33.3 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 101.519 -3.511 . . . . 0.0 101.519 178.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.474 ' HB ' ' O ' ' A' ' 182' ' ' ILE . 1.7 mp -109.23 114.11 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 104.234 -2.506 . . . . 0.0 104.234 176.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -107.6 177.55 4.8 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 118.859 -1.136 . . . . 0.0 113.898 -170.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -134.24 160.58 37.42 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 174.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 47.4 p-10 -117.67 -160.51 0.78 Allowed 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 118.456 -1.298 . . . . 0.0 110.406 177.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -101.32 42.26 1.14 Allowed 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 122.398 1.094 . . . . 0.0 108.586 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 5.4 tmtm? -127.01 -44.16 1.63 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 177.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 135.78 -41.08 1.46 Allowed Glycine 0 N--CA 1.485 1.936 0 N-CA-C 108.455 -1.858 . . . . 0.0 108.455 -178.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -53.58 163.38 0.66 Allowed 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 116.037 1.866 . . . . 0.0 116.037 -178.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -103.52 157.08 17.29 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 110.835 -2.893 . . . . 0.0 115.422 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 191' ' ' ILE . . . -134.61 -179.56 16.6 Favored Glycine 0 N--CA 1.483 1.827 0 CA-C-N 112.671 -2.059 . . . . 0.0 113.978 -175.433 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.475 ' HB3' ' CD1' ' A' ' 189' ' ' TRP . 32.0 mt -131.97 89.38 2.67 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 111.698 -2.251 . . . . 0.0 105.43 177.443 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . 0.251 2.3 t -97.13 148.53 34.54 Favored Pre-proline 0 C--N 1.305 -1.343 0 CA-C-N 114.269 -1.332 . . . . 0.0 113.928 -174.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -92.43 155.21 3.03 Favored 'Trans proline' 0 C--N 1.299 -2.032 0 N-CA-C 107.67 -1.704 . . . . 0.0 107.67 172.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' ARG . . . . . 0.516 ' HB2' ' CE2' ' A' ' 190' ' ' TRP . 8.6 tpt180 -74.59 -51.99 13.04 Favored 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 176.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 65.3 p -22.07 -45.85 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 127.528 3.017 . . . . 0.0 114.912 178.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -112.61 50.0 0.9 Allowed 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.468 -0.893 . . . . 0.0 113.199 -178.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 97.7 mt -131.05 155.96 46.0 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 176.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -130.26 142.19 44.56 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 103.916 -2.624 . . . . 0.0 103.916 174.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -66.32 155.44 69.92 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 N-CA-C 107.271 -1.857 . . . . 0.0 107.271 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' TYR . . . . . 0.413 ' CD1' HG21 ' A' ' 158' ' ' ILE . 9.7 t80 -130.38 176.4 8.17 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 118.559 -1.256 . . . . 0.0 110.002 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 22.9 t -121.26 30.89 6.58 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.4 -0.92 . . . . 0.0 110.974 -179.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 114.383 -2.722 . . . . 0.0 105.856 177.494 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 28.2 m . . . . . 0 N--CA 1.489 1.476 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 109.43 179.18 21.19 Favored Glycine 0 N--CA 1.486 1.993 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.966 -178.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -121.42 159.15 26.79 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 101.504 -3.517 . . . . 0.0 101.504 178.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -100.64 129.62 46.58 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 116.035 -2.266 . . . . 0.0 111.35 -177.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.631 ' CD1' HG21 ' A' ' 181' ' ' VAL . 4.9 m-85 -118.9 172.17 7.72 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 101.4 -3.556 . . . . 0.0 101.4 177.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.48 ' HA ' ' O ' ' A' ' 177' ' ' GLU . 1.7 pt -126.97 142.53 43.18 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 N-CA-C 103.44 -2.8 . . . . 0.0 103.44 174.252 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 176' ' ' GLY . . . -80.13 155.3 27.54 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 104.19 -2.522 . . . . 0.0 104.19 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.1 m -131.18 8.73 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 126.764 2.54 . . . . 0.0 108.447 178.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -127.68 159.1 21.5 Favored Glycine 0 N--CA 1.486 1.99 0 N-CA-C 106.018 -2.833 . . . . 0.0 106.018 176.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.408 ' HA ' ' HA ' ' A' ' 174' ' ' LYS . 33.1 t70 -108.54 97.34 7.02 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.253 -0.979 . . . . 0.0 113.083 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.44 ' HB3' ' CZ ' ' A' ' 173' ' ' PHE . 58.4 t80 -111.02 151.88 27.48 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 55.4 m -122.43 157.4 32.0 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.31 105.88 15.49 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 178.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -98.61 -17.43 18.64 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 -178.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -120.72 168.19 11.68 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 102.57 -3.122 . . . . 0.0 102.57 177.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 48.7 t -91.39 156.01 3.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 109.56 -41.12 2.32 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 107.502 -2.239 . . . . 0.0 107.502 -178.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.538 ' HA ' ' H ' ' A' ' 201' ' ' LEU . 11.2 m-20 -80.22 167.97 19.65 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 111.532 -2.334 . . . . 0.0 111.637 -179.144 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 24.5 mt -118.95 175.93 5.53 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.996 177.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 45.2 m -117.57 96.31 5.33 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 114.58 -1.191 . . . . 0.0 109.479 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.44 ' CZ ' ' HB3' ' A' ' 163' ' ' PHE . 8.9 p90 -119.24 164.43 15.64 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 114.488 -1.233 . . . . 0.0 111.63 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 162' ' ' ASP . 6.6 ptpp? -128.71 160.44 32.5 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 116.384 1.994 . . . . 0.0 116.384 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 42.9 tttm -41.91 76.91 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.766 1 CA-C-N 107.609 -4.36 . . . . 0.0 115.533 173.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 159' ' ' ALA . . . 112.67 50.44 0.56 Allowed Glycine 0 N--CA 1.491 2.306 0 CA-C-N 114.097 -1.411 . . . . 0.0 112.55 176.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.48 ' O ' ' HA ' ' A' ' 158' ' ' ILE . 15.4 pt-20 -131.4 168.93 16.75 Favored 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 176.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.428 ' HA ' ' HA ' ' A' ' 158' ' ' ILE . 1.5 mt -112.98 125.89 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 116.545 2.054 . . . . 0.0 116.545 -175.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 17.9 mt -118.41 176.02 5.44 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 112.339 -2.21 . . . . 0.0 110.756 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 33.5 mt -114.61 159.87 19.95 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 174.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.631 HG21 ' CD1' ' A' ' 157' ' ' TYR . 46.2 t -121.6 124.74 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -176.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.486 ' O ' ' HB ' ' A' ' 191' ' ' ILE . 11.7 mt -141.57 77.24 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.972 -174.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' GLU . . . . . 0.546 ' O ' ' CE3' ' A' ' 190' ' ' TRP . 44.6 tt0 138.15 149.58 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.037 0 C-N-CA 127.177 2.191 . . . . 0.0 108.402 176.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -116.62 100.94 8.17 Favored 'General case' 0 N--CA 1.508 2.436 0 N-CA-C 115.972 1.842 . . . . 0.0 115.972 -175.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.506 ' CG ' ' HE1' ' A' ' 190' ' ' TRP . 21.6 pttp -13.65 78.15 0.02 OUTLIER Pre-proline 0 N--CA 1.5 2.045 1 N-CA-C 122.075 4.102 . . . . 0.0 122.075 -177.79 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.45 ' HD2' ' O ' ' A' ' 189' ' ' TRP . 13.4 Cg_endo -47.68 -59.85 1.1 Allowed 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 123.061 2.508 . . . . 0.0 106.582 171.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -123.6 22.4 9.11 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 112.331 -2.213 . . . . 0.0 110.229 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.448 ' CA ' ' HB2' ' A' ' 185' ' ' LYS . . . 113.74 17.68 7.34 Favored Glycine 0 N--CA 1.491 2.354 0 C-N-CA 120.473 -0.87 . . . . 0.0 111.046 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' TRP . . . . . 0.45 ' O ' ' HD2' ' A' ' 186' ' ' PRO . 1.4 m-90 -125.62 126.05 44.11 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 121.395 3.85 . . . . 0.0 121.395 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' TRP . . . . . 0.594 ' CE2' ' HB2' ' A' ' 204' ' ' ARG . 16.3 m95 -118.44 159.86 22.74 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 102.072 -3.307 . . . . 0.0 102.072 176.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.486 ' HB ' ' O ' ' A' ' 182' ' ' ILE . 79.3 mt -114.72 113.67 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 104.372 -2.455 . . . . 0.0 104.372 176.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -108.41 178.5 4.47 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 119.453 -0.899 . . . . 0.0 112.658 -172.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 199' ' ' GLU . 64.9 mttm -137.21 169.1 18.35 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 173.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 43.5 p-10 -121.71 -164.79 1.18 Allowed 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.144 -1.022 . . . . 0.0 109.958 177.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -100.2 39.85 1.31 Allowed 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.928 0.871 . . . . 0.0 108.691 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -126.76 -37.13 2.16 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 113.609 -1.632 . . . . 0.0 107.282 177.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 134.96 -37.4 1.94 Allowed Glycine 0 N--CA 1.487 2.05 0 N-CA-C 110.074 -1.211 . . . . 0.0 110.074 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 22.4 p30 -63.94 164.74 9.86 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 118.591 -1.244 . . . . 0.0 114.167 -178.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 193' ' ' LYS . 0.0 OUTLIER -125.8 157.91 36.31 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 111.858 -2.428 . . . . 0.0 109.492 179.405 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 200' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 191' ' ' ILE . . . -136.36 -175.23 13.7 Favored Glycine 0 N--CA 1.48 1.572 0 CA-C-O 122.319 0.955 . . . . 0.0 111.634 -178.424 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.538 ' H ' ' HA ' ' A' ' 170' ' ' ASP . 13.8 mt -122.04 82.5 1.97 Allowed 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 111.419 -2.391 . . . . 0.0 105.202 177.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 4.5 m -115.57 154.97 47.87 Favored Pre-proline 0 N--CA 1.495 1.806 0 C-N-CA 119.579 -0.848 . . . . 0.0 109.415 -175.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -81.74 179.97 5.29 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 123.121 2.547 . . . . 0.0 112.156 -178.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' ARG . . . . . 0.594 ' HB2' ' CE2' ' A' ' 190' ' ' TRP . 17.5 ttp85 -91.24 -49.19 6.5 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 103.762 -2.681 . . . . 0.0 103.762 176.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.406 HG23 ' H ' ' A' ' 205' ' ' THR . 68.2 p -19.3 -48.53 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 127.146 2.779 . . . . 0.0 117.026 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -108.51 42.57 1.37 Allowed 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 119.063 -1.055 . . . . 0.0 112.614 -177.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 84.9 mt -129.68 158.42 39.41 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 115.063 -0.972 . . . . 0.0 109.007 177.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -132.82 152.44 79.86 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 104.553 -2.388 . . . . 0.0 104.553 170.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -68.66 165.79 28.23 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 N-CA-C 108.064 -1.552 . . . . 0.0 108.064 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -120.24 -160.41 0.83 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 68.9 p -95.83 45.27 1.08 Allowed 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.02 -1.072 . . . . 0.0 110.429 -178.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 116.416 -1.754 . . . . 0.0 108.282 177.28 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 35.4 m . . . . . 0 N--CA 1.492 1.644 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -116.07 179.44 17.87 Favored Glycine 0 N--CA 1.487 2.051 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.852 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -135.15 -179.98 5.96 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.329 -1.359 . . . . 0.0 107.329 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -109.93 126.52 53.97 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 114.839 1.422 . . . . 0.0 114.839 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.527 ' CD1' HG21 ' A' ' 181' ' ' VAL . 44.8 m-85 -121.88 177.94 5.08 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 101.183 -3.636 . . . . 0.0 101.183 175.054 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.511 ' HA ' ' HA ' ' A' ' 178' ' ' ILE . 2.9 pt -123.72 153.32 29.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 100.79 -3.781 . . . . 0.0 100.79 170.139 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -91.83 153.18 19.73 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 100.768 -3.789 . . . . 0.0 100.768 177.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 31.2 m -125.07 17.36 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 125.908 2.005 . . . . 0.0 108.021 176.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -138.53 164.51 25.67 Favored Glycine 0 N--CA 1.483 1.806 0 N-CA-C 105.628 -2.989 . . . . 0.0 105.628 175.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -106.02 144.5 32.65 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 104.837 -2.283 . . . . 0.0 104.837 177.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -124.69 172.64 9.12 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 77.8 m -130.17 152.55 49.49 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.623 -0.831 . . . . 0.0 109.577 178.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -107.89 122.41 46.73 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 177.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -110.24 -19.51 12.98 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.127 -1.397 . . . . 0.0 108.121 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -123.35 176.7 5.99 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 114.057 -1.429 . . . . 0.0 108.339 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 15.2 t -95.53 49.93 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -131.81 -46.93 0.12 Allowed Glycine 0 N--CA 1.485 1.915 0 CA-C-N 113.282 -1.781 . . . . 0.0 108.788 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.419 ' HA ' ' H ' ' A' ' 201' ' ' LEU . 1.8 m-20 -87.62 169.2 12.36 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 112.503 -1.849 . . . . 0.0 114.385 -178.46 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.422 ' HG ' ' CA ' ' A' ' 200' ' ' GLY . 39.2 mt -117.97 -176.83 3.13 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 112.547 -2.115 . . . . 0.0 105.806 176.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 73.4 m -108.95 -59.4 1.89 Allowed 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.158 -179.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 43.1 p90 37.42 164.43 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.25 0 N-CA-C 117.617 2.451 . . . . 0.0 117.617 -175.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -124.52 143.62 50.57 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 120.173 3.397 . . . . 0.0 120.173 -178.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -26.75 81.29 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.589 1 CA-C-N 107.847 -4.251 . . . . 0.0 115.868 169.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 112.18 46.98 0.73 Allowed Glycine 0 N--CA 1.492 2.427 0 CA-C-N 114.617 -1.174 . . . . 0.0 113.392 176.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.418 ' O ' ' HA ' ' A' ' 158' ' ' ILE . 7.0 pt-20 -140.75 152.98 45.69 Favored 'General case' 0 N--CA 1.503 2.205 0 C-N-CA 117.092 -1.843 . . . . 0.0 109.485 176.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.511 ' HA ' ' HA ' ' A' ' 158' ' ' ILE . 1.3 mp -74.9 131.53 34.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -178.504 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 44.0 mt -122.66 168.35 12.3 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 112.339 -2.21 . . . . 0.0 107.044 176.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.408 HD13 ' H ' ' A' ' 181' ' ' VAL . 0.4 OUTLIER -113.05 148.02 36.03 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 101.796 -3.409 . . . . 0.0 101.796 179.591 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.527 HG21 ' CD1' ' A' ' 157' ' ' TYR . 2.7 t -124.01 138.51 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 CA-C-N 121.458 1.935 . . . . 0.0 111.467 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.455 ' O ' ' CB ' ' A' ' 183' ' ' GLU . 0.5 OUTLIER -146.52 81.28 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 O-C-N 123.169 0.293 . . . . 0.0 110.619 -173.371 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 183' ' ' GLU . . . . . 0.532 ' O ' ' CE3' ' A' ' 190' ' ' TRP . 34.9 tt0 139.31 153.18 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.96 0 C-N-CA 127.024 2.13 . . . . 0.0 107.748 178.375 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -117.92 99.95 7.25 Favored 'General case' 0 N--CA 1.508 2.445 0 N-CA-C 116.227 1.936 . . . . 0.0 116.227 -175.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.551 ' CG ' ' HE1' ' A' ' 190' ' ' TRP . 22.1 pttp -13.07 77.16 0.02 OUTLIER Pre-proline 0 N--CA 1.5 2.057 1 N-CA-C 122.183 4.142 . . . . 0.0 122.183 -177.325 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.492 ' HD2' ' HA ' ' A' ' 185' ' ' LYS . 12.3 Cg_endo -47.13 -59.34 1.28 Allowed 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 123.096 2.531 . . . . 0.0 106.999 171.097 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -121.11 19.58 11.55 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 112.285 -2.234 . . . . 0.0 110.563 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.498 ' CA ' ' HB2' ' A' ' 185' ' ' LYS . . . 112.94 15.85 8.94 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' TRP . . . . . 0.448 ' O ' ' HD2' ' A' ' 186' ' ' PRO . 1.3 m-90 -125.51 127.03 45.8 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 120.58 3.548 . . . . 0.0 120.58 179.025 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' TRP . . . . . 0.659 ' CE2' ' HB2' ' A' ' 204' ' ' ARG . 15.2 m95 -117.84 161.19 20.14 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 101.095 -3.668 . . . . 0.0 101.095 177.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.411 ' HB ' ' O ' ' A' ' 182' ' ' ILE . 28.8 mm -98.28 166.77 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.395 1 N-CA-C 99.679 -4.193 . . . . 0.0 99.679 176.963 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 192' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 199' ' ' GLU . . . -150.74 -177.8 6.2 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 116.125 -2.23 . . . . 0.0 111.447 178.219 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -137.69 163.69 30.67 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 174.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 26.0 p-10 -112.7 -160.72 0.73 Allowed 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.373 -0.931 . . . . 0.0 108.567 177.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -108.26 35.7 3.07 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 118.874 -1.13 . . . . 0.0 110.215 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -129.23 -67.72 0.76 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 105.48 -2.045 . . . . 0.0 105.48 175.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -165.58 -67.24 0.03 OUTLIER Glycine 0 N--CA 1.488 2.133 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.208 178.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -34.85 160.78 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 119.65 3.204 . . . . 0.0 119.65 -178.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.419 ' HG3' ' N ' ' A' ' 200' ' ' GLY . 0.0 OUTLIER -118.65 160.4 21.89 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 111.904 -2.407 . . . . 0.0 109.573 179.251 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 200' ' ' GLY . . . . . 0.422 ' CA ' ' HG ' ' A' ' 171' ' ' LEU . . . -135.54 -169.72 11.91 Favored Glycine 0 N--CA 1.487 2.082 0 CA-C-O 122.998 1.332 . . . . 0.0 114.238 -177.556 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.419 ' H ' ' HA ' ' A' ' 170' ' ' ASP . 16.5 mt -130.09 84.89 2.24 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 111.138 -2.531 . . . . 0.0 105.236 178.048 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 3.0 m -113.04 156.04 43.38 Favored Pre-proline 0 N--CA 1.495 1.816 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 -175.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -90.35 173.24 3.31 Favored 'Trans proline' 0 C--N 1.302 -1.903 0 C-N-CA 122.429 2.086 . . . . 0.0 107.365 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' ARG . . . . . 0.659 ' HB2' ' CE2' ' A' ' 190' ' ' TRP . 22.7 ttt180 -102.07 -35.62 8.87 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 117.029 -1.869 . . . . 0.0 106.43 175.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 70.2 p -25.05 -46.67 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 126.057 2.098 . . . . 0.0 114.732 174.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -110.98 43.94 1.37 Allowed 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 119.762 -0.775 . . . . 0.0 112.659 -178.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 60.4 mt -127.17 151.53 48.56 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.618 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -123.64 150.03 60.45 Favored Pre-proline 0 C--N 1.301 -1.512 0 N-CA-C 104.148 -2.538 . . . . 0.0 104.148 174.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -68.81 160.13 50.94 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 C-N-CA 121.363 1.376 . . . . 0.0 110.738 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' TYR . . . . . 0.411 ' CE1' HD11 ' A' ' 178' ' ' ILE . 10.7 t80 -127.84 151.17 49.39 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 177.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.1 t -130.69 49.51 2.3 Favored 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 118.989 -1.085 . . . . 0.0 113.107 -177.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 116.232 -1.842 . . . . 0.0 109.335 177.738 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 10.1 t . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 116.99 179.29 17.75 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 110.241 -1.143 . . . . 0.0 110.241 -178.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -116.32 165.14 13.53 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 104.381 -2.452 . . . . 0.0 104.381 -178.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -99.15 119.51 37.97 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 117.098 -1.841 . . . . 0.0 114.417 -178.014 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.481 ' CD1' HG21 ' A' ' 181' ' ' VAL . 2.2 m-85 -123.87 174.09 7.77 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 101.145 -3.65 . . . . 0.0 101.145 175.256 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.513 HG21 ' CD1' ' A' ' 210' ' ' TYR . 3.3 pt -127.49 153.84 37.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 101.943 -3.354 . . . . 0.0 101.943 173.465 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -84.24 152.66 24.07 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 103.582 -2.747 . . . . 0.0 103.582 178.271 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 32.9 m -132.8 6.13 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 125.939 2.025 . . . . 0.0 108.734 177.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -131.37 149.68 19.3 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 106.36 -2.696 . . . . 0.0 106.36 177.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -101.77 92.26 4.76 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 118.887 -1.125 . . . . 0.0 108.798 -177.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -107.99 151.18 26.16 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 114.436 -1.256 . . . . 0.0 109.624 -178.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 52.7 m -120.98 158.81 26.93 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -81.29 151.54 28.02 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 118.076 -1.45 . . . . 0.0 109.022 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -112.72 -36.17 5.27 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 112.456 -2.156 . . . . 0.0 105.267 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -120.42 171.89 8.21 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 113.368 -1.742 . . . . 0.0 106.996 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.454 HG12 ' H ' ' A' ' 168' ' ' VAL . 0.1 OUTLIER -59.63 -46.8 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 117.489 -1.685 . . . . 0.0 108.693 177.766 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -29.55 -60.96 0.17 Allowed Glycine 0 N--CA 1.492 2.376 0 O-C-N 125.355 1.66 . . . . 0.0 113.834 177.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.504 ' HA ' ' H ' ' A' ' 201' ' ' LEU . 1.1 m-20 -77.23 168.86 19.34 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -176.409 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.436 ' CD2' HD22 ' A' ' 198' ' ' ASN . 14.2 mt -117.54 176.55 5.12 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 113.715 -1.584 . . . . 0.0 110.478 178.499 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 42.6 m -120.46 97.07 5.4 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 113.875 -1.512 . . . . 0.0 110.733 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.423 ' CD1' ' N ' ' A' ' 173' ' ' PHE . 8.2 p90 -121.05 171.09 8.92 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.495 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -107.4 -163.35 0.89 Allowed 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 122.691 1.234 . . . . 0.0 113.338 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 42.1 tttm -107.15 89.82 3.11 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 111.002 -2.817 . . . . 0.0 112.146 -175.191 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 109.16 50.65 0.71 Allowed Glycine 0 N--CA 1.492 2.401 0 CA-C-N 113.228 -1.806 . . . . 0.0 110.695 177.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.413 ' O ' ' HB ' ' A' ' 158' ' ' ILE . 6.0 pt-20 -128.78 176.59 7.7 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 177.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 21.9 mm -104.0 119.56 52.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 C-N-CA 118.669 -1.213 . . . . 0.0 112.451 -178.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 59.5 mt -121.16 163.62 18.17 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 113.933 -1.485 . . . . 0.0 110.031 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 59.6 mt -110.7 156.67 20.69 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 176.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.481 HG21 ' CD1' ' A' ' 157' ' ' TYR . 2.5 t -126.55 138.67 54.01 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 C-N-CA 117.981 -1.488 . . . . 0.0 110.221 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.453 ' O ' ' HB ' ' A' ' 191' ' ' ILE . 25.6 mt -141.04 82.0 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -174.158 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' GLU . . . . . 0.478 ' HG2' ' N ' ' A' ' 184' ' ' LYS . 41.9 tt0 138.02 150.52 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.393 0 C-N-CA 127.042 2.137 . . . . 0.0 108.004 176.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' LYS . . . . . 0.478 ' N ' ' HG2' ' A' ' 183' ' ' GLU . 97.9 mttt -116.84 115.68 26.0 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 124.628 1.205 . . . . 0.0 111.927 -179.279 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.537 ' CG ' ' HE1' ' A' ' 190' ' ' TRP . 0.1 OUTLIER -6.96 77.34 0.03 OUTLIER Pre-proline 0 N--CA 1.505 2.291 0 N-CA-C 117.652 2.464 . . . . 0.0 117.652 178.443 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -68.6 -55.95 0.2 Allowed 'Trans proline' 0 C--N 1.307 -1.629 0 N-CA-C 105.516 -2.532 . . . . 0.0 105.516 175.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -125.16 24.53 7.44 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 112.877 -1.965 . . . . 0.0 112.741 -177.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.511 ' CA ' ' HG2' ' A' ' 185' ' ' LYS . . . 116.65 -19.4 12.59 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 118.708 -1.711 . . . . 0.0 109.603 -179.199 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 16.3 m-90 -115.28 158.71 21.97 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 117.783 2.512 . . . . 0.0 117.783 -176.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' TRP . . . . . 0.537 ' HE1' ' CG ' ' A' ' 185' ' ' LYS . 23.9 m95 -129.97 162.43 28.68 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 100.457 -3.905 . . . . 0.0 100.457 -178.08 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.456 HG12 ' CB ' ' A' ' 183' ' ' GLU . 10.9 mm -113.33 106.21 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 C-N-CA 116.382 -2.127 . . . . 0.0 106.479 177.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -101.94 175.49 5.52 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -172.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.462 ' HG2' ' HB2' ' A' ' 199' ' ' GLU . 63.1 mttm -126.51 165.12 19.71 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 174.113 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -122.82 -158.16 0.78 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 124.467 1.104 . . . . 0.0 110.376 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -100.26 36.95 1.75 Allowed 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 121.693 0.758 . . . . 0.0 110.822 -178.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -125.38 -43.42 1.92 Allowed 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 176.202 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 138.29 -43.3 1.2 Allowed Glycine 0 N--CA 1.483 1.817 0 N-CA-C 106.477 -2.649 . . . . 0.0 106.477 -178.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' ASN . . . . . 0.436 HD22 ' CD2' ' A' ' 171' ' ' LEU . 0.9 OUTLIER -53.57 155.91 2.82 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 179.361 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.462 ' HB2' ' HG2' ' A' ' 193' ' ' LYS . 0.0 OUTLIER -127.89 155.0 44.87 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 112.949 -1.932 . . . . 0.0 110.357 -179.936 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 200' ' ' GLY . . . . . 0.416 ' HA3' ' HG ' ' A' ' 171' ' ' LEU . . . -145.0 -176.68 19.21 Favored Glycine 0 N--CA 1.485 1.964 0 C-N-CA 119.195 -1.479 . . . . 0.0 112.924 -178.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.504 ' H ' ' HA ' ' A' ' 170' ' ' ASP . 0.8 OUTLIER -92.78 92.05 7.76 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 112.757 -1.722 . . . . 0.0 106.741 176.943 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 5.0 m -113.81 147.85 38.57 Favored Pre-proline 0 N--CA 1.494 1.757 0 C-N-CA 117.43 -1.708 . . . . 0.0 106.739 -179.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -79.22 179.06 6.77 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 C-N-CA 122.291 1.994 . . . . 0.0 112.014 -177.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' ARG . . . . . 0.473 ' HB2' ' HE1' ' A' ' 190' ' ' TRP . 0.1 OUTLIER -86.25 -46.22 10.55 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 103.552 -2.759 . . . . 0.0 103.552 178.164 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 71.8 p -22.2 -50.62 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 O-C-N 126.013 2.071 . . . . 0.0 116.168 178.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -112.79 43.2 1.71 Allowed 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.587 0.708 . . . . 0.0 111.985 -178.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 12.3 mt -140.25 108.86 5.9 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 113.793 -1.548 . . . . 0.0 109.346 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -110.73 153.37 43.69 Favored Pre-proline 0 N--CA 1.49 1.55 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 178.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -59.6 165.39 9.72 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.093 1.862 . . . . 0.0 111.252 -178.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' TYR . . . . . 0.513 ' CD1' HG21 ' A' ' 158' ' ' ILE . 9.0 t80 -126.67 169.11 13.48 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 119.024 -1.071 . . . . 0.0 111.99 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 211' ' ' SER . . . . . 0.45 ' N ' ' CG ' ' A' ' 210' ' ' TYR . 42.8 p -121.93 73.19 1.07 Allowed 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 113.824 -1.535 . . . . 0.0 108.486 178.231 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 116.22 -1.848 . . . . 0.0 109.741 -179.33 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 77.4 p . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.528 0.68 . . . . 0.0 109.902 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.402 ' HA3' ' O ' ' A' ' 181' ' ' VAL . . . -115.62 -156.68 11.09 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.092 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 -105.87 167.19 9.95 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 112.681 -1.76 . . . . 0.0 108.436 -178.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -112.71 141.57 46.35 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 124.598 2.142 . . . . 0.0 113.175 -177.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.513 ' CG ' HD23 ' A' ' 207' ' ' LEU . 76.0 m-85 -133.57 -179.73 5.7 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 108.462 -3.972 . . . . 0.0 107.326 -176.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.535 ' HA ' ' HA ' ' A' ' 178' ' ' ILE . 7.5 pt -128.66 162.2 36.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 102.188 -3.264 . . . . 0.0 102.188 168.128 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.418 ' O ' ' N ' ' A' ' 176' ' ' GLY . . . -90.98 157.47 17.27 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 103.405 -2.813 . . . . 0.0 103.405 -179.206 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 16.6 m -126.63 -0.24 4.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 125.809 1.943 . . . . 0.0 108.381 175.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -132.11 165.71 23.46 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 107.812 -2.115 . . . . 0.0 107.812 177.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -106.97 122.33 46.22 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 173' ' ' PHE . 36.6 t80 -122.05 156.21 34.02 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.085 179.014 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 75.3 m -124.44 161.65 25.59 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -92.96 144.59 25.1 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 118.012 -1.475 . . . . 0.0 108.389 178.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -113.23 -32.69 6.21 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 112.834 -1.985 . . . . 0.0 106.645 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -112.52 177.59 4.58 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 113.66 -1.609 . . . . 0.0 107.027 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 17.3 t -95.84 49.34 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 104.502 -2.407 . . . . 0.0 104.502 178.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -130.65 -49.36 0.11 Allowed Glycine 0 N--CA 1.485 1.947 0 CA-C-N 112.697 -2.047 . . . . 0.0 109.27 -178.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.548 ' HA ' ' H ' ' A' ' 201' ' ' LEU . 29.2 m-20 -79.43 175.13 10.88 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 113.293 -1.454 . . . . 0.0 111.797 -178.273 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.51 ' HG ' ' HA3' ' A' ' 200' ' ' GLY . 14.1 mt -115.89 174.52 5.99 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 114.394 -1.276 . . . . 0.0 108.466 177.075 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 52.5 m -120.97 91.37 3.51 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 113.796 -1.547 . . . . 0.0 108.078 178.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.425 ' CZ ' ' HB3' ' A' ' 163' ' ' PHE . 9.9 p90 -121.87 169.45 10.77 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 113.698 -1.592 . . . . 0.0 111.064 -178.349 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -109.44 -163.67 0.88 Allowed 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 122.78 1.276 . . . . 0.0 111.373 178.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 67.9 tttt -92.87 156.3 17.05 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 110.724 -2.944 . . . . 0.0 110.661 -178.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 159' ' ' ALA . . . 53.61 44.66 68.61 Favored Glycine 0 N--CA 1.485 1.935 0 CA-C-N 112.783 -2.008 . . . . 0.0 108.1 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -130.49 128.25 40.84 Favored 'General case' 0 N--CA 1.504 2.256 0 C-N-CA 116.881 -1.928 . . . . 0.0 113.988 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.535 ' HA ' ' HA ' ' A' ' 158' ' ' ILE . 1.6 mp -58.95 119.27 3.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 -178.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 19.6 mt -118.63 155.45 30.97 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 113.766 -1.561 . . . . 0.0 107.6 175.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 23.7 tp -111.99 158.42 19.54 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 104.575 -2.38 . . . . 0.0 104.575 177.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.613 HG22 ' CZ3' ' A' ' 190' ' ' TRP . 98.5 t -110.39 147.74 14.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 C-N-CA 119.078 -1.049 . . . . 0.0 109.899 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.56 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 8.9 mt -148.69 74.97 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 C-N-CA 118.148 -1.421 . . . . 0.0 108.991 173.081 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' GLU . . . . . 0.56 ' HB2' ' O ' ' A' ' 182' ' ' ILE . 12.8 tm-20 139.07 165.21 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.224 0 C-N-CA 129.04 2.936 . . . . 0.0 105.314 176.072 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -113.76 88.69 2.9 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 117.444 2.387 . . . . 0.0 117.444 -175.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.542 ' HB3' ' CD1' ' A' ' 190' ' ' TRP . 7.4 pttm -8.69 76.05 0.03 OUTLIER Pre-proline 0 N--CA 1.505 2.319 0 N-CA-C 116.704 2.113 . . . . 0.0 116.704 177.275 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.467 ' HD2' ' HA ' ' A' ' 185' ' ' LYS . 11.8 Cg_endo -44.52 -56.27 2.7 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 123.37 2.713 . . . . 0.0 107.598 176.705 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -128.8 16.4 6.35 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 111.634 -2.53 . . . . 0.0 110.04 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 111.4 26.01 4.73 Favored Glycine 0 N--CA 1.485 1.917 0 N-CA-C 107.501 -2.24 . . . . 0.0 107.501 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 2.7 m-90 -134.45 97.74 3.9 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 116.72 2.119 . . . . 0.0 116.72 178.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' TRP . . . . . 0.686 ' CD1' ' N ' ' A' ' 190' ' ' TRP . 0.0 OUTLIER -112.68 171.72 7.36 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.597 179.636 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.512 ' HB ' ' O ' ' A' ' 182' ' ' ILE . 1.9 mp -108.9 111.23 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 N-CA-C 104.037 -2.579 . . . . 0.0 104.037 -179.186 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 192' ' ' ALA . . . . . 0.572 ' HB2' ' CZ3' ' A' ' 190' ' ' TRP . . . -109.91 -178.37 3.51 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -173.35 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -137.26 166.76 23.01 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 105.38 -2.081 . . . . 0.0 105.38 176.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 53.3 p-10 -121.26 -148.48 0.41 Allowed 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.121 -1.032 . . . . 0.0 111.637 177.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -103.76 19.37 20.04 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -176.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 8.4 ptmm? -124.07 -26.21 4.06 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 174.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 137.73 -35.11 2.09 Favored Glycine 0 N--CA 1.49 2.259 0 C-N-CA 119.097 -1.525 . . . . 0.0 113.363 178.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' ASN . . . . . 0.498 ' C ' HD21 ' A' ' 198' ' ' ASN . 0.4 OUTLIER -61.56 162.17 8.63 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 117.546 -1.662 . . . . 0.0 113.417 -177.677 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -128.72 155.01 45.77 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 112.712 -2.04 . . . . 0.0 111.026 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 200' ' ' GLY . . . . . 0.51 ' HA3' ' HG ' ' A' ' 171' ' ' LEU . . . -144.7 -160.71 8.65 Favored Glycine 0 N--CA 1.489 2.175 0 CA-C-O 122.276 0.931 . . . . 0.0 112.581 -178.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.548 ' H ' ' HA ' ' A' ' 170' ' ' ASP . 20.1 mt -121.94 110.14 15.48 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 111.499 -2.35 . . . . 0.0 105.844 175.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.54 HG23 ' CD2' ' A' ' 190' ' ' TRP . 13.7 m -129.82 163.36 47.65 Favored Pre-proline 0 N--CA 1.498 1.958 0 C-N-CA 117.867 -1.533 . . . . 0.0 111.626 -175.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -100.24 139.28 0.26 Allowed 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 123.661 2.907 . . . . 0.0 109.713 174.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 204' ' ' ARG . . . . . 0.504 ' N ' ' HE1' ' A' ' 190' ' ' TRP . 0.1 OUTLIER -81.43 -23.57 37.45 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 104.64 -2.355 . . . . 0.0 104.64 179.954 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.44 ' C ' ' O ' ' A' ' 204' ' ' ARG . 68.2 p -24.65 -43.75 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.156 0 O-C-N 124.518 1.137 . . . . 0.0 113.602 171.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -114.33 50.23 0.96 Allowed 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 120.098 -0.641 . . . . 0.0 111.977 179.201 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.513 HD23 ' CG ' ' A' ' 157' ' ' TYR . 1.0 OUTLIER -133.95 152.73 51.96 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.255 -179.005 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -132.03 153.5 81.38 Favored Pre-proline 0 N--CA 1.491 1.601 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 172.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -64.52 164.91 21.89 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.077 1.851 . . . . 0.0 111.684 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' TYR . . . . . 0.432 ' CD1' ' CG2' ' A' ' 158' ' ' ILE . 35.1 t80 -127.24 176.78 7.14 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 211' ' ' SER . . . . . 0.417 ' N ' ' CG ' ' A' ' 210' ' ' TYR . 49.8 m -116.04 48.63 1.21 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 178.025 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 . . . . . 0 N--CA 1.497 1.889 0 CA-C-O 115.702 -2.094 . . . . 0.0 112.7 179.321 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 9.7 t . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.439 ' HA2' ' O ' ' A' ' 181' ' ' VAL . . . -120.24 177.66 16.4 Favored Glycine 0 N--CA 1.486 2.021 0 C-N-CA 119.792 -1.194 . . . . 0.0 111.609 179.016 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -115.6 165.76 12.67 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -178.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -94.65 123.04 37.85 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 117.551 -1.66 . . . . 0.0 113.695 -176.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.507 ' CD1' HG21 ' A' ' 181' ' ' VAL . 4.0 m-85 -124.83 172.26 9.49 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 111.071 -2.786 . . . . 0.0 105.138 177.576 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.526 HG21 ' CD1' ' A' ' 210' ' ' TYR . 2.1 pt -129.98 150.33 34.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 102.959 -2.978 . . . . 0.0 102.959 171.59 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.407 ' O ' ' N ' ' A' ' 176' ' ' GLY . . . -86.59 150.7 24.04 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 102.435 -3.172 . . . . 0.0 102.435 178.17 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 33.8 m -132.68 23.18 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 126.189 2.181 . . . . 0.0 107.642 178.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -144.06 160.19 27.76 Favored Glycine 0 N--CA 1.483 1.784 0 N-CA-C 107.86 -2.096 . . . . 0.0 107.86 176.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -106.49 78.73 1.3 Allowed 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.292 -0.963 . . . . 0.0 108.449 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.421 ' HB3' ' CZ ' ' A' ' 173' ' ' PHE . 68.5 t80 -99.9 149.86 22.98 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 114.36 -1.291 . . . . 0.0 108.163 -178.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 93.6 m -120.81 157.96 28.62 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 114.023 -1.444 . . . . 0.0 108.856 -177.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -79.32 135.27 36.68 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 178.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -114.13 -28.26 7.38 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 113.804 -1.544 . . . . 0.0 107.293 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -114.77 178.61 4.22 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 179.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 58.8 t -90.78 149.9 3.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 104.003 -2.591 . . . . 0.0 104.003 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 110.53 -42.7 1.89 Allowed Glycine 0 N--CA 1.487 2.059 0 C-N-CA 118.407 -1.854 . . . . 0.0 108.703 -178.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.464 ' HA ' ' H ' ' A' ' 201' ' ' LEU . 3.0 m-20 -78.28 168.37 19.94 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 113.079 -1.561 . . . . 0.0 113.239 -179.006 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.539 ' HG ' ' CA ' ' A' ' 200' ' ' GLY . 76.6 mt -123.22 179.05 4.84 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 114.506 -1.225 . . . . 0.0 110.28 178.451 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 37.0 m -120.78 98.41 6.0 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 113.392 -1.731 . . . . 0.0 108.372 177.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.421 ' CZ ' ' HB3' ' A' ' 163' ' ' PHE . 17.4 p90 -113.23 165.31 12.54 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 118.73 -1.188 . . . . 0.0 111.379 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -122.59 152.84 40.03 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 117.736 2.495 . . . . 0.0 117.736 -177.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -37.11 76.66 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 108.575 -3.92 . . . . 0.0 114.923 173.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 159' ' ' ALA . . . 106.86 54.69 0.67 Allowed Glycine 0 N--CA 1.491 2.35 0 CA-C-N 114.986 -1.007 . . . . 0.0 112.973 175.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.47 ' O ' ' HA ' ' A' ' 158' ' ' ILE . 5.0 pt-20 -124.17 175.46 7.01 Favored 'General case' 0 N--CA 1.504 2.273 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 176.15 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.434 HD12 ' CE2' ' A' ' 210' ' ' TYR . 14.2 mm -112.46 131.9 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 119.068 -1.053 . . . . 0.0 111.607 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.507 ' N ' HD23 ' A' ' 179' ' ' LEU . 0.7 OUTLIER -140.26 174.87 10.08 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 114.653 -1.158 . . . . 0.0 113.69 177.826 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 83.6 mt -114.5 154.1 28.83 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.858 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.507 HG21 ' CD1' ' A' ' 157' ' ' TYR . 57.3 t -116.33 104.94 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 114.83 1.419 . . . . 0.0 114.83 -177.468 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.475 ' O ' ' HB ' ' A' ' 191' ' ' ILE . 13.3 mt -117.1 77.34 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-O 122.94 1.352 . . . . 0.0 108.178 -176.295 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' GLU . . . . . 0.462 ' HB3' ' H ' ' A' ' 191' ' ' ILE . 42.4 tt0 146.39 157.15 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.12 0 CA-C-N 109.715 -3.402 . . . . 0.0 108.262 173.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' LYS . . . . . 0.438 ' N ' ' HG2' ' A' ' 183' ' ' GLU . 64.1 mttp -117.37 102.21 9.05 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 114.655 -1.157 . . . . 0.0 112.233 -177.613 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.524 ' HB2' ' HE1' ' A' ' 190' ' ' TRP . 38.5 tttm -5.76 76.03 0.03 OUTLIER Pre-proline 0 N--CA 1.507 2.392 0 O-C-N 126.798 2.561 . . . . 0.0 115.005 178.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -66.81 -57.42 0.2 Allowed 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 123.565 2.843 . . . . 0.0 105.88 178.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 27.7 p-10 -121.01 20.36 11.54 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 111.329 -2.669 . . . . 0.0 112.992 -177.249 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 116.52 -27.49 7.97 Favored Glycine 0 N--CA 1.48 1.578 0 C-N-CA 117.424 -2.322 . . . . 0.0 108.93 -179.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 8.0 m-90 -118.02 148.65 42.04 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 118.332 -1.347 . . . . 0.0 114.474 -177.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' TRP . . . . . 0.524 ' HE1' ' HB2' ' A' ' 185' ' ' LYS . 3.0 m0 -112.39 173.45 6.36 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 102.684 -3.08 . . . . 0.0 102.684 178.385 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.511 ' HA ' ' O ' ' A' ' 200' ' ' GLY . 12.9 mt -115.58 114.34 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 N-CA-C 103.209 -2.886 . . . . 0.0 103.209 175.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -113.92 173.63 6.34 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 116.249 1.944 . . . . 0.0 116.249 -170.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 26.0 mmmt -121.37 141.1 51.28 Favored 'General case' 0 C--N 1.298 -1.638 1 N-CA-C 99.769 -4.159 . . . . 0.0 99.769 173.459 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -110.4 -160.1 0.7 Allowed 'General case' 0 N--CA 1.502 2.145 0 C-N-CA 117.433 -1.707 . . . . 0.0 112.089 -177.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -88.87 31.93 0.83 Allowed 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.245 -0.982 . . . . 0.0 111.077 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -123.99 -43.31 2.11 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 175.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 132.43 -40.3 1.64 Allowed Glycine 0 N--CA 1.485 1.939 0 N-CA-C 107.984 -2.046 . . . . 0.0 107.984 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' ASN . . . . . 0.428 ' OD1' HD22 ' A' ' 171' ' ' LEU . 15.1 p30 -56.79 167.35 0.78 Allowed 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 115.162 1.541 . . . . 0.0 115.162 -178.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -98.01 150.72 21.08 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 112.737 -2.029 . . . . 0.0 115.746 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' GLY . . . . . 0.539 ' CA ' ' HG ' ' A' ' 171' ' ' LEU . . . -133.18 -177.16 14.75 Favored Glycine 0 N--CA 1.48 1.568 0 CA-C-N 112.827 -1.988 . . . . 0.0 114.522 -176.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.464 ' H ' ' HA ' ' A' ' 170' ' ' ASP . 19.6 mt -131.77 76.82 1.73 Allowed 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 101.492 -3.521 . . . . 0.0 101.492 175.272 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 5.0 m -107.08 140.14 21.13 Favored Pre-proline 0 N--CA 1.494 1.749 0 C-N-CA 117.997 -1.481 . . . . 0.0 110.207 -172.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 0.4 OUTLIER -90.93 177.77 2.02 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 C-N-CA 122.725 2.283 . . . . 0.0 115.287 -175.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 204' ' ' ARG . . . . . 0.481 ' HB2' ' HD2' ' A' ' 185' ' ' LYS . 41.6 ttt-85 -89.16 -35.7 16.1 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 174.477 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 72.9 p -33.46 -41.31 0.08 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 125.527 1.767 . . . . 0.0 113.3 174.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -113.68 5.12 16.34 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 114.522 1.305 . . . . 0.0 114.522 -178.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.411 HD23 ' HB3' ' A' ' 157' ' ' TYR . 0.3 OUTLIER -118.68 161.01 20.8 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 178.374 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -132.57 157.65 77.76 Favored Pre-proline 0 N--CA 1.487 1.383 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 174.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -69.98 173.32 11.34 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.223 1.949 . . . . 0.0 109.47 178.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' TYR . . . . . 0.526 ' CD1' HG21 ' A' ' 158' ' ' ILE . 2.4 t80 -127.66 -177.15 3.99 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 30.5 t -116.85 44.73 1.99 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 178.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 115.052 -2.404 . . . . 0.0 107.491 179.123 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 10.2 t . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 108.8 171.38 21.05 Favored Glycine 0 N--CA 1.486 2.021 0 C-N-CA 120.113 -1.042 . . . . 0.0 113.67 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -132.16 148.29 52.46 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 103.921 -2.622 . . . . 0.0 103.921 177.031 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -107.49 142.36 37.48 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 116.82 -1.952 . . . . 0.0 111.577 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.408 ' CE1' HG21 ' A' ' 181' ' ' VAL . 11.2 m-85 -125.29 -179.51 4.63 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 100.91 -3.737 . . . . 0.0 100.91 -179.265 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.479 HG21 ' CD1' ' A' ' 210' ' ' TYR . 1.5 pt -125.92 147.69 30.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 101.295 -3.594 . . . . 0.0 101.295 174.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.447 ' O ' ' N ' ' A' ' 176' ' ' GLY . . . -86.29 154.44 21.25 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 103.45 -2.796 . . . . 0.0 103.45 178.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.0 m -124.8 -0.93 5.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 126.089 2.118 . . . . 0.0 107.655 177.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -133.2 165.28 24.08 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 177.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -105.27 145.77 30.23 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 178.069 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -137.77 177.59 7.76 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 117.978 -1.489 . . . . 0.0 109.119 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 87.9 m -132.28 160.7 35.44 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.101 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -100.52 130.51 46.61 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 175.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -106.82 -30.51 8.87 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 -178.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -119.44 -177.82 3.46 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 113.253 -1.794 . . . . 0.0 108.22 -179.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 61.1 t -92.77 150.97 3.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 101.899 -3.371 . . . . 0.0 101.899 176.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 110.39 -48.44 0.94 Allowed Glycine 0 N--CA 1.488 2.142 0 N-CA-C 106.057 -2.817 . . . . 0.0 106.057 -176.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.434 ' HA ' ' HB2' ' A' ' 201' ' ' LEU . 0.3 OUTLIER -73.29 169.6 16.77 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 123.879 1.8 . . . . 0.0 114.189 179.911 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.452 ' HG ' ' HA3' ' A' ' 200' ' ' GLY . 9.7 mt -121.04 -178.05 3.65 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 109.404 -3.544 . . . . 0.0 110.243 177.203 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 18.4 m -115.09 -65.15 1.22 Allowed 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 113.955 -1.475 . . . . 0.0 107.967 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 21.7 p90 42.64 166.26 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 116.867 2.173 . . . . 0.0 116.867 -178.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -113.82 -166.84 1.13 Allowed 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 113.562 -1.653 . . . . 0.0 112.728 179.217 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.415 ' CG ' ' N ' ' A' ' 176' ' ' GLY . 37.2 tttp -98.39 161.56 13.62 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 110.924 -2.853 . . . . 0.0 112.826 -178.548 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 159' ' ' ALA . . . 37.39 46.45 1.44 Allowed Glycine 0 N--CA 1.492 2.399 0 CA-C-N 112.665 -2.061 . . . . 0.0 110.172 179.297 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.451 ' O ' ' HA ' ' A' ' 158' ' ' ILE . 5.0 pt-20 -123.35 176.41 6.15 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-N 111.045 -2.578 . . . . 0.0 106.875 177.313 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 13.9 mm -108.24 125.67 64.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 C-N-CA 119.392 -0.923 . . . . 0.0 111.338 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 24.2 mt -119.78 165.59 14.36 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 114.575 -1.193 . . . . 0.0 108.37 177.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.403 ' HG ' ' N ' ' A' ' 181' ' ' VAL . 45.7 tp -118.11 163.24 16.93 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 178.553 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.408 HG21 ' CE1' ' A' ' 157' ' ' TYR . 69.0 t -113.24 142.25 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 178.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.554 ' O ' ' HB ' ' A' ' 191' ' ' ILE . 3.2 mm -141.86 75.41 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 104.551 -2.389 . . . . 0.0 104.551 173.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' GLU . . . . . 0.51 ' HG2' ' N ' ' A' ' 184' ' ' LYS . 38.8 tt0 127.47 148.39 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.539 0 C-N-CA 127.255 2.222 . . . . 0.0 108.794 178.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' LYS . . . . . 0.51 ' N ' ' HG2' ' A' ' 183' ' ' GLU . 92.6 mttt -126.4 133.06 51.38 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.117 -1.033 . . . . 0.0 111.787 177.418 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.51 ' CG ' ' HE1' ' A' ' 190' ' ' TRP . 3.5 tttm -7.98 80.86 0.03 OUTLIER Pre-proline 0 N--CA 1.501 2.081 0 O-C-N 126.683 2.489 . . . . 0.0 116.972 177.279 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 185' ' ' LYS . 58.3 Cg_endo -72.59 -56.57 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.732 0 N-CA-C 104.136 -3.063 . . . . 0.0 104.136 175.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -134.14 23.2 3.82 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 113.604 -1.635 . . . . 0.0 107.999 178.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.474 ' HA2' ' HG2' ' A' ' 185' ' ' LYS . . . 127.65 -21.46 5.64 Favored Glycine 0 N--CA 1.489 2.223 0 CA-C-O 117.902 -1.499 . . . . 0.0 113.258 -178.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -105.05 156.14 18.34 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 118.018 2.599 . . . . 0.0 118.018 -176.129 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' TRP . . . . . 0.524 ' NE1' ' HB2' ' A' ' 204' ' ' ARG . 20.4 m95 -130.12 147.47 51.86 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 100.344 -3.947 . . . . 0.0 100.344 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.554 ' HB ' ' O ' ' A' ' 182' ' ' ILE . 12.4 mm -109.22 87.27 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 N-CA-C 102.998 -2.964 . . . . 0.0 102.998 178.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -80.02 175.04 10.99 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 113.247 -1.797 . . . . 0.0 113.848 -173.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -130.4 166.45 20.44 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 174.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -126.34 -161.89 1.09 Allowed 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 118.869 -1.132 . . . . 0.0 110.416 178.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -101.44 32.77 3.18 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.711 -178.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -129.1 -33.8 1.94 Allowed 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.092 176.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 138.07 -39.03 1.64 Allowed Glycine 0 N--CA 1.486 1.967 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.525 -179.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 21.3 p30 -56.84 159.84 3.81 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 118.536 -1.266 . . . . 0.0 114.267 -178.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.457 ' HG3' ' N ' ' A' ' 200' ' ' GLY . 0.1 OUTLIER -140.69 166.12 25.62 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 112.008 -2.36 . . . . 0.0 109.573 179.175 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 200' ' ' GLY . . . . . 0.457 ' N ' ' HG3' ' A' ' 199' ' ' GLU . . . 159.41 174.01 28.59 Favored Glycine 0 N--CA 1.486 2.013 0 C-N-CA 118.148 -1.977 . . . . 0.0 114.684 177.576 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.434 ' HB2' ' HA ' ' A' ' 170' ' ' ASP . 9.8 mp -59.45 91.82 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 117.052 2.241 . . . . 0.0 117.052 -179.078 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 5.5 m -107.41 149.62 39.02 Favored Pre-proline 0 C--N 1.302 -1.495 0 N-CA-C 100.417 -3.92 . . . . 0.0 100.417 174.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -86.17 167.41 9.33 Favored 'Trans proline' 0 C--N 1.299 -2.033 0 N-CA-C 107.437 -1.794 . . . . 0.0 107.437 178.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' ARG . . . . . 0.524 ' HB2' ' NE1' ' A' ' 190' ' ' TRP . 12.2 ttp85 -80.22 -36.88 34.13 Favored 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 115.856 -2.338 . . . . 0.0 107.458 176.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 40.8 p -23.73 -54.82 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -110.52 47.4 0.97 Allowed 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.539 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -134.33 101.1 4.88 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 179.361 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -102.52 151.41 38.22 Favored Pre-proline 0 C--N 1.298 -1.654 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -57.61 164.78 6.96 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.176 1.918 . . . . 0.0 111.757 -178.112 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' TYR . . . . . 0.479 ' CD1' HG21 ' A' ' 158' ' ' ILE . 9.7 t80 -121.69 179.23 4.54 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.544 -0.862 . . . . 0.0 109.592 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 48.8 m -111.77 24.5 12.64 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.596 -0.842 . . . . 0.0 110.277 -179.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 . . . . . 0 N--CA 1.487 1.414 0 CA-C-O 115.103 -2.38 . . . . 0.0 106.256 177.212 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 91.7 m . . . . . 0 N--CA 1.492 1.626 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 40.62 -168.68 0.01 OUTLIER Glycine 0 N--CA 1.497 2.717 0 N-CA-C 116.64 1.416 . . . . 0.0 116.64 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -123.46 168.31 12.73 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 178.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -112.32 135.21 53.29 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 124.216 1.96 . . . . 0.0 110.782 -178.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.485 ' CE1' HG21 ' A' ' 181' ' ' VAL . 16.9 m-85 -133.57 175.12 9.71 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 109.28 -3.6 . . . . 0.0 106.251 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.485 ' HA ' ' HA ' ' A' ' 178' ' ' ILE . 1.3 pt -132.03 152.54 36.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 101.475 -3.528 . . . . 0.0 101.475 171.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.48 ' O ' ' N ' ' A' ' 176' ' ' GLY . . . -90.33 152.89 20.82 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 102.287 -3.227 . . . . 0.0 102.287 177.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.444 ' C ' ' HB2' ' A' ' 175' ' ' LYS . 29.1 m -129.41 10.96 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 125.864 1.978 . . . . 0.0 107.765 177.386 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.401 ' N ' ' HB2' ' A' ' 175' ' ' LYS . . . -137.82 161.05 25.43 Favored Glycine 0 N--CA 1.478 1.474 0 N-CA-C 106.751 -2.54 . . . . 0.0 106.751 173.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -101.18 150.2 23.2 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 104.061 -2.57 . . . . 0.0 104.061 176.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -132.7 177.33 7.71 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 117.816 -1.554 . . . . 0.0 109.145 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 96.8 m -128.65 157.95 39.89 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 177.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -100.09 145.03 28.43 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 178.105 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 55.3 tp60 -111.21 -37.24 5.37 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -125.56 171.66 10.36 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 113.312 -1.767 . . . . 0.0 108.098 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 67.9 t -60.42 -48.63 87.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 103.873 -2.64 . . . . 0.0 103.873 177.1 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -30.29 -50.73 0.18 Allowed Glycine 0 N--CA 1.491 2.306 0 CA-C-N 112.308 -2.223 . . . . 0.0 113.399 174.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.536 ' HA ' ' H ' ' A' ' 201' ' ' LEU . 28.7 m-20 -79.83 164.15 23.84 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 113.738 -1.231 . . . . 0.0 113.339 -178.676 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.434 HD11 ' C ' ' A' ' 199' ' ' GLU . 16.6 mt -114.92 177.95 4.46 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 104.345 -2.465 . . . . 0.0 104.345 175.27 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 31.4 m -107.66 -57.46 2.09 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 33.1 p90 33.76 164.38 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 118.811 2.893 . . . . 0.0 118.811 -178.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -109.25 -166.55 1.12 Allowed 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 113.749 -1.569 . . . . 0.0 112.476 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.444 ' HB2' ' C ' ' A' ' 160' ' ' VAL . 10.4 ptpt -107.51 176.83 5.02 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 111.222 -2.717 . . . . 0.0 113.73 -176.506 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 159' ' ' ALA . . . 34.72 44.21 0.45 Allowed Glycine 0 N--CA 1.491 2.351 0 O-C-N 126.327 2.267 . . . . 0.0 109.097 -177.56 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.421 ' O ' ' HA ' ' A' ' 158' ' ' ILE . 16.7 pt-20 -130.0 175.6 8.75 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-N 110.758 -2.721 . . . . 0.0 106.555 177.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.485 ' HA ' ' HA ' ' A' ' 158' ' ' ILE . 17.9 mm -101.6 123.19 54.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -175.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 6.8 mp -116.89 156.27 27.64 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.568 177.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.496 HD13 ' H ' ' A' ' 181' ' ' VAL . 0.6 OUTLIER -114.77 152.05 32.73 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 -177.181 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.496 ' H ' HD13 ' A' ' 180' ' ' LEU . 59.6 t -111.6 132.91 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 -179.273 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.569 ' O ' ' HB ' ' A' ' 191' ' ' ILE . 9.9 mt -142.59 78.88 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 CA-C-N 114.177 -1.374 . . . . 0.0 108.758 179.262 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' GLU . . . . . 0.484 ' HG2' ' N ' ' A' ' 184' ' ' LYS . 33.6 tt0 122.0 165.13 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 C-N-CA 128.081 2.552 . . . . 0.0 109.616 173.564 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' LYS . . . . . 0.484 ' N ' ' HG2' ' A' ' 183' ' ' GLU . 98.4 mttt -110.37 167.03 10.51 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.206 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.708 ' HB3' ' CD1' ' A' ' 190' ' ' TRP . 17.8 pttp -95.85 68.4 0.03 OUTLIER Pre-proline 0 N--CA 1.508 2.469 0 N-CA-C 120.623 3.564 . . . . 0.0 120.623 -179.014 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -35.1 -56.5 0.5 Allowed 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 123.288 2.659 . . . . 0.0 108.938 171.137 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -121.16 23.77 10.39 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 112.95 -1.932 . . . . 0.0 114.069 179.255 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.602 ' CA ' ' HB2' ' A' ' 185' ' ' LYS . . . 110.7 17.46 9.14 Favored Glycine 0 N--CA 1.5 2.962 0 C-N-CA 119.644 -1.265 . . . . 0.0 112.658 178.235 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 2.0 m-90 -129.81 111.99 13.16 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 119.41 3.115 . . . . 0.0 119.41 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' TRP . . . . . 0.708 ' CD1' ' HB3' ' A' ' 185' ' ' LYS . 28.7 m0 -106.54 160.4 15.45 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 101.856 -3.387 . . . . 0.0 101.856 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.569 ' HB ' ' O ' ' A' ' 182' ' ' ILE . 1.5 mp -115.43 114.21 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 N-CA-C 103.359 -2.83 . . . . 0.0 103.359 173.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -116.26 176.84 4.92 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -171.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 199' ' ' GLU . 27.3 mtpp -126.84 161.03 29.2 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 173.041 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 17.9 p30 -120.59 -165.85 1.25 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 124.254 0.971 . . . . 0.0 111.64 178.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -99.9 39.12 1.36 Allowed 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 40.8 mmtm -118.66 -37.37 3.29 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 179.139 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 134.62 -35.87 2.15 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 120.142 -1.028 . . . . 0.0 111.47 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 38.2 p30 -90.96 174.78 7.24 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 116.153 1.909 . . . . 0.0 116.153 -178.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.434 ' C ' HD11 ' A' ' 171' ' ' LEU . 0.3 OUTLIER -117.74 161.27 19.97 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 111.964 -2.38 . . . . 0.0 110.08 -179.383 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 200' ' ' GLY . . . . . 0.423 ' N ' ' HG3' ' A' ' 199' ' ' GLU . . . -144.97 -170.21 13.9 Favored Glycine 0 N--CA 1.477 1.411 0 C-N-CA 119.326 -1.416 . . . . 0.0 111.453 -179.433 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.536 ' H ' ' HA ' ' A' ' 170' ' ' ASP . 14.4 mt -113.92 88.01 2.75 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 110.645 -2.777 . . . . 0.0 103.914 177.044 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 4.8 m -115.27 156.65 45.35 Favored Pre-proline 0 N--CA 1.489 1.493 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 -174.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -90.02 -179.82 1.87 Allowed 'Trans proline' 0 C--N 1.298 -2.087 0 C-N-CA 122.299 2.0 . . . . 0.0 106.976 178.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' ARG . . . . . 0.554 ' HB2' ' CE2' ' A' ' 190' ' ' TRP . 0.7 OUTLIER -102.9 -41.93 5.99 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 102.503 -3.147 . . . . 0.0 102.503 175.849 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 77.9 p -17.76 -46.28 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 O-C-N 126.616 2.447 . . . . 0.0 116.515 176.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 206' ' ' TYR . . . . . 0.403 ' N ' ' O ' ' A' ' 204' ' ' ARG . 36.4 m-85 -110.27 42.1 1.62 Allowed 'General case' 0 N--CA 1.503 2.205 0 CA-C-N 118.85 0.75 . . . . 0.0 112.643 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 6.1 mp -131.06 162.21 30.32 Favored 'General case' 0 N--CA 1.499 1.979 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.014 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -134.5 156.81 78.49 Favored Pre-proline 0 C--N 1.303 -1.433 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 172.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -72.26 170.69 18.54 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 N-CA-C 106.995 -1.964 . . . . 0.0 106.995 178.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' TYR . . . . . 0.451 ' CD1' HG21 ' A' ' 158' ' ' ILE . 5.2 t80 -122.91 173.16 7.97 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 118.483 -1.287 . . . . 0.0 110.004 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 32.8 t -123.49 62.19 1.04 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 123.87 0.732 . . . . 0.0 111.448 -179.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 . . . . . 0 N--CA 1.494 1.756 0 CA-C-O 115.68 -2.105 . . . . 0.0 108.861 177.838 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 35.6 m . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -46.22 170.18 0.03 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 116.377 1.311 . . . . 0.0 116.377 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -122.15 156.07 34.43 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 113.196 -1.502 . . . . 0.0 107.977 -179.217 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -104.61 128.04 52.52 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 117.897 -1.521 . . . . 0.0 111.373 -178.255 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.461 ' CE1' HG21 ' A' ' 181' ' ' VAL . 15.9 m-85 -122.1 174.8 6.71 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 104.678 -2.341 . . . . 0.0 104.678 178.315 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.48 HG21 ' CD1' ' A' ' 210' ' ' TYR . 1.7 pt -125.53 146.32 31.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 102.694 -3.076 . . . . 0.0 102.694 172.472 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.41 156.47 20.15 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 101.361 -3.57 . . . . 0.0 101.361 176.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 33.2 m -122.52 2.53 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 126.106 2.129 . . . . 0.0 108.274 178.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -125.92 167.73 18.24 Favored Glycine 0 N--CA 1.482 1.76 0 N-CA-C 106.504 -2.638 . . . . 0.0 106.504 177.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.413 ' HA ' ' HA ' ' A' ' 174' ' ' LYS . 23.2 t70 -105.53 114.36 28.49 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.271 -0.972 . . . . 0.0 109.913 179.201 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.445 ' HB3' ' CZ ' ' A' ' 173' ' ' PHE . 46.2 t80 -112.3 154.63 25.37 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.409 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 99.9 m -130.16 159.78 35.78 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 178.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -96.7 103.54 15.46 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 118.31 -1.356 . . . . 0.0 109.404 178.027 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -117.75 -0.72 11.72 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.009 -178.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.402 ' O ' ' C ' ' A' ' 168' ' ' VAL . 22.0 mm100 -121.43 179.14 4.53 Favored 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 118.418 -1.313 . . . . 0.0 109.639 -177.618 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.402 ' C ' ' O ' ' A' ' 167' ' ' GLN . 96.0 t -25.25 -73.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 126.112 2.132 . . . . 0.0 111.06 179.533 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -133.55 141.13 12.45 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 107.489 -2.244 . . . . 0.0 107.489 174.152 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -167.64 -179.24 4.24 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 110.372 -2.914 . . . . 0.0 108.181 -179.263 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.499 ' HG ' ' CA ' ' A' ' 200' ' ' GLY . 16.5 mt -132.34 175.23 9.46 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 169.692 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 55.1 m -122.05 96.21 4.96 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.282 178.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.445 ' CZ ' ' HB3' ' A' ' 163' ' ' PHE . 17.6 p90 -118.6 168.47 10.67 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.944 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 162' ' ' ASP . 13.2 ptpt -126.1 151.25 47.47 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 116.299 1.963 . . . . 0.0 116.299 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 60.1 tttt -27.11 79.1 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.665 1 CA-C-N 108.337 -4.028 . . . . 0.0 116.14 171.22 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 109.61 48.21 0.81 Allowed Glycine 0 N--CA 1.491 2.309 0 CA-C-N 114.775 -1.102 . . . . 0.0 112.611 176.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' A' ' 158' ' ' ILE . 9.5 pt-20 -138.49 151.81 47.72 Favored 'General case' 0 N--CA 1.507 2.38 0 C-N-CA 117.35 -1.74 . . . . 0.0 109.135 178.184 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.465 HD12 ' N ' ' A' ' 178' ' ' ILE . 1.3 mp -82.95 137.59 20.74 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 117.765 2.505 . . . . 0.0 117.765 -177.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.413 HD22 ' N ' ' A' ' 179' ' ' LEU . 2.4 mm? -125.63 173.37 9.03 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 104.2 -2.518 . . . . 0.0 104.2 175.466 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.5 ' HB2' ' HB2' ' A' ' 193' ' ' LYS . 9.8 mt -117.75 161.34 19.86 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 176.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.461 HG21 ' CE1' ' A' ' 157' ' ' TYR . 78.1 t -113.49 124.43 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 N-CA-C 117.674 2.472 . . . . 0.0 117.674 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.566 ' O ' ' HB ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -135.45 77.53 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 CA-C-N 111.371 -2.65 . . . . 0.0 108.257 176.406 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 183' ' ' GLU . . . . . 0.55 ' HG2' ' N ' ' A' ' 184' ' ' LYS . 35.7 tt0 117.13 164.28 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 128.214 2.606 . . . . 0.0 110.129 173.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' LYS . . . . . 0.55 ' N ' ' HG2' ' A' ' 183' ' ' GLU . 99.5 mttt -108.87 -177.45 3.31 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.368 178.53 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.69 ' HD2' ' HB3' ' A' ' 204' ' ' ARG . 8.2 ptmm? -91.43 73.34 0.01 OUTLIER Pre-proline 0 N--CA 1.515 2.782 0 C-N-CA 130.326 3.45 . . . . 0.0 118.018 -177.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.505 ' HD2' ' O ' ' A' ' 184' ' ' LYS . 9.2 Cg_endo -44.31 -56.57 2.46 Favored 'Trans proline' 0 C--N 1.3 -1.981 0 C-N-CA 123.251 2.634 . . . . 0.0 106.802 174.009 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -126.24 24.2 6.88 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 112.582 -2.099 . . . . 0.0 110.665 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.498 ' CA ' ' HB2' ' A' ' 185' ' ' LYS . . . 110.22 15.78 11.19 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -128.13 102.78 6.86 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 119.933 3.309 . . . . 0.0 119.933 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' TRP . . . . . 0.675 ' CD1' ' HB3' ' A' ' 185' ' ' LYS . 10.7 m0 -95.93 157.05 16.07 Favored 'General case' 0 N--CA 1.498 1.933 1 N-CA-C 99.685 -4.191 . . . . 0.0 99.685 -177.926 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.566 ' HB ' ' O ' ' A' ' 182' ' ' ILE . 1.4 mp -112.54 140.99 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 1 N-CA-C 99.893 -4.114 . . . . 0.0 99.893 173.698 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -132.87 -177.95 4.73 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 119.319 -0.952 . . . . 0.0 113.542 -174.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.5 ' HB2' ' HB2' ' A' ' 180' ' ' LEU . 62.6 mmtt -128.22 169.25 14.37 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 172.537 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -125.03 -158.0 0.81 Allowed 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.34 -0.944 . . . . 0.0 109.548 178.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -104.71 39.06 1.76 Allowed 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 121.33 0.586 . . . . 0.0 109.967 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -132.26 -37.39 1.1 Allowed 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.56 177.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 134.72 -22.24 3.69 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 -178.311 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -78.08 164.6 24.87 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.005 -1.078 . . . . 0.0 112.934 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.76 158.17 30.76 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 112.203 -2.271 . . . . 0.0 109.74 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 200' ' ' GLY . . . . . 0.499 ' CA ' ' HG ' ' A' ' 171' ' ' LEU . . . -135.46 -172.22 12.63 Favored Glycine 0 N--CA 1.479 1.501 0 CA-C-O 123.985 1.881 . . . . 0.0 115.115 -177.211 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.455 HD23 ' HA ' ' A' ' 201' ' ' LEU . 9.5 mt -126.2 87.06 2.61 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 108.568 -3.816 . . . . 0.0 103.684 177.007 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 4.9 m -116.79 156.5 47.86 Favored Pre-proline 0 C--N 1.303 -1.45 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 -173.061 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 0.6 OUTLIER -92.0 174.7 2.18 Favored 'Trans proline' 0 C--N 1.299 -2.061 0 N-CA-C 105.564 -2.514 . . . . 0.0 105.564 178.181 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 204' ' ' ARG . . . . . 0.69 ' HB3' ' HD2' ' A' ' 185' ' ' LYS . 0.4 OUTLIER -108.85 -31.06 7.83 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 175.502 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 82.5 p -23.68 -47.16 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.173 0 O-C-N 125.742 1.901 . . . . 0.0 113.875 171.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -112.53 49.49 0.92 Allowed 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 119.745 -0.782 . . . . 0.0 111.77 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -132.68 156.89 46.15 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.332 -179.449 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -132.02 157.6 77.78 Favored Pre-proline 0 N--CA 1.495 1.791 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 174.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -73.24 158.61 48.56 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 121.283 1.322 . . . . 0.0 108.708 178.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' TYR . . . . . 0.48 ' CD1' HG21 ' A' ' 158' ' ' ILE . 6.8 t80 -137.18 58.79 1.7 Allowed 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.4 -0.92 . . . . 0.0 109.066 179.148 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 49.2 m -100.51 61.51 1.03 Allowed 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 -178.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.303 -1.455 0 CA-C-N 112.297 -2.229 . . . . 0.0 109.952 -179.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 10.1 t . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -115.73 -175.22 18.09 Favored Glycine 0 N--CA 1.485 1.907 0 C-N-CA 120.399 -0.905 . . . . 0.0 113.707 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -119.29 166.59 12.82 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 104.907 -2.257 . . . . 0.0 104.907 -179.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -103.48 117.01 33.47 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 117.704 -1.598 . . . . 0.0 113.492 -178.057 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.462 ' CD1' HG21 ' A' ' 181' ' ' VAL . 5.5 m-85 -123.59 174.91 7.13 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 102.623 -3.103 . . . . 0.0 102.623 177.013 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.511 HG22 HG13 ' A' ' 178' ' ' ILE . 5.7 pt -131.62 150.76 34.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 103.312 -2.847 . . . . 0.0 103.312 172.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -81.71 151.45 27.51 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 102.848 -3.019 . . . . 0.0 102.848 176.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 26.8 m -129.69 10.72 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 125.866 1.978 . . . . 0.0 107.75 177.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -126.89 164.18 20.55 Favored Glycine 0 N--CA 1.484 1.852 0 N-CA-C 105.17 -3.172 . . . . 0.0 105.17 176.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -105.83 83.91 1.99 Allowed 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 118.709 -1.196 . . . . 0.0 109.277 -179.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -104.43 115.96 31.28 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 122.605 1.193 . . . . 0.0 108.425 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 18.2 m -101.01 154.35 18.77 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 111.944 -2.389 . . . . 0.0 106.379 -179.077 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.39 129.71 34.75 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 117.168 -1.813 . . . . 0.0 106.447 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -107.42 -29.31 9.32 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 -178.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -119.2 -175.67 2.97 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 113.586 -1.643 . . . . 0.0 106.616 179.149 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 61.4 t -88.76 151.76 3.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 179.172 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 114.33 -53.04 0.62 Allowed Glycine 0 N--CA 1.487 2.074 0 N-CA-C 108.644 -1.782 . . . . 0.0 108.644 -178.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.5 ' HA ' ' H ' ' A' ' 201' ' ' LEU . 39.8 m-20 -78.58 169.52 18.11 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 113.951 -1.125 . . . . 0.0 111.668 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.428 ' HG ' ' HA3' ' A' ' 200' ' ' GLY . 15.4 mt -121.01 176.02 5.77 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.182 177.319 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 31.3 m -116.92 93.09 4.06 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 114.12 -1.4 . . . . 0.0 112.273 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -128.17 166.85 17.73 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 113.512 -1.676 . . . . 0.0 109.274 177.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -125.39 159.82 30.9 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 117.001 2.223 . . . . 0.0 117.001 -178.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 44.4 tttm -35.97 77.45 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.659 1 CA-C-N 108.008 -4.178 . . . . 0.0 116.655 173.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 114.9 47.86 0.55 Allowed Glycine 0 N--CA 1.494 2.504 0 CA-C-N 114.866 -1.061 . . . . 0.0 115.126 174.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -137.51 158.66 43.92 Favored 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 117.472 -1.691 . . . . 0.0 107.576 175.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.511 HG13 HG22 ' A' ' 158' ' ' ILE . 1.1 mp -84.57 134.26 27.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 -176.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.7 mp -135.62 168.83 18.54 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 113.158 -1.837 . . . . 0.0 108.7 175.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.429 ' O ' ' HB1' ' A' ' 192' ' ' ALA . 27.9 mt -107.09 154.09 21.66 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 176.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.465 HG12 ' HB3' ' A' ' 190' ' ' TRP . 2.3 t -122.52 132.69 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 118.367 -1.333 . . . . 0.0 108.502 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.473 ' O ' ' CB ' ' A' ' 183' ' ' GLU . 16.6 mt -139.77 79.99 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 120.264 -0.575 . . . . 0.0 111.658 -173.602 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' GLU . . . . . 0.506 ' O ' ' CE3' ' A' ' 190' ' ' TRP . 3.7 tm-20 136.34 147.56 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.976 0 C-N-CA 127.63 2.372 . . . . 0.0 108.816 173.249 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' LYS . . . . . 0.439 ' HG2' ' CZ3' ' A' ' 190' ' ' TRP . 62.0 mttp -105.54 104.19 13.87 Favored 'General case' 0 N--CA 1.509 2.504 0 N-CA-C 119.727 3.232 . . . . 0.0 119.727 -171.509 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.523 ' HA ' ' HD2' ' A' ' 186' ' ' PRO . 21.8 pttp -15.09 79.25 0.02 OUTLIER Pre-proline 0 N--CA 1.5 2.074 1 N-CA-C 122.407 4.225 . . . . 0.0 122.407 179.249 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.523 ' HD2' ' HA ' ' A' ' 185' ' ' LYS . 11.0 Cg_endo -45.35 -59.93 1.01 Allowed 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 123.886 3.057 . . . . 0.0 107.321 171.562 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -121.86 20.75 10.82 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 111.399 -2.637 . . . . 0.0 110.638 -178.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.513 ' CA ' ' HB2' ' A' ' 185' ' ' LYS . . . 114.71 12.18 10.64 Favored Glycine 0 N--CA 1.488 2.154 0 C-N-CA 119.717 -1.23 . . . . 0.0 110.876 179.591 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 189' ' ' TRP . . . . . 0.402 ' O ' ' HD2' ' A' ' 186' ' ' PRO . 2.5 m-90 -127.49 134.3 49.82 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 120.318 3.451 . . . . 0.0 120.318 179.344 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 190' ' ' TRP . . . . . 0.506 ' CE3' ' O ' ' A' ' 183' ' ' GLU . 10.2 m95 -120.11 163.06 18.27 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 104.824 -2.287 . . . . 0.0 104.824 178.617 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.457 ' HB ' ' O ' ' A' ' 182' ' ' ILE . 1.7 mp -107.45 113.0 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 104.179 -2.526 . . . . 0.0 104.179 177.048 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 192' ' ' ALA . . . . . 0.442 ' HB2' HG22 ' A' ' 202' ' ' VAL . . . -108.2 -179.81 3.99 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -173.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 199' ' ' GLU . 96.5 mttt -133.6 165.31 25.21 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 172.454 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -115.62 -160.0 0.73 Allowed 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 118.822 -1.151 . . . . 0.0 109.658 -179.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -97.18 38.67 1.23 Allowed 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.874 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -133.36 -38.38 0.94 Allowed 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.45 177.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 136.87 -39.71 1.6 Allowed Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -178.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 21.5 p30 -52.78 164.27 0.39 Allowed 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.411 ' C ' HD11 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -122.95 157.69 32.07 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 113.049 -1.887 . . . . 0.0 110.552 179.83 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 200' ' ' GLY . . . . . 0.428 ' HA3' ' HG ' ' A' ' 171' ' ' LEU . . . -142.58 -165.48 10.6 Favored Glycine 0 N--CA 1.482 1.709 0 CA-C-O 122.671 1.151 . . . . 0.0 112.387 -177.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.5 ' H ' ' HA ' ' A' ' 170' ' ' ASP . 33.7 mt -125.2 89.98 3.15 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 111.242 -2.479 . . . . 0.0 106.547 177.22 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.442 HG22 ' HB2' ' A' ' 192' ' ' ALA . 2.1 m -116.74 154.82 49.45 Favored Pre-proline 0 N--CA 1.496 1.871 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -177.313 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -89.59 176.26 2.99 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 C-N-CA 123.177 2.585 . . . . 0.0 111.391 -177.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 204' ' ' ARG . . . . . 0.476 ' HB2' ' CE2' ' A' ' 190' ' ' TRP . 29.3 ttm180 -97.97 -40.09 8.64 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 102.637 -3.097 . . . . 0.0 102.637 174.04 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 73.8 p -25.14 -55.24 0.05 OUTLIER 'General case' 0 N--CA 1.503 2.202 0 O-C-N 125.512 1.758 . . . . 0.0 115.54 176.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -113.66 45.65 1.41 Allowed 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 122.62 1.2 . . . . 0.0 109.387 -178.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -135.75 128.73 31.41 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 112.361 -2.2 . . . . 0.0 105.369 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -114.2 156.09 44.71 Favored Pre-proline 0 N--CA 1.494 1.744 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 178.383 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -63.21 166.11 15.53 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 121.693 1.595 . . . . 0.0 110.122 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' TYR . . . . . 0.428 ' CG ' ' N ' ' A' ' 211' ' ' SER . 35.6 t80 -124.33 172.69 8.92 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.688 -0.805 . . . . 0.0 109.511 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 211' ' ' SER . . . . . 0.428 ' N ' ' CG ' ' A' ' 210' ' ' TYR . 56.1 m -116.11 50.52 1.03 Allowed 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.004 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 . . . . . 0 N--CA 1.494 1.753 0 CA-C-O 115.121 -2.371 . . . . 0.0 115.495 178.9 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.119 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -126.55 161.31 28.3 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 103.537 -2.764 . . . . 0.0 103.537 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -115.1 136.3 53.27 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 116.444 -2.102 . . . . 0.0 112.855 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.484 ' CD1' HG21 ' A' ' 181' ' ' VAL . 6.0 m-85 -124.99 -178.99 4.36 Favored 'General case' 0 C--N 1.299 -1.6 1 N-CA-C 100.068 -4.049 . . . . 0.0 100.068 179.085 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.408 HD13 HG21 ' A' ' 158' ' ' ILE . 3.5 pt -125.22 154.6 33.61 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 N-CA-C 101.914 -3.365 . . . . 0.0 101.914 173.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -89.26 150.63 22.54 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 102.02 -3.326 . . . . 0.0 102.02 177.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.2 m -130.09 28.36 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 126.238 2.211 . . . . 0.0 106.545 177.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -142.23 158.94 27.01 Favored Glycine 0 N--CA 1.482 1.754 0 N-CA-C 105.711 -2.956 . . . . 0.0 105.711 174.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.438 ' HA ' ' HA ' ' A' ' 174' ' ' LYS . 9.9 t70 -107.68 94.29 5.0 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 118.928 -1.109 . . . . 0.0 108.786 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.498 ' HB3' ' CZ ' ' A' ' 173' ' ' PHE . 47.6 t80 -107.65 154.09 21.96 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.086 -1.046 . . . . 0.0 108.921 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.416 ' HB ' HE22 ' A' ' 166' ' ' GLN . 56.7 m -127.0 163.43 23.72 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 105.442 -2.059 . . . . 0.0 105.442 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -95.25 135.03 37.34 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 177.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . 0.416 HE22 ' HB ' ' A' ' 164' ' ' THR . 16.6 mp0 -110.74 -29.81 7.84 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -115.63 -178.07 3.3 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 58.5 t -88.95 150.91 3.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 104.822 -2.288 . . . . 0.0 104.822 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 113.51 -51.89 0.68 Allowed Glycine 0 N--CA 1.485 1.929 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 -178.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.591 ' HA ' ' H ' ' A' ' 201' ' ' LEU . 2.9 m-20 -76.99 166.5 23.23 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -178.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.508 ' HG ' ' HA3' ' A' ' 200' ' ' GLY . 16.4 mt -121.26 178.82 4.62 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 113.449 -1.705 . . . . 0.0 109.935 179.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 39.0 m -122.03 100.02 6.75 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.57 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.498 ' CZ ' ' HB3' ' A' ' 163' ' ' PHE . 18.0 p90 -119.21 168.28 11.03 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.531 -0.867 . . . . 0.0 110.88 178.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 162' ' ' ASP . 57.2 pttt -124.84 142.79 51.2 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 115.882 1.808 . . . . 0.0 115.882 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 49.9 tptt -23.9 77.95 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 109.583 -3.462 . . . . 0.0 115.215 170.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 107.78 50.5 0.79 Allowed Glycine 0 N--CA 1.49 2.281 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.913 176.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.402 ' O ' ' HA ' ' A' ' 158' ' ' ILE . 8.0 pt-20 -127.95 170.85 12.39 Favored 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 176.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.405 ' HA ' ' HA ' ' A' ' 158' ' ' ILE . 14.4 mm -99.8 132.76 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 117.98 -1.488 . . . . 0.0 112.11 -177.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 57.9 mt -124.74 167.79 14.09 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 113.561 -1.654 . . . . 0.0 110.077 177.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.402 ' O ' ' HB1' ' A' ' 192' ' ' ALA . 22.2 tp -117.47 159.72 22.36 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 102.746 -3.057 . . . . 0.0 102.746 177.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.484 HG21 ' CD1' ' A' ' 157' ' ' TYR . 3.2 t -128.14 136.71 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 CA-C-N 120.915 1.689 . . . . 0.0 109.306 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.505 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 45.8 mt -145.35 86.13 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.093 -176.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . 0.505 ' HB2' ' O ' ' A' ' 182' ' ' ILE . 10.1 tm-20 130.56 153.18 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.753 0 C-N-CA 128.109 2.564 . . . . 0.0 107.654 172.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -109.83 123.0 48.81 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 118.426 2.75 . . . . 0.0 118.426 -174.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.459 ' CG ' ' HE1' ' A' ' 190' ' ' TRP . 8.4 tttm -9.79 78.37 0.03 OUTLIER Pre-proline 0 N--CA 1.507 2.413 0 N-CA-C 117.746 2.499 . . . . 0.0 117.746 175.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -69.09 -56.53 0.16 Allowed 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 123.165 2.577 . . . . 0.0 105.96 175.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -125.35 19.28 8.18 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 112.067 -2.333 . . . . 0.0 111.791 -177.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.403 ' HA2' ' NZ ' ' A' ' 185' ' ' LYS . . . 122.07 -23.84 7.19 Favored Glycine 0 N--CA 1.487 2.074 0 C-N-CA 118.452 -1.832 . . . . 0.0 111.242 -178.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 24.7 m-90 -113.39 154.6 26.67 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 115.842 1.793 . . . . 0.0 115.842 -176.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' TRP . . . . . 0.459 ' HE1' ' CG ' ' A' ' 185' ' ' LYS . 18.3 m95 -122.73 163.91 19.28 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 101.767 -3.42 . . . . 0.0 101.767 -178.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.493 HG12 ' CB ' ' A' ' 183' ' ' GLU . 8.2 mm -102.9 105.57 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 C-N-CA 115.522 -2.471 . . . . 0.0 105.043 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . 0.425 ' HB2' HG22 ' A' ' 202' ' ' VAL . . . -98.43 -177.88 3.84 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -173.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . 0.465 ' HA ' ' HA ' ' A' ' 199' ' ' GLU . 34.0 ttmt -137.17 164.45 28.44 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 177.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 47.2 p-10 -122.45 -163.23 1.06 Allowed 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.664 -0.814 . . . . 0.0 110.077 178.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -103.36 40.86 1.34 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -126.17 -35.6 2.41 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 113.709 -1.587 . . . . 0.0 107.455 177.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 134.9 -38.96 1.75 Allowed Glycine 0 N--CA 1.487 2.071 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 21.1 p30 -67.8 163.78 21.03 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -178.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . 0.465 ' HA ' ' HA ' ' A' ' 193' ' ' LYS . 0.0 OUTLIER -129.53 149.48 51.28 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 112.121 -2.309 . . . . 0.0 108.609 177.181 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . 0.508 ' HA3' ' HG ' ' A' ' 171' ' ' LEU . . . -139.28 -156.34 6.94 Favored Glycine 0 N--CA 1.482 1.714 0 CA-C-N 114.789 -1.096 . . . . 0.0 113.187 -177.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.591 ' H ' ' HA ' ' A' ' 170' ' ' ASP . 90.3 mt -117.12 101.94 8.89 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 111.622 -2.289 . . . . 0.0 107.56 178.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.425 HG22 ' HB2' ' A' ' 192' ' ' ALA . 4.9 m -120.5 151.44 53.91 Favored Pre-proline 0 N--CA 1.496 1.828 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -82.38 175.85 8.56 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 121.19 1.26 . . . . 0.0 109.05 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . 0.411 ' HB2' ' NE1' ' A' ' 190' ' ' TRP . 0.0 OUTLIER -96.37 -42.89 7.91 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 102.994 -2.965 . . . . 0.0 102.994 178.273 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 77.3 p -23.44 -53.67 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 O-C-N 125.579 1.799 . . . . 0.0 115.469 178.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -112.34 49.04 0.94 Allowed 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.891 -0.724 . . . . 0.0 110.807 -178.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -131.15 129.49 41.85 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 179.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -121.0 143.68 37.48 Favored Pre-proline 0 N--CA 1.493 1.675 0 C-N-CA 118.729 -1.189 . . . . 0.0 108.198 177.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -58.91 161.21 16.02 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 121.703 1.602 . . . . 0.0 109.798 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 38.7 t80 . . . . . 0 N--CA 1.491 1.599 0 C-N-CA 118.853 -1.139 . . . . 0.0 112.176 -179.06 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.159 0 CA-C-O 121.169 0.316 . . . . 0.0 112.603 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -117.55 162.52 17.86 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 103.195 -2.891 . . . . 0.0 103.195 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 9.3 mp0 -116.31 118.63 33.28 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 117.54 -1.664 . . . . 0.0 110.943 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.515 ' CD1' HG21 ' A' ' 181' ' ' VAL . 41.3 m-85 -126.0 176.46 6.99 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 104.346 -2.464 . . . . 0.0 104.346 178.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.455 ' CG2' ' CD1' ' A' ' 210' ' ' TYR . 1.7 pt -124.87 146.2 30.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 1 N-CA-C 100.155 -4.017 . . . . 0.0 100.155 170.728 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -92.7 155.07 17.95 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 116.849 -1.941 . . . . 0.0 106.246 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.6 m -130.2 25.64 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 125.719 1.887 . . . . 0.0 110.02 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -121.66 146.28 17.09 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 106.687 -2.565 . . . . 0.0 106.687 176.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -104.9 78.06 1.39 Allowed 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -178.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -106.51 155.81 19.21 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.021 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 97.6 m -118.32 161.82 19.3 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -86.41 144.34 27.36 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 117.49 -1.684 . . . . 0.0 107.868 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -113.61 -30.07 6.94 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 113.043 -1.89 . . . . 0.0 106.584 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -116.88 176.39 5.14 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 19.4 t -96.83 45.42 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 103.925 -2.621 . . . . 0.0 103.925 176.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -127.68 -46.02 0.2 Allowed Glycine 0 N--CA 1.484 1.882 0 N-CA-C 106.84 -2.504 . . . . 0.0 106.84 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.522 ' HA ' ' H ' ' A' ' 201' ' ' LEU . 25.3 m-20 -79.89 169.85 17.31 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 112.7 -1.75 . . . . 0.0 111.308 179.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.457 ' HG ' ' HA3' ' A' ' 200' ' ' GLY . 15.9 mt -121.07 176.73 5.43 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.427 176.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 47.2 m -119.62 99.46 6.67 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 114.354 -1.294 . . . . 0.0 110.994 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.444 ' N ' ' CD1' ' A' ' 173' ' ' PHE . 1.3 p90 -118.67 161.94 19.25 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.021 -1.072 . . . . 0.0 111.282 178.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -118.51 62.98 0.77 Allowed 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 120.047 3.351 . . . . 0.0 120.047 -175.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 70.4 tttt 37.05 76.83 0.05 OUTLIER 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 116.838 2.162 . . . . 0.0 116.838 173.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 119.1 52.4 0.29 Allowed Glycine 0 N--CA 1.495 2.595 0 CA-C-N 113.68 -1.6 . . . . 0.0 111.703 177.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -131.1 173.37 11.09 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 177.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.444 ' HA ' ' HA ' ' A' ' 158' ' ' ILE . 18.0 mm -97.16 125.06 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 C-N-CA 118.672 -1.211 . . . . 0.0 112.456 -177.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 17.9 mt -118.31 168.25 10.79 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 114.104 -1.407 . . . . 0.0 110.234 177.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 14.5 tp -118.35 157.98 26.11 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 103.826 -2.657 . . . . 0.0 103.826 177.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.515 HG21 ' CD1' ' A' ' 157' ' ' TYR . 43.7 t -120.0 128.3 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-N 120.675 1.579 . . . . 0.0 112.865 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.514 ' O ' ' HB ' ' A' ' 191' ' ' ILE . 56.3 mt -145.61 86.19 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.284 -176.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . 0.491 ' CB ' ' O ' ' A' ' 182' ' ' ILE . 5.0 tm-20 131.08 151.26 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.932 0 C-N-CA 127.672 2.389 . . . . 0.0 109.11 172.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . 0.499 ' HG2' ' CZ3' ' A' ' 190' ' ' TRP . 55.2 mttp -119.37 123.74 44.89 Favored 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 119.69 3.218 . . . . 0.0 119.69 -171.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.559 ' CG ' ' HE1' ' A' ' 190' ' ' TRP . 2.9 tttm -12.43 80.67 0.03 OUTLIER Pre-proline 0 N--CA 1.512 2.664 0 N-CA-C 118.515 2.783 . . . . 0.0 118.515 175.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 189' ' ' TRP . 11.4 Cg_exo -78.59 -55.23 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.527 0 N-CA-C 105.143 -2.676 . . . . 0.0 105.143 174.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . 0.403 ' H ' ' HD2' ' A' ' 186' ' ' PRO . 4.6 p-10 -121.99 17.96 10.89 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 112.502 -2.135 . . . . 0.0 110.94 -178.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.504 ' HA2' ' HG2' ' A' ' 185' ' ' LYS . . . 114.02 6.81 20.27 Favored Glycine 0 N--CA 1.487 2.057 0 C-N-CA 118.846 -1.645 . . . . 0.0 109.219 -178.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . 0.488 ' O ' ' HD3' ' A' ' 186' ' ' PRO . 1.1 m-90 -121.65 147.26 46.1 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 119.829 3.27 . . . . 0.0 119.829 -177.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' TRP . . . . . 0.559 ' HE1' ' CG ' ' A' ' 185' ' ' LYS . 42.1 m95 -128.66 160.13 33.42 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 101.43 -3.545 . . . . 0.0 101.43 176.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.514 ' HB ' ' O ' ' A' ' 182' ' ' ILE . 7.7 mt -115.9 116.37 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 177.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -105.4 -177.46 3.37 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -171.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . 0.458 ' HA ' ' HA ' ' A' ' 199' ' ' GLU . 3.3 ttmp? -134.83 166.7 22.37 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 175.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.406 ' H ' ' HG2' ' A' ' 193' ' ' LYS . 6.1 p-10 -119.67 -159.12 0.76 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -103.47 37.58 1.98 Allowed 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 120.114 -0.634 . . . . 0.0 110.205 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -128.8 -38.21 1.69 Allowed 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 176.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 138.9 -40.69 1.42 Allowed Glycine 0 N--CA 1.485 1.919 0 N-CA-C 109.021 -1.632 . . . . 0.0 109.021 -178.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -56.35 159.67 3.48 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 118.943 -1.103 . . . . 0.0 113.803 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 193' ' ' LYS . 0.0 OUTLIER -129.98 154.26 47.56 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 112.533 -2.121 . . . . 0.0 109.791 179.468 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . 0.457 ' HA3' ' HG ' ' A' ' 171' ' ' LEU . . . -135.53 -170.26 12.05 Favored Glycine 0 N--CA 1.482 1.755 0 CA-C-O 122.913 1.285 . . . . 0.0 114.094 -177.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.522 ' H ' ' HA ' ' A' ' 170' ' ' ASP . 13.2 mt -115.41 92.41 3.91 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 110.483 -2.858 . . . . 0.0 105.554 177.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 25.1 m -117.45 158.0 46.06 Favored Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 -177.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -82.86 178.63 5.86 Favored 'Trans proline' 0 C--N 1.302 -1.919 0 N-CA-C 107.945 -1.598 . . . . 0.0 107.945 179.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . 0.413 ' HB2' ' NE1' ' A' ' 190' ' ' TRP . 13.3 ttt-85 -96.82 -42.69 7.85 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 105.164 -2.162 . . . . 0.0 105.164 179.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 41.6 p -23.21 -46.03 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.987 0 O-C-N 126.544 2.402 . . . . 0.0 115.777 176.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -106.12 51.78 0.74 Allowed 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 119.271 -0.972 . . . . 0.0 111.898 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 73.3 mt -127.9 135.88 50.61 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 176.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -119.41 145.33 38.47 Favored Pre-proline 0 C--N 1.303 -1.422 0 N-CA-C 103.732 -2.692 . . . . 0.0 103.732 177.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -62.93 158.03 45.34 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 121.427 1.418 . . . . 0.0 108.457 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . 0.455 ' CD1' ' CG2' ' A' ' 158' ' ' ILE . 17.6 t80 . . . . . 0 N--CA 1.488 1.448 0 C-N-CA 118.509 -1.276 . . . . 0.0 110.552 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.147 0 CA-C-O 121.348 0.416 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -123.06 170.65 9.96 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 103.873 -2.64 . . . . 0.0 103.873 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -106.75 130.01 54.53 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 117.319 -1.752 . . . . 0.0 112.301 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.483 ' CD1' HG21 ' A' ' 181' ' ' VAL . 6.2 m-85 -122.53 178.95 4.76 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 101.756 -3.424 . . . . 0.0 101.756 177.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.452 HG22 HG13 ' A' ' 178' ' ' ILE . 6.6 pt -127.76 154.8 38.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 103.519 -2.771 . . . . 0.0 103.519 170.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -88.84 151.22 22.49 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 100.308 -3.96 . . . . 0.0 100.308 176.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 35.9 m -127.2 17.56 3.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 125.845 1.965 . . . . 0.0 107.966 178.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -130.59 159.3 22.83 Favored Glycine 0 N--CA 1.484 1.835 0 N-CA-C 105.895 -2.882 . . . . 0.0 105.895 176.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.408 ' HA ' ' HA ' ' A' ' 174' ' ' LYS . 31.0 t70 -107.3 93.05 4.34 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.026 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -106.86 156.95 18.14 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 118.645 -1.222 . . . . 0.0 108.393 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 90.8 m -120.15 162.31 19.55 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 104.677 -2.342 . . . . 0.0 104.677 179.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -88.25 139.76 30.17 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 117.412 -1.715 . . . . 0.0 106.479 178.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -112.05 -33.51 6.24 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -114.4 -178.22 3.32 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 113.428 -1.714 . . . . 0.0 106.581 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 14.4 p -94.37 40.22 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-O 124.261 1.981 . . . . 0.0 108.199 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -118.75 -53.41 0.29 Allowed Glycine 0 N--CA 1.485 1.935 0 CA-C-N 112.18 -2.282 . . . . 0.0 109.181 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.528 ' HA ' ' H ' ' A' ' 201' ' ' LEU . 1.7 m-20 -81.78 174.95 10.85 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.433 ' HG ' ' HA3' ' A' ' 200' ' ' GLY . 38.8 mt -117.28 177.66 4.65 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 111.92 -2.4 . . . . 0.0 108.202 178.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 42.7 m -116.58 91.48 3.6 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 114.182 -1.372 . . . . 0.0 108.004 177.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 16.8 p90 -118.07 164.57 14.93 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 114.0 -1.455 . . . . 0.0 110.497 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 162' ' ' ASP . 17.8 ptpt -126.54 142.85 51.4 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 117.638 2.459 . . . . 0.0 117.638 -179.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 71.3 tttt -22.25 76.25 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.726 1 CA-C-N 108.03 -4.168 . . . . 0.0 117.016 171.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 114.92 48.89 0.52 Allowed Glycine 0 N--CA 1.488 2.115 0 CA-C-N 114.225 -1.352 . . . . 0.0 112.998 175.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.415 ' O ' ' HA ' ' A' ' 158' ' ' ILE . 8.5 pt-20 -131.39 155.71 46.8 Favored 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 176.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.496 ' N ' ' CD1' ' A' ' 178' ' ' ILE . 1.1 mp -85.88 135.01 25.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -179.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.401 ' N ' HD22 ' A' ' 179' ' ' LEU . 2.7 mm? -124.3 170.98 10.25 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 112.819 -1.992 . . . . 0.0 105.796 175.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 16.6 tp -117.45 154.49 31.3 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 102.028 -3.323 . . . . 0.0 102.028 176.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.483 HG21 ' CD1' ' A' ' 157' ' ' TYR . 2.9 t -126.22 118.93 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 CA-C-N 120.685 1.584 . . . . 0.0 114.681 -176.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.489 ' N ' HD13 ' A' ' 182' ' ' ILE . 0.0 OUTLIER -135.78 93.13 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-O 123.886 1.803 . . . . 0.0 111.046 -177.962 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . 0.45 ' HG2' ' N ' ' A' ' 184' ' ' LYS . 44.1 tt0 140.1 155.8 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.584 1 CA-C-N 107.649 -4.341 . . . . 0.0 107.347 175.905 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . 0.45 ' N ' ' HG2' ' A' ' 183' ' ' GLU . 97.6 mttt -118.53 97.68 5.87 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 117.246 2.313 . . . . 0.0 117.246 -174.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.74 ' HB2' ' NE1' ' A' ' 190' ' ' TRP . 46.0 tttm -15.52 86.7 0.03 OUTLIER Pre-proline 0 N--CA 1.506 2.345 0 N-CA-C 117.095 2.258 . . . . 0.0 117.095 176.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -70.06 -58.46 0.1 OUTLIER 'Trans proline' 0 C--N 1.304 -1.776 0 N-CA-C 103.548 -3.289 . . . . 0.0 103.548 174.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -126.01 28.97 5.98 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 112.812 -1.995 . . . . 0.0 113.018 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.471 ' H ' ' HG3' ' A' ' 185' ' ' LYS . . . 115.75 12.04 9.77 Favored Glycine 0 N--CA 1.494 2.527 0 C-N-CA 119.631 -1.271 . . . . 0.0 110.378 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 3.4 m-90 -131.27 122.74 27.0 Favored 'General case' 0 N--CA 1.489 1.517 1 N-CA-C 123.336 4.569 . . . . 0.0 123.336 -178.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' TRP . . . . . 0.74 ' NE1' ' HB2' ' A' ' 185' ' ' LYS . 12.2 m95 -119.09 164.71 15.13 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 100.248 -3.982 . . . . 0.0 100.248 173.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 27.4 mt -115.66 119.91 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 102.185 -3.265 . . . . 0.0 102.185 176.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -112.23 177.39 4.66 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 118.259 -1.376 . . . . 0.0 113.843 -174.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -130.16 165.43 22.34 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 173.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 43.0 p-10 -122.75 -163.76 1.12 Allowed 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.258 -0.977 . . . . 0.0 110.025 177.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -98.87 40.93 1.17 Allowed 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 121.935 0.874 . . . . 0.0 108.787 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -128.56 -37.68 1.77 Allowed 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 113.556 -1.656 . . . . 0.0 107.677 177.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 133.29 -37.97 1.92 Allowed Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 19.9 p30 -64.14 165.65 8.92 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 -178.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.17 154.41 48.4 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 112.723 -2.035 . . . . 0.0 111.443 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . 0.433 ' HA3' ' HG ' ' A' ' 171' ' ' LEU . . . -135.47 -173.25 12.97 Favored Glycine 0 N--CA 1.486 2.02 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.587 -178.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.528 ' H ' ' HA ' ' A' ' 170' ' ' ASP . 9.6 mt -116.82 82.38 1.79 Allowed 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 104.636 -2.357 . . . . 0.0 104.636 178.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 3.2 m -107.21 156.0 38.35 Favored Pre-proline 0 N--CA 1.498 1.941 0 C-N-CA 119.02 -1.072 . . . . 0.0 109.839 -171.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -88.1 179.26 2.83 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 C-N-CA 123.08 2.52 . . . . 0.0 113.084 -177.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . 0.413 ' HB2' ' NE1' ' A' ' 190' ' ' TRP . 43.2 ttp180 -96.51 -41.84 8.37 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 103.685 -2.709 . . . . 0.0 103.685 174.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 69.8 p -23.55 -52.73 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 O-C-N 126.067 2.104 . . . . 0.0 115.718 178.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -115.49 46.17 1.54 Allowed 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 120.003 -0.679 . . . . 0.0 112.396 -178.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.43 144.55 51.3 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 114.585 -1.188 . . . . 0.0 107.961 179.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -128.41 154.04 79.2 Favored Pre-proline 0 N--CA 1.493 1.691 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 175.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -64.34 154.98 68.36 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 C-N-CA 121.658 1.572 . . . . 0.0 112.582 -178.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . 0.43 ' CE1' HD11 ' A' ' 178' ' ' ILE . 32.4 t80 . . . . . 0 N--CA 1.492 1.664 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 177.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . 0.403 ' HA2' ' O ' ' A' ' 181' ' ' VAL . . . . . . . . 0 N--CA 1.489 2.203 0 CA-C-O 121.103 0.28 . . . . 0.0 112.918 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -115.96 167.32 11.06 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 103.298 -2.852 . . . . 0.0 103.298 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -101.96 122.15 43.5 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 117.274 -1.77 . . . . 0.0 112.407 -176.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.559 ' CD1' HG21 ' A' ' 181' ' ' VAL . 1.0 OUTLIER -126.95 169.8 12.93 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 102.613 -3.106 . . . . 0.0 102.613 176.485 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.971 HG22 HG12 ' A' ' 178' ' ' ILE . 36.7 pt -125.34 142.14 43.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 C-N-CA 118.058 -1.457 . . . . 0.0 108.524 170.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.462 ' O ' ' N ' ' A' ' 176' ' ' GLY . . . -72.33 152.52 42.04 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 101.631 -3.47 . . . . 0.0 101.631 178.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 26.8 m -118.47 -4.12 10.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 125.892 1.995 . . . . 0.0 108.521 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -137.16 177.01 20.13 Favored Glycine 0 N--CA 1.485 1.962 0 N-CA-C 107.363 -2.295 . . . . 0.0 107.363 178.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.408 ' HA ' ' HA ' ' A' ' 174' ' ' LYS . 8.5 t70 -106.51 132.2 52.8 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 118.857 -1.137 . . . . 0.0 109.205 178.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.421 ' HB3' ' CZ ' ' A' ' 173' ' ' PHE . 60.8 t80 -123.29 153.37 40.31 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 176.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 67.9 m -126.77 156.35 41.36 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -95.79 138.49 33.36 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 178.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -111.82 -34.88 5.88 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 88.0 mm-40 -117.45 -176.01 2.93 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 113.314 -1.767 . . . . 0.0 106.328 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 61.9 t -87.62 154.94 3.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 104.224 -2.51 . . . . 0.0 104.224 178.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 113.28 -48.2 0.96 Allowed Glycine 0 N--CA 1.485 1.948 0 N-CA-C 107.905 -2.078 . . . . 0.0 107.905 -178.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.611 ' HA ' ' H ' ' A' ' 201' ' ' LEU . 3.4 m-20 -83.91 167.42 17.0 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 113.731 -1.235 . . . . 0.0 113.785 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.462 ' CD2' HD22 ' A' ' 198' ' ' ASN . 19.3 mt -121.22 173.68 7.16 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 114.128 -1.396 . . . . 0.0 109.624 178.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 55.0 m -123.94 93.76 4.02 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 114.355 -1.293 . . . . 0.0 110.128 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.425 ' N ' ' CD1' ' A' ' 173' ' ' PHE . 20.1 p90 -126.6 167.92 15.01 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.862 -178.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 162' ' ' ASP . 63.7 pttt -118.27 165.93 13.23 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 123.504 1.621 . . . . 0.0 114.338 177.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 52.2 tttm -39.02 154.37 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 110.534 -3.03 . . . . 0.0 117.081 175.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 159' ' ' ALA . . . 33.14 48.75 0.42 Allowed Glycine 0 N--CA 1.493 2.454 0 CA-C-N 112.095 -2.321 . . . . 0.0 111.02 177.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' A' ' 158' ' ' ILE . 5.4 pt-20 -121.39 162.68 19.96 Favored 'General case' 0 N--CA 1.506 2.348 0 CA-C-N 111.722 -2.239 . . . . 0.0 108.372 176.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.971 HG12 HG22 ' A' ' 158' ' ' ILE . 44.7 mt -99.53 120.41 48.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 N-CA-C 118.69 2.848 . . . . 0.0 118.69 -176.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 21.4 mt -118.72 168.59 10.59 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 110.992 -2.822 . . . . 0.0 108.854 178.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.401 HD13 ' HA ' ' A' ' 180' ' ' LEU . 4.1 mm? -110.74 158.5 18.58 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 177.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.559 HG21 ' CD1' ' A' ' 157' ' ' TYR . 50.5 t -119.38 117.81 55.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 C-N-CA 119.65 -0.82 . . . . 0.0 112.975 -178.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.605 ' O ' ' HB ' ' A' ' 191' ' ' ILE . 3.4 mp -139.55 83.31 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.203 -1.35 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.292 -174.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . 0.49 ' HB3' ' H ' ' A' ' 191' ' ' ILE . 35.8 tt0 136.14 150.59 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.764 0 C-N-CA 127.931 2.493 . . . . 0.0 107.897 173.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . 0.414 ' N ' ' HG2' ' A' ' 183' ' ' GLU . 67.0 mttm -115.94 124.55 50.85 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 -176.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.481 ' CG ' ' HE1' ' A' ' 190' ' ' TRP . 3.6 tttm -10.7 77.4 0.03 OUTLIER Pre-proline 0 N--CA 1.504 2.261 0 O-C-N 126.658 2.473 . . . . 0.0 116.912 177.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -69.39 -57.04 0.13 Allowed 'Trans proline' 0 C--N 1.307 -1.615 0 N-CA-C 105.306 -2.613 . . . . 0.0 105.306 175.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -122.44 17.38 10.53 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 111.406 -2.634 . . . . 0.0 113.176 -177.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.412 ' HA2' ' NZ ' ' A' ' 185' ' ' LYS . . . 121.19 -25.7 6.96 Favored Glycine 0 N--CA 1.489 2.173 0 C-N-CA 118.359 -1.877 . . . . 0.0 110.596 -178.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 31.3 m-90 -114.84 153.42 30.47 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 122.826 1.298 . . . . 0.0 113.925 -176.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' TRP . . . . . 0.481 ' HE1' ' CG ' ' A' ' 185' ' ' LYS . 16.7 m95 -115.9 168.58 9.93 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 100.266 -3.976 . . . . 0.0 100.266 -178.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.605 ' HB ' ' O ' ' A' ' 182' ' ' ILE . 2.1 mm -111.0 109.98 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 103.367 -2.827 . . . . 0.0 103.367 -179.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -106.26 179.99 4.11 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -172.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 199' ' ' GLU . 36.6 ttpt -139.97 163.24 33.2 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 118.748 -1.181 . . . . 0.0 109.549 177.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -121.19 -165.91 1.29 Allowed 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.885 178.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -106.15 40.44 1.59 Allowed 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.897 0.856 . . . . 0.0 109.603 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -118.53 -42.54 2.75 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 177.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 141.94 -48.27 0.8 Allowed Glycine 0 N--CA 1.482 1.718 0 N-CA-C 106.005 -2.838 . . . . 0.0 106.005 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . 0.462 HD22 ' CD2' ' A' ' 171' ' ' LEU . 0.8 OUTLIER -55.15 154.01 6.16 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 179.345 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . 0.49 ' HA ' ' HA ' ' A' ' 193' ' ' LYS . 0.0 OUTLIER -129.17 154.35 46.83 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 112.73 -2.032 . . . . 0.0 107.777 178.13 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . 0.446 ' O ' ' HA ' ' A' ' 191' ' ' ILE . . . -136.03 -161.04 9.04 Favored Glycine 0 N--CA 1.479 1.514 0 C-N-CA 120.009 -1.091 . . . . 0.0 113.161 -176.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.611 ' H ' ' HA ' ' A' ' 170' ' ' ASP . 36.2 mt -118.67 94.08 4.34 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 110.497 -2.852 . . . . 0.0 105.727 179.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 5.3 m -112.81 150.54 42.95 Favored Pre-proline 0 N--CA 1.498 1.932 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 -177.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -75.3 175.35 11.38 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 C-N-CA 121.174 1.25 . . . . 0.0 109.761 -177.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.4 -40.63 8.19 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 103.562 -2.755 . . . . 0.0 103.562 178.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 76.7 p -28.87 -50.97 0.09 Allowed 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 113.3 -1.773 . . . . 0.0 114.602 175.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -113.62 39.12 2.73 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.569 0.7 . . . . 0.0 112.331 -178.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.91 98.56 5.57 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 104.937 -2.246 . . . . 0.0 104.937 178.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -106.62 148.33 36.62 Favored Pre-proline 0 C--N 1.299 -1.621 0 N-CA-C 104.039 -2.578 . . . . 0.0 104.039 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -53.57 165.81 1.52 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.489 2.126 . . . . 0.0 113.18 -177.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . 0.474 ' CE1' HD11 ' A' ' 178' ' ' ILE . 45.4 t80 . . . . . 0 C--N 1.305 -1.361 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.734 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . 0.403 ' HA2' ' O ' ' A' ' 181' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.29 0 N-CA-C 114.681 0.632 . . . . 0.0 114.681 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -128.82 159.5 35.54 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 103.965 -2.606 . . . . 0.0 103.965 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -105.63 134.4 48.8 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 115.968 -2.293 . . . . 0.0 112.967 -177.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.504 ' CD1' HG21 ' A' ' 181' ' ' VAL . 7.1 m-85 -115.49 -178.41 3.38 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 101.397 -3.557 . . . . 0.0 101.397 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.492 ' HA ' ' O ' ' A' ' 177' ' ' GLU . 0.1 OUTLIER -126.11 152.72 33.68 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 N-CA-C 100.504 -3.887 . . . . 0.0 100.504 175.15 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -91.88 148.64 22.07 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 102.824 -3.028 . . . . 0.0 102.824 178.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 32.7 m -126.6 9.46 3.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 125.128 1.518 . . . . 0.0 108.773 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -130.03 161.83 23.03 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 104.989 -3.244 . . . . 0.0 104.989 176.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.428 ' HA ' ' HA ' ' A' ' 174' ' ' LYS . 9.9 t70 -109.3 97.54 7.12 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 118.95 -1.1 . . . . 0.0 109.107 178.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.4 ' HB3' ' CZ ' ' A' ' 173' ' ' PHE . 13.7 t80 -104.3 155.1 19.04 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 118.361 -1.336 . . . . 0.0 107.628 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 88.3 m -123.21 165.24 17.24 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 103.862 -2.644 . . . . 0.0 103.862 179.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -91.63 145.25 24.74 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 117.653 -1.619 . . . . 0.0 108.452 179.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -113.7 -38.53 4.26 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -121.45 158.99 27.18 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 113.456 -1.702 . . . . 0.0 106.539 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 83.3 t -41.47 -57.68 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 125.099 1.499 . . . . 0.0 107.472 176.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -27.19 -56.22 0.1 OUTLIER Glycine 0 N--CA 1.486 2.025 0 CA-C-N 112.431 -2.168 . . . . 0.0 114.055 175.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.543 ' HA ' ' H ' ' A' ' 201' ' ' LEU . 18.2 m-20 -75.68 161.83 28.75 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -177.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.478 HD13 ' CA ' ' A' ' 200' ' ' GLY . 1.5 tp -116.88 -178.58 3.47 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 112.966 -1.925 . . . . 0.0 109.424 177.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 33.7 m -129.24 98.63 4.95 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 112.394 -2.185 . . . . 0.0 111.805 -178.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.4 ' CZ ' ' HB3' ' A' ' 163' ' ' PHE . 25.1 p90 -122.17 167.44 13.18 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.785 178.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 162' ' ' ASP . 18.8 ptpt -121.53 144.11 48.9 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 116.732 2.123 . . . . 0.0 116.732 179.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -35.07 80.66 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 108.529 -3.941 . . . . 0.0 114.426 172.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 111.33 50.16 0.63 Allowed Glycine 0 N--CA 1.49 2.293 0 CA-C-N 114.726 -1.125 . . . . 0.0 112.125 178.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.492 ' O ' ' HA ' ' A' ' 158' ' ' ILE . 5.9 pt-20 -126.91 -172.66 2.69 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 177.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 14.4 mm -109.26 137.54 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 123.992 0.807 . . . . 0.0 111.139 177.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 54.2 mt -128.92 169.12 15.01 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 113.588 -1.642 . . . . 0.0 110.008 178.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.63 ' HB2' ' HB2' ' A' ' 193' ' ' LYS . 6.9 mt -121.74 157.82 30.14 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 174.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.504 HG21 ' CD1' ' A' ' 157' ' ' TYR . 92.6 t -119.14 117.48 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 116.714 2.116 . . . . 0.0 116.714 -178.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.507 ' O ' ' HB ' ' A' ' 191' ' ' ILE . 1.7 mm -123.63 70.79 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 105.472 -2.048 . . . . 0.0 105.472 178.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' A' ' 182' ' ' ILE . 10.8 tp10 125.35 141.53 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.296 0 C-N-CA 128.853 2.861 . . . . 0.0 109.756 177.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -120.14 113.54 20.61 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 177.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.634 ' HB2' ' CA ' ' A' ' 188' ' ' GLY . 0.0 OUTLIER -14.37 75.75 0.02 OUTLIER Pre-proline 0 N--CA 1.495 1.781 0 N-CA-C 121.383 3.846 . . . . 0.0 121.383 -171.503 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.449 ' HD2' ' HA ' ' A' ' 185' ' ' LYS . 9.9 Cg_endo -43.65 -58.81 1.25 Allowed 'Trans proline' 0 C--N 1.314 -1.289 0 C-N-CA 123.647 2.898 . . . . 0.0 106.221 171.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -124.98 23.17 7.87 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 111.761 -2.472 . . . . 0.0 111.645 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.634 ' CA ' ' HB2' ' A' ' 185' ' ' LYS . . . 113.53 2.16 24.39 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . 0.428 ' O ' ' HD2' ' A' ' 186' ' ' PRO . 3.9 m-90 -126.33 119.74 28.11 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 119.621 3.193 . . . . 0.0 119.621 -176.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' TRP . . . . . 0.55 ' CD1' ' HB3' ' A' ' 185' ' ' LYS . 5.7 m0 -103.21 150.61 23.53 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 104.084 -2.562 . . . . 0.0 104.084 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.507 ' HB ' ' O ' ' A' ' 182' ' ' ILE . 8.0 mm -113.76 102.19 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 100.341 -3.948 . . . . 0.0 100.341 177.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -106.06 169.4 8.52 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 118.174 -1.411 . . . . 0.0 112.614 -171.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . 0.63 ' HB2' ' HB2' ' A' ' 180' ' ' LEU . 93.7 mttt -117.86 161.93 18.94 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 104.117 -2.549 . . . . 0.0 104.117 176.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -126.35 -162.63 1.15 Allowed 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 118.557 -1.257 . . . . 0.0 110.474 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -98.96 40.85 1.17 Allowed 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.692 -0.803 . . . . 0.0 109.773 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -128.56 -40.75 1.56 Allowed 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 176.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 140.28 -47.39 0.88 Allowed Glycine 0 N--CA 1.487 2.099 0 N-CA-C 107.348 -2.301 . . . . 0.0 107.348 178.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -57.26 161.31 3.34 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 114.965 1.468 . . . . 0.0 114.965 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . 0.448 ' HG3' ' N ' ' A' ' 200' ' ' GLY . 0.0 OUTLIER -130.55 151.42 51.04 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 113.598 -1.637 . . . . 0.0 108.464 176.772 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . 0.478 ' CA ' HD13 ' A' ' 171' ' ' LEU . . . -139.64 -157.05 7.14 Favored Glycine 0 N--CA 1.484 1.877 0 C-N-CA 119.333 -1.413 . . . . 0.0 113.399 -178.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.543 ' H ' ' HA ' ' A' ' 170' ' ' ASP . 42.4 mt -112.34 96.15 5.85 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 111.133 -2.533 . . . . 0.0 108.708 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 3.7 m -112.26 154.46 44.41 Favored Pre-proline 0 N--CA 1.49 1.525 0 N-CA-C 105.777 -1.934 . . . . 0.0 105.777 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 0.4 OUTLIER -88.4 -178.24 2.01 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 C-N-CA 123.721 2.947 . . . . 0.0 112.346 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . 0.55 ' HB2' ' CD ' ' A' ' 185' ' ' LYS . 24.8 ttt85 -74.29 -59.65 2.63 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 173.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 69.5 p -18.37 -48.55 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.134 0 CA-C-N 109.876 -3.329 . . . . 0.0 117.187 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -110.45 38.32 2.49 Favored 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 119.192 -1.003 . . . . 0.0 112.243 -178.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -123.53 104.98 9.38 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 124.238 0.961 . . . . 0.0 111.427 -178.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -112.61 155.04 44.46 Favored Pre-proline 0 N--CA 1.496 1.853 0 C-N-CA 117.891 -1.524 . . . . 0.0 107.021 175.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -64.19 164.21 23.43 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 121.809 1.672 . . . . 0.0 111.963 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 21.2 t80 . . . . . 0 N--CA 1.492 1.658 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.594 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . 0.409 ' HA3' ' O ' ' A' ' 181' ' ' VAL . . . . . . . . 0 N--CA 1.488 2.113 0 N-CA-C 113.616 0.207 . . . . 0.0 113.616 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -130.79 170.98 13.64 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.531 ' H ' ' CD ' ' A' ' 156' ' ' GLU . 0.0 OUTLIER -110.79 123.83 50.84 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 116.972 -1.891 . . . . 0.0 112.969 -178.001 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.52 ' CD1' HG21 ' A' ' 181' ' ' VAL . 5.9 m-85 -119.18 178.11 4.64 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 102.649 -3.093 . . . . 0.0 102.649 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.504 HG22 HG13 ' A' ' 178' ' ' ILE . 2.9 pt -128.28 145.48 35.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 102.409 -3.182 . . . . 0.0 102.409 172.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -92.26 151.55 20.27 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 115.011 -2.676 . . . . 0.0 103.876 177.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 28.0 m -127.67 32.81 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 125.838 1.961 . . . . 0.0 108.23 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -129.96 158.03 22.14 Favored Glycine 0 N--CA 1.483 1.824 0 N-CA-C 105.762 -2.935 . . . . 0.0 105.762 173.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -106.06 76.14 1.15 Allowed 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -102.21 148.53 25.32 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 118.463 -1.295 . . . . 0.0 108.428 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 87.5 m -120.21 161.49 20.98 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 104.461 -2.422 . . . . 0.0 104.461 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -93.17 135.77 34.05 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 105.744 -1.946 . . . . 0.0 105.744 178.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -110.65 -31.34 7.25 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 -115.71 -178.88 3.49 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 105.091 -2.189 . . . . 0.0 105.091 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 61.8 t -89.94 152.47 3.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 103.317 -2.846 . . . . 0.0 103.317 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 114.54 -47.86 1.0 Allowed Glycine 0 N--CA 1.486 2.02 0 N-CA-C 108.503 -1.839 . . . . 0.0 108.503 -177.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.489 ' HA ' ' H ' ' A' ' 201' ' ' LEU . 26.4 m-20 -82.2 168.7 17.4 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 113.964 -1.118 . . . . 0.0 112.622 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.441 HD11 ' C ' ' A' ' 199' ' ' GLU . 41.8 mt -127.66 178.7 5.95 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.842 176.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 57.3 m -122.13 102.57 8.22 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 114.453 -1.248 . . . . 0.0 113.316 -178.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -118.92 167.96 11.23 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.315 -0.954 . . . . 0.0 111.522 177.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -114.99 62.21 0.68 Allowed 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 121.019 3.711 . . . . 0.0 121.019 -175.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.439 ' O ' ' HG3' ' A' ' 175' ' ' LYS . 15.6 tptm 41.02 74.12 0.11 Allowed 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 117.102 2.26 . . . . 0.0 117.102 174.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 116.53 50.99 0.4 Allowed Glycine 0 N--CA 1.495 2.609 0 CA-C-N 114.412 -1.267 . . . . 0.0 113.822 173.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.474 ' CD ' ' N ' ' A' ' 177' ' ' GLU . 0.2 OUTLIER -139.92 163.45 32.63 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 177.837 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.504 HG13 HG22 ' A' ' 158' ' ' ILE . 1.0 OUTLIER -87.99 134.01 29.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 116.361 1.986 . . . . 0.0 116.361 -176.376 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.5 mp -131.42 175.62 8.98 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 112.671 -2.059 . . . . 0.0 108.076 174.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.472 HD13 ' H ' ' A' ' 181' ' ' VAL . 0.5 OUTLIER -112.92 156.18 23.44 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 102.713 -3.069 . . . . 0.0 102.713 -179.449 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.52 HG21 ' CD1' ' A' ' 157' ' ' TYR . 2.8 t -127.15 135.74 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 CA-C-N 120.924 1.693 . . . . 0.0 109.906 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.464 ' O ' ' HB ' ' A' ' 191' ' ' ILE . 4.3 mt -143.49 84.13 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -174.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . 0.446 ' CB ' ' O ' ' A' ' 182' ' ' ILE . 34.2 tt0 142.32 154.13 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.54 0 C-N-CA 126.446 1.898 . . . . 0.0 108.594 176.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . 0.442 ' N ' ' HG2' ' A' ' 183' ' ' GLU . 97.9 mttt -121.34 116.95 25.77 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 115.256 1.576 . . . . 0.0 115.256 -178.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.481 ' HB2' ' NE1' ' A' ' 190' ' ' TRP . 9.3 tttm -7.27 81.18 0.03 OUTLIER Pre-proline 0 N--CA 1.5 2.071 0 CA-C-N 111.757 -2.474 . . . . 0.0 117.378 175.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.468 ' HD2' ' H ' ' A' ' 189' ' ' TRP . 97.1 Cg_endo -78.66 -52.83 0.06 OUTLIER 'Trans proline' 0 C--N 1.302 -1.877 0 C-N-CA 122.797 2.331 . . . . 0.0 106.805 175.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -126.79 14.07 7.45 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.244 -1.343 . . . . 0.0 109.085 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.432 ' HA2' ' HG2' ' A' ' 185' ' ' LYS . . . 118.18 7.49 11.26 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 -178.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . 0.468 ' H ' ' HD2' ' A' ' 186' ' ' PRO . 1.4 m-90 -122.54 142.13 50.94 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 119.767 3.247 . . . . 0.0 119.767 -179.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' TRP . . . . . 0.514 ' NE1' ' HB2' ' A' ' 204' ' ' ARG . 22.7 m95 -124.7 157.7 34.99 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 100.412 -3.921 . . . . 0.0 100.412 177.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.464 ' HB ' ' O ' ' A' ' 182' ' ' ILE . 31.2 mm -97.99 171.06 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.866 1 N-CA-C 99.845 -4.131 . . . . 0.0 99.845 176.671 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . 0.436 ' O ' ' HA ' ' A' ' 199' ' ' GLU . . . -152.95 176.17 12.14 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 116.683 -2.007 . . . . 0.0 109.893 177.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -134.02 159.58 40.36 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 170.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 58.4 p30 -120.12 -162.78 0.95 Allowed 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 118.594 -1.242 . . . . 0.0 111.426 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -99.54 39.44 1.31 Allowed 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.086 -1.046 . . . . 0.0 109.692 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -121.38 -39.35 2.68 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 176.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 126.98 -1.79 7.29 Favored Glycine 0 N--CA 1.492 2.402 0 CA-C-N 114.803 -1.09 . . . . 0.0 111.224 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 26.3 p30 -100.7 176.68 5.23 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . 0.441 ' C ' HD11 ' A' ' 171' ' ' LEU . 1.5 pt-20 -113.28 166.57 11.34 Favored 'General case' 0 N--CA 1.484 1.27 0 O-C-N 125.859 1.974 . . . . 0.0 109.332 -179.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . 0.415 ' CA ' ' HG ' ' A' ' 171' ' ' LEU . . . -144.58 -178.46 20.25 Favored Glycine 0 N--CA 1.481 1.698 0 CA-C-O 122.389 0.994 . . . . 0.0 113.428 -175.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.489 ' H ' ' HA ' ' A' ' 170' ' ' ASP . 15.4 mt -125.26 89.18 3.01 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 177.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 3.9 m -111.7 157.16 40.18 Favored Pre-proline 0 N--CA 1.487 1.409 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 -175.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -90.08 179.57 1.98 Allowed 'Trans proline' 0 C--N 1.3 -2.014 0 C-N-CA 122.103 1.869 . . . . 0.0 109.405 178.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . 0.514 ' HB2' ' NE1' ' A' ' 190' ' ' TRP . 10.8 tpt180 -97.54 -43.23 7.33 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 176.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.442 ' HG1' ' HD1' ' A' ' 206' ' ' TYR . 43.0 p -25.56 -51.31 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 126.231 2.207 . . . . 0.0 114.731 177.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . 0.442 ' HD1' ' HG1' ' A' ' 205' ' ' THR . 85.7 m-85 -113.88 50.43 0.92 Allowed 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 119.778 -0.769 . . . . 0.0 111.781 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -133.5 135.95 44.77 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 177.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -125.39 154.67 72.32 Favored Pre-proline 0 N--CA 1.489 1.516 0 N-CA-C 105.785 -1.932 . . . . 0.0 105.785 176.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -67.2 165.97 24.83 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 N-CA-C 108.617 -1.34 . . . . 0.0 108.617 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . 0.41 ' CE1' HD11 ' A' ' 178' ' ' ILE . 34.5 t80 . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.496 0 N-CA-C 116.102 1.201 . . . . 0.0 116.102 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.424 ' CD ' ' N ' ' A' ' 155' ' ' GLU . 1.4 pm0 -131.36 169.86 15.43 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 106.02 -1.845 . . . . 0.0 106.02 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -121.78 142.16 50.49 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 117.502 -1.679 . . . . 0.0 114.937 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -128.93 -178.91 4.82 Favored 'General case' 0 C--N 1.301 -1.516 1 N-CA-C 99.664 -4.199 . . . . 0.0 99.664 177.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.508 HG22 HG13 ' A' ' 178' ' ' ILE . 4.2 pt -130.54 152.87 38.18 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 101.647 -3.464 . . . . 0.0 101.647 170.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -91.5 156.2 17.86 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 104.325 -2.472 . . . . 0.0 104.325 179.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 20.3 m -125.33 8.61 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 126.045 2.091 . . . . 0.0 107.916 176.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -132.97 168.7 22.83 Favored Glycine 0 N--CA 1.483 1.83 0 N-CA-C 105.746 -2.942 . . . . 0.0 105.746 175.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -107.06 146.6 31.0 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 177.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -124.8 160.53 28.5 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 104.805 -2.295 . . . . 0.0 104.805 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 96.4 m -129.45 151.48 50.03 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 118.864 -1.134 . . . . 0.0 108.333 178.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -98.51 138.67 35.39 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 118.296 -1.362 . . . . 0.0 108.01 178.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -114.42 -32.58 5.88 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 113.213 -1.812 . . . . 0.0 106.708 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -112.9 179.85 3.85 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 114.144 -1.389 . . . . 0.0 107.86 -179.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 16.3 t -95.45 47.21 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -128.76 -53.53 0.11 Allowed Glycine 0 N--CA 1.485 1.944 0 N-CA-C 108.331 -1.907 . . . . 0.0 108.331 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -76.48 163.47 26.9 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 113.542 -1.329 . . . . 0.0 113.788 -178.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.449 HD13 ' HA3' ' A' ' 200' ' ' GLY . 1.1 tp -108.51 -171.61 1.89 Allowed 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 111.954 -2.384 . . . . 0.0 109.078 175.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 53.6 m -120.88 -69.24 0.85 Allowed 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 113.736 -1.575 . . . . 0.0 114.335 -177.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 54.2 p90 37.52 164.33 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.527 0 N-CA-C 117.12 2.267 . . . . 0.0 117.12 -174.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -130.16 151.83 50.26 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 118.391 2.737 . . . . 0.0 118.391 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -21.28 80.41 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.568 1 CA-C-N 108.342 -4.026 . . . . 0.0 118.057 171.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 110.04 47.99 0.8 Allowed Glycine 0 N--CA 1.493 2.473 0 CA-C-N 114.728 -1.124 . . . . 0.0 112.878 174.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -135.84 154.91 51.03 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 117.309 -1.757 . . . . 0.0 108.045 177.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.508 HG13 HG22 ' A' ' 158' ' ' ILE . 1.1 mp -80.6 130.94 35.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -178.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 27.7 mt -120.15 162.59 19.07 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 113.129 -1.851 . . . . 0.0 108.222 176.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.529 HD13 ' N ' ' A' ' 181' ' ' VAL . 1.6 tm? -116.06 151.38 35.65 Favored 'General case' 0 N--CA 1.498 1.93 1 N-CA-C 100.105 -4.035 . . . . 0.0 100.105 179.345 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.529 ' N ' HD13 ' A' ' 180' ' ' LEU . 2.4 t -121.05 139.12 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 CA-C-N 122.041 2.2 . . . . 0.0 111.074 -179.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.484 ' O ' ' HB ' ' A' ' 191' ' ' ILE . 42.9 mt -145.0 87.09 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-O 121.105 0.479 . . . . 0.0 111.004 -176.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . 0.485 ' O ' ' CE3' ' A' ' 190' ' ' TRP . 0.0 OUTLIER 135.96 148.7 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.586 0 C-N-CA 128.359 2.664 . . . . 0.0 107.084 172.59 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -106.24 117.45 34.06 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 118.276 2.695 . . . . 0.0 118.276 -172.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.544 ' HE2' ' HE1' ' A' ' 190' ' ' TRP . 0.8 OUTLIER -11.97 81.38 0.03 OUTLIER Pre-proline 0 N--CA 1.507 2.389 0 N-CA-C 118.124 2.639 . . . . 0.0 118.124 175.24 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -73.06 -56.23 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 123.549 2.833 . . . . 0.0 105.684 175.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 21.3 p-10 -120.97 16.34 11.69 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 112.08 -2.327 . . . . 0.0 113.877 -177.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.491 ' CA ' ' HG2' ' A' ' 185' ' ' LYS . . . 118.09 -15.81 12.1 Favored Glycine 0 N--CA 1.493 2.465 0 C-N-CA 118.712 -1.709 . . . . 0.0 109.002 -178.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 13.5 m-90 -116.61 149.39 39.77 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 116.761 2.134 . . . . 0.0 116.761 -176.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' TRP . . . . . 0.544 ' HE1' ' HE2' ' A' ' 185' ' ' LYS . 20.0 m95 -122.88 169.15 11.41 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 102.396 -3.187 . . . . 0.0 102.396 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.484 ' HB ' ' O ' ' A' ' 182' ' ' ILE . 2.5 mp -113.95 103.58 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 104.652 -2.351 . . . . 0.0 104.652 175.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . 0.437 ' HB1' ' O ' ' A' ' 180' ' ' LEU . . . -94.34 178.35 5.65 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -173.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -124.91 158.58 33.2 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 103.273 -2.862 . . . . 0.0 103.273 175.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 51.6 p-10 -124.69 -167.1 1.61 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.279 -0.968 . . . . 0.0 111.148 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -99.09 43.14 1.07 Allowed 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 122.123 0.963 . . . . 0.0 108.47 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 4.8 tmtm? -126.05 -45.11 1.73 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 104.204 -2.517 . . . . 0.0 104.204 177.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 137.91 -40.17 1.51 Allowed Glycine 0 N--CA 1.485 1.925 0 N-CA-C 108.109 -1.996 . . . . 0.0 108.109 -178.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -69.98 164.15 24.53 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 118.795 -1.162 . . . . 0.0 113.626 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . 0.439 ' C ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -137.36 157.68 46.06 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 112.9 -1.955 . . . . 0.0 109.238 -179.915 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . 0.449 ' HA3' HD13 ' A' ' 171' ' ' LEU . . . 179.58 -173.76 45.54 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 118.248 -1.929 . . . . 0.0 112.418 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 59.2 mt -71.63 96.25 1.54 Allowed 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -176.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 3.2 m -119.54 153.96 54.27 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 103.641 -2.726 . . . . 0.0 103.641 177.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -87.12 174.72 5.2 Favored 'Trans proline' 0 C--N 1.301 -1.945 0 C-N-CA 121.804 1.669 . . . . 0.0 109.197 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 28.9 ttt180 -106.16 -22.81 12.76 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 177.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 53.9 p -34.37 -50.18 0.41 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 113.91 -1.495 . . . . 0.0 114.368 173.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -105.38 34.3 3.31 Favored 'General case' 0 N--CA 1.503 2.198 0 C-N-CA 118.354 -1.338 . . . . 0.0 111.681 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 3.2 mp -119.42 118.78 32.05 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 124.817 1.323 . . . . 0.0 110.65 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . 0.412 ' CD ' ' N ' ' A' ' 208' ' ' GLU . 43.6 mp0 -115.57 150.74 45.21 Favored Pre-proline 0 C--N 1.297 -1.712 0 N-CA-C 105.982 -1.858 . . . . 0.0 105.982 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -55.16 164.43 3.68 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.292 1.995 . . . . 0.0 113.308 -177.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 43.3 t80 . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 179.13 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.061 0 CA-C-O 121.18 0.322 . . . . 0.0 113.549 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -128.9 165.18 21.54 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 104.053 -2.573 . . . . 0.0 104.053 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -107.76 135.59 48.92 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 116.92 -1.912 . . . . 0.0 111.081 -178.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.463 ' CD1' HG21 ' A' ' 181' ' ' VAL . 28.2 m-85 -132.6 176.24 8.62 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 109.503 -3.499 . . . . 0.0 105.285 179.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.449 ' HA ' ' O ' ' A' ' 177' ' ' GLU . 0.4 OUTLIER -126.31 143.05 41.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 1 N-CA-C 99.572 -4.232 . . . . 0.0 99.572 172.273 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -93.1 151.96 19.55 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 115.983 -2.287 . . . . 0.0 105.311 178.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 35.6 m -127.81 24.3 2.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 125.39 1.681 . . . . 0.0 109.054 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -123.55 153.6 17.26 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 106.697 -2.561 . . . . 0.0 106.697 177.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -105.66 82.53 1.81 Allowed 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 120.069 -0.652 . . . . 0.0 109.834 -179.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -108.68 151.88 25.57 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 118.879 -1.129 . . . . 0.0 108.54 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 53.7 m -122.07 159.86 26.21 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -89.15 133.25 34.47 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 178.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -109.83 -29.23 8.39 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 26.8 pt20 -117.64 -176.31 3.0 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 178.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 9.9 p -91.3 157.02 2.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 177.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 111.44 -50.44 0.77 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 -178.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -79.38 169.65 17.76 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 113.806 -1.197 . . . . 0.0 112.116 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 66.4 mt -126.02 178.22 5.89 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 114.223 -1.353 . . . . 0.0 109.744 177.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 53.5 m -120.48 99.28 6.47 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 114.484 -1.235 . . . . 0.0 112.179 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -115.65 165.87 12.56 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 118.82 -1.152 . . . . 0.0 110.172 177.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? -121.13 57.37 1.0 Allowed 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 121.22 3.785 . . . . 0.0 121.22 -174.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 70.9 tttt 46.67 76.78 0.09 Allowed 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 116.554 2.057 . . . . 0.0 116.554 174.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 117.28 52.27 0.34 Allowed Glycine 0 N--CA 1.495 2.632 0 CA-C-N 114.15 -1.386 . . . . 0.0 111.743 175.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.451 ' CD ' ' N ' ' A' ' 177' ' ' GLU . 2.8 pm0 -131.88 -179.12 5.21 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 178.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 7.0 mm -112.58 120.06 61.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 124.513 1.133 . . . . 0.0 113.885 -175.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.452 ' N ' HD22 ' A' ' 179' ' ' LEU . 2.0 mm? -123.72 170.3 10.64 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 16.6 tp -111.12 156.24 21.65 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 100.586 -3.857 . . . . 0.0 100.586 175.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.506 ' CG1' ' HB3' ' A' ' 190' ' ' TRP . 2.4 t -126.66 140.33 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 CA-C-N 120.42 1.463 . . . . 0.0 109.243 -178.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.474 ' O ' ' HB ' ' A' ' 191' ' ' ILE . 21.3 mt -143.57 78.07 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 120.251 -0.579 . . . . 0.0 110.779 -174.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . 0.52 ' O ' ' CE3' ' A' ' 190' ' ' TRP . 31.4 tt0 139.85 150.02 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.708 0 C-N-CA 127.005 2.122 . . . . 0.0 108.576 177.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . 0.441 ' HB3' ' NZ ' ' A' ' 184' ' ' LYS . 8.1 mtpm? -114.15 100.87 8.7 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -176.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.503 ' HA ' ' HD2' ' A' ' 186' ' ' PRO . 19.9 pttp -11.52 77.09 0.02 OUTLIER Pre-proline 0 N--CA 1.496 1.854 0 N-CA-C 121.656 3.947 . . . . 0.0 121.656 -177.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.503 ' HD2' ' HA ' ' A' ' 185' ' ' LYS . 11.4 Cg_endo -46.26 -59.95 1.03 Allowed 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 123.341 2.694 . . . . 0.0 106.932 171.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -121.81 21.85 10.61 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 111.922 -2.399 . . . . 0.0 110.431 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.488 ' CA ' ' HB2' ' A' ' 185' ' ' LYS . . . 114.21 11.29 12.32 Favored Glycine 0 N--CA 1.488 2.162 0 C-N-CA 119.629 -1.272 . . . . 0.0 110.986 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . 0.475 ' CD1' ' HB3' ' A' ' 201' ' ' LEU . 2.1 m-90 -125.02 136.55 53.82 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 121.433 3.864 . . . . 0.0 121.433 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' TRP . . . . . 0.52 ' CE3' ' O ' ' A' ' 183' ' ' GLU . 32.4 m95 -119.4 154.66 33.3 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 101.519 -3.511 . . . . 0.0 101.519 178.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.474 ' HB ' ' O ' ' A' ' 182' ' ' ILE . 1.7 mp -109.23 114.11 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 104.234 -2.506 . . . . 0.0 104.234 176.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -107.6 177.55 4.8 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 118.859 -1.136 . . . . 0.0 113.898 -170.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -134.24 160.58 37.42 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 174.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 47.4 p-10 -117.67 -160.51 0.78 Allowed 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 118.456 -1.298 . . . . 0.0 110.406 177.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -101.32 42.26 1.14 Allowed 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 122.398 1.094 . . . . 0.0 108.586 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 5.4 tmtm? -127.01 -44.16 1.63 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 177.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 135.78 -41.08 1.46 Allowed Glycine 0 N--CA 1.485 1.936 0 N-CA-C 108.455 -1.858 . . . . 0.0 108.455 -178.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -53.58 163.38 0.66 Allowed 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 116.037 1.866 . . . . 0.0 116.037 -178.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -103.52 157.08 17.29 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 110.835 -2.893 . . . . 0.0 115.422 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 191' ' ' ILE . . . -134.61 -179.56 16.6 Favored Glycine 0 N--CA 1.483 1.827 0 CA-C-N 112.671 -2.059 . . . . 0.0 113.978 -175.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.475 ' HB3' ' CD1' ' A' ' 189' ' ' TRP . 32.0 mt -131.97 89.38 2.67 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 111.698 -2.251 . . . . 0.0 105.43 177.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . 0.251 2.3 t -97.13 148.53 34.54 Favored Pre-proline 0 C--N 1.305 -1.343 0 CA-C-N 114.269 -1.332 . . . . 0.0 113.928 -174.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -92.43 155.21 3.03 Favored 'Trans proline' 0 C--N 1.299 -2.032 0 N-CA-C 107.67 -1.704 . . . . 0.0 107.67 172.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . 0.516 ' HB2' ' CE2' ' A' ' 190' ' ' TRP . 8.6 tpt180 -74.59 -51.99 13.04 Favored 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 176.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 65.3 p -22.07 -45.85 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 127.528 3.017 . . . . 0.0 114.912 178.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -112.61 50.0 0.9 Allowed 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.468 -0.893 . . . . 0.0 113.199 -178.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 97.7 mt -131.05 155.96 46.0 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 176.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -130.26 142.19 44.56 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 103.916 -2.624 . . . . 0.0 103.916 174.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -66.32 155.44 69.92 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 N-CA-C 107.271 -1.857 . . . . 0.0 107.271 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . 0.413 ' CD1' HG21 ' A' ' 158' ' ' ILE . 9.7 t80 . . . . . 0 N--CA 1.49 1.564 0 C-N-CA 118.559 -1.256 . . . . 0.0 110.002 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.993 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -121.42 159.15 26.79 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 101.504 -3.517 . . . . 0.0 101.504 178.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -100.64 129.62 46.58 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 116.035 -2.266 . . . . 0.0 111.35 -177.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.631 ' CD1' HG21 ' A' ' 181' ' ' VAL . 4.9 m-85 -118.9 172.17 7.72 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 101.4 -3.556 . . . . 0.0 101.4 177.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.48 ' HA ' ' O ' ' A' ' 177' ' ' GLU . 1.7 pt -126.97 142.53 43.18 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 N-CA-C 103.44 -2.8 . . . . 0.0 103.44 174.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 176' ' ' GLY . . . -80.13 155.3 27.54 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 104.19 -2.522 . . . . 0.0 104.19 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.1 m -131.18 8.73 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 126.764 2.54 . . . . 0.0 108.447 178.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -127.68 159.1 21.5 Favored Glycine 0 N--CA 1.486 1.99 0 N-CA-C 106.018 -2.833 . . . . 0.0 106.018 176.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.408 ' HA ' ' HA ' ' A' ' 174' ' ' LYS . 33.1 t70 -108.54 97.34 7.02 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.253 -0.979 . . . . 0.0 113.083 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.44 ' HB3' ' CZ ' ' A' ' 173' ' ' PHE . 58.4 t80 -111.02 151.88 27.48 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 55.4 m -122.43 157.4 32.0 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.31 105.88 15.49 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 178.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -98.61 -17.43 18.64 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 -178.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -120.72 168.19 11.68 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 102.57 -3.122 . . . . 0.0 102.57 177.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 48.7 t -91.39 156.01 3.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 109.56 -41.12 2.32 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 107.502 -2.239 . . . . 0.0 107.502 -178.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.538 ' HA ' ' H ' ' A' ' 201' ' ' LEU . 11.2 m-20 -80.22 167.97 19.65 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 111.532 -2.334 . . . . 0.0 111.637 -179.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 24.5 mt -118.95 175.93 5.53 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.996 177.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 45.2 m -117.57 96.31 5.33 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 114.58 -1.191 . . . . 0.0 109.479 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.44 ' CZ ' ' HB3' ' A' ' 163' ' ' PHE . 8.9 p90 -119.24 164.43 15.64 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 114.488 -1.233 . . . . 0.0 111.63 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 162' ' ' ASP . 6.6 ptpp? -128.71 160.44 32.5 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 116.384 1.994 . . . . 0.0 116.384 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 42.9 tttm -41.91 76.91 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.766 1 CA-C-N 107.609 -4.36 . . . . 0.0 115.533 173.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 159' ' ' ALA . . . 112.67 50.44 0.56 Allowed Glycine 0 N--CA 1.491 2.306 0 CA-C-N 114.097 -1.411 . . . . 0.0 112.55 176.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.48 ' O ' ' HA ' ' A' ' 158' ' ' ILE . 15.4 pt-20 -131.4 168.93 16.75 Favored 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 176.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.428 ' HA ' ' HA ' ' A' ' 158' ' ' ILE . 1.5 mt -112.98 125.89 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 116.545 2.054 . . . . 0.0 116.545 -175.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 17.9 mt -118.41 176.02 5.44 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 112.339 -2.21 . . . . 0.0 110.756 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 33.5 mt -114.61 159.87 19.95 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 174.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.631 HG21 ' CD1' ' A' ' 157' ' ' TYR . 46.2 t -121.6 124.74 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -176.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.486 ' O ' ' HB ' ' A' ' 191' ' ' ILE . 11.7 mt -141.57 77.24 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.972 -174.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . 0.546 ' O ' ' CE3' ' A' ' 190' ' ' TRP . 44.6 tt0 138.15 149.58 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.037 0 C-N-CA 127.177 2.191 . . . . 0.0 108.402 176.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -116.62 100.94 8.17 Favored 'General case' 0 N--CA 1.508 2.436 0 N-CA-C 115.972 1.842 . . . . 0.0 115.972 -175.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.506 ' CG ' ' HE1' ' A' ' 190' ' ' TRP . 21.6 pttp -13.65 78.15 0.02 OUTLIER Pre-proline 0 N--CA 1.5 2.045 1 N-CA-C 122.075 4.102 . . . . 0.0 122.075 -177.79 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.45 ' HD2' ' O ' ' A' ' 189' ' ' TRP . 13.4 Cg_endo -47.68 -59.85 1.1 Allowed 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 123.061 2.508 . . . . 0.0 106.582 171.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -123.6 22.4 9.11 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 112.331 -2.213 . . . . 0.0 110.229 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.448 ' CA ' ' HB2' ' A' ' 185' ' ' LYS . . . 113.74 17.68 7.34 Favored Glycine 0 N--CA 1.491 2.354 0 C-N-CA 120.473 -0.87 . . . . 0.0 111.046 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . 0.45 ' O ' ' HD2' ' A' ' 186' ' ' PRO . 1.4 m-90 -125.62 126.05 44.11 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 121.395 3.85 . . . . 0.0 121.395 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' TRP . . . . . 0.594 ' CE2' ' HB2' ' A' ' 204' ' ' ARG . 16.3 m95 -118.44 159.86 22.74 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 102.072 -3.307 . . . . 0.0 102.072 176.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.486 ' HB ' ' O ' ' A' ' 182' ' ' ILE . 79.3 mt -114.72 113.67 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 104.372 -2.455 . . . . 0.0 104.372 176.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -108.41 178.5 4.47 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 119.453 -0.899 . . . . 0.0 112.658 -172.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 199' ' ' GLU . 64.9 mttm -137.21 169.1 18.35 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 173.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 43.5 p-10 -121.71 -164.79 1.18 Allowed 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.144 -1.022 . . . . 0.0 109.958 177.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -100.2 39.85 1.31 Allowed 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.928 0.871 . . . . 0.0 108.691 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -126.76 -37.13 2.16 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 113.609 -1.632 . . . . 0.0 107.282 177.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 134.96 -37.4 1.94 Allowed Glycine 0 N--CA 1.487 2.05 0 N-CA-C 110.074 -1.211 . . . . 0.0 110.074 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 22.4 p30 -63.94 164.74 9.86 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 118.591 -1.244 . . . . 0.0 114.167 -178.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 193' ' ' LYS . 0.0 OUTLIER -125.8 157.91 36.31 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 111.858 -2.428 . . . . 0.0 109.492 179.405 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 191' ' ' ILE . . . -136.36 -175.23 13.7 Favored Glycine 0 N--CA 1.48 1.572 0 CA-C-O 122.319 0.955 . . . . 0.0 111.634 -178.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.538 ' H ' ' HA ' ' A' ' 170' ' ' ASP . 13.8 mt -122.04 82.5 1.97 Allowed 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 111.419 -2.391 . . . . 0.0 105.202 177.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 4.5 m -115.57 154.97 47.87 Favored Pre-proline 0 N--CA 1.495 1.806 0 C-N-CA 119.579 -0.848 . . . . 0.0 109.415 -175.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -81.74 179.97 5.29 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 123.121 2.547 . . . . 0.0 112.156 -178.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . 0.594 ' HB2' ' CE2' ' A' ' 190' ' ' TRP . 17.5 ttp85 -91.24 -49.19 6.5 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 103.762 -2.681 . . . . 0.0 103.762 176.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.406 HG23 ' H ' ' A' ' 205' ' ' THR . 68.2 p -19.3 -48.53 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 127.146 2.779 . . . . 0.0 117.026 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -108.51 42.57 1.37 Allowed 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 119.063 -1.055 . . . . 0.0 112.614 -177.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 84.9 mt -129.68 158.42 39.41 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 115.063 -0.972 . . . . 0.0 109.007 177.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -132.82 152.44 79.86 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 104.553 -2.388 . . . . 0.0 104.553 170.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -68.66 165.79 28.23 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 N-CA-C 108.064 -1.552 . . . . 0.0 108.064 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 32.2 t80 . . . . . 0 C--N 1.301 -1.542 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 179.489 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.051 0 CA-C-O 120.974 0.208 . . . . 0.0 112.852 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -135.15 -179.98 5.96 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.329 -1.359 . . . . 0.0 107.329 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -109.93 126.52 53.97 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 114.839 1.422 . . . . 0.0 114.839 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.527 ' CD1' HG21 ' A' ' 181' ' ' VAL . 44.8 m-85 -121.88 177.94 5.08 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 101.183 -3.636 . . . . 0.0 101.183 175.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.511 ' HA ' ' HA ' ' A' ' 178' ' ' ILE . 2.9 pt -123.72 153.32 29.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 100.79 -3.781 . . . . 0.0 100.79 170.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -91.83 153.18 19.73 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 100.768 -3.789 . . . . 0.0 100.768 177.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 31.2 m -125.07 17.36 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 125.908 2.005 . . . . 0.0 108.021 176.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -138.53 164.51 25.67 Favored Glycine 0 N--CA 1.483 1.806 0 N-CA-C 105.628 -2.989 . . . . 0.0 105.628 175.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -106.02 144.5 32.65 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 104.837 -2.283 . . . . 0.0 104.837 177.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -124.69 172.64 9.12 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 77.8 m -130.17 152.55 49.49 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.623 -0.831 . . . . 0.0 109.577 178.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -107.89 122.41 46.73 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 177.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -110.24 -19.51 12.98 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.127 -1.397 . . . . 0.0 108.121 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -123.35 176.7 5.99 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 114.057 -1.429 . . . . 0.0 108.339 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 15.2 t -95.53 49.93 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -131.81 -46.93 0.12 Allowed Glycine 0 N--CA 1.485 1.915 0 CA-C-N 113.282 -1.781 . . . . 0.0 108.788 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.419 ' HA ' ' H ' ' A' ' 201' ' ' LEU . 1.8 m-20 -87.62 169.2 12.36 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 112.503 -1.849 . . . . 0.0 114.385 -178.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.422 ' HG ' ' CA ' ' A' ' 200' ' ' GLY . 39.2 mt -117.97 -176.83 3.13 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 112.547 -2.115 . . . . 0.0 105.806 176.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 73.4 m -108.95 -59.4 1.89 Allowed 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.158 -179.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 43.1 p90 37.42 164.43 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.25 0 N-CA-C 117.617 2.451 . . . . 0.0 117.617 -175.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -124.52 143.62 50.57 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 120.173 3.397 . . . . 0.0 120.173 -178.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -26.75 81.29 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.589 1 CA-C-N 107.847 -4.251 . . . . 0.0 115.868 169.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 112.18 46.98 0.73 Allowed Glycine 0 N--CA 1.492 2.427 0 CA-C-N 114.617 -1.174 . . . . 0.0 113.392 176.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.418 ' O ' ' HA ' ' A' ' 158' ' ' ILE . 7.0 pt-20 -140.75 152.98 45.69 Favored 'General case' 0 N--CA 1.503 2.205 0 C-N-CA 117.092 -1.843 . . . . 0.0 109.485 176.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.511 ' HA ' ' HA ' ' A' ' 158' ' ' ILE . 1.3 mp -74.9 131.53 34.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -178.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 44.0 mt -122.66 168.35 12.3 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 112.339 -2.21 . . . . 0.0 107.044 176.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.408 HD13 ' H ' ' A' ' 181' ' ' VAL . 0.4 OUTLIER -113.05 148.02 36.03 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 101.796 -3.409 . . . . 0.0 101.796 179.591 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.527 HG21 ' CD1' ' A' ' 157' ' ' TYR . 2.7 t -124.01 138.51 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 CA-C-N 121.458 1.935 . . . . 0.0 111.467 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.455 ' O ' ' CB ' ' A' ' 183' ' ' GLU . 0.5 OUTLIER -146.52 81.28 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 O-C-N 123.169 0.293 . . . . 0.0 110.619 -173.371 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . 0.532 ' O ' ' CE3' ' A' ' 190' ' ' TRP . 34.9 tt0 139.31 153.18 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.96 0 C-N-CA 127.024 2.13 . . . . 0.0 107.748 178.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -117.92 99.95 7.25 Favored 'General case' 0 N--CA 1.508 2.445 0 N-CA-C 116.227 1.936 . . . . 0.0 116.227 -175.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.551 ' CG ' ' HE1' ' A' ' 190' ' ' TRP . 22.1 pttp -13.07 77.16 0.02 OUTLIER Pre-proline 0 N--CA 1.5 2.057 1 N-CA-C 122.183 4.142 . . . . 0.0 122.183 -177.325 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.492 ' HD2' ' HA ' ' A' ' 185' ' ' LYS . 12.3 Cg_endo -47.13 -59.34 1.28 Allowed 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 123.096 2.531 . . . . 0.0 106.999 171.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -121.11 19.58 11.55 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 112.285 -2.234 . . . . 0.0 110.563 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.498 ' CA ' ' HB2' ' A' ' 185' ' ' LYS . . . 112.94 15.85 8.94 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . 0.448 ' O ' ' HD2' ' A' ' 186' ' ' PRO . 1.3 m-90 -125.51 127.03 45.8 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 120.58 3.548 . . . . 0.0 120.58 179.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' TRP . . . . . 0.659 ' CE2' ' HB2' ' A' ' 204' ' ' ARG . 15.2 m95 -117.84 161.19 20.14 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 101.095 -3.668 . . . . 0.0 101.095 177.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.411 ' HB ' ' O ' ' A' ' 182' ' ' ILE . 28.8 mm -98.28 166.77 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.395 1 N-CA-C 99.679 -4.193 . . . . 0.0 99.679 176.963 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 199' ' ' GLU . . . -150.74 -177.8 6.2 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 116.125 -2.23 . . . . 0.0 111.447 178.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -137.69 163.69 30.67 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 174.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 26.0 p-10 -112.7 -160.72 0.73 Allowed 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.373 -0.931 . . . . 0.0 108.567 177.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -108.26 35.7 3.07 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 118.874 -1.13 . . . . 0.0 110.215 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -129.23 -67.72 0.76 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 105.48 -2.045 . . . . 0.0 105.48 175.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -165.58 -67.24 0.03 OUTLIER Glycine 0 N--CA 1.488 2.133 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.208 178.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -34.85 160.78 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 119.65 3.204 . . . . 0.0 119.65 -178.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . 0.419 ' HG3' ' N ' ' A' ' 200' ' ' GLY . 0.0 OUTLIER -118.65 160.4 21.89 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 111.904 -2.407 . . . . 0.0 109.573 179.251 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . 0.422 ' CA ' ' HG ' ' A' ' 171' ' ' LEU . . . -135.54 -169.72 11.91 Favored Glycine 0 N--CA 1.487 2.082 0 CA-C-O 122.998 1.332 . . . . 0.0 114.238 -177.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.419 ' H ' ' HA ' ' A' ' 170' ' ' ASP . 16.5 mt -130.09 84.89 2.24 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 111.138 -2.531 . . . . 0.0 105.236 178.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 3.0 m -113.04 156.04 43.38 Favored Pre-proline 0 N--CA 1.495 1.816 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 -175.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -90.35 173.24 3.31 Favored 'Trans proline' 0 C--N 1.302 -1.903 0 C-N-CA 122.429 2.086 . . . . 0.0 107.365 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . 0.659 ' HB2' ' CE2' ' A' ' 190' ' ' TRP . 22.7 ttt180 -102.07 -35.62 8.87 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 117.029 -1.869 . . . . 0.0 106.43 175.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 70.2 p -25.05 -46.67 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 126.057 2.098 . . . . 0.0 114.732 174.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -110.98 43.94 1.37 Allowed 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 119.762 -0.775 . . . . 0.0 112.659 -178.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 60.4 mt -127.17 151.53 48.56 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.618 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -123.64 150.03 60.45 Favored Pre-proline 0 C--N 1.301 -1.512 0 N-CA-C 104.148 -2.538 . . . . 0.0 104.148 174.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -68.81 160.13 50.94 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 C-N-CA 121.363 1.376 . . . . 0.0 110.738 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . 0.411 ' CE1' HD11 ' A' ' 178' ' ' ILE . 10.7 t80 . . . . . 0 N--CA 1.494 1.739 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 177.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.059 0 N-CA-C 110.241 -1.143 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -116.32 165.14 13.53 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 104.381 -2.452 . . . . 0.0 104.381 -178.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -99.15 119.51 37.97 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 117.098 -1.841 . . . . 0.0 114.417 -178.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.481 ' CD1' HG21 ' A' ' 181' ' ' VAL . 2.2 m-85 -123.87 174.09 7.77 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 101.145 -3.65 . . . . 0.0 101.145 175.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.513 HG21 ' CD1' ' A' ' 210' ' ' TYR . 3.3 pt -127.49 153.84 37.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 101.943 -3.354 . . . . 0.0 101.943 173.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -84.24 152.66 24.07 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 103.582 -2.747 . . . . 0.0 103.582 178.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 32.9 m -132.8 6.13 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 125.939 2.025 . . . . 0.0 108.734 177.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -131.37 149.68 19.3 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 106.36 -2.696 . . . . 0.0 106.36 177.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -101.77 92.26 4.76 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 118.887 -1.125 . . . . 0.0 108.798 -177.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -107.99 151.18 26.16 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 114.436 -1.256 . . . . 0.0 109.624 -178.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 52.7 m -120.98 158.81 26.93 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -81.29 151.54 28.02 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 118.076 -1.45 . . . . 0.0 109.022 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -112.72 -36.17 5.27 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 112.456 -2.156 . . . . 0.0 105.267 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -120.42 171.89 8.21 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 113.368 -1.742 . . . . 0.0 106.996 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.454 HG12 ' H ' ' A' ' 168' ' ' VAL . 0.1 OUTLIER -59.63 -46.8 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 117.489 -1.685 . . . . 0.0 108.693 177.766 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -29.55 -60.96 0.17 Allowed Glycine 0 N--CA 1.492 2.376 0 O-C-N 125.355 1.66 . . . . 0.0 113.834 177.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.504 ' HA ' ' H ' ' A' ' 201' ' ' LEU . 1.1 m-20 -77.23 168.86 19.34 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -176.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.436 ' CD2' HD22 ' A' ' 198' ' ' ASN . 14.2 mt -117.54 176.55 5.12 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 113.715 -1.584 . . . . 0.0 110.478 178.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 42.6 m -120.46 97.07 5.4 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 113.875 -1.512 . . . . 0.0 110.733 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.423 ' CD1' ' N ' ' A' ' 173' ' ' PHE . 8.2 p90 -121.05 171.09 8.92 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.495 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -107.4 -163.35 0.89 Allowed 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 122.691 1.234 . . . . 0.0 113.338 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 42.1 tttm -107.15 89.82 3.11 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 111.002 -2.817 . . . . 0.0 112.146 -175.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 109.16 50.65 0.71 Allowed Glycine 0 N--CA 1.492 2.401 0 CA-C-N 113.228 -1.806 . . . . 0.0 110.695 177.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.413 ' O ' ' HB ' ' A' ' 158' ' ' ILE . 6.0 pt-20 -128.78 176.59 7.7 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 177.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 21.9 mm -104.0 119.56 52.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 C-N-CA 118.669 -1.213 . . . . 0.0 112.451 -178.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 59.5 mt -121.16 163.62 18.17 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 113.933 -1.485 . . . . 0.0 110.031 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 59.6 mt -110.7 156.67 20.69 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 176.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.481 HG21 ' CD1' ' A' ' 157' ' ' TYR . 2.5 t -126.55 138.67 54.01 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 C-N-CA 117.981 -1.488 . . . . 0.0 110.221 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.453 ' O ' ' HB ' ' A' ' 191' ' ' ILE . 25.6 mt -141.04 82.0 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -174.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . 0.478 ' HG2' ' N ' ' A' ' 184' ' ' LYS . 41.9 tt0 138.02 150.52 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.393 0 C-N-CA 127.042 2.137 . . . . 0.0 108.004 176.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . 0.478 ' N ' ' HG2' ' A' ' 183' ' ' GLU . 97.9 mttt -116.84 115.68 26.0 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 124.628 1.205 . . . . 0.0 111.927 -179.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.537 ' CG ' ' HE1' ' A' ' 190' ' ' TRP . 0.1 OUTLIER -6.96 77.34 0.03 OUTLIER Pre-proline 0 N--CA 1.505 2.291 0 N-CA-C 117.652 2.464 . . . . 0.0 117.652 178.443 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -68.6 -55.95 0.2 Allowed 'Trans proline' 0 C--N 1.307 -1.629 0 N-CA-C 105.516 -2.532 . . . . 0.0 105.516 175.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -125.16 24.53 7.44 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 112.877 -1.965 . . . . 0.0 112.741 -177.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.511 ' CA ' ' HG2' ' A' ' 185' ' ' LYS . . . 116.65 -19.4 12.59 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 118.708 -1.711 . . . . 0.0 109.603 -179.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 16.3 m-90 -115.28 158.71 21.97 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 117.783 2.512 . . . . 0.0 117.783 -176.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' TRP . . . . . 0.537 ' HE1' ' CG ' ' A' ' 185' ' ' LYS . 23.9 m95 -129.97 162.43 28.68 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 100.457 -3.905 . . . . 0.0 100.457 -178.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.456 HG12 ' CB ' ' A' ' 183' ' ' GLU . 10.9 mm -113.33 106.21 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 C-N-CA 116.382 -2.127 . . . . 0.0 106.479 177.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -101.94 175.49 5.52 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -172.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . 0.462 ' HG2' ' HB2' ' A' ' 199' ' ' GLU . 63.1 mttm -126.51 165.12 19.71 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 174.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -122.82 -158.16 0.78 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 124.467 1.104 . . . . 0.0 110.376 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -100.26 36.95 1.75 Allowed 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 121.693 0.758 . . . . 0.0 110.822 -178.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -125.38 -43.42 1.92 Allowed 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 176.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 138.29 -43.3 1.2 Allowed Glycine 0 N--CA 1.483 1.817 0 N-CA-C 106.477 -2.649 . . . . 0.0 106.477 -178.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . 0.436 HD22 ' CD2' ' A' ' 171' ' ' LEU . 0.9 OUTLIER -53.57 155.91 2.82 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 179.361 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . 0.462 ' HB2' ' HG2' ' A' ' 193' ' ' LYS . 0.0 OUTLIER -127.89 155.0 44.87 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 112.949 -1.932 . . . . 0.0 110.357 -179.936 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . 0.416 ' HA3' ' HG ' ' A' ' 171' ' ' LEU . . . -145.0 -176.68 19.21 Favored Glycine 0 N--CA 1.485 1.964 0 C-N-CA 119.195 -1.479 . . . . 0.0 112.924 -178.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.504 ' H ' ' HA ' ' A' ' 170' ' ' ASP . 0.8 OUTLIER -92.78 92.05 7.76 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 112.757 -1.722 . . . . 0.0 106.741 176.943 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 5.0 m -113.81 147.85 38.57 Favored Pre-proline 0 N--CA 1.494 1.757 0 C-N-CA 117.43 -1.708 . . . . 0.0 106.739 -179.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -79.22 179.06 6.77 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 C-N-CA 122.291 1.994 . . . . 0.0 112.014 -177.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . 0.473 ' HB2' ' HE1' ' A' ' 190' ' ' TRP . 0.1 OUTLIER -86.25 -46.22 10.55 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 103.552 -2.759 . . . . 0.0 103.552 178.164 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 71.8 p -22.2 -50.62 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 O-C-N 126.013 2.071 . . . . 0.0 116.168 178.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -112.79 43.2 1.71 Allowed 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.587 0.708 . . . . 0.0 111.985 -178.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 12.3 mt -140.25 108.86 5.9 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 113.793 -1.548 . . . . 0.0 109.346 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -110.73 153.37 43.69 Favored Pre-proline 0 N--CA 1.49 1.55 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 178.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -59.6 165.39 9.72 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.093 1.862 . . . . 0.0 111.252 -178.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . 0.513 ' CD1' HG21 ' A' ' 158' ' ' ILE . 9.0 t80 . . . . . 0 N--CA 1.492 1.647 0 C-N-CA 119.024 -1.071 . . . . 0.0 111.99 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . 0.402 ' HA3' ' O ' ' A' ' 181' ' ' VAL . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 -105.87 167.19 9.95 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 112.681 -1.76 . . . . 0.0 108.436 -178.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -112.71 141.57 46.35 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 124.598 2.142 . . . . 0.0 113.175 -177.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.513 ' CG ' HD23 ' A' ' 207' ' ' LEU . 76.0 m-85 -133.57 -179.73 5.7 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 108.462 -3.972 . . . . 0.0 107.326 -176.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.535 ' HA ' ' HA ' ' A' ' 178' ' ' ILE . 7.5 pt -128.66 162.2 36.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 102.188 -3.264 . . . . 0.0 102.188 168.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.418 ' O ' ' N ' ' A' ' 176' ' ' GLY . . . -90.98 157.47 17.27 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 103.405 -2.813 . . . . 0.0 103.405 -179.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 16.6 m -126.63 -0.24 4.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 125.809 1.943 . . . . 0.0 108.381 175.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -132.11 165.71 23.46 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 107.812 -2.115 . . . . 0.0 107.812 177.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -106.97 122.33 46.22 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 173' ' ' PHE . 36.6 t80 -122.05 156.21 34.02 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.085 179.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 75.3 m -124.44 161.65 25.59 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -92.96 144.59 25.1 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 118.012 -1.475 . . . . 0.0 108.389 178.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -113.23 -32.69 6.21 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 112.834 -1.985 . . . . 0.0 106.645 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -112.52 177.59 4.58 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 113.66 -1.609 . . . . 0.0 107.027 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 17.3 t -95.84 49.34 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 104.502 -2.407 . . . . 0.0 104.502 178.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -130.65 -49.36 0.11 Allowed Glycine 0 N--CA 1.485 1.947 0 CA-C-N 112.697 -2.047 . . . . 0.0 109.27 -178.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.548 ' HA ' ' H ' ' A' ' 201' ' ' LEU . 29.2 m-20 -79.43 175.13 10.88 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 113.293 -1.454 . . . . 0.0 111.797 -178.273 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.51 ' HG ' ' HA3' ' A' ' 200' ' ' GLY . 14.1 mt -115.89 174.52 5.99 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 114.394 -1.276 . . . . 0.0 108.466 177.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 52.5 m -120.97 91.37 3.51 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 113.796 -1.547 . . . . 0.0 108.078 178.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.425 ' CZ ' ' HB3' ' A' ' 163' ' ' PHE . 9.9 p90 -121.87 169.45 10.77 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 113.698 -1.592 . . . . 0.0 111.064 -178.349 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -109.44 -163.67 0.88 Allowed 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 122.78 1.276 . . . . 0.0 111.373 178.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 67.9 tttt -92.87 156.3 17.05 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 110.724 -2.944 . . . . 0.0 110.661 -178.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 159' ' ' ALA . . . 53.61 44.66 68.61 Favored Glycine 0 N--CA 1.485 1.935 0 CA-C-N 112.783 -2.008 . . . . 0.0 108.1 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -130.49 128.25 40.84 Favored 'General case' 0 N--CA 1.504 2.256 0 C-N-CA 116.881 -1.928 . . . . 0.0 113.988 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.535 ' HA ' ' HA ' ' A' ' 158' ' ' ILE . 1.6 mp -58.95 119.27 3.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 -178.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 19.6 mt -118.63 155.45 30.97 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 113.766 -1.561 . . . . 0.0 107.6 175.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 23.7 tp -111.99 158.42 19.54 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 104.575 -2.38 . . . . 0.0 104.575 177.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.613 HG22 ' CZ3' ' A' ' 190' ' ' TRP . 98.5 t -110.39 147.74 14.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 C-N-CA 119.078 -1.049 . . . . 0.0 109.899 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.56 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 8.9 mt -148.69 74.97 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 C-N-CA 118.148 -1.421 . . . . 0.0 108.991 173.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . 0.56 ' HB2' ' O ' ' A' ' 182' ' ' ILE . 12.8 tm-20 139.07 165.21 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.224 0 C-N-CA 129.04 2.936 . . . . 0.0 105.314 176.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -113.76 88.69 2.9 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 117.444 2.387 . . . . 0.0 117.444 -175.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.542 ' HB3' ' CD1' ' A' ' 190' ' ' TRP . 7.4 pttm -8.69 76.05 0.03 OUTLIER Pre-proline 0 N--CA 1.505 2.319 0 N-CA-C 116.704 2.113 . . . . 0.0 116.704 177.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.467 ' HD2' ' HA ' ' A' ' 185' ' ' LYS . 11.8 Cg_endo -44.52 -56.27 2.7 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 123.37 2.713 . . . . 0.0 107.598 176.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -128.8 16.4 6.35 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 111.634 -2.53 . . . . 0.0 110.04 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 111.4 26.01 4.73 Favored Glycine 0 N--CA 1.485 1.917 0 N-CA-C 107.501 -2.24 . . . . 0.0 107.501 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 2.7 m-90 -134.45 97.74 3.9 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 116.72 2.119 . . . . 0.0 116.72 178.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' TRP . . . . . 0.686 ' CD1' ' N ' ' A' ' 190' ' ' TRP . 0.0 OUTLIER -112.68 171.72 7.36 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.597 179.636 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.512 ' HB ' ' O ' ' A' ' 182' ' ' ILE . 1.9 mp -108.9 111.23 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 N-CA-C 104.037 -2.579 . . . . 0.0 104.037 -179.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . 0.572 ' HB2' ' CZ3' ' A' ' 190' ' ' TRP . . . -109.91 -178.37 3.51 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -173.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -137.26 166.76 23.01 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 105.38 -2.081 . . . . 0.0 105.38 176.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 53.3 p-10 -121.26 -148.48 0.41 Allowed 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.121 -1.032 . . . . 0.0 111.637 177.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -103.76 19.37 20.04 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -176.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . 0.492 ' NZ ' HD22 ' A' ' 198' ' ' ASN . 8.4 ptmm? -124.07 -26.21 4.06 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 174.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 137.73 -35.11 2.09 Favored Glycine 0 N--CA 1.49 2.259 0 C-N-CA 119.097 -1.525 . . . . 0.0 113.363 178.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . 0.492 HD22 ' NZ ' ' A' ' 196' ' ' LYS . 24.2 p30 -61.56 162.17 8.63 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 117.546 -1.662 . . . . 0.0 113.417 -177.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -128.72 155.01 45.77 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 112.712 -2.04 . . . . 0.0 111.026 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . 0.51 ' HA3' ' HG ' ' A' ' 171' ' ' LEU . . . -144.7 -160.71 8.65 Favored Glycine 0 N--CA 1.489 2.175 0 CA-C-O 122.276 0.931 . . . . 0.0 112.581 -178.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.548 ' H ' ' HA ' ' A' ' 170' ' ' ASP . 20.1 mt -121.94 110.14 15.48 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 111.499 -2.35 . . . . 0.0 105.844 175.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.54 HG23 ' CD2' ' A' ' 190' ' ' TRP . 13.7 m -129.82 163.36 47.65 Favored Pre-proline 0 N--CA 1.498 1.958 0 C-N-CA 117.867 -1.533 . . . . 0.0 111.626 -175.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -100.24 139.28 0.26 Allowed 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 123.661 2.907 . . . . 0.0 109.713 174.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . 0.504 ' N ' ' HE1' ' A' ' 190' ' ' TRP . 0.1 OUTLIER -81.43 -23.57 37.45 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 104.64 -2.355 . . . . 0.0 104.64 179.954 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.44 ' C ' ' O ' ' A' ' 204' ' ' ARG . 68.2 p -24.65 -43.75 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.156 0 O-C-N 124.518 1.137 . . . . 0.0 113.602 171.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -114.33 50.23 0.96 Allowed 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 120.098 -0.641 . . . . 0.0 111.977 179.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.513 HD23 ' CG ' ' A' ' 157' ' ' TYR . 1.0 OUTLIER -133.95 152.73 51.96 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.255 -179.005 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -132.03 153.5 81.38 Favored Pre-proline 0 N--CA 1.491 1.601 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 172.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -64.52 164.91 21.89 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.077 1.851 . . . . 0.0 111.684 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . 0.432 ' CD1' ' CG2' ' A' ' 158' ' ' ILE . 35.1 t80 . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . 0.439 ' HA2' ' O ' ' A' ' 181' ' ' VAL . . . . . . . . 0 N--CA 1.486 2.021 0 N-CA-C 111.609 -0.596 . . . . 0.0 111.609 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -115.6 165.76 12.67 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -178.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -94.65 123.04 37.85 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 117.551 -1.66 . . . . 0.0 113.695 -176.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.507 ' CD1' HG21 ' A' ' 181' ' ' VAL . 4.0 m-85 -124.83 172.26 9.49 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 111.071 -2.786 . . . . 0.0 105.138 177.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.526 HG21 ' CD1' ' A' ' 210' ' ' TYR . 2.1 pt -129.98 150.33 34.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 102.959 -2.978 . . . . 0.0 102.959 171.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.407 ' O ' ' N ' ' A' ' 176' ' ' GLY . . . -86.59 150.7 24.04 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 102.435 -3.172 . . . . 0.0 102.435 178.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 33.8 m -132.68 23.18 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 126.189 2.181 . . . . 0.0 107.642 178.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -144.06 160.19 27.76 Favored Glycine 0 N--CA 1.483 1.784 0 N-CA-C 107.86 -2.096 . . . . 0.0 107.86 176.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -106.49 78.73 1.3 Allowed 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.292 -0.963 . . . . 0.0 108.449 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.421 ' HB3' ' CZ ' ' A' ' 173' ' ' PHE . 68.5 t80 -99.9 149.86 22.98 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 114.36 -1.291 . . . . 0.0 108.163 -178.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 93.6 m -120.81 157.96 28.62 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 114.023 -1.444 . . . . 0.0 108.856 -177.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -79.32 135.27 36.68 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 178.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -114.13 -28.26 7.38 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 113.804 -1.544 . . . . 0.0 107.293 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -114.77 178.61 4.22 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 179.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 58.8 t -90.78 149.9 3.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 104.003 -2.591 . . . . 0.0 104.003 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 110.53 -42.7 1.89 Allowed Glycine 0 N--CA 1.487 2.059 0 C-N-CA 118.407 -1.854 . . . . 0.0 108.703 -178.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.464 ' HA ' ' H ' ' A' ' 201' ' ' LEU . 3.0 m-20 -78.28 168.37 19.94 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 113.079 -1.561 . . . . 0.0 113.239 -179.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.539 ' HG ' ' CA ' ' A' ' 200' ' ' GLY . 76.6 mt -123.22 179.05 4.84 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 114.506 -1.225 . . . . 0.0 110.28 178.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 37.0 m -120.78 98.41 6.0 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 113.392 -1.731 . . . . 0.0 108.372 177.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.421 ' CZ ' ' HB3' ' A' ' 163' ' ' PHE . 17.4 p90 -113.23 165.31 12.54 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 118.73 -1.188 . . . . 0.0 111.379 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -122.59 152.84 40.03 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 117.736 2.495 . . . . 0.0 117.736 -177.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -37.11 76.66 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 108.575 -3.92 . . . . 0.0 114.923 173.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 159' ' ' ALA . . . 106.86 54.69 0.67 Allowed Glycine 0 N--CA 1.491 2.35 0 CA-C-N 114.986 -1.007 . . . . 0.0 112.973 175.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.47 ' O ' ' HA ' ' A' ' 158' ' ' ILE . 5.0 pt-20 -124.17 175.46 7.01 Favored 'General case' 0 N--CA 1.504 2.273 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 176.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.434 HD12 ' CE2' ' A' ' 210' ' ' TYR . 14.2 mm -112.46 131.9 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 119.068 -1.053 . . . . 0.0 111.607 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.507 HD23 ' N ' ' A' ' 179' ' ' LEU . 0.7 OUTLIER -140.26 174.87 10.08 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 114.653 -1.158 . . . . 0.0 113.69 177.826 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 83.6 mt -114.5 154.1 28.83 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.858 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.507 HG21 ' CD1' ' A' ' 157' ' ' TYR . 57.3 t -116.33 104.94 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 114.83 1.419 . . . . 0.0 114.83 -177.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.475 ' O ' ' HB ' ' A' ' 191' ' ' ILE . 13.3 mt -117.1 77.34 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-O 122.94 1.352 . . . . 0.0 108.178 -176.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . 0.462 ' HB3' ' H ' ' A' ' 191' ' ' ILE . 42.4 tt0 146.39 157.15 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.12 0 CA-C-N 109.715 -3.402 . . . . 0.0 108.262 173.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . 0.438 ' N ' ' HG2' ' A' ' 183' ' ' GLU . 64.1 mttp -117.37 102.21 9.05 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 114.655 -1.157 . . . . 0.0 112.233 -177.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.524 ' HB2' ' HE1' ' A' ' 190' ' ' TRP . 38.5 tttm -5.76 76.03 0.03 OUTLIER Pre-proline 0 N--CA 1.507 2.392 0 O-C-N 126.798 2.561 . . . . 0.0 115.005 178.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -66.81 -57.42 0.2 Allowed 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 123.565 2.843 . . . . 0.0 105.88 178.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 27.7 p-10 -121.01 20.36 11.54 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 111.329 -2.669 . . . . 0.0 112.992 -177.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 116.52 -27.49 7.97 Favored Glycine 0 N--CA 1.48 1.578 0 C-N-CA 117.424 -2.322 . . . . 0.0 108.93 -179.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 8.0 m-90 -118.02 148.65 42.04 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 118.332 -1.347 . . . . 0.0 114.474 -177.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' TRP . . . . . 0.524 ' HE1' ' HB2' ' A' ' 185' ' ' LYS . 3.0 m0 -112.39 173.45 6.36 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 102.684 -3.08 . . . . 0.0 102.684 178.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.511 ' HA ' ' O ' ' A' ' 200' ' ' GLY . 12.9 mt -115.58 114.34 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 N-CA-C 103.209 -2.886 . . . . 0.0 103.209 175.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -113.92 173.63 6.34 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 116.249 1.944 . . . . 0.0 116.249 -170.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 26.0 mmmt -121.37 141.1 51.28 Favored 'General case' 0 C--N 1.298 -1.638 1 N-CA-C 99.769 -4.159 . . . . 0.0 99.769 173.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -110.4 -160.1 0.7 Allowed 'General case' 0 N--CA 1.502 2.145 0 C-N-CA 117.433 -1.707 . . . . 0.0 112.089 -177.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -88.87 31.93 0.83 Allowed 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.245 -0.982 . . . . 0.0 111.077 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -123.99 -43.31 2.11 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 175.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 132.43 -40.3 1.64 Allowed Glycine 0 N--CA 1.485 1.939 0 N-CA-C 107.984 -2.046 . . . . 0.0 107.984 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . 0.428 ' OD1' HD22 ' A' ' 171' ' ' LEU . 15.1 p30 -56.79 167.35 0.78 Allowed 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 115.162 1.541 . . . . 0.0 115.162 -178.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -98.01 150.72 21.08 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 112.737 -2.029 . . . . 0.0 115.746 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . 0.539 ' CA ' ' HG ' ' A' ' 171' ' ' LEU . . . -133.18 -177.16 14.75 Favored Glycine 0 N--CA 1.48 1.568 0 CA-C-N 112.827 -1.988 . . . . 0.0 114.522 -176.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.464 ' H ' ' HA ' ' A' ' 170' ' ' ASP . 19.6 mt -131.77 76.82 1.73 Allowed 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 101.492 -3.521 . . . . 0.0 101.492 175.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 5.0 m -107.08 140.14 21.13 Favored Pre-proline 0 N--CA 1.494 1.749 0 C-N-CA 117.997 -1.481 . . . . 0.0 110.207 -172.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 0.4 OUTLIER -90.93 177.77 2.02 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 C-N-CA 122.725 2.283 . . . . 0.0 115.287 -175.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . 0.481 ' HB2' ' HD2' ' A' ' 185' ' ' LYS . 41.6 ttt-85 -89.16 -35.7 16.1 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 174.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 72.9 p -33.46 -41.31 0.08 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 125.527 1.767 . . . . 0.0 113.3 174.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -113.68 5.12 16.34 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 114.522 1.305 . . . . 0.0 114.522 -178.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.411 HD23 ' HB3' ' A' ' 157' ' ' TYR . 0.3 OUTLIER -118.68 161.01 20.8 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 178.374 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -132.57 157.65 77.76 Favored Pre-proline 0 N--CA 1.487 1.383 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 174.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -69.98 173.32 11.34 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.223 1.949 . . . . 0.0 109.47 178.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . 0.526 ' CD1' HG21 ' A' ' 158' ' ' ILE . 2.4 t80 . . . . . 0 N--CA 1.492 1.657 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 2.021 0 CA-C-O 122.149 0.86 . . . . 0.0 113.67 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -132.16 148.29 52.46 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 103.921 -2.622 . . . . 0.0 103.921 177.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -107.49 142.36 37.48 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 116.82 -1.952 . . . . 0.0 111.577 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.408 ' CE1' HG21 ' A' ' 181' ' ' VAL . 11.2 m-85 -125.29 -179.51 4.63 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 100.91 -3.737 . . . . 0.0 100.91 -179.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.479 HG21 ' CD1' ' A' ' 210' ' ' TYR . 1.5 pt -125.92 147.69 30.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 101.295 -3.594 . . . . 0.0 101.295 174.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.447 ' O ' ' N ' ' A' ' 176' ' ' GLY . . . -86.29 154.44 21.25 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 103.45 -2.796 . . . . 0.0 103.45 178.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.0 m -124.8 -0.93 5.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 126.089 2.118 . . . . 0.0 107.655 177.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -133.2 165.28 24.08 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 177.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -105.27 145.77 30.23 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 178.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -137.77 177.59 7.76 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 117.978 -1.489 . . . . 0.0 109.119 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 87.9 m -132.28 160.7 35.44 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -100.52 130.51 46.61 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 175.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -106.82 -30.51 8.87 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 -178.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -119.44 -177.82 3.46 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 113.253 -1.794 . . . . 0.0 108.22 -179.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 61.1 t -92.77 150.97 3.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 101.899 -3.371 . . . . 0.0 101.899 176.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 110.39 -48.44 0.94 Allowed Glycine 0 N--CA 1.488 2.142 0 N-CA-C 106.057 -2.817 . . . . 0.0 106.057 -176.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.434 ' HA ' ' HB2' ' A' ' 201' ' ' LEU . 0.3 OUTLIER -73.29 169.6 16.77 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 123.879 1.8 . . . . 0.0 114.189 179.911 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.452 ' HG ' ' HA3' ' A' ' 200' ' ' GLY . 9.7 mt -121.04 -178.05 3.65 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 109.404 -3.544 . . . . 0.0 110.243 177.203 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 18.4 m -115.09 -65.15 1.22 Allowed 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 113.955 -1.475 . . . . 0.0 107.967 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 21.7 p90 42.64 166.26 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 116.867 2.173 . . . . 0.0 116.867 -178.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -113.82 -166.84 1.13 Allowed 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 113.562 -1.653 . . . . 0.0 112.728 179.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.415 ' CG ' ' N ' ' A' ' 176' ' ' GLY . 37.2 tttp -98.39 161.56 13.62 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 110.924 -2.853 . . . . 0.0 112.826 -178.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 159' ' ' ALA . . . 37.39 46.45 1.44 Allowed Glycine 0 N--CA 1.492 2.399 0 CA-C-N 112.665 -2.061 . . . . 0.0 110.172 179.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.451 ' O ' ' HA ' ' A' ' 158' ' ' ILE . 5.0 pt-20 -123.35 176.41 6.15 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-N 111.045 -2.578 . . . . 0.0 106.875 177.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 13.9 mm -108.24 125.67 64.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 C-N-CA 119.392 -0.923 . . . . 0.0 111.338 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 24.2 mt -119.78 165.59 14.36 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 114.575 -1.193 . . . . 0.0 108.37 177.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.403 ' HG ' ' N ' ' A' ' 181' ' ' VAL . 45.7 tp -118.11 163.24 16.93 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 178.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.408 HG21 ' CE1' ' A' ' 157' ' ' TYR . 69.0 t -113.24 142.25 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 178.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.554 ' O ' ' HB ' ' A' ' 191' ' ' ILE . 3.2 mm -141.86 75.41 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 104.551 -2.389 . . . . 0.0 104.551 173.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . 0.51 ' HG2' ' N ' ' A' ' 184' ' ' LYS . 38.8 tt0 127.47 148.39 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.539 0 C-N-CA 127.255 2.222 . . . . 0.0 108.794 178.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . 0.51 ' N ' ' HG2' ' A' ' 183' ' ' GLU . 92.6 mttt -126.4 133.06 51.38 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.117 -1.033 . . . . 0.0 111.787 177.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.51 ' CG ' ' HE1' ' A' ' 190' ' ' TRP . 3.5 tttm -7.98 80.86 0.03 OUTLIER Pre-proline 0 N--CA 1.501 2.081 0 O-C-N 126.683 2.489 . . . . 0.0 116.972 177.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 185' ' ' LYS . 58.3 Cg_endo -72.59 -56.57 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.732 0 N-CA-C 104.136 -3.063 . . . . 0.0 104.136 175.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -134.14 23.2 3.82 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 113.604 -1.635 . . . . 0.0 107.999 178.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.474 ' HA2' ' HG2' ' A' ' 185' ' ' LYS . . . 127.65 -21.46 5.64 Favored Glycine 0 N--CA 1.489 2.223 0 CA-C-O 117.902 -1.499 . . . . 0.0 113.258 -178.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -105.05 156.14 18.34 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 118.018 2.599 . . . . 0.0 118.018 -176.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' TRP . . . . . 0.524 ' NE1' ' HB2' ' A' ' 204' ' ' ARG . 20.4 m95 -130.12 147.47 51.86 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 100.344 -3.947 . . . . 0.0 100.344 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.554 ' HB ' ' O ' ' A' ' 182' ' ' ILE . 12.4 mm -109.22 87.27 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 N-CA-C 102.998 -2.964 . . . . 0.0 102.998 178.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -80.02 175.04 10.99 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 113.247 -1.797 . . . . 0.0 113.848 -173.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -130.4 166.45 20.44 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 174.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -126.34 -161.89 1.09 Allowed 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 118.869 -1.132 . . . . 0.0 110.416 178.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -101.44 32.77 3.18 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.711 -178.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -129.1 -33.8 1.94 Allowed 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.092 176.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 138.07 -39.03 1.64 Allowed Glycine 0 N--CA 1.486 1.967 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.525 -179.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 21.3 p30 -56.84 159.84 3.81 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 118.536 -1.266 . . . . 0.0 114.267 -178.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . 0.457 ' HG3' ' N ' ' A' ' 200' ' ' GLY . 0.1 OUTLIER -140.69 166.12 25.62 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 112.008 -2.36 . . . . 0.0 109.573 179.175 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . 0.457 ' N ' ' HG3' ' A' ' 199' ' ' GLU . . . 159.41 174.01 28.59 Favored Glycine 0 N--CA 1.486 2.013 0 C-N-CA 118.148 -1.977 . . . . 0.0 114.684 177.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.434 ' HB2' ' HA ' ' A' ' 170' ' ' ASP . 9.8 mp -59.45 91.82 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 117.052 2.241 . . . . 0.0 117.052 -179.078 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 5.5 m -107.41 149.62 39.02 Favored Pre-proline 0 C--N 1.302 -1.495 0 N-CA-C 100.417 -3.92 . . . . 0.0 100.417 174.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -86.17 167.41 9.33 Favored 'Trans proline' 0 C--N 1.299 -2.033 0 N-CA-C 107.437 -1.794 . . . . 0.0 107.437 178.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . 0.524 ' HB2' ' NE1' ' A' ' 190' ' ' TRP . 12.2 ttp85 -80.22 -36.88 34.13 Favored 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 115.856 -2.338 . . . . 0.0 107.458 176.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 40.8 p -23.73 -54.82 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -110.52 47.4 0.97 Allowed 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.539 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -134.33 101.1 4.88 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 179.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -102.52 151.41 38.22 Favored Pre-proline 0 C--N 1.298 -1.654 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -57.61 164.78 6.96 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.176 1.918 . . . . 0.0 111.757 -178.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . 0.479 ' CD1' HG21 ' A' ' 158' ' ' ILE . 9.7 t80 . . . . . 0 N--CA 1.488 1.464 0 C-N-CA 119.544 -0.862 . . . . 0.0 109.592 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.717 0 N-CA-C 116.64 1.416 . . . . 0.0 116.64 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -123.46 168.31 12.73 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 178.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -112.32 135.21 53.29 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 124.216 1.96 . . . . 0.0 110.782 -178.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.485 ' CE1' HG21 ' A' ' 181' ' ' VAL . 16.9 m-85 -133.57 175.12 9.71 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 109.28 -3.6 . . . . 0.0 106.251 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.485 ' HA ' ' HA ' ' A' ' 178' ' ' ILE . 1.3 pt -132.03 152.54 36.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 101.475 -3.528 . . . . 0.0 101.475 171.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.48 ' O ' ' N ' ' A' ' 176' ' ' GLY . . . -90.33 152.89 20.82 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 102.287 -3.227 . . . . 0.0 102.287 177.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.444 ' C ' ' HB2' ' A' ' 175' ' ' LYS . 29.1 m -129.41 10.96 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 125.864 1.978 . . . . 0.0 107.765 177.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.401 ' N ' ' HB2' ' A' ' 175' ' ' LYS . . . -137.82 161.05 25.43 Favored Glycine 0 N--CA 1.478 1.474 0 N-CA-C 106.751 -2.54 . . . . 0.0 106.751 173.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -101.18 150.2 23.2 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 104.061 -2.57 . . . . 0.0 104.061 176.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -132.7 177.33 7.71 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 117.816 -1.554 . . . . 0.0 109.145 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 96.8 m -128.65 157.95 39.89 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 177.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -100.09 145.03 28.43 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 178.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 55.3 tp60 -111.21 -37.24 5.37 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -125.56 171.66 10.36 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 113.312 -1.767 . . . . 0.0 108.098 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 67.9 t -60.42 -48.63 87.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 103.873 -2.64 . . . . 0.0 103.873 177.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -30.29 -50.73 0.18 Allowed Glycine 0 N--CA 1.491 2.306 0 CA-C-N 112.308 -2.223 . . . . 0.0 113.399 174.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.536 ' HA ' ' H ' ' A' ' 201' ' ' LEU . 28.7 m-20 -79.83 164.15 23.84 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 113.738 -1.231 . . . . 0.0 113.339 -178.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.434 HD11 ' C ' ' A' ' 199' ' ' GLU . 16.6 mt -114.92 177.95 4.46 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 104.345 -2.465 . . . . 0.0 104.345 175.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 31.4 m -107.66 -57.46 2.09 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 33.1 p90 33.76 164.38 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 118.811 2.893 . . . . 0.0 118.811 -178.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -109.25 -166.55 1.12 Allowed 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 113.749 -1.569 . . . . 0.0 112.476 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.444 ' HB2' ' C ' ' A' ' 160' ' ' VAL . 10.4 ptpt -107.51 176.83 5.02 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 111.222 -2.717 . . . . 0.0 113.73 -176.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 159' ' ' ALA . . . 34.72 44.21 0.45 Allowed Glycine 0 N--CA 1.491 2.351 0 O-C-N 126.327 2.267 . . . . 0.0 109.097 -177.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.421 ' O ' ' HA ' ' A' ' 158' ' ' ILE . 16.7 pt-20 -130.0 175.6 8.75 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-N 110.758 -2.721 . . . . 0.0 106.555 177.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.485 ' HA ' ' HA ' ' A' ' 158' ' ' ILE . 17.9 mm -101.6 123.19 54.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -175.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 6.8 mp -116.89 156.27 27.64 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.568 177.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.496 HD13 ' H ' ' A' ' 181' ' ' VAL . 0.6 OUTLIER -114.77 152.05 32.73 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 -177.181 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.496 ' H ' HD13 ' A' ' 180' ' ' LEU . 59.6 t -111.6 132.91 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 -179.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.569 ' O ' ' HB ' ' A' ' 191' ' ' ILE . 9.9 mt -142.59 78.88 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 CA-C-N 114.177 -1.374 . . . . 0.0 108.758 179.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . 0.484 ' HG2' ' N ' ' A' ' 184' ' ' LYS . 33.6 tt0 122.0 165.13 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 C-N-CA 128.081 2.552 . . . . 0.0 109.616 173.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . 0.484 ' N ' ' HG2' ' A' ' 183' ' ' GLU . 98.4 mttt -110.37 167.03 10.51 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.206 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.708 ' HB3' ' CD1' ' A' ' 190' ' ' TRP . 17.8 pttp -95.85 68.4 0.03 OUTLIER Pre-proline 0 N--CA 1.508 2.469 0 N-CA-C 120.623 3.564 . . . . 0.0 120.623 -179.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -35.1 -56.5 0.5 Allowed 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 123.288 2.659 . . . . 0.0 108.938 171.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -121.16 23.77 10.39 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 112.95 -1.932 . . . . 0.0 114.069 179.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.602 ' CA ' ' HB2' ' A' ' 185' ' ' LYS . . . 110.7 17.46 9.14 Favored Glycine 0 N--CA 1.5 2.962 0 C-N-CA 119.644 -1.265 . . . . 0.0 112.658 178.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 2.0 m-90 -129.81 111.99 13.16 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 119.41 3.115 . . . . 0.0 119.41 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' TRP . . . . . 0.708 ' CD1' ' HB3' ' A' ' 185' ' ' LYS . 28.7 m0 -106.54 160.4 15.45 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 101.856 -3.387 . . . . 0.0 101.856 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.569 ' HB ' ' O ' ' A' ' 182' ' ' ILE . 1.5 mp -115.43 114.21 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 N-CA-C 103.359 -2.83 . . . . 0.0 103.359 173.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -116.26 176.84 4.92 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -171.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 199' ' ' GLU . 27.3 mtpp -126.84 161.03 29.2 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 173.041 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 17.9 p30 -120.59 -165.85 1.25 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 124.254 0.971 . . . . 0.0 111.64 178.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -99.9 39.12 1.36 Allowed 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 40.8 mmtm -118.66 -37.37 3.29 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 179.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 134.62 -35.87 2.15 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 120.142 -1.028 . . . . 0.0 111.47 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . 0.477 ' ND2' ' H ' ' A' ' 198' ' ' ASN . 0.1 OUTLIER -90.96 174.78 7.24 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 116.153 1.909 . . . . 0.0 116.153 -178.469 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . 0.434 ' C ' HD11 ' A' ' 171' ' ' LEU . 0.3 OUTLIER -117.74 161.27 19.97 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 111.964 -2.38 . . . . 0.0 110.08 -179.383 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . 0.423 ' N ' ' HG3' ' A' ' 199' ' ' GLU . . . -144.97 -170.21 13.9 Favored Glycine 0 N--CA 1.477 1.411 0 C-N-CA 119.326 -1.416 . . . . 0.0 111.453 -179.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.536 ' H ' ' HA ' ' A' ' 170' ' ' ASP . 14.4 mt -113.92 88.01 2.75 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 110.645 -2.777 . . . . 0.0 103.914 177.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 4.8 m -115.27 156.65 45.35 Favored Pre-proline 0 N--CA 1.489 1.493 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 -174.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -90.02 -179.82 1.87 Allowed 'Trans proline' 0 C--N 1.298 -2.087 0 C-N-CA 122.299 2.0 . . . . 0.0 106.976 178.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . 0.554 ' HB2' ' CE2' ' A' ' 190' ' ' TRP . 0.7 OUTLIER -102.9 -41.93 5.99 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 102.503 -3.147 . . . . 0.0 102.503 175.849 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 77.9 p -17.76 -46.28 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 O-C-N 126.616 2.447 . . . . 0.0 116.515 176.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . 0.403 ' N ' ' O ' ' A' ' 204' ' ' ARG . 36.4 m-85 -110.27 42.1 1.62 Allowed 'General case' 0 N--CA 1.503 2.205 0 CA-C-N 118.85 0.75 . . . . 0.0 112.643 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 6.1 mp -131.06 162.21 30.32 Favored 'General case' 0 N--CA 1.499 1.979 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.014 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -134.5 156.81 78.49 Favored Pre-proline 0 C--N 1.303 -1.433 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 172.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -72.26 170.69 18.54 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 N-CA-C 106.995 -1.964 . . . . 0.0 106.995 178.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . 0.451 ' CD1' HG21 ' A' ' 158' ' ' ILE . 5.2 t80 . . . . . 0 N--CA 1.491 1.602 0 C-N-CA 118.483 -1.287 . . . . 0.0 110.004 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 N-CA-C 116.377 1.311 . . . . 0.0 116.377 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -122.15 156.07 34.43 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 113.196 -1.502 . . . . 0.0 107.977 -179.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -104.61 128.04 52.52 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 117.897 -1.521 . . . . 0.0 111.373 -178.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.461 ' CE1' HG21 ' A' ' 181' ' ' VAL . 15.9 m-85 -122.1 174.8 6.71 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 104.678 -2.341 . . . . 0.0 104.678 178.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.48 HG21 ' CD1' ' A' ' 210' ' ' TYR . 1.7 pt -125.53 146.32 31.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 102.694 -3.076 . . . . 0.0 102.694 172.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.41 156.47 20.15 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 101.361 -3.57 . . . . 0.0 101.361 176.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 33.2 m -122.52 2.53 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 126.106 2.129 . . . . 0.0 108.274 178.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -125.92 167.73 18.24 Favored Glycine 0 N--CA 1.482 1.76 0 N-CA-C 106.504 -2.638 . . . . 0.0 106.504 177.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.413 ' HA ' ' HA ' ' A' ' 174' ' ' LYS . 23.2 t70 -105.53 114.36 28.49 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.271 -0.972 . . . . 0.0 109.913 179.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.445 ' HB3' ' CZ ' ' A' ' 173' ' ' PHE . 46.2 t80 -112.3 154.63 25.37 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.409 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 99.9 m -130.16 159.78 35.78 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 178.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -96.7 103.54 15.46 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 118.31 -1.356 . . . . 0.0 109.404 178.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -117.75 -0.72 11.72 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.009 -178.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.402 ' O ' ' C ' ' A' ' 168' ' ' VAL . 78.3 mm-40 -121.43 179.14 4.53 Favored 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 118.418 -1.313 . . . . 0.0 109.639 -177.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.402 ' C ' ' O ' ' A' ' 167' ' ' GLN . 96.0 t -25.25 -73.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 126.112 2.132 . . . . 0.0 111.06 179.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -133.55 141.13 12.45 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 107.489 -2.244 . . . . 0.0 107.489 174.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -167.64 -179.24 4.24 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 110.372 -2.914 . . . . 0.0 108.181 -179.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.499 ' HG ' ' CA ' ' A' ' 200' ' ' GLY . 16.5 mt -132.34 175.23 9.46 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 169.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 55.1 m -122.05 96.21 4.96 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.282 178.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.445 ' CZ ' ' HB3' ' A' ' 163' ' ' PHE . 17.6 p90 -118.6 168.47 10.67 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.944 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 162' ' ' ASP . 13.2 ptpt -126.1 151.25 47.47 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 116.299 1.963 . . . . 0.0 116.299 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 60.1 tttt -27.11 79.1 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.665 1 CA-C-N 108.337 -4.028 . . . . 0.0 116.14 171.22 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 109.61 48.21 0.81 Allowed Glycine 0 N--CA 1.491 2.309 0 CA-C-N 114.775 -1.102 . . . . 0.0 112.611 176.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' A' ' 158' ' ' ILE . 9.5 pt-20 -138.49 151.81 47.72 Favored 'General case' 0 N--CA 1.507 2.38 0 C-N-CA 117.35 -1.74 . . . . 0.0 109.135 178.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.465 ' N ' HD12 ' A' ' 178' ' ' ILE . 1.3 mp -82.95 137.59 20.74 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 117.765 2.505 . . . . 0.0 117.765 -177.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.413 ' N ' HD22 ' A' ' 179' ' ' LEU . 2.4 mm? -125.63 173.37 9.03 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 104.2 -2.518 . . . . 0.0 104.2 175.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.5 ' HB2' ' HB2' ' A' ' 193' ' ' LYS . 9.8 mt -117.75 161.34 19.86 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 176.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.461 HG21 ' CE1' ' A' ' 157' ' ' TYR . 78.1 t -113.49 124.43 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 N-CA-C 117.674 2.472 . . . . 0.0 117.674 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.566 ' O ' ' HB ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -135.45 77.53 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 CA-C-N 111.371 -2.65 . . . . 0.0 108.257 176.406 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . 0.55 ' HG2' ' N ' ' A' ' 184' ' ' LYS . 35.7 tt0 117.13 164.28 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 128.214 2.606 . . . . 0.0 110.129 173.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . 0.55 ' N ' ' HG2' ' A' ' 183' ' ' GLU . 99.5 mttt -108.87 -177.45 3.31 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.368 178.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.69 ' HD2' ' HB3' ' A' ' 204' ' ' ARG . 8.2 ptmm? -91.43 73.34 0.01 OUTLIER Pre-proline 0 N--CA 1.515 2.782 0 C-N-CA 130.326 3.45 . . . . 0.0 118.018 -177.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.505 ' HD2' ' O ' ' A' ' 184' ' ' LYS . 9.2 Cg_endo -44.31 -56.57 2.46 Favored 'Trans proline' 0 C--N 1.3 -1.981 0 C-N-CA 123.251 2.634 . . . . 0.0 106.802 174.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -126.24 24.2 6.88 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 112.582 -2.099 . . . . 0.0 110.665 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.498 ' CA ' ' HB2' ' A' ' 185' ' ' LYS . . . 110.22 15.78 11.19 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -128.13 102.78 6.86 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 119.933 3.309 . . . . 0.0 119.933 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' TRP . . . . . 0.675 ' CD1' ' HB3' ' A' ' 185' ' ' LYS . 10.7 m0 -95.93 157.05 16.07 Favored 'General case' 0 N--CA 1.498 1.933 1 N-CA-C 99.685 -4.191 . . . . 0.0 99.685 -177.926 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.566 ' HB ' ' O ' ' A' ' 182' ' ' ILE . 1.4 mp -112.54 140.99 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 1 N-CA-C 99.893 -4.114 . . . . 0.0 99.893 173.698 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -132.87 -177.95 4.73 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 119.319 -0.952 . . . . 0.0 113.542 -174.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . 0.5 ' HB2' ' HB2' ' A' ' 180' ' ' LEU . 62.6 mmtt -128.22 169.25 14.37 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 172.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -125.03 -158.0 0.81 Allowed 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.34 -0.944 . . . . 0.0 109.548 178.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -104.71 39.06 1.76 Allowed 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 121.33 0.586 . . . . 0.0 109.967 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -132.26 -37.39 1.1 Allowed 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.56 177.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 134.72 -22.24 3.69 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 -178.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -78.08 164.6 24.87 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.005 -1.078 . . . . 0.0 112.934 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.76 158.17 30.76 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 112.203 -2.271 . . . . 0.0 109.74 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . 0.499 ' CA ' ' HG ' ' A' ' 171' ' ' LEU . . . -135.46 -172.22 12.63 Favored Glycine 0 N--CA 1.479 1.501 0 CA-C-O 123.985 1.881 . . . . 0.0 115.115 -177.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.455 HD23 ' HA ' ' A' ' 201' ' ' LEU . 9.5 mt -126.2 87.06 2.61 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 108.568 -3.816 . . . . 0.0 103.684 177.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 4.9 m -116.79 156.5 47.86 Favored Pre-proline 0 C--N 1.303 -1.45 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 -173.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 0.6 OUTLIER -92.0 174.7 2.18 Favored 'Trans proline' 0 C--N 1.299 -2.061 0 N-CA-C 105.564 -2.514 . . . . 0.0 105.564 178.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . 0.69 ' HB3' ' HD2' ' A' ' 185' ' ' LYS . 0.4 OUTLIER -108.85 -31.06 7.83 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 175.502 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 82.5 p -23.68 -47.16 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.173 0 O-C-N 125.742 1.901 . . . . 0.0 113.875 171.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -112.53 49.49 0.92 Allowed 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 119.745 -0.782 . . . . 0.0 111.77 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -132.68 156.89 46.15 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.332 -179.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -132.02 157.6 77.78 Favored Pre-proline 0 N--CA 1.495 1.791 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 174.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -73.24 158.61 48.56 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 121.283 1.322 . . . . 0.0 108.708 178.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . 0.48 ' CD1' HG21 ' A' ' 158' ' ' ILE . 6.8 t80 . . . . . 0 N--CA 1.49 1.526 0 C-N-CA 119.4 -0.92 . . . . 0.0 109.066 179.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.907 0 CA-C-O 121.67 0.595 . . . . 0.0 113.707 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -119.29 166.59 12.82 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 104.907 -2.257 . . . . 0.0 104.907 -179.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -103.48 117.01 33.47 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 117.704 -1.598 . . . . 0.0 113.492 -178.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.462 ' CD1' HG21 ' A' ' 181' ' ' VAL . 5.5 m-85 -123.59 174.91 7.13 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 102.623 -3.103 . . . . 0.0 102.623 177.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.511 HG22 HG13 ' A' ' 178' ' ' ILE . 5.7 pt -131.62 150.76 34.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 103.312 -2.847 . . . . 0.0 103.312 172.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -81.71 151.45 27.51 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 102.848 -3.019 . . . . 0.0 102.848 176.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 26.8 m -129.69 10.72 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 125.866 1.978 . . . . 0.0 107.75 177.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -126.89 164.18 20.55 Favored Glycine 0 N--CA 1.484 1.852 0 N-CA-C 105.17 -3.172 . . . . 0.0 105.17 176.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -105.83 83.91 1.99 Allowed 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 118.709 -1.196 . . . . 0.0 109.277 -179.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -104.43 115.96 31.28 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 122.605 1.193 . . . . 0.0 108.425 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 18.2 m -101.01 154.35 18.77 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 111.944 -2.389 . . . . 0.0 106.379 -179.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.39 129.71 34.75 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 117.168 -1.813 . . . . 0.0 106.447 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -107.42 -29.31 9.32 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 -178.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -119.2 -175.67 2.97 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 113.586 -1.643 . . . . 0.0 106.616 179.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 61.4 t -88.76 151.76 3.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 179.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 114.33 -53.04 0.62 Allowed Glycine 0 N--CA 1.487 2.074 0 N-CA-C 108.644 -1.782 . . . . 0.0 108.644 -178.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.5 ' HA ' ' H ' ' A' ' 201' ' ' LEU . 39.8 m-20 -78.58 169.52 18.11 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 113.951 -1.125 . . . . 0.0 111.668 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.428 ' HG ' ' HA3' ' A' ' 200' ' ' GLY . 15.4 mt -121.01 176.02 5.77 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.182 177.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 31.3 m -116.92 93.09 4.06 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 114.12 -1.4 . . . . 0.0 112.273 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -128.17 166.85 17.73 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 113.512 -1.676 . . . . 0.0 109.274 177.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -125.39 159.82 30.9 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 117.001 2.223 . . . . 0.0 117.001 -178.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 44.4 tttm -35.97 77.45 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.659 1 CA-C-N 108.008 -4.178 . . . . 0.0 116.655 173.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 114.9 47.86 0.55 Allowed Glycine 0 N--CA 1.494 2.504 0 CA-C-N 114.866 -1.061 . . . . 0.0 115.126 174.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -137.51 158.66 43.92 Favored 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 117.472 -1.691 . . . . 0.0 107.576 175.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.511 HG13 HG22 ' A' ' 158' ' ' ILE . 1.1 mp -84.57 134.26 27.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 -176.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.7 mp -135.62 168.83 18.54 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 113.158 -1.837 . . . . 0.0 108.7 175.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.429 ' O ' ' HB1' ' A' ' 192' ' ' ALA . 27.9 mt -107.09 154.09 21.66 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 176.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.465 HG12 ' HB3' ' A' ' 190' ' ' TRP . 2.3 t -122.52 132.69 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 118.367 -1.333 . . . . 0.0 108.502 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.473 ' O ' ' CB ' ' A' ' 183' ' ' GLU . 16.6 mt -139.77 79.99 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 120.264 -0.575 . . . . 0.0 111.658 -173.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . 0.506 ' O ' ' CE3' ' A' ' 190' ' ' TRP . 3.7 tm-20 136.34 147.56 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.976 0 C-N-CA 127.63 2.372 . . . . 0.0 108.816 173.249 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . 0.439 ' HG2' ' CZ3' ' A' ' 190' ' ' TRP . 62.0 mttp -105.54 104.19 13.87 Favored 'General case' 0 N--CA 1.509 2.504 0 N-CA-C 119.727 3.232 . . . . 0.0 119.727 -171.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.523 ' HA ' ' HD2' ' A' ' 186' ' ' PRO . 21.8 pttp -15.09 79.25 0.02 OUTLIER Pre-proline 0 N--CA 1.5 2.074 1 N-CA-C 122.407 4.225 . . . . 0.0 122.407 179.249 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.523 ' HD2' ' HA ' ' A' ' 185' ' ' LYS . 11.0 Cg_endo -45.35 -59.93 1.01 Allowed 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 123.886 3.057 . . . . 0.0 107.321 171.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -121.86 20.75 10.82 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 111.399 -2.637 . . . . 0.0 110.638 -178.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.513 ' CA ' ' HB2' ' A' ' 185' ' ' LYS . . . 114.71 12.18 10.64 Favored Glycine 0 N--CA 1.488 2.154 0 C-N-CA 119.717 -1.23 . . . . 0.0 110.876 179.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . 0.402 ' O ' ' HD2' ' A' ' 186' ' ' PRO . 2.5 m-90 -127.49 134.3 49.82 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 120.318 3.451 . . . . 0.0 120.318 179.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' TRP . . . . . 0.506 ' CE3' ' O ' ' A' ' 183' ' ' GLU . 10.2 m95 -120.11 163.06 18.27 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 104.824 -2.287 . . . . 0.0 104.824 178.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.457 ' HB ' ' O ' ' A' ' 182' ' ' ILE . 1.7 mp -107.45 113.0 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 104.179 -2.526 . . . . 0.0 104.179 177.048 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . 0.442 ' HB2' HG22 ' A' ' 202' ' ' VAL . . . -108.2 -179.81 3.99 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -173.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 199' ' ' GLU . 96.5 mttt -133.6 165.31 25.21 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 172.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -115.62 -160.0 0.73 Allowed 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 118.822 -1.151 . . . . 0.0 109.658 -179.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -97.18 38.67 1.23 Allowed 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.874 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -133.36 -38.38 0.94 Allowed 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.45 177.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 136.87 -39.71 1.6 Allowed Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -178.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 21.5 p30 -52.78 164.27 0.39 Allowed 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . 0.411 ' C ' HD11 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -122.95 157.69 32.07 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 113.049 -1.887 . . . . 0.0 110.552 179.83 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . 0.428 ' HA3' ' HG ' ' A' ' 171' ' ' LEU . . . -142.58 -165.48 10.6 Favored Glycine 0 N--CA 1.482 1.709 0 CA-C-O 122.671 1.151 . . . . 0.0 112.387 -177.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.5 ' H ' ' HA ' ' A' ' 170' ' ' ASP . 33.7 mt -125.2 89.98 3.15 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 111.242 -2.479 . . . . 0.0 106.547 177.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.442 HG22 ' HB2' ' A' ' 192' ' ' ALA . 2.1 m -116.74 154.82 49.45 Favored Pre-proline 0 N--CA 1.496 1.871 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -177.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -89.59 176.26 2.99 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 C-N-CA 123.177 2.585 . . . . 0.0 111.391 -177.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . 0.476 ' HB2' ' CE2' ' A' ' 190' ' ' TRP . 29.3 ttm180 -97.97 -40.09 8.64 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 102.637 -3.097 . . . . 0.0 102.637 174.04 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 73.8 p -25.14 -55.24 0.05 OUTLIER 'General case' 0 N--CA 1.503 2.202 0 O-C-N 125.512 1.758 . . . . 0.0 115.54 176.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -113.66 45.65 1.41 Allowed 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 122.62 1.2 . . . . 0.0 109.387 -178.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -135.75 128.73 31.41 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 112.361 -2.2 . . . . 0.0 105.369 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -114.2 156.09 44.71 Favored Pre-proline 0 N--CA 1.494 1.744 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 178.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -63.21 166.11 15.53 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 121.693 1.595 . . . . 0.0 110.122 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . 0.406 ' CD1' HG21 ' A' ' 158' ' ' ILE . 35.6 t80 . . . . . 0 N--CA 1.491 1.616 0 C-N-CA 119.688 -0.805 . . . . 0.0 109.511 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 36.6 m . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 112.08 178.72 19.95 Favored Glycine 0 N--CA 1.488 2.119 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.343 -178.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -126.55 161.31 28.3 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 103.537 -2.764 . . . . 0.0 103.537 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -115.1 136.3 53.27 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 116.444 -2.102 . . . . 0.0 112.855 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.484 ' CD1' HG21 ' A' ' 181' ' ' VAL . 6.0 m-85 -124.99 -178.99 4.36 Favored 'General case' 0 C--N 1.299 -1.6 1 N-CA-C 100.068 -4.049 . . . . 0.0 100.068 179.085 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.408 HD13 HG21 ' A' ' 158' ' ' ILE . 3.5 pt -125.22 154.6 33.61 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 N-CA-C 101.914 -3.365 . . . . 0.0 101.914 173.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -89.26 150.63 22.54 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 102.02 -3.326 . . . . 0.0 102.02 177.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.2 m -130.09 28.36 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 126.238 2.211 . . . . 0.0 106.545 177.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -142.23 158.94 27.01 Favored Glycine 0 N--CA 1.482 1.754 0 N-CA-C 105.711 -2.956 . . . . 0.0 105.711 174.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.438 ' HA ' ' HA ' ' A' ' 174' ' ' LYS . 9.9 t70 -107.68 94.29 5.0 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 118.928 -1.109 . . . . 0.0 108.786 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.498 ' HB3' ' CZ ' ' A' ' 173' ' ' PHE . 47.6 t80 -107.65 154.09 21.96 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.086 -1.046 . . . . 0.0 108.921 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.416 ' HB ' HE22 ' A' ' 166' ' ' GLN . 56.7 m -127.0 163.43 23.72 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 105.442 -2.059 . . . . 0.0 105.442 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -95.25 135.03 37.34 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 177.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . 0.416 HE22 ' HB ' ' A' ' 164' ' ' THR . 16.6 mp0 -110.74 -29.81 7.84 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -115.63 -178.07 3.3 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 58.5 t -88.95 150.91 3.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 104.822 -2.288 . . . . 0.0 104.822 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 113.51 -51.89 0.68 Allowed Glycine 0 N--CA 1.485 1.929 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 -178.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.591 ' HA ' ' H ' ' A' ' 201' ' ' LEU . 2.9 m-20 -76.99 166.5 23.23 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -178.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.508 ' HG ' ' HA3' ' A' ' 200' ' ' GLY . 16.4 mt -121.26 178.82 4.62 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 113.449 -1.705 . . . . 0.0 109.935 179.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 39.0 m -122.03 100.02 6.75 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.57 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.498 ' CZ ' ' HB3' ' A' ' 163' ' ' PHE . 18.0 p90 -119.21 168.28 11.03 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.531 -0.867 . . . . 0.0 110.88 178.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 162' ' ' ASP . 57.2 pttt -124.84 142.79 51.2 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 115.882 1.808 . . . . 0.0 115.882 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 49.9 tptt -23.9 77.95 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 109.583 -3.462 . . . . 0.0 115.215 170.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 107.78 50.5 0.79 Allowed Glycine 0 N--CA 1.49 2.281 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.913 176.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.402 ' O ' ' HA ' ' A' ' 158' ' ' ILE . 8.0 pt-20 -127.95 170.85 12.39 Favored 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 176.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.405 ' HA ' ' HA ' ' A' ' 158' ' ' ILE . 14.4 mm -99.8 132.76 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 117.98 -1.488 . . . . 0.0 112.11 -177.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 57.9 mt -124.74 167.79 14.09 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 113.561 -1.654 . . . . 0.0 110.077 177.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.402 ' O ' ' HB1' ' A' ' 192' ' ' ALA . 22.2 tp -117.47 159.72 22.36 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 102.746 -3.057 . . . . 0.0 102.746 177.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.484 HG21 ' CD1' ' A' ' 157' ' ' TYR . 3.2 t -128.14 136.71 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 CA-C-N 120.915 1.689 . . . . 0.0 109.306 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.505 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 45.8 mt -145.35 86.13 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.093 -176.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . 0.505 ' HB2' ' O ' ' A' ' 182' ' ' ILE . 10.1 tm-20 130.56 153.18 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.753 0 C-N-CA 128.109 2.564 . . . . 0.0 107.654 172.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -109.83 123.0 48.81 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 118.426 2.75 . . . . 0.0 118.426 -174.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.459 ' CG ' ' HE1' ' A' ' 190' ' ' TRP . 8.4 tttm -9.79 78.37 0.03 OUTLIER Pre-proline 0 N--CA 1.507 2.413 0 N-CA-C 117.746 2.499 . . . . 0.0 117.746 175.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -69.09 -56.53 0.16 Allowed 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 123.165 2.577 . . . . 0.0 105.96 175.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -125.35 19.28 8.18 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 112.067 -2.333 . . . . 0.0 111.791 -177.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.403 ' HA2' ' NZ ' ' A' ' 185' ' ' LYS . . . 122.07 -23.84 7.19 Favored Glycine 0 N--CA 1.487 2.074 0 C-N-CA 118.452 -1.832 . . . . 0.0 111.242 -178.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 24.7 m-90 -113.39 154.6 26.67 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 115.842 1.793 . . . . 0.0 115.842 -176.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' TRP . . . . . 0.459 ' HE1' ' CG ' ' A' ' 185' ' ' LYS . 18.3 m95 -122.73 163.91 19.28 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 101.767 -3.42 . . . . 0.0 101.767 -178.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.493 HG12 ' CB ' ' A' ' 183' ' ' GLU . 8.2 mm -102.9 105.57 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 C-N-CA 115.522 -2.471 . . . . 0.0 105.043 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . 0.425 ' HB2' HG22 ' A' ' 202' ' ' VAL . . . -98.43 -177.88 3.84 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -173.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.465 ' HA ' ' HA ' ' A' ' 199' ' ' GLU . 34.0 ttmt -137.17 164.45 28.44 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 177.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 47.2 p-10 -122.45 -163.23 1.06 Allowed 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.664 -0.814 . . . . 0.0 110.077 178.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -103.36 40.86 1.34 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -126.17 -35.6 2.41 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 113.709 -1.587 . . . . 0.0 107.455 177.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 134.9 -38.96 1.75 Allowed Glycine 0 N--CA 1.487 2.071 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 21.1 p30 -67.8 163.78 21.03 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -178.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.465 ' HA ' ' HA ' ' A' ' 193' ' ' LYS . 0.0 OUTLIER -129.53 149.48 51.28 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 112.121 -2.309 . . . . 0.0 108.609 177.181 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . 0.508 ' HA3' ' HG ' ' A' ' 171' ' ' LEU . . . -139.28 -156.34 6.94 Favored Glycine 0 N--CA 1.482 1.714 0 CA-C-N 114.789 -1.096 . . . . 0.0 113.187 -177.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.591 ' H ' ' HA ' ' A' ' 170' ' ' ASP . 90.3 mt -117.12 101.94 8.89 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 111.622 -2.289 . . . . 0.0 107.56 178.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.425 HG22 ' HB2' ' A' ' 192' ' ' ALA . 4.9 m -120.5 151.44 53.91 Favored Pre-proline 0 N--CA 1.496 1.828 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -82.38 175.85 8.56 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 121.19 1.26 . . . . 0.0 109.05 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . 0.411 ' HB2' ' NE1' ' A' ' 190' ' ' TRP . 0.0 OUTLIER -96.37 -42.89 7.91 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 102.994 -2.965 . . . . 0.0 102.994 178.273 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 77.3 p -23.44 -53.67 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 O-C-N 125.579 1.799 . . . . 0.0 115.469 178.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -112.34 49.04 0.94 Allowed 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.891 -0.724 . . . . 0.0 110.807 -178.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -131.15 129.49 41.85 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 179.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -121.0 143.68 37.48 Favored Pre-proline 0 N--CA 1.493 1.675 0 C-N-CA 118.729 -1.189 . . . . 0.0 108.198 177.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -58.91 161.21 16.02 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 121.703 1.602 . . . . 0.0 109.798 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . 0.466 ' CG ' ' N ' ' A' ' 211' ' ' SER . 38.7 t80 -121.24 168.89 11.11 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 118.853 -1.139 . . . . 0.0 112.176 -179.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . 0.466 ' N ' ' CG ' ' A' ' 210' ' ' TYR . 47.5 t -110.75 73.55 0.83 Allowed 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.428 ' CD ' ' H ' ' A' ' 212' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.825 0 CA-C-N 112.562 -2.108 . . . . 0.0 114.029 -179.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 58.3 m . . . . . 0 N--CA 1.492 1.633 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 70.39 -179.43 29.21 Favored Glycine 0 N--CA 1.488 2.159 0 C-N-CA 119.873 -1.156 . . . . 0.0 112.603 178.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -117.55 162.52 17.86 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 103.195 -2.891 . . . . 0.0 103.195 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 9.3 mp0 -116.31 118.63 33.28 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 117.54 -1.664 . . . . 0.0 110.943 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.515 ' CD1' HG21 ' A' ' 181' ' ' VAL . 41.3 m-85 -126.0 176.46 6.99 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 104.346 -2.464 . . . . 0.0 104.346 178.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.455 ' CG2' ' CD1' ' A' ' 210' ' ' TYR . 1.7 pt -124.87 146.2 30.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 1 N-CA-C 100.155 -4.017 . . . . 0.0 100.155 170.728 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -92.7 155.07 17.95 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 116.849 -1.941 . . . . 0.0 106.246 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.6 m -130.2 25.64 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 125.719 1.887 . . . . 0.0 110.02 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -121.66 146.28 17.09 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 106.687 -2.565 . . . . 0.0 106.687 176.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -104.9 78.06 1.39 Allowed 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -178.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -106.51 155.81 19.21 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.021 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 97.6 m -118.32 161.82 19.3 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -86.41 144.34 27.36 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 117.49 -1.684 . . . . 0.0 107.868 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -113.61 -30.07 6.94 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 113.043 -1.89 . . . . 0.0 106.584 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -116.88 176.39 5.14 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 19.4 t -96.83 45.42 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 103.925 -2.621 . . . . 0.0 103.925 176.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -127.68 -46.02 0.2 Allowed Glycine 0 N--CA 1.484 1.882 0 N-CA-C 106.84 -2.504 . . . . 0.0 106.84 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.522 ' HA ' ' H ' ' A' ' 201' ' ' LEU . 25.3 m-20 -79.89 169.85 17.31 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 112.7 -1.75 . . . . 0.0 111.308 179.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.457 ' HG ' ' HA3' ' A' ' 200' ' ' GLY . 15.9 mt -121.07 176.73 5.43 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.427 176.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 47.2 m -119.62 99.46 6.67 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 114.354 -1.294 . . . . 0.0 110.994 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.444 ' N ' ' CD1' ' A' ' 173' ' ' PHE . 1.3 p90 -118.67 161.94 19.25 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.021 -1.072 . . . . 0.0 111.282 178.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -118.51 62.98 0.77 Allowed 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 120.047 3.351 . . . . 0.0 120.047 -175.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 70.4 tttt 37.05 76.83 0.05 OUTLIER 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 116.838 2.162 . . . . 0.0 116.838 173.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 119.1 52.4 0.29 Allowed Glycine 0 N--CA 1.495 2.595 0 CA-C-N 113.68 -1.6 . . . . 0.0 111.703 177.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -131.1 173.37 11.09 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 177.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.444 ' HA ' ' HA ' ' A' ' 158' ' ' ILE . 18.0 mm -97.16 125.06 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 C-N-CA 118.672 -1.211 . . . . 0.0 112.456 -177.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 17.9 mt -118.31 168.25 10.79 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 114.104 -1.407 . . . . 0.0 110.234 177.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 14.5 tp -118.35 157.98 26.11 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 103.826 -2.657 . . . . 0.0 103.826 177.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.515 HG21 ' CD1' ' A' ' 157' ' ' TYR . 43.7 t -120.0 128.3 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-N 120.675 1.579 . . . . 0.0 112.865 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.514 ' O ' ' HB ' ' A' ' 191' ' ' ILE . 56.3 mt -145.61 86.19 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.284 -176.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . 0.491 ' CB ' ' O ' ' A' ' 182' ' ' ILE . 5.0 tm-20 131.08 151.26 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.932 0 C-N-CA 127.672 2.389 . . . . 0.0 109.11 172.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . 0.499 ' HG2' ' CZ3' ' A' ' 190' ' ' TRP . 55.2 mttp -119.37 123.74 44.89 Favored 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 119.69 3.218 . . . . 0.0 119.69 -171.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.559 ' CG ' ' HE1' ' A' ' 190' ' ' TRP . 2.9 tttm -12.43 80.67 0.03 OUTLIER Pre-proline 0 N--CA 1.512 2.664 0 N-CA-C 118.515 2.783 . . . . 0.0 118.515 175.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 189' ' ' TRP . 11.4 Cg_exo -78.59 -55.23 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.527 0 N-CA-C 105.143 -2.676 . . . . 0.0 105.143 174.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.403 ' H ' ' HD2' ' A' ' 186' ' ' PRO . 4.6 p-10 -121.99 17.96 10.89 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 112.502 -2.135 . . . . 0.0 110.94 -178.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.504 ' HA2' ' HG2' ' A' ' 185' ' ' LYS . . . 114.02 6.81 20.27 Favored Glycine 0 N--CA 1.487 2.057 0 C-N-CA 118.846 -1.645 . . . . 0.0 109.219 -178.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . 0.488 ' O ' ' HD3' ' A' ' 186' ' ' PRO . 1.1 m-90 -121.65 147.26 46.1 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 119.829 3.27 . . . . 0.0 119.829 -177.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' TRP . . . . . 0.559 ' HE1' ' CG ' ' A' ' 185' ' ' LYS . 42.1 m95 -128.66 160.13 33.42 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 101.43 -3.545 . . . . 0.0 101.43 176.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.514 ' HB ' ' O ' ' A' ' 182' ' ' ILE . 7.7 mt -115.9 116.37 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 177.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -105.4 -177.46 3.37 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -171.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.458 ' HA ' ' HA ' ' A' ' 199' ' ' GLU . 3.3 ttmp? -134.83 166.7 22.37 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 175.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.406 ' H ' ' HG2' ' A' ' 193' ' ' LYS . 6.1 p-10 -119.67 -159.12 0.76 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -103.47 37.58 1.98 Allowed 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 120.114 -0.634 . . . . 0.0 110.205 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -128.8 -38.21 1.69 Allowed 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 176.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 138.9 -40.69 1.42 Allowed Glycine 0 N--CA 1.485 1.919 0 N-CA-C 109.021 -1.632 . . . . 0.0 109.021 -178.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -56.35 159.67 3.48 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 118.943 -1.103 . . . . 0.0 113.803 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 193' ' ' LYS . 0.0 OUTLIER -129.98 154.26 47.56 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 112.533 -2.121 . . . . 0.0 109.791 179.468 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . 0.457 ' HA3' ' HG ' ' A' ' 171' ' ' LEU . . . -135.53 -170.26 12.05 Favored Glycine 0 N--CA 1.482 1.755 0 CA-C-O 122.913 1.285 . . . . 0.0 114.094 -177.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.522 ' H ' ' HA ' ' A' ' 170' ' ' ASP . 13.2 mt -115.41 92.41 3.91 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 110.483 -2.858 . . . . 0.0 105.554 177.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 25.1 m -117.45 158.0 46.06 Favored Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 -177.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -82.86 178.63 5.86 Favored 'Trans proline' 0 C--N 1.302 -1.919 0 N-CA-C 107.945 -1.598 . . . . 0.0 107.945 179.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . 0.413 ' HB2' ' NE1' ' A' ' 190' ' ' TRP . 13.3 ttt-85 -96.82 -42.69 7.85 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 105.164 -2.162 . . . . 0.0 105.164 179.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 41.6 p -23.21 -46.03 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.987 0 O-C-N 126.544 2.402 . . . . 0.0 115.777 176.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -106.12 51.78 0.74 Allowed 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 119.271 -0.972 . . . . 0.0 111.898 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 73.3 mt -127.9 135.88 50.61 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 176.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -119.41 145.33 38.47 Favored Pre-proline 0 C--N 1.303 -1.422 0 N-CA-C 103.732 -2.692 . . . . 0.0 103.732 177.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -62.93 158.03 45.34 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 121.427 1.418 . . . . 0.0 108.457 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . 0.455 ' CD1' ' CG2' ' A' ' 158' ' ' ILE . 17.6 t80 -129.47 165.67 21.15 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 118.509 -1.276 . . . . 0.0 110.552 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 29.1 t -119.45 52.0 1.12 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 . . . . . 0 N--CA 1.494 1.769 0 CA-C-N 112.805 -1.998 . . . . 0.0 115.142 -179.674 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 4.1 t . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 122.713 1.244 . . . . 0.0 109.357 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -114.5 175.31 16.06 Favored Glycine 0 N--CA 1.488 2.147 0 CA-C-N 114.196 -1.365 . . . . 0.0 112.485 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -123.06 170.65 9.96 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 103.873 -2.64 . . . . 0.0 103.873 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -106.75 130.01 54.53 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 117.319 -1.752 . . . . 0.0 112.301 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.483 ' CD1' HG21 ' A' ' 181' ' ' VAL . 6.2 m-85 -122.53 178.95 4.76 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 101.756 -3.424 . . . . 0.0 101.756 177.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.452 HG22 HG13 ' A' ' 178' ' ' ILE . 6.6 pt -127.76 154.8 38.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 103.519 -2.771 . . . . 0.0 103.519 170.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -88.84 151.22 22.49 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 100.308 -3.96 . . . . 0.0 100.308 176.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 35.9 m -127.2 17.56 3.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 125.845 1.965 . . . . 0.0 107.966 178.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -130.59 159.3 22.83 Favored Glycine 0 N--CA 1.484 1.835 0 N-CA-C 105.895 -2.882 . . . . 0.0 105.895 176.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.408 ' HA ' ' HA ' ' A' ' 174' ' ' LYS . 31.0 t70 -107.3 93.05 4.34 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.026 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -106.86 156.95 18.14 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 118.645 -1.222 . . . . 0.0 108.393 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 90.8 m -120.15 162.31 19.55 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 104.677 -2.342 . . . . 0.0 104.677 179.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -88.25 139.76 30.17 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 117.412 -1.715 . . . . 0.0 106.479 178.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -112.05 -33.51 6.24 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -114.4 -178.22 3.32 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 113.428 -1.714 . . . . 0.0 106.581 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 14.4 p -94.37 40.22 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-O 124.261 1.981 . . . . 0.0 108.199 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -118.75 -53.41 0.29 Allowed Glycine 0 N--CA 1.485 1.935 0 CA-C-N 112.18 -2.282 . . . . 0.0 109.181 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.528 ' HA ' ' H ' ' A' ' 201' ' ' LEU . 1.7 m-20 -81.78 174.95 10.85 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.433 ' HG ' ' HA3' ' A' ' 200' ' ' GLY . 38.8 mt -117.28 177.66 4.65 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 111.92 -2.4 . . . . 0.0 108.202 178.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 42.7 m -116.58 91.48 3.6 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 114.182 -1.372 . . . . 0.0 108.004 177.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 16.8 p90 -118.07 164.57 14.93 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 114.0 -1.455 . . . . 0.0 110.497 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 162' ' ' ASP . 17.8 ptpt -126.54 142.85 51.4 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 117.638 2.459 . . . . 0.0 117.638 -179.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 71.3 tttt -22.25 76.25 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.726 1 CA-C-N 108.03 -4.168 . . . . 0.0 117.016 171.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 114.92 48.89 0.52 Allowed Glycine 0 N--CA 1.488 2.115 0 CA-C-N 114.225 -1.352 . . . . 0.0 112.998 175.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.415 ' O ' ' HA ' ' A' ' 158' ' ' ILE . 8.5 pt-20 -131.39 155.71 46.8 Favored 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 176.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.496 ' N ' ' CD1' ' A' ' 178' ' ' ILE . 1.1 mp -85.88 135.01 25.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -179.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.401 ' N ' HD22 ' A' ' 179' ' ' LEU . 2.7 mm? -124.3 170.98 10.25 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 112.819 -1.992 . . . . 0.0 105.796 175.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 16.6 tp -117.45 154.49 31.3 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 102.028 -3.323 . . . . 0.0 102.028 176.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.483 HG21 ' CD1' ' A' ' 157' ' ' TYR . 2.9 t -126.22 118.93 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 CA-C-N 120.685 1.584 . . . . 0.0 114.681 -176.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.489 ' N ' HD13 ' A' ' 182' ' ' ILE . 0.0 OUTLIER -135.78 93.13 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-O 123.886 1.803 . . . . 0.0 111.046 -177.962 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . 0.45 ' HG2' ' N ' ' A' ' 184' ' ' LYS . 44.1 tt0 140.1 155.8 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.584 1 CA-C-N 107.649 -4.341 . . . . 0.0 107.347 175.905 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . 0.45 ' N ' ' HG2' ' A' ' 183' ' ' GLU . 97.6 mttt -118.53 97.68 5.87 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 117.246 2.313 . . . . 0.0 117.246 -174.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.74 ' HB2' ' NE1' ' A' ' 190' ' ' TRP . 46.0 tttm -15.52 86.7 0.03 OUTLIER Pre-proline 0 N--CA 1.506 2.345 0 N-CA-C 117.095 2.258 . . . . 0.0 117.095 176.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -70.06 -58.46 0.1 OUTLIER 'Trans proline' 0 C--N 1.304 -1.776 0 N-CA-C 103.548 -3.289 . . . . 0.0 103.548 174.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -126.01 28.97 5.98 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 112.812 -1.995 . . . . 0.0 113.018 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.471 ' H ' ' HG3' ' A' ' 185' ' ' LYS . . . 115.75 12.04 9.77 Favored Glycine 0 N--CA 1.494 2.527 0 C-N-CA 119.631 -1.271 . . . . 0.0 110.378 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 3.4 m-90 -131.27 122.74 27.0 Favored 'General case' 0 N--CA 1.489 1.517 1 N-CA-C 123.336 4.569 . . . . 0.0 123.336 -178.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' TRP . . . . . 0.74 ' NE1' ' HB2' ' A' ' 185' ' ' LYS . 12.2 m95 -119.09 164.71 15.13 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 100.248 -3.982 . . . . 0.0 100.248 173.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 27.4 mt -115.66 119.91 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 102.185 -3.265 . . . . 0.0 102.185 176.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -112.23 177.39 4.66 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 118.259 -1.376 . . . . 0.0 113.843 -174.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -130.16 165.43 22.34 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 173.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 43.0 p-10 -122.75 -163.76 1.12 Allowed 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.258 -0.977 . . . . 0.0 110.025 177.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -98.87 40.93 1.17 Allowed 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 121.935 0.874 . . . . 0.0 108.787 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -128.56 -37.68 1.77 Allowed 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 113.556 -1.656 . . . . 0.0 107.677 177.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 133.29 -37.97 1.92 Allowed Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 19.9 p30 -64.14 165.65 8.92 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 -178.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.17 154.41 48.4 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 112.723 -2.035 . . . . 0.0 111.443 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . 0.433 ' HA3' ' HG ' ' A' ' 171' ' ' LEU . . . -135.47 -173.25 12.97 Favored Glycine 0 N--CA 1.486 2.02 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.587 -178.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.528 ' H ' ' HA ' ' A' ' 170' ' ' ASP . 9.6 mt -116.82 82.38 1.79 Allowed 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 104.636 -2.357 . . . . 0.0 104.636 178.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 3.2 m -107.21 156.0 38.35 Favored Pre-proline 0 N--CA 1.498 1.941 0 C-N-CA 119.02 -1.072 . . . . 0.0 109.839 -171.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -88.1 179.26 2.83 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 C-N-CA 123.08 2.52 . . . . 0.0 113.084 -177.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . 0.413 ' HB2' ' NE1' ' A' ' 190' ' ' TRP . 43.2 ttp180 -96.51 -41.84 8.37 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 103.685 -2.709 . . . . 0.0 103.685 174.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 69.8 p -23.55 -52.73 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 O-C-N 126.067 2.104 . . . . 0.0 115.718 178.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -115.49 46.17 1.54 Allowed 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 120.003 -0.679 . . . . 0.0 112.396 -178.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.43 144.55 51.3 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 114.585 -1.188 . . . . 0.0 107.961 179.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -128.41 154.04 79.2 Favored Pre-proline 0 N--CA 1.493 1.691 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 175.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -64.34 154.98 68.36 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 C-N-CA 121.658 1.572 . . . . 0.0 112.582 -178.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . 0.43 ' CE1' HD11 ' A' ' 178' ' ' ILE . 32.4 t80 -134.07 51.13 2.15 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 177.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 35.2 t -100.72 63.05 1.04 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 106.606 -1.628 . . . . 0.0 106.606 -178.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.302 -1.489 0 CA-C-N 112.166 -2.288 . . . . 0.0 110.733 -179.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 86.4 m . . . . . 0 N--CA 1.492 1.67 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.403 ' HA2' ' O ' ' A' ' 181' ' ' VAL . . . 108.94 -179.2 21.1 Favored Glycine 0 N--CA 1.489 2.203 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.918 179.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -115.96 167.32 11.06 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 103.298 -2.852 . . . . 0.0 103.298 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -101.96 122.15 43.5 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 117.274 -1.77 . . . . 0.0 112.407 -176.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.559 ' CD1' HG21 ' A' ' 181' ' ' VAL . 1.0 OUTLIER -126.95 169.8 12.93 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 102.613 -3.106 . . . . 0.0 102.613 176.485 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.971 HG22 HG12 ' A' ' 178' ' ' ILE . 36.7 pt -125.34 142.14 43.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 C-N-CA 118.058 -1.457 . . . . 0.0 108.524 170.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.462 ' O ' ' N ' ' A' ' 176' ' ' GLY . . . -72.33 152.52 42.04 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 101.631 -3.47 . . . . 0.0 101.631 178.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 26.8 m -118.47 -4.12 10.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 125.892 1.995 . . . . 0.0 108.521 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -137.16 177.01 20.13 Favored Glycine 0 N--CA 1.485 1.962 0 N-CA-C 107.363 -2.295 . . . . 0.0 107.363 178.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.408 ' HA ' ' HA ' ' A' ' 174' ' ' LYS . 8.5 t70 -106.51 132.2 52.8 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 118.857 -1.137 . . . . 0.0 109.205 178.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.421 ' HB3' ' CZ ' ' A' ' 173' ' ' PHE . 60.8 t80 -123.29 153.37 40.31 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 176.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 67.9 m -126.77 156.35 41.36 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -95.79 138.49 33.36 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 178.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -111.82 -34.88 5.88 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 88.0 mm-40 -117.45 -176.01 2.93 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 113.314 -1.767 . . . . 0.0 106.328 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 61.9 t -87.62 154.94 3.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 104.224 -2.51 . . . . 0.0 104.224 178.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 113.28 -48.2 0.96 Allowed Glycine 0 N--CA 1.485 1.948 0 N-CA-C 107.905 -2.078 . . . . 0.0 107.905 -178.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.611 ' HA ' ' H ' ' A' ' 201' ' ' LEU . 3.4 m-20 -83.91 167.42 17.0 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 113.731 -1.235 . . . . 0.0 113.785 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.462 ' CD2' HD22 ' A' ' 198' ' ' ASN . 19.3 mt -121.22 173.68 7.16 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 114.128 -1.396 . . . . 0.0 109.624 178.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 55.0 m -123.94 93.76 4.02 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 114.355 -1.293 . . . . 0.0 110.128 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.425 ' N ' ' CD1' ' A' ' 173' ' ' PHE . 20.1 p90 -126.6 167.92 15.01 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.862 -178.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 162' ' ' ASP . 63.7 pttt -118.27 165.93 13.23 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 123.504 1.621 . . . . 0.0 114.338 177.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 52.2 tttm -39.02 154.37 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 110.534 -3.03 . . . . 0.0 117.081 175.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 159' ' ' ALA . . . 33.14 48.75 0.42 Allowed Glycine 0 N--CA 1.493 2.454 0 CA-C-N 112.095 -2.321 . . . . 0.0 111.02 177.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' A' ' 158' ' ' ILE . 5.4 pt-20 -121.39 162.68 19.96 Favored 'General case' 0 N--CA 1.506 2.348 0 CA-C-N 111.722 -2.239 . . . . 0.0 108.372 176.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.971 HG12 HG22 ' A' ' 158' ' ' ILE . 44.7 mt -99.53 120.41 48.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 N-CA-C 118.69 2.848 . . . . 0.0 118.69 -176.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 21.4 mt -118.72 168.59 10.59 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 110.992 -2.822 . . . . 0.0 108.854 178.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.401 HD13 ' HA ' ' A' ' 180' ' ' LEU . 4.1 mm? -110.74 158.5 18.58 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 177.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.559 HG21 ' CD1' ' A' ' 157' ' ' TYR . 50.5 t -119.38 117.81 55.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 C-N-CA 119.65 -0.82 . . . . 0.0 112.975 -178.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.605 ' O ' ' HB ' ' A' ' 191' ' ' ILE . 3.4 mp -139.55 83.31 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.203 -1.35 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.292 -174.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . 0.49 ' HB3' ' H ' ' A' ' 191' ' ' ILE . 35.8 tt0 136.14 150.59 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.764 0 C-N-CA 127.931 2.493 . . . . 0.0 107.897 173.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . 0.414 ' N ' ' HG2' ' A' ' 183' ' ' GLU . 67.0 mttm -115.94 124.55 50.85 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 -176.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.481 ' CG ' ' HE1' ' A' ' 190' ' ' TRP . 3.6 tttm -10.7 77.4 0.03 OUTLIER Pre-proline 0 N--CA 1.504 2.261 0 O-C-N 126.658 2.473 . . . . 0.0 116.912 177.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -69.39 -57.04 0.13 Allowed 'Trans proline' 0 C--N 1.307 -1.615 0 N-CA-C 105.306 -2.613 . . . . 0.0 105.306 175.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -122.44 17.38 10.53 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 111.406 -2.634 . . . . 0.0 113.176 -177.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.412 ' HA2' ' NZ ' ' A' ' 185' ' ' LYS . . . 121.19 -25.7 6.96 Favored Glycine 0 N--CA 1.489 2.173 0 C-N-CA 118.359 -1.877 . . . . 0.0 110.596 -178.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 31.3 m-90 -114.84 153.42 30.47 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 122.826 1.298 . . . . 0.0 113.925 -176.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' TRP . . . . . 0.481 ' HE1' ' CG ' ' A' ' 185' ' ' LYS . 16.7 m95 -115.9 168.58 9.93 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 100.266 -3.976 . . . . 0.0 100.266 -178.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.605 ' HB ' ' O ' ' A' ' 182' ' ' ILE . 2.1 mm -111.0 109.98 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 103.367 -2.827 . . . . 0.0 103.367 -179.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -106.26 179.99 4.11 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -172.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 199' ' ' GLU . 36.6 ttpt -139.97 163.24 33.2 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 118.748 -1.181 . . . . 0.0 109.549 177.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -121.19 -165.91 1.29 Allowed 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.885 178.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -106.15 40.44 1.59 Allowed 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.897 0.856 . . . . 0.0 109.603 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -118.53 -42.54 2.75 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 177.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 141.94 -48.27 0.8 Allowed Glycine 0 N--CA 1.482 1.718 0 N-CA-C 106.005 -2.838 . . . . 0.0 106.005 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . 0.462 HD22 ' CD2' ' A' ' 171' ' ' LEU . 0.8 OUTLIER -55.15 154.01 6.16 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 179.345 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.49 ' HA ' ' HA ' ' A' ' 193' ' ' LYS . 0.0 OUTLIER -129.17 154.35 46.83 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 112.73 -2.032 . . . . 0.0 107.777 178.13 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . 0.446 ' O ' ' HA ' ' A' ' 191' ' ' ILE . . . -136.03 -161.04 9.04 Favored Glycine 0 N--CA 1.479 1.514 0 C-N-CA 120.009 -1.091 . . . . 0.0 113.161 -176.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.611 ' H ' ' HA ' ' A' ' 170' ' ' ASP . 36.2 mt -118.67 94.08 4.34 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 110.497 -2.852 . . . . 0.0 105.727 179.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 5.3 m -112.81 150.54 42.95 Favored Pre-proline 0 N--CA 1.498 1.932 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 -177.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -75.3 175.35 11.38 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 C-N-CA 121.174 1.25 . . . . 0.0 109.761 -177.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.4 -40.63 8.19 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 103.562 -2.755 . . . . 0.0 103.562 178.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 76.7 p -28.87 -50.97 0.09 Allowed 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 113.3 -1.773 . . . . 0.0 114.602 175.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -113.62 39.12 2.73 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.569 0.7 . . . . 0.0 112.331 -178.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.91 98.56 5.57 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 104.937 -2.246 . . . . 0.0 104.937 178.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -106.62 148.33 36.62 Favored Pre-proline 0 C--N 1.299 -1.621 0 N-CA-C 104.039 -2.578 . . . . 0.0 104.039 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -53.57 165.81 1.52 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.489 2.126 . . . . 0.0 113.18 -177.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . 0.474 ' CE1' HD11 ' A' ' 178' ' ' ILE . 45.4 t80 -116.7 -99.27 0.44 Allowed 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.734 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . 0.412 ' N ' ' CG ' ' A' ' 210' ' ' TYR . 46.6 m -125.69 -52.22 1.58 Allowed 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 123.872 1.796 . . . . 0.0 108.299 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 . . . . . 0 C--N 1.292 -1.922 0 CA-C-N 109.537 -3.483 . . . . 0.0 110.668 -179.429 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 25.7 p . . . . . 0 N--CA 1.488 1.472 0 CA-C-O 121.209 0.528 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.403 ' HA2' ' O ' ' A' ' 181' ' ' VAL . . . 110.39 170.19 19.69 Favored Glycine 0 N--CA 1.49 2.29 0 CA-C-N 114.973 -1.012 . . . . 0.0 114.681 177.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -128.82 159.5 35.54 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 103.965 -2.606 . . . . 0.0 103.965 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -105.63 134.4 48.8 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 115.968 -2.293 . . . . 0.0 112.967 -177.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.504 ' CD1' HG21 ' A' ' 181' ' ' VAL . 7.1 m-85 -115.49 -178.41 3.38 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 101.397 -3.557 . . . . 0.0 101.397 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.492 ' HA ' ' O ' ' A' ' 177' ' ' GLU . 0.1 OUTLIER -126.11 152.72 33.68 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 N-CA-C 100.504 -3.887 . . . . 0.0 100.504 175.15 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -91.88 148.64 22.07 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 102.824 -3.028 . . . . 0.0 102.824 178.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 32.7 m -126.6 9.46 3.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 125.128 1.518 . . . . 0.0 108.773 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -130.03 161.83 23.03 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 104.989 -3.244 . . . . 0.0 104.989 176.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.428 ' HA ' ' HA ' ' A' ' 174' ' ' LYS . 9.9 t70 -109.3 97.54 7.12 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 118.95 -1.1 . . . . 0.0 109.107 178.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.4 ' HB3' ' CZ ' ' A' ' 173' ' ' PHE . 13.7 t80 -104.3 155.1 19.04 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 118.361 -1.336 . . . . 0.0 107.628 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 88.3 m -123.21 165.24 17.24 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 103.862 -2.644 . . . . 0.0 103.862 179.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -91.63 145.25 24.74 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 117.653 -1.619 . . . . 0.0 108.452 179.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -113.7 -38.53 4.26 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -121.45 158.99 27.18 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 113.456 -1.702 . . . . 0.0 106.539 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 83.3 t -41.47 -57.68 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 125.099 1.499 . . . . 0.0 107.472 176.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -27.19 -56.22 0.1 OUTLIER Glycine 0 N--CA 1.486 2.025 0 CA-C-N 112.431 -2.168 . . . . 0.0 114.055 175.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.543 ' HA ' ' H ' ' A' ' 201' ' ' LEU . 18.2 m-20 -75.68 161.83 28.75 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -177.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.478 HD13 ' CA ' ' A' ' 200' ' ' GLY . 1.5 tp -116.88 -178.58 3.47 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 112.966 -1.925 . . . . 0.0 109.424 177.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 33.7 m -129.24 98.63 4.95 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 112.394 -2.185 . . . . 0.0 111.805 -178.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.4 ' CZ ' ' HB3' ' A' ' 163' ' ' PHE . 25.1 p90 -122.17 167.44 13.18 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.785 178.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 162' ' ' ASP . 18.8 ptpt -121.53 144.11 48.9 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 116.732 2.123 . . . . 0.0 116.732 179.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -35.07 80.66 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 108.529 -3.941 . . . . 0.0 114.426 172.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 111.33 50.16 0.63 Allowed Glycine 0 N--CA 1.49 2.293 0 CA-C-N 114.726 -1.125 . . . . 0.0 112.125 178.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.492 ' O ' ' HA ' ' A' ' 158' ' ' ILE . 5.9 pt-20 -126.91 -172.66 2.69 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 177.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 14.4 mm -109.26 137.54 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 123.992 0.807 . . . . 0.0 111.139 177.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 54.2 mt -128.92 169.12 15.01 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 113.588 -1.642 . . . . 0.0 110.008 178.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.63 ' HB2' ' HB2' ' A' ' 193' ' ' LYS . 6.9 mt -121.74 157.82 30.14 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 174.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.504 HG21 ' CD1' ' A' ' 157' ' ' TYR . 92.6 t -119.14 117.48 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 116.714 2.116 . . . . 0.0 116.714 -178.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.507 ' O ' ' HB ' ' A' ' 191' ' ' ILE . 1.7 mm -123.63 70.79 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 105.472 -2.048 . . . . 0.0 105.472 178.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' A' ' 182' ' ' ILE . 10.8 tp10 125.35 141.53 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.296 0 C-N-CA 128.853 2.861 . . . . 0.0 109.756 177.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -120.14 113.54 20.61 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 177.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.634 ' HB2' ' CA ' ' A' ' 188' ' ' GLY . 0.0 OUTLIER -14.37 75.75 0.02 OUTLIER Pre-proline 0 N--CA 1.495 1.781 0 N-CA-C 121.383 3.846 . . . . 0.0 121.383 -171.503 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.449 ' HD2' ' HA ' ' A' ' 185' ' ' LYS . 9.9 Cg_endo -43.65 -58.81 1.25 Allowed 'Trans proline' 0 C--N 1.314 -1.289 0 C-N-CA 123.647 2.898 . . . . 0.0 106.221 171.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -124.98 23.17 7.87 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 111.761 -2.472 . . . . 0.0 111.645 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.634 ' CA ' ' HB2' ' A' ' 185' ' ' LYS . . . 113.53 2.16 24.39 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . 0.428 ' O ' ' HD2' ' A' ' 186' ' ' PRO . 3.9 m-90 -126.33 119.74 28.11 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 119.621 3.193 . . . . 0.0 119.621 -176.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' TRP . . . . . 0.55 ' CD1' ' HB3' ' A' ' 185' ' ' LYS . 5.7 m0 -103.21 150.61 23.53 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 104.084 -2.562 . . . . 0.0 104.084 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.507 ' HB ' ' O ' ' A' ' 182' ' ' ILE . 8.0 mm -113.76 102.19 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 100.341 -3.948 . . . . 0.0 100.341 177.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -106.06 169.4 8.52 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 118.174 -1.411 . . . . 0.0 112.614 -171.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.63 ' HB2' ' HB2' ' A' ' 180' ' ' LEU . 93.7 mttt -117.86 161.93 18.94 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 104.117 -2.549 . . . . 0.0 104.117 176.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -126.35 -162.63 1.15 Allowed 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 118.557 -1.257 . . . . 0.0 110.474 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -98.96 40.85 1.17 Allowed 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.692 -0.803 . . . . 0.0 109.773 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -128.56 -40.75 1.56 Allowed 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 176.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 140.28 -47.39 0.88 Allowed Glycine 0 N--CA 1.487 2.099 0 N-CA-C 107.348 -2.301 . . . . 0.0 107.348 178.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -57.26 161.31 3.34 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 114.965 1.468 . . . . 0.0 114.965 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.448 ' HG3' ' N ' ' A' ' 200' ' ' GLY . 0.0 OUTLIER -130.55 151.42 51.04 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 113.598 -1.637 . . . . 0.0 108.464 176.772 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . 0.478 ' CA ' HD13 ' A' ' 171' ' ' LEU . . . -139.64 -157.05 7.14 Favored Glycine 0 N--CA 1.484 1.877 0 C-N-CA 119.333 -1.413 . . . . 0.0 113.399 -178.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.543 ' H ' ' HA ' ' A' ' 170' ' ' ASP . 42.4 mt -112.34 96.15 5.85 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 111.133 -2.533 . . . . 0.0 108.708 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 3.7 m -112.26 154.46 44.41 Favored Pre-proline 0 N--CA 1.49 1.525 0 N-CA-C 105.777 -1.934 . . . . 0.0 105.777 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 0.4 OUTLIER -88.4 -178.24 2.01 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 C-N-CA 123.721 2.947 . . . . 0.0 112.346 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . 0.55 ' HB2' ' CD ' ' A' ' 185' ' ' LYS . 24.8 ttt85 -74.29 -59.65 2.63 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 173.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 69.5 p -18.37 -48.55 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.134 0 CA-C-N 109.876 -3.329 . . . . 0.0 117.187 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -110.45 38.32 2.49 Favored 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 119.192 -1.003 . . . . 0.0 112.243 -178.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -123.53 104.98 9.38 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 124.238 0.961 . . . . 0.0 111.427 -178.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -112.61 155.04 44.46 Favored Pre-proline 0 N--CA 1.496 1.853 0 C-N-CA 117.891 -1.524 . . . . 0.0 107.021 175.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -64.19 164.21 23.43 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 121.809 1.672 . . . . 0.0 111.963 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -123.39 -178.81 4.11 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 79.1 p -118.8 32.57 6.06 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.587 -0.845 . . . . 0.0 112.253 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 115.045 -2.407 . . . . 0.0 107.212 176.842 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.483 HG22 ' H ' ' A' ' 154' ' ' GLY . 37.2 m . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.483 ' H ' HG22 ' A' ' 153' ' ' THR . . . -113.49 -178.66 19.36 Favored Glycine 0 N--CA 1.488 2.113 0 C-N-CA 120.561 -0.828 . . . . 0.0 113.616 -179.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -130.79 170.98 13.64 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.531 ' H ' ' CD ' ' A' ' 156' ' ' GLU . 0.0 OUTLIER -110.79 123.83 50.84 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 116.972 -1.891 . . . . 0.0 112.969 -178.001 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.52 ' CD1' HG21 ' A' ' 181' ' ' VAL . 5.9 m-85 -119.18 178.11 4.64 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 102.649 -3.093 . . . . 0.0 102.649 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.504 HG22 HG13 ' A' ' 178' ' ' ILE . 2.9 pt -128.28 145.48 35.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 102.409 -3.182 . . . . 0.0 102.409 172.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -92.26 151.55 20.27 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 115.011 -2.676 . . . . 0.0 103.876 177.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 28.0 m -127.67 32.81 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 125.838 1.961 . . . . 0.0 108.23 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -129.96 158.03 22.14 Favored Glycine 0 N--CA 1.483 1.824 0 N-CA-C 105.762 -2.935 . . . . 0.0 105.762 173.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -106.06 76.14 1.15 Allowed 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -102.21 148.53 25.32 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 118.463 -1.295 . . . . 0.0 108.428 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 87.5 m -120.21 161.49 20.98 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 104.461 -2.422 . . . . 0.0 104.461 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -93.17 135.77 34.05 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 105.744 -1.946 . . . . 0.0 105.744 178.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -110.65 -31.34 7.25 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 -115.71 -178.88 3.49 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 105.091 -2.189 . . . . 0.0 105.091 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 61.8 t -89.94 152.47 3.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 103.317 -2.846 . . . . 0.0 103.317 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 114.54 -47.86 1.0 Allowed Glycine 0 N--CA 1.486 2.02 0 N-CA-C 108.503 -1.839 . . . . 0.0 108.503 -177.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.489 ' HA ' ' H ' ' A' ' 201' ' ' LEU . 26.4 m-20 -82.2 168.7 17.4 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 113.964 -1.118 . . . . 0.0 112.622 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.441 HD11 ' C ' ' A' ' 199' ' ' GLU . 41.8 mt -127.66 178.7 5.95 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.842 176.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 57.3 m -122.13 102.57 8.22 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 114.453 -1.248 . . . . 0.0 113.316 -178.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -118.92 167.96 11.23 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.315 -0.954 . . . . 0.0 111.522 177.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -114.99 62.21 0.68 Allowed 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 121.019 3.711 . . . . 0.0 121.019 -175.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.439 ' O ' ' HG3' ' A' ' 175' ' ' LYS . 15.6 tptm 41.02 74.12 0.11 Allowed 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 117.102 2.26 . . . . 0.0 117.102 174.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 116.53 50.99 0.4 Allowed Glycine 0 N--CA 1.495 2.609 0 CA-C-N 114.412 -1.267 . . . . 0.0 113.822 173.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.474 ' CD ' ' N ' ' A' ' 177' ' ' GLU . 0.2 OUTLIER -139.92 163.45 32.63 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 177.837 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.504 HG13 HG22 ' A' ' 158' ' ' ILE . 1.0 OUTLIER -87.99 134.01 29.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 116.361 1.986 . . . . 0.0 116.361 -176.376 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.5 mp -131.42 175.62 8.98 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 112.671 -2.059 . . . . 0.0 108.076 174.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.472 HD13 ' H ' ' A' ' 181' ' ' VAL . 0.5 OUTLIER -112.92 156.18 23.44 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 102.713 -3.069 . . . . 0.0 102.713 -179.449 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.52 HG21 ' CD1' ' A' ' 157' ' ' TYR . 2.8 t -127.15 135.74 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 CA-C-N 120.924 1.693 . . . . 0.0 109.906 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.464 ' O ' ' HB ' ' A' ' 191' ' ' ILE . 4.3 mt -143.49 84.13 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -174.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . 0.446 ' CB ' ' O ' ' A' ' 182' ' ' ILE . 34.2 tt0 142.32 154.13 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.54 0 C-N-CA 126.446 1.898 . . . . 0.0 108.594 176.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . 0.442 ' N ' ' HG2' ' A' ' 183' ' ' GLU . 97.9 mttt -121.34 116.95 25.77 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 115.256 1.576 . . . . 0.0 115.256 -178.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.481 ' HB2' ' NE1' ' A' ' 190' ' ' TRP . 9.3 tttm -7.27 81.18 0.03 OUTLIER Pre-proline 0 N--CA 1.5 2.071 0 CA-C-N 111.757 -2.474 . . . . 0.0 117.378 175.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.468 ' HD2' ' H ' ' A' ' 189' ' ' TRP . 97.1 Cg_endo -78.66 -52.83 0.06 OUTLIER 'Trans proline' 0 C--N 1.302 -1.877 0 C-N-CA 122.797 2.331 . . . . 0.0 106.805 175.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -126.79 14.07 7.45 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.244 -1.343 . . . . 0.0 109.085 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.432 ' HA2' ' HG2' ' A' ' 185' ' ' LYS . . . 118.18 7.49 11.26 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 -178.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . 0.468 ' H ' ' HD2' ' A' ' 186' ' ' PRO . 1.4 m-90 -122.54 142.13 50.94 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 119.767 3.247 . . . . 0.0 119.767 -179.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' TRP . . . . . 0.514 ' NE1' ' HB2' ' A' ' 204' ' ' ARG . 22.7 m95 -124.7 157.7 34.99 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 100.412 -3.921 . . . . 0.0 100.412 177.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.464 ' HB ' ' O ' ' A' ' 182' ' ' ILE . 31.2 mm -97.99 171.06 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.866 1 N-CA-C 99.845 -4.131 . . . . 0.0 99.845 176.671 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . 0.436 ' O ' ' HA ' ' A' ' 199' ' ' GLU . . . -152.95 176.17 12.14 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 116.683 -2.007 . . . . 0.0 109.893 177.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -134.02 159.58 40.36 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 170.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 58.4 p30 -120.12 -162.78 0.95 Allowed 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 118.594 -1.242 . . . . 0.0 111.426 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -99.54 39.44 1.31 Allowed 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.086 -1.046 . . . . 0.0 109.692 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -121.38 -39.35 2.68 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 176.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 126.98 -1.79 7.29 Favored Glycine 0 N--CA 1.492 2.402 0 CA-C-N 114.803 -1.09 . . . . 0.0 111.224 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 26.3 p30 -100.7 176.68 5.23 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.441 ' C ' HD11 ' A' ' 171' ' ' LEU . 1.5 pt-20 -113.28 166.57 11.34 Favored 'General case' 0 N--CA 1.484 1.27 0 O-C-N 125.859 1.974 . . . . 0.0 109.332 -179.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . 0.415 ' CA ' ' HG ' ' A' ' 171' ' ' LEU . . . -144.58 -178.46 20.25 Favored Glycine 0 N--CA 1.481 1.698 0 CA-C-O 122.389 0.994 . . . . 0.0 113.428 -175.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.489 ' H ' ' HA ' ' A' ' 170' ' ' ASP . 15.4 mt -125.26 89.18 3.01 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 177.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 3.9 m -111.7 157.16 40.18 Favored Pre-proline 0 N--CA 1.487 1.409 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 -175.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -90.08 179.57 1.98 Allowed 'Trans proline' 0 C--N 1.3 -2.014 0 C-N-CA 122.103 1.869 . . . . 0.0 109.405 178.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . 0.514 ' HB2' ' NE1' ' A' ' 190' ' ' TRP . 10.8 tpt180 -97.54 -43.23 7.33 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 176.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.442 ' HG1' ' HD1' ' A' ' 206' ' ' TYR . 43.0 p -25.56 -51.31 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 126.231 2.207 . . . . 0.0 114.731 177.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . 0.442 ' HD1' ' HG1' ' A' ' 205' ' ' THR . 85.7 m-85 -113.88 50.43 0.92 Allowed 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 119.778 -0.769 . . . . 0.0 111.781 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -133.5 135.95 44.77 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 177.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -125.39 154.67 72.32 Favored Pre-proline 0 N--CA 1.489 1.516 0 N-CA-C 105.785 -1.932 . . . . 0.0 105.785 176.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -67.2 165.97 24.83 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 N-CA-C 108.617 -1.34 . . . . 0.0 108.617 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . 0.41 ' CE1' HD11 ' A' ' 178' ' ' ILE . 34.5 t80 -123.18 -179.73 4.4 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 179.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 65.5 p -110.43 44.72 1.21 Allowed 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.833 -0.747 . . . . 0.0 111.096 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 114.825 -2.512 . . . . 0.0 107.248 177.589 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 75.1 m . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 47.57 -174.28 0.02 OUTLIER Glycine 0 N--CA 1.493 2.496 0 N-CA-C 116.102 1.201 . . . . 0.0 116.102 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.424 ' CD ' ' N ' ' A' ' 155' ' ' GLU . 1.4 pm0 -131.36 169.86 15.43 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 106.02 -1.845 . . . . 0.0 106.02 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -121.78 142.16 50.49 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 117.502 -1.679 . . . . 0.0 114.937 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -128.93 -178.91 4.82 Favored 'General case' 0 C--N 1.301 -1.516 1 N-CA-C 99.664 -4.199 . . . . 0.0 99.664 177.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.508 HG22 HG13 ' A' ' 178' ' ' ILE . 4.2 pt -130.54 152.87 38.18 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 101.647 -3.464 . . . . 0.0 101.647 170.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -91.5 156.2 17.86 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 104.325 -2.472 . . . . 0.0 104.325 179.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 20.3 m -125.33 8.61 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 126.045 2.091 . . . . 0.0 107.916 176.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -132.97 168.7 22.83 Favored Glycine 0 N--CA 1.483 1.83 0 N-CA-C 105.746 -2.942 . . . . 0.0 105.746 175.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -107.06 146.6 31.0 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 177.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -124.8 160.53 28.5 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 104.805 -2.295 . . . . 0.0 104.805 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 96.4 m -129.45 151.48 50.03 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 118.864 -1.134 . . . . 0.0 108.333 178.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -98.51 138.67 35.39 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 118.296 -1.362 . . . . 0.0 108.01 178.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -114.42 -32.58 5.88 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 113.213 -1.812 . . . . 0.0 106.708 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -112.9 179.85 3.85 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 114.144 -1.389 . . . . 0.0 107.86 -179.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 16.3 t -95.45 47.21 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -128.76 -53.53 0.11 Allowed Glycine 0 N--CA 1.485 1.944 0 N-CA-C 108.331 -1.907 . . . . 0.0 108.331 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -76.48 163.47 26.9 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 113.542 -1.329 . . . . 0.0 113.788 -178.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.449 HD13 ' HA3' ' A' ' 200' ' ' GLY . 1.1 tp -108.51 -171.61 1.89 Allowed 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 111.954 -2.384 . . . . 0.0 109.078 175.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 53.6 m -120.88 -69.24 0.85 Allowed 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 113.736 -1.575 . . . . 0.0 114.335 -177.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 54.2 p90 37.52 164.33 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.527 0 N-CA-C 117.12 2.267 . . . . 0.0 117.12 -174.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -130.16 151.83 50.26 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 118.391 2.737 . . . . 0.0 118.391 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -21.28 80.41 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.568 1 CA-C-N 108.342 -4.026 . . . . 0.0 118.057 171.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 110.04 47.99 0.8 Allowed Glycine 0 N--CA 1.493 2.473 0 CA-C-N 114.728 -1.124 . . . . 0.0 112.878 174.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -135.84 154.91 51.03 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 117.309 -1.757 . . . . 0.0 108.045 177.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.508 HG13 HG22 ' A' ' 158' ' ' ILE . 1.1 mp -80.6 130.94 35.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -178.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 27.7 mt -120.15 162.59 19.07 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 113.129 -1.851 . . . . 0.0 108.222 176.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.529 HD13 ' N ' ' A' ' 181' ' ' VAL . 1.6 tm? -116.06 151.38 35.65 Favored 'General case' 0 N--CA 1.498 1.93 1 N-CA-C 100.105 -4.035 . . . . 0.0 100.105 179.345 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.529 ' N ' HD13 ' A' ' 180' ' ' LEU . 2.4 t -121.05 139.12 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 CA-C-N 122.041 2.2 . . . . 0.0 111.074 -179.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.484 ' O ' ' HB ' ' A' ' 191' ' ' ILE . 42.9 mt -145.0 87.09 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-O 121.105 0.479 . . . . 0.0 111.004 -176.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . 0.485 ' O ' ' CE3' ' A' ' 190' ' ' TRP . 0.0 OUTLIER 135.96 148.7 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.586 0 C-N-CA 128.359 2.664 . . . . 0.0 107.084 172.59 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -106.24 117.45 34.06 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 118.276 2.695 . . . . 0.0 118.276 -172.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.544 ' HE2' ' HE1' ' A' ' 190' ' ' TRP . 0.8 OUTLIER -11.97 81.38 0.03 OUTLIER Pre-proline 0 N--CA 1.507 2.389 0 N-CA-C 118.124 2.639 . . . . 0.0 118.124 175.24 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -73.06 -56.23 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 123.549 2.833 . . . . 0.0 105.684 175.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 21.3 p-10 -120.97 16.34 11.69 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 112.08 -2.327 . . . . 0.0 113.877 -177.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.491 ' CA ' ' HG2' ' A' ' 185' ' ' LYS . . . 118.09 -15.81 12.1 Favored Glycine 0 N--CA 1.493 2.465 0 C-N-CA 118.712 -1.709 . . . . 0.0 109.002 -178.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 13.5 m-90 -116.61 149.39 39.77 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 116.761 2.134 . . . . 0.0 116.761 -176.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' TRP . . . . . 0.544 ' HE1' ' HE2' ' A' ' 185' ' ' LYS . 20.0 m95 -122.88 169.15 11.41 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 102.396 -3.187 . . . . 0.0 102.396 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.484 ' HB ' ' O ' ' A' ' 182' ' ' ILE . 2.5 mp -113.95 103.58 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 104.652 -2.351 . . . . 0.0 104.652 175.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . 0.437 ' HB1' ' O ' ' A' ' 180' ' ' LEU . . . -94.34 178.35 5.65 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -173.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -124.91 158.58 33.2 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 103.273 -2.862 . . . . 0.0 103.273 175.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 51.6 p-10 -124.69 -167.1 1.61 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.279 -0.968 . . . . 0.0 111.148 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -99.09 43.14 1.07 Allowed 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 122.123 0.963 . . . . 0.0 108.47 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 4.8 tmtm? -126.05 -45.11 1.73 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 104.204 -2.517 . . . . 0.0 104.204 177.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 137.91 -40.17 1.51 Allowed Glycine 0 N--CA 1.485 1.925 0 N-CA-C 108.109 -1.996 . . . . 0.0 108.109 -178.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -69.98 164.15 24.53 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 118.795 -1.162 . . . . 0.0 113.626 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.439 ' C ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -137.36 157.68 46.06 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 112.9 -1.955 . . . . 0.0 109.238 -179.915 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . 0.449 ' HA3' HD13 ' A' ' 171' ' ' LEU . . . 179.58 -173.76 45.54 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 118.248 -1.929 . . . . 0.0 112.418 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 59.2 mt -71.63 96.25 1.54 Allowed 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -176.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 3.2 m -119.54 153.96 54.27 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 103.641 -2.726 . . . . 0.0 103.641 177.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -87.12 174.72 5.2 Favored 'Trans proline' 0 C--N 1.301 -1.945 0 C-N-CA 121.804 1.669 . . . . 0.0 109.197 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 28.9 ttt180 -106.16 -22.81 12.76 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 177.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 53.9 p -34.37 -50.18 0.41 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 113.91 -1.495 . . . . 0.0 114.368 173.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -105.38 34.3 3.31 Favored 'General case' 0 N--CA 1.503 2.198 0 C-N-CA 118.354 -1.338 . . . . 0.0 111.681 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 3.2 mp -119.42 118.78 32.05 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 124.817 1.323 . . . . 0.0 110.65 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . 0.412 ' CD ' ' N ' ' A' ' 208' ' ' GLU . 43.6 mp0 -115.57 150.74 45.21 Favored Pre-proline 0 C--N 1.297 -1.712 0 N-CA-C 105.982 -1.858 . . . . 0.0 105.982 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -55.16 164.43 3.68 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.292 1.995 . . . . 0.0 113.308 -177.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . 0.471 ' CG ' ' N ' ' A' ' 211' ' ' SER . 43.3 t80 -118.78 -178.72 3.61 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 179.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . 0.471 ' N ' ' CG ' ' A' ' 210' ' ' TYR . 77.6 p -101.58 33.87 2.81 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 178.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 115.312 -2.28 . . . . 0.0 115.088 178.045 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 43.4 p . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -120.73 -179.19 16.18 Favored Glycine 0 N--CA 1.487 2.061 0 CA-C-N 114.514 -1.221 . . . . 0.0 113.549 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -128.9 165.18 21.54 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 104.053 -2.573 . . . . 0.0 104.053 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -107.76 135.59 48.92 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 116.92 -1.912 . . . . 0.0 111.081 -178.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.463 ' CD1' HG21 ' A' ' 181' ' ' VAL . 28.2 m-85 -132.6 176.24 8.62 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 109.503 -3.499 . . . . 0.0 105.285 179.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.449 ' HA ' ' O ' ' A' ' 177' ' ' GLU . 0.4 OUTLIER -126.31 143.05 41.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 1 N-CA-C 99.572 -4.232 . . . . 0.0 99.572 172.273 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -93.1 151.96 19.55 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 115.983 -2.287 . . . . 0.0 105.311 178.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 35.6 m -127.81 24.3 2.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 125.39 1.681 . . . . 0.0 109.054 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -123.55 153.6 17.26 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 106.697 -2.561 . . . . 0.0 106.697 177.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -105.66 82.53 1.81 Allowed 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 120.069 -0.652 . . . . 0.0 109.834 -179.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -108.68 151.88 25.57 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 118.879 -1.129 . . . . 0.0 108.54 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 53.7 m -122.07 159.86 26.21 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -89.15 133.25 34.47 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 178.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -109.83 -29.23 8.39 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 26.8 pt20 -117.64 -176.31 3.0 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 178.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 9.9 p -91.3 157.02 2.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 177.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 111.44 -50.44 0.77 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 -178.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -79.38 169.65 17.76 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 113.806 -1.197 . . . . 0.0 112.116 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 66.4 mt -126.02 178.22 5.89 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 114.223 -1.353 . . . . 0.0 109.744 177.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 53.5 m -120.48 99.28 6.47 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 114.484 -1.235 . . . . 0.0 112.179 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -115.65 165.87 12.56 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 118.82 -1.152 . . . . 0.0 110.172 177.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? -121.13 57.37 1.0 Allowed 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 121.22 3.785 . . . . 0.0 121.22 -174.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 70.9 tttt 46.67 76.78 0.09 Allowed 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 116.554 2.057 . . . . 0.0 116.554 174.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 117.28 52.27 0.34 Allowed Glycine 0 N--CA 1.495 2.632 0 CA-C-N 114.15 -1.386 . . . . 0.0 111.743 175.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.451 ' CD ' ' N ' ' A' ' 177' ' ' GLU . 2.8 pm0 -131.88 -179.12 5.21 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 178.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 7.0 mm -112.58 120.06 61.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 124.513 1.133 . . . . 0.0 113.885 -175.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.452 ' N ' HD22 ' A' ' 179' ' ' LEU . 2.0 mm? -123.72 170.3 10.64 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 16.6 tp -111.12 156.24 21.65 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 100.586 -3.857 . . . . 0.0 100.586 175.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.506 ' CG1' ' HB3' ' A' ' 190' ' ' TRP . 2.4 t -126.66 140.33 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 CA-C-N 120.42 1.463 . . . . 0.0 109.243 -178.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.474 ' O ' ' HB ' ' A' ' 191' ' ' ILE . 21.3 mt -143.57 78.07 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 120.251 -0.579 . . . . 0.0 110.779 -174.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . 0.52 ' O ' ' CE3' ' A' ' 190' ' ' TRP . 31.4 tt0 139.85 150.02 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.708 0 C-N-CA 127.005 2.122 . . . . 0.0 108.576 177.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . 0.441 ' HB3' ' NZ ' ' A' ' 184' ' ' LYS . 8.1 mtpm? -114.15 100.87 8.7 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -176.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.503 ' HA ' ' HD2' ' A' ' 186' ' ' PRO . 19.9 pttp -11.52 77.09 0.02 OUTLIER Pre-proline 0 N--CA 1.496 1.854 0 N-CA-C 121.656 3.947 . . . . 0.0 121.656 -177.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.503 ' HD2' ' HA ' ' A' ' 185' ' ' LYS . 11.4 Cg_endo -46.26 -59.95 1.03 Allowed 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 123.341 2.694 . . . . 0.0 106.932 171.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -121.81 21.85 10.61 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 111.922 -2.399 . . . . 0.0 110.431 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.488 ' CA ' ' HB2' ' A' ' 185' ' ' LYS . . . 114.21 11.29 12.32 Favored Glycine 0 N--CA 1.488 2.162 0 C-N-CA 119.629 -1.272 . . . . 0.0 110.986 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . 0.475 ' CD1' ' HB3' ' A' ' 201' ' ' LEU . 2.1 m-90 -125.02 136.55 53.82 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 121.433 3.864 . . . . 0.0 121.433 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' TRP . . . . . 0.52 ' CE3' ' O ' ' A' ' 183' ' ' GLU . 32.4 m95 -119.4 154.66 33.3 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 101.519 -3.511 . . . . 0.0 101.519 178.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.474 ' HB ' ' O ' ' A' ' 182' ' ' ILE . 1.7 mp -109.23 114.11 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 104.234 -2.506 . . . . 0.0 104.234 176.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -107.6 177.55 4.8 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 118.859 -1.136 . . . . 0.0 113.898 -170.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -134.24 160.58 37.42 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 174.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 47.4 p-10 -117.67 -160.51 0.78 Allowed 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 118.456 -1.298 . . . . 0.0 110.406 177.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -101.32 42.26 1.14 Allowed 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 122.398 1.094 . . . . 0.0 108.586 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 5.4 tmtm? -127.01 -44.16 1.63 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 177.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 135.78 -41.08 1.46 Allowed Glycine 0 N--CA 1.485 1.936 0 N-CA-C 108.455 -1.858 . . . . 0.0 108.455 -178.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -53.58 163.38 0.66 Allowed 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 116.037 1.866 . . . . 0.0 116.037 -178.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -103.52 157.08 17.29 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 110.835 -2.893 . . . . 0.0 115.422 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 191' ' ' ILE . . . -134.61 -179.56 16.6 Favored Glycine 0 N--CA 1.483 1.827 0 CA-C-N 112.671 -2.059 . . . . 0.0 113.978 -175.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.475 ' HB3' ' CD1' ' A' ' 189' ' ' TRP . 32.0 mt -131.97 89.38 2.67 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 111.698 -2.251 . . . . 0.0 105.43 177.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . 0.251 2.3 t -97.13 148.53 34.54 Favored Pre-proline 0 C--N 1.305 -1.343 0 CA-C-N 114.269 -1.332 . . . . 0.0 113.928 -174.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -92.43 155.21 3.03 Favored 'Trans proline' 0 C--N 1.299 -2.032 0 N-CA-C 107.67 -1.704 . . . . 0.0 107.67 172.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . 0.516 ' HB2' ' CE2' ' A' ' 190' ' ' TRP . 8.6 tpt180 -74.59 -51.99 13.04 Favored 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 176.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 65.3 p -22.07 -45.85 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 127.528 3.017 . . . . 0.0 114.912 178.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -112.61 50.0 0.9 Allowed 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.468 -0.893 . . . . 0.0 113.199 -178.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 97.7 mt -131.05 155.96 46.0 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 176.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -130.26 142.19 44.56 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 103.916 -2.624 . . . . 0.0 103.916 174.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -66.32 155.44 69.92 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 N-CA-C 107.271 -1.857 . . . . 0.0 107.271 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . 0.413 ' CD1' HG21 ' A' ' 158' ' ' ILE . 9.7 t80 -130.38 176.4 8.17 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 118.559 -1.256 . . . . 0.0 110.002 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 22.9 t -121.26 30.89 6.58 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.4 -0.92 . . . . 0.0 110.974 -179.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 114.383 -2.722 . . . . 0.0 105.856 177.494 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 28.2 m . . . . . 0 N--CA 1.489 1.476 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 109.43 179.18 21.19 Favored Glycine 0 N--CA 1.486 1.993 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.966 -178.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -121.42 159.15 26.79 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 101.504 -3.517 . . . . 0.0 101.504 178.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -100.64 129.62 46.58 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 116.035 -2.266 . . . . 0.0 111.35 -177.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.631 ' CD1' HG21 ' A' ' 181' ' ' VAL . 4.9 m-85 -118.9 172.17 7.72 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 101.4 -3.556 . . . . 0.0 101.4 177.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.48 ' HA ' ' O ' ' A' ' 177' ' ' GLU . 1.7 pt -126.97 142.53 43.18 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 N-CA-C 103.44 -2.8 . . . . 0.0 103.44 174.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 176' ' ' GLY . . . -80.13 155.3 27.54 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 104.19 -2.522 . . . . 0.0 104.19 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.1 m -131.18 8.73 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 126.764 2.54 . . . . 0.0 108.447 178.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -127.68 159.1 21.5 Favored Glycine 0 N--CA 1.486 1.99 0 N-CA-C 106.018 -2.833 . . . . 0.0 106.018 176.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.408 ' HA ' ' HA ' ' A' ' 174' ' ' LYS . 33.1 t70 -108.54 97.34 7.02 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.253 -0.979 . . . . 0.0 113.083 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.44 ' HB3' ' CZ ' ' A' ' 173' ' ' PHE . 58.4 t80 -111.02 151.88 27.48 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 55.4 m -122.43 157.4 32.0 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.31 105.88 15.49 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 178.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -98.61 -17.43 18.64 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 -178.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -120.72 168.19 11.68 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 102.57 -3.122 . . . . 0.0 102.57 177.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 48.7 t -91.39 156.01 3.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 109.56 -41.12 2.32 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 107.502 -2.239 . . . . 0.0 107.502 -178.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.538 ' HA ' ' H ' ' A' ' 201' ' ' LEU . 11.2 m-20 -80.22 167.97 19.65 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 111.532 -2.334 . . . . 0.0 111.637 -179.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 24.5 mt -118.95 175.93 5.53 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.996 177.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 45.2 m -117.57 96.31 5.33 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 114.58 -1.191 . . . . 0.0 109.479 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.44 ' CZ ' ' HB3' ' A' ' 163' ' ' PHE . 8.9 p90 -119.24 164.43 15.64 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 114.488 -1.233 . . . . 0.0 111.63 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 162' ' ' ASP . 6.6 ptpp? -128.71 160.44 32.5 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 116.384 1.994 . . . . 0.0 116.384 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 42.9 tttm -41.91 76.91 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.766 1 CA-C-N 107.609 -4.36 . . . . 0.0 115.533 173.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 159' ' ' ALA . . . 112.67 50.44 0.56 Allowed Glycine 0 N--CA 1.491 2.306 0 CA-C-N 114.097 -1.411 . . . . 0.0 112.55 176.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.48 ' O ' ' HA ' ' A' ' 158' ' ' ILE . 15.4 pt-20 -131.4 168.93 16.75 Favored 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 176.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.428 ' HA ' ' HA ' ' A' ' 158' ' ' ILE . 1.5 mt -112.98 125.89 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 116.545 2.054 . . . . 0.0 116.545 -175.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 17.9 mt -118.41 176.02 5.44 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 112.339 -2.21 . . . . 0.0 110.756 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 33.5 mt -114.61 159.87 19.95 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 174.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.631 HG21 ' CD1' ' A' ' 157' ' ' TYR . 46.2 t -121.6 124.74 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -176.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.486 ' O ' ' HB ' ' A' ' 191' ' ' ILE . 11.7 mt -141.57 77.24 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.972 -174.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . 0.546 ' O ' ' CE3' ' A' ' 190' ' ' TRP . 44.6 tt0 138.15 149.58 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.037 0 C-N-CA 127.177 2.191 . . . . 0.0 108.402 176.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -116.62 100.94 8.17 Favored 'General case' 0 N--CA 1.508 2.436 0 N-CA-C 115.972 1.842 . . . . 0.0 115.972 -175.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.506 ' CG ' ' HE1' ' A' ' 190' ' ' TRP . 21.6 pttp -13.65 78.15 0.02 OUTLIER Pre-proline 0 N--CA 1.5 2.045 1 N-CA-C 122.075 4.102 . . . . 0.0 122.075 -177.79 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.45 ' HD2' ' O ' ' A' ' 189' ' ' TRP . 13.4 Cg_endo -47.68 -59.85 1.1 Allowed 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 123.061 2.508 . . . . 0.0 106.582 171.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -123.6 22.4 9.11 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 112.331 -2.213 . . . . 0.0 110.229 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.448 ' CA ' ' HB2' ' A' ' 185' ' ' LYS . . . 113.74 17.68 7.34 Favored Glycine 0 N--CA 1.491 2.354 0 C-N-CA 120.473 -0.87 . . . . 0.0 111.046 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . 0.45 ' O ' ' HD2' ' A' ' 186' ' ' PRO . 1.4 m-90 -125.62 126.05 44.11 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 121.395 3.85 . . . . 0.0 121.395 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' TRP . . . . . 0.594 ' CE2' ' HB2' ' A' ' 204' ' ' ARG . 16.3 m95 -118.44 159.86 22.74 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 102.072 -3.307 . . . . 0.0 102.072 176.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.486 ' HB ' ' O ' ' A' ' 182' ' ' ILE . 79.3 mt -114.72 113.67 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 104.372 -2.455 . . . . 0.0 104.372 176.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -108.41 178.5 4.47 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 119.453 -0.899 . . . . 0.0 112.658 -172.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 199' ' ' GLU . 64.9 mttm -137.21 169.1 18.35 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 173.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 43.5 p-10 -121.71 -164.79 1.18 Allowed 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.144 -1.022 . . . . 0.0 109.958 177.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -100.2 39.85 1.31 Allowed 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.928 0.871 . . . . 0.0 108.691 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -126.76 -37.13 2.16 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 113.609 -1.632 . . . . 0.0 107.282 177.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 134.96 -37.4 1.94 Allowed Glycine 0 N--CA 1.487 2.05 0 N-CA-C 110.074 -1.211 . . . . 0.0 110.074 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 22.4 p30 -63.94 164.74 9.86 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 118.591 -1.244 . . . . 0.0 114.167 -178.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 193' ' ' LYS . 0.0 OUTLIER -125.8 157.91 36.31 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 111.858 -2.428 . . . . 0.0 109.492 179.405 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 191' ' ' ILE . . . -136.36 -175.23 13.7 Favored Glycine 0 N--CA 1.48 1.572 0 CA-C-O 122.319 0.955 . . . . 0.0 111.634 -178.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.538 ' H ' ' HA ' ' A' ' 170' ' ' ASP . 13.8 mt -122.04 82.5 1.97 Allowed 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 111.419 -2.391 . . . . 0.0 105.202 177.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 4.5 m -115.57 154.97 47.87 Favored Pre-proline 0 N--CA 1.495 1.806 0 C-N-CA 119.579 -0.848 . . . . 0.0 109.415 -175.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -81.74 179.97 5.29 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 123.121 2.547 . . . . 0.0 112.156 -178.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . 0.594 ' HB2' ' CE2' ' A' ' 190' ' ' TRP . 17.5 ttp85 -91.24 -49.19 6.5 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 103.762 -2.681 . . . . 0.0 103.762 176.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.406 HG23 ' H ' ' A' ' 205' ' ' THR . 68.2 p -19.3 -48.53 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 127.146 2.779 . . . . 0.0 117.026 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -108.51 42.57 1.37 Allowed 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 119.063 -1.055 . . . . 0.0 112.614 -177.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 84.9 mt -129.68 158.42 39.41 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 115.063 -0.972 . . . . 0.0 109.007 177.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -132.82 152.44 79.86 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 104.553 -2.388 . . . . 0.0 104.553 170.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -68.66 165.79 28.23 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 N-CA-C 108.064 -1.552 . . . . 0.0 108.064 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -120.24 -160.41 0.83 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 68.9 p -95.83 45.27 1.08 Allowed 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.02 -1.072 . . . . 0.0 110.429 -178.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 116.416 -1.754 . . . . 0.0 108.282 177.28 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 35.4 m . . . . . 0 N--CA 1.492 1.644 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -116.07 179.44 17.87 Favored Glycine 0 N--CA 1.487 2.051 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.852 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -135.15 -179.98 5.96 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.329 -1.359 . . . . 0.0 107.329 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -109.93 126.52 53.97 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 114.839 1.422 . . . . 0.0 114.839 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.527 ' CD1' HG21 ' A' ' 181' ' ' VAL . 44.8 m-85 -121.88 177.94 5.08 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 101.183 -3.636 . . . . 0.0 101.183 175.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.511 ' HA ' ' HA ' ' A' ' 178' ' ' ILE . 2.9 pt -123.72 153.32 29.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 100.79 -3.781 . . . . 0.0 100.79 170.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -91.83 153.18 19.73 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 100.768 -3.789 . . . . 0.0 100.768 177.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 31.2 m -125.07 17.36 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 125.908 2.005 . . . . 0.0 108.021 176.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -138.53 164.51 25.67 Favored Glycine 0 N--CA 1.483 1.806 0 N-CA-C 105.628 -2.989 . . . . 0.0 105.628 175.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -106.02 144.5 32.65 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 104.837 -2.283 . . . . 0.0 104.837 177.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -124.69 172.64 9.12 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 77.8 m -130.17 152.55 49.49 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.623 -0.831 . . . . 0.0 109.577 178.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -107.89 122.41 46.73 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 177.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -110.24 -19.51 12.98 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.127 -1.397 . . . . 0.0 108.121 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -123.35 176.7 5.99 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 114.057 -1.429 . . . . 0.0 108.339 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 15.2 t -95.53 49.93 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -131.81 -46.93 0.12 Allowed Glycine 0 N--CA 1.485 1.915 0 CA-C-N 113.282 -1.781 . . . . 0.0 108.788 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.419 ' HA ' ' H ' ' A' ' 201' ' ' LEU . 1.8 m-20 -87.62 169.2 12.36 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 112.503 -1.849 . . . . 0.0 114.385 -178.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.422 ' HG ' ' CA ' ' A' ' 200' ' ' GLY . 39.2 mt -117.97 -176.83 3.13 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 112.547 -2.115 . . . . 0.0 105.806 176.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 73.4 m -108.95 -59.4 1.89 Allowed 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.158 -179.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 43.1 p90 37.42 164.43 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.25 0 N-CA-C 117.617 2.451 . . . . 0.0 117.617 -175.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -124.52 143.62 50.57 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 120.173 3.397 . . . . 0.0 120.173 -178.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -26.75 81.29 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.589 1 CA-C-N 107.847 -4.251 . . . . 0.0 115.868 169.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 112.18 46.98 0.73 Allowed Glycine 0 N--CA 1.492 2.427 0 CA-C-N 114.617 -1.174 . . . . 0.0 113.392 176.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.418 ' O ' ' HA ' ' A' ' 158' ' ' ILE . 7.0 pt-20 -140.75 152.98 45.69 Favored 'General case' 0 N--CA 1.503 2.205 0 C-N-CA 117.092 -1.843 . . . . 0.0 109.485 176.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.511 ' HA ' ' HA ' ' A' ' 158' ' ' ILE . 1.3 mp -74.9 131.53 34.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -178.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 44.0 mt -122.66 168.35 12.3 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 112.339 -2.21 . . . . 0.0 107.044 176.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.408 HD13 ' H ' ' A' ' 181' ' ' VAL . 0.4 OUTLIER -113.05 148.02 36.03 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 101.796 -3.409 . . . . 0.0 101.796 179.591 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.527 HG21 ' CD1' ' A' ' 157' ' ' TYR . 2.7 t -124.01 138.51 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 CA-C-N 121.458 1.935 . . . . 0.0 111.467 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.455 ' O ' ' CB ' ' A' ' 183' ' ' GLU . 0.5 OUTLIER -146.52 81.28 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 O-C-N 123.169 0.293 . . . . 0.0 110.619 -173.371 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . 0.532 ' O ' ' CE3' ' A' ' 190' ' ' TRP . 34.9 tt0 139.31 153.18 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.96 0 C-N-CA 127.024 2.13 . . . . 0.0 107.748 178.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -117.92 99.95 7.25 Favored 'General case' 0 N--CA 1.508 2.445 0 N-CA-C 116.227 1.936 . . . . 0.0 116.227 -175.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.551 ' CG ' ' HE1' ' A' ' 190' ' ' TRP . 22.1 pttp -13.07 77.16 0.02 OUTLIER Pre-proline 0 N--CA 1.5 2.057 1 N-CA-C 122.183 4.142 . . . . 0.0 122.183 -177.325 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.492 ' HD2' ' HA ' ' A' ' 185' ' ' LYS . 12.3 Cg_endo -47.13 -59.34 1.28 Allowed 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 123.096 2.531 . . . . 0.0 106.999 171.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -121.11 19.58 11.55 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 112.285 -2.234 . . . . 0.0 110.563 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.498 ' CA ' ' HB2' ' A' ' 185' ' ' LYS . . . 112.94 15.85 8.94 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . 0.448 ' O ' ' HD2' ' A' ' 186' ' ' PRO . 1.3 m-90 -125.51 127.03 45.8 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 120.58 3.548 . . . . 0.0 120.58 179.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' TRP . . . . . 0.659 ' CE2' ' HB2' ' A' ' 204' ' ' ARG . 15.2 m95 -117.84 161.19 20.14 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 101.095 -3.668 . . . . 0.0 101.095 177.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.411 ' HB ' ' O ' ' A' ' 182' ' ' ILE . 28.8 mm -98.28 166.77 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.395 1 N-CA-C 99.679 -4.193 . . . . 0.0 99.679 176.963 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 199' ' ' GLU . . . -150.74 -177.8 6.2 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 116.125 -2.23 . . . . 0.0 111.447 178.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -137.69 163.69 30.67 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 174.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 26.0 p-10 -112.7 -160.72 0.73 Allowed 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.373 -0.931 . . . . 0.0 108.567 177.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -108.26 35.7 3.07 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 118.874 -1.13 . . . . 0.0 110.215 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -129.23 -67.72 0.76 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 105.48 -2.045 . . . . 0.0 105.48 175.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -165.58 -67.24 0.03 OUTLIER Glycine 0 N--CA 1.488 2.133 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.208 178.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -34.85 160.78 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 119.65 3.204 . . . . 0.0 119.65 -178.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.419 ' HG3' ' N ' ' A' ' 200' ' ' GLY . 0.0 OUTLIER -118.65 160.4 21.89 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 111.904 -2.407 . . . . 0.0 109.573 179.251 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . 0.422 ' CA ' ' HG ' ' A' ' 171' ' ' LEU . . . -135.54 -169.72 11.91 Favored Glycine 0 N--CA 1.487 2.082 0 CA-C-O 122.998 1.332 . . . . 0.0 114.238 -177.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.419 ' H ' ' HA ' ' A' ' 170' ' ' ASP . 16.5 mt -130.09 84.89 2.24 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 111.138 -2.531 . . . . 0.0 105.236 178.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 3.0 m -113.04 156.04 43.38 Favored Pre-proline 0 N--CA 1.495 1.816 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 -175.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -90.35 173.24 3.31 Favored 'Trans proline' 0 C--N 1.302 -1.903 0 C-N-CA 122.429 2.086 . . . . 0.0 107.365 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . 0.659 ' HB2' ' CE2' ' A' ' 190' ' ' TRP . 22.7 ttt180 -102.07 -35.62 8.87 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 117.029 -1.869 . . . . 0.0 106.43 175.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 70.2 p -25.05 -46.67 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 126.057 2.098 . . . . 0.0 114.732 174.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -110.98 43.94 1.37 Allowed 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 119.762 -0.775 . . . . 0.0 112.659 -178.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 60.4 mt -127.17 151.53 48.56 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.618 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -123.64 150.03 60.45 Favored Pre-proline 0 C--N 1.301 -1.512 0 N-CA-C 104.148 -2.538 . . . . 0.0 104.148 174.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -68.81 160.13 50.94 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 C-N-CA 121.363 1.376 . . . . 0.0 110.738 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . 0.411 ' CE1' HD11 ' A' ' 178' ' ' ILE . 10.7 t80 -127.84 151.17 49.39 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 177.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.1 t -130.69 49.51 2.3 Favored 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 118.989 -1.085 . . . . 0.0 113.107 -177.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 116.232 -1.842 . . . . 0.0 109.335 177.738 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 10.1 t . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 116.99 179.29 17.75 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 110.241 -1.143 . . . . 0.0 110.241 -178.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -116.32 165.14 13.53 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 104.381 -2.452 . . . . 0.0 104.381 -178.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -99.15 119.51 37.97 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 117.098 -1.841 . . . . 0.0 114.417 -178.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.481 ' CD1' HG21 ' A' ' 181' ' ' VAL . 2.2 m-85 -123.87 174.09 7.77 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 101.145 -3.65 . . . . 0.0 101.145 175.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.513 HG21 ' CD1' ' A' ' 210' ' ' TYR . 3.3 pt -127.49 153.84 37.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 101.943 -3.354 . . . . 0.0 101.943 173.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -84.24 152.66 24.07 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 103.582 -2.747 . . . . 0.0 103.582 178.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 32.9 m -132.8 6.13 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 125.939 2.025 . . . . 0.0 108.734 177.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -131.37 149.68 19.3 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 106.36 -2.696 . . . . 0.0 106.36 177.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -101.77 92.26 4.76 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 118.887 -1.125 . . . . 0.0 108.798 -177.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -107.99 151.18 26.16 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 114.436 -1.256 . . . . 0.0 109.624 -178.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 52.7 m -120.98 158.81 26.93 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -81.29 151.54 28.02 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 118.076 -1.45 . . . . 0.0 109.022 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -112.72 -36.17 5.27 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 112.456 -2.156 . . . . 0.0 105.267 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -120.42 171.89 8.21 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 113.368 -1.742 . . . . 0.0 106.996 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.454 HG12 ' H ' ' A' ' 168' ' ' VAL . 0.1 OUTLIER -59.63 -46.8 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 117.489 -1.685 . . . . 0.0 108.693 177.766 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -29.55 -60.96 0.17 Allowed Glycine 0 N--CA 1.492 2.376 0 O-C-N 125.355 1.66 . . . . 0.0 113.834 177.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.504 ' HA ' ' H ' ' A' ' 201' ' ' LEU . 1.1 m-20 -77.23 168.86 19.34 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -176.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.436 ' CD2' HD22 ' A' ' 198' ' ' ASN . 14.2 mt -117.54 176.55 5.12 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 113.715 -1.584 . . . . 0.0 110.478 178.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 42.6 m -120.46 97.07 5.4 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 113.875 -1.512 . . . . 0.0 110.733 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.423 ' CD1' ' N ' ' A' ' 173' ' ' PHE . 8.2 p90 -121.05 171.09 8.92 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.495 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -107.4 -163.35 0.89 Allowed 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 122.691 1.234 . . . . 0.0 113.338 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 42.1 tttm -107.15 89.82 3.11 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 111.002 -2.817 . . . . 0.0 112.146 -175.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 109.16 50.65 0.71 Allowed Glycine 0 N--CA 1.492 2.401 0 CA-C-N 113.228 -1.806 . . . . 0.0 110.695 177.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.413 ' O ' ' HB ' ' A' ' 158' ' ' ILE . 6.0 pt-20 -128.78 176.59 7.7 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 177.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 21.9 mm -104.0 119.56 52.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 C-N-CA 118.669 -1.213 . . . . 0.0 112.451 -178.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 59.5 mt -121.16 163.62 18.17 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 113.933 -1.485 . . . . 0.0 110.031 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 59.6 mt -110.7 156.67 20.69 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 176.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.481 HG21 ' CD1' ' A' ' 157' ' ' TYR . 2.5 t -126.55 138.67 54.01 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 C-N-CA 117.981 -1.488 . . . . 0.0 110.221 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.453 ' O ' ' HB ' ' A' ' 191' ' ' ILE . 25.6 mt -141.04 82.0 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -174.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . 0.478 ' HG2' ' N ' ' A' ' 184' ' ' LYS . 41.9 tt0 138.02 150.52 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.393 0 C-N-CA 127.042 2.137 . . . . 0.0 108.004 176.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . 0.478 ' N ' ' HG2' ' A' ' 183' ' ' GLU . 97.9 mttt -116.84 115.68 26.0 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 124.628 1.205 . . . . 0.0 111.927 -179.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.537 ' CG ' ' HE1' ' A' ' 190' ' ' TRP . 0.1 OUTLIER -6.96 77.34 0.03 OUTLIER Pre-proline 0 N--CA 1.505 2.291 0 N-CA-C 117.652 2.464 . . . . 0.0 117.652 178.443 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -68.6 -55.95 0.2 Allowed 'Trans proline' 0 C--N 1.307 -1.629 0 N-CA-C 105.516 -2.532 . . . . 0.0 105.516 175.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -125.16 24.53 7.44 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 112.877 -1.965 . . . . 0.0 112.741 -177.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.511 ' CA ' ' HG2' ' A' ' 185' ' ' LYS . . . 116.65 -19.4 12.59 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 118.708 -1.711 . . . . 0.0 109.603 -179.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 16.3 m-90 -115.28 158.71 21.97 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 117.783 2.512 . . . . 0.0 117.783 -176.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' TRP . . . . . 0.537 ' HE1' ' CG ' ' A' ' 185' ' ' LYS . 23.9 m95 -129.97 162.43 28.68 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 100.457 -3.905 . . . . 0.0 100.457 -178.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.456 HG12 ' CB ' ' A' ' 183' ' ' GLU . 10.9 mm -113.33 106.21 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 C-N-CA 116.382 -2.127 . . . . 0.0 106.479 177.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -101.94 175.49 5.52 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -172.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.462 ' HG2' ' HB2' ' A' ' 199' ' ' GLU . 63.1 mttm -126.51 165.12 19.71 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 174.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -122.82 -158.16 0.78 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 124.467 1.104 . . . . 0.0 110.376 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -100.26 36.95 1.75 Allowed 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 121.693 0.758 . . . . 0.0 110.822 -178.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -125.38 -43.42 1.92 Allowed 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 176.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 138.29 -43.3 1.2 Allowed Glycine 0 N--CA 1.483 1.817 0 N-CA-C 106.477 -2.649 . . . . 0.0 106.477 -178.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . 0.436 HD22 ' CD2' ' A' ' 171' ' ' LEU . 0.9 OUTLIER -53.57 155.91 2.82 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 179.361 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.462 ' HB2' ' HG2' ' A' ' 193' ' ' LYS . 0.0 OUTLIER -127.89 155.0 44.87 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 112.949 -1.932 . . . . 0.0 110.357 -179.936 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . 0.416 ' HA3' ' HG ' ' A' ' 171' ' ' LEU . . . -145.0 -176.68 19.21 Favored Glycine 0 N--CA 1.485 1.964 0 C-N-CA 119.195 -1.479 . . . . 0.0 112.924 -178.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.504 ' H ' ' HA ' ' A' ' 170' ' ' ASP . 0.8 OUTLIER -92.78 92.05 7.76 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 112.757 -1.722 . . . . 0.0 106.741 176.943 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 5.0 m -113.81 147.85 38.57 Favored Pre-proline 0 N--CA 1.494 1.757 0 C-N-CA 117.43 -1.708 . . . . 0.0 106.739 -179.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -79.22 179.06 6.77 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 C-N-CA 122.291 1.994 . . . . 0.0 112.014 -177.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . 0.473 ' HB2' ' HE1' ' A' ' 190' ' ' TRP . 0.1 OUTLIER -86.25 -46.22 10.55 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 103.552 -2.759 . . . . 0.0 103.552 178.164 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 71.8 p -22.2 -50.62 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 O-C-N 126.013 2.071 . . . . 0.0 116.168 178.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -112.79 43.2 1.71 Allowed 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.587 0.708 . . . . 0.0 111.985 -178.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 12.3 mt -140.25 108.86 5.9 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 113.793 -1.548 . . . . 0.0 109.346 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -110.73 153.37 43.69 Favored Pre-proline 0 N--CA 1.49 1.55 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 178.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -59.6 165.39 9.72 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.093 1.862 . . . . 0.0 111.252 -178.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . 0.513 ' CD1' HG21 ' A' ' 158' ' ' ILE . 9.0 t80 -126.67 169.11 13.48 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 119.024 -1.071 . . . . 0.0 111.99 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . 0.45 ' N ' ' CG ' ' A' ' 210' ' ' TYR . 42.8 p -121.93 73.19 1.07 Allowed 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 113.824 -1.535 . . . . 0.0 108.486 178.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 116.22 -1.848 . . . . 0.0 109.741 -179.33 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 77.4 p . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.528 0.68 . . . . 0.0 109.902 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.402 ' HA3' ' O ' ' A' ' 181' ' ' VAL . . . -115.62 -156.68 11.09 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 -105.87 167.19 9.95 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 112.681 -1.76 . . . . 0.0 108.436 -178.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -112.71 141.57 46.35 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 124.598 2.142 . . . . 0.0 113.175 -177.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.513 ' CG ' HD23 ' A' ' 207' ' ' LEU . 76.0 m-85 -133.57 -179.73 5.7 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 108.462 -3.972 . . . . 0.0 107.326 -176.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.535 ' HA ' ' HA ' ' A' ' 178' ' ' ILE . 7.5 pt -128.66 162.2 36.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 102.188 -3.264 . . . . 0.0 102.188 168.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.418 ' O ' ' N ' ' A' ' 176' ' ' GLY . . . -90.98 157.47 17.27 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 103.405 -2.813 . . . . 0.0 103.405 -179.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 16.6 m -126.63 -0.24 4.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 125.809 1.943 . . . . 0.0 108.381 175.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -132.11 165.71 23.46 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 107.812 -2.115 . . . . 0.0 107.812 177.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -106.97 122.33 46.22 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 173' ' ' PHE . 36.6 t80 -122.05 156.21 34.02 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.085 179.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 75.3 m -124.44 161.65 25.59 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -92.96 144.59 25.1 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 118.012 -1.475 . . . . 0.0 108.389 178.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -113.23 -32.69 6.21 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 112.834 -1.985 . . . . 0.0 106.645 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -112.52 177.59 4.58 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 113.66 -1.609 . . . . 0.0 107.027 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 17.3 t -95.84 49.34 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 104.502 -2.407 . . . . 0.0 104.502 178.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -130.65 -49.36 0.11 Allowed Glycine 0 N--CA 1.485 1.947 0 CA-C-N 112.697 -2.047 . . . . 0.0 109.27 -178.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.548 ' HA ' ' H ' ' A' ' 201' ' ' LEU . 29.2 m-20 -79.43 175.13 10.88 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 113.293 -1.454 . . . . 0.0 111.797 -178.273 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.51 ' HG ' ' HA3' ' A' ' 200' ' ' GLY . 14.1 mt -115.89 174.52 5.99 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 114.394 -1.276 . . . . 0.0 108.466 177.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 52.5 m -120.97 91.37 3.51 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 113.796 -1.547 . . . . 0.0 108.078 178.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.425 ' CZ ' ' HB3' ' A' ' 163' ' ' PHE . 9.9 p90 -121.87 169.45 10.77 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 113.698 -1.592 . . . . 0.0 111.064 -178.349 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -109.44 -163.67 0.88 Allowed 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 122.78 1.276 . . . . 0.0 111.373 178.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 67.9 tttt -92.87 156.3 17.05 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 110.724 -2.944 . . . . 0.0 110.661 -178.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 159' ' ' ALA . . . 53.61 44.66 68.61 Favored Glycine 0 N--CA 1.485 1.935 0 CA-C-N 112.783 -2.008 . . . . 0.0 108.1 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -130.49 128.25 40.84 Favored 'General case' 0 N--CA 1.504 2.256 0 C-N-CA 116.881 -1.928 . . . . 0.0 113.988 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.535 ' HA ' ' HA ' ' A' ' 158' ' ' ILE . 1.6 mp -58.95 119.27 3.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 -178.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 19.6 mt -118.63 155.45 30.97 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 113.766 -1.561 . . . . 0.0 107.6 175.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 23.7 tp -111.99 158.42 19.54 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 104.575 -2.38 . . . . 0.0 104.575 177.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.613 HG22 ' CZ3' ' A' ' 190' ' ' TRP . 98.5 t -110.39 147.74 14.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 C-N-CA 119.078 -1.049 . . . . 0.0 109.899 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.56 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 8.9 mt -148.69 74.97 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 C-N-CA 118.148 -1.421 . . . . 0.0 108.991 173.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . 0.56 ' HB2' ' O ' ' A' ' 182' ' ' ILE . 12.8 tm-20 139.07 165.21 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.224 0 C-N-CA 129.04 2.936 . . . . 0.0 105.314 176.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -113.76 88.69 2.9 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 117.444 2.387 . . . . 0.0 117.444 -175.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.542 ' HB3' ' CD1' ' A' ' 190' ' ' TRP . 7.4 pttm -8.69 76.05 0.03 OUTLIER Pre-proline 0 N--CA 1.505 2.319 0 N-CA-C 116.704 2.113 . . . . 0.0 116.704 177.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.467 ' HD2' ' HA ' ' A' ' 185' ' ' LYS . 11.8 Cg_endo -44.52 -56.27 2.7 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 123.37 2.713 . . . . 0.0 107.598 176.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -128.8 16.4 6.35 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 111.634 -2.53 . . . . 0.0 110.04 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 111.4 26.01 4.73 Favored Glycine 0 N--CA 1.485 1.917 0 N-CA-C 107.501 -2.24 . . . . 0.0 107.501 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 2.7 m-90 -134.45 97.74 3.9 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 116.72 2.119 . . . . 0.0 116.72 178.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' TRP . . . . . 0.686 ' CD1' ' N ' ' A' ' 190' ' ' TRP . 0.0 OUTLIER -112.68 171.72 7.36 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.597 179.636 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.512 ' HB ' ' O ' ' A' ' 182' ' ' ILE . 1.9 mp -108.9 111.23 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 N-CA-C 104.037 -2.579 . . . . 0.0 104.037 -179.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . 0.572 ' HB2' ' CZ3' ' A' ' 190' ' ' TRP . . . -109.91 -178.37 3.51 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -173.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -137.26 166.76 23.01 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 105.38 -2.081 . . . . 0.0 105.38 176.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 53.3 p-10 -121.26 -148.48 0.41 Allowed 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.121 -1.032 . . . . 0.0 111.637 177.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -103.76 19.37 20.04 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -176.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . 0.492 ' NZ ' HD22 ' A' ' 198' ' ' ASN . 8.4 ptmm? -124.07 -26.21 4.06 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 174.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 137.73 -35.11 2.09 Favored Glycine 0 N--CA 1.49 2.259 0 C-N-CA 119.097 -1.525 . . . . 0.0 113.363 178.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . 0.492 HD22 ' NZ ' ' A' ' 196' ' ' LYS . 24.2 p30 -61.56 162.17 8.63 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 117.546 -1.662 . . . . 0.0 113.417 -177.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -128.72 155.01 45.77 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 112.712 -2.04 . . . . 0.0 111.026 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . 0.51 ' HA3' ' HG ' ' A' ' 171' ' ' LEU . . . -144.7 -160.71 8.65 Favored Glycine 0 N--CA 1.489 2.175 0 CA-C-O 122.276 0.931 . . . . 0.0 112.581 -178.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.548 ' H ' ' HA ' ' A' ' 170' ' ' ASP . 20.1 mt -121.94 110.14 15.48 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 111.499 -2.35 . . . . 0.0 105.844 175.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.54 HG23 ' CD2' ' A' ' 190' ' ' TRP . 13.7 m -129.82 163.36 47.65 Favored Pre-proline 0 N--CA 1.498 1.958 0 C-N-CA 117.867 -1.533 . . . . 0.0 111.626 -175.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -100.24 139.28 0.26 Allowed 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 123.661 2.907 . . . . 0.0 109.713 174.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . 0.504 ' N ' ' HE1' ' A' ' 190' ' ' TRP . 0.1 OUTLIER -81.43 -23.57 37.45 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 104.64 -2.355 . . . . 0.0 104.64 179.954 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.44 ' C ' ' O ' ' A' ' 204' ' ' ARG . 68.2 p -24.65 -43.75 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.156 0 O-C-N 124.518 1.137 . . . . 0.0 113.602 171.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -114.33 50.23 0.96 Allowed 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 120.098 -0.641 . . . . 0.0 111.977 179.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.513 HD23 ' CG ' ' A' ' 157' ' ' TYR . 1.0 OUTLIER -133.95 152.73 51.96 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.255 -179.005 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -132.03 153.5 81.38 Favored Pre-proline 0 N--CA 1.491 1.601 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 172.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -64.52 164.91 21.89 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.077 1.851 . . . . 0.0 111.684 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . 0.432 ' CD1' ' CG2' ' A' ' 158' ' ' ILE . 35.1 t80 -127.24 176.78 7.14 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . 0.417 ' N ' ' CG ' ' A' ' 210' ' ' TYR . 49.8 m -116.04 48.63 1.21 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 178.025 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 . . . . . 0 N--CA 1.497 1.889 0 CA-C-O 115.702 -2.094 . . . . 0.0 112.7 179.321 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 9.7 t . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.439 ' HA2' ' O ' ' A' ' 181' ' ' VAL . . . -120.24 177.66 16.4 Favored Glycine 0 N--CA 1.486 2.021 0 C-N-CA 119.792 -1.194 . . . . 0.0 111.609 179.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -115.6 165.76 12.67 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 -178.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -94.65 123.04 37.85 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 117.551 -1.66 . . . . 0.0 113.695 -176.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.507 ' CD1' HG21 ' A' ' 181' ' ' VAL . 4.0 m-85 -124.83 172.26 9.49 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 111.071 -2.786 . . . . 0.0 105.138 177.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.526 HG21 ' CD1' ' A' ' 210' ' ' TYR . 2.1 pt -129.98 150.33 34.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 102.959 -2.978 . . . . 0.0 102.959 171.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.407 ' O ' ' N ' ' A' ' 176' ' ' GLY . . . -86.59 150.7 24.04 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 102.435 -3.172 . . . . 0.0 102.435 178.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 33.8 m -132.68 23.18 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 126.189 2.181 . . . . 0.0 107.642 178.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -144.06 160.19 27.76 Favored Glycine 0 N--CA 1.483 1.784 0 N-CA-C 107.86 -2.096 . . . . 0.0 107.86 176.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -106.49 78.73 1.3 Allowed 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.292 -0.963 . . . . 0.0 108.449 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.421 ' HB3' ' CZ ' ' A' ' 173' ' ' PHE . 68.5 t80 -99.9 149.86 22.98 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 114.36 -1.291 . . . . 0.0 108.163 -178.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 93.6 m -120.81 157.96 28.62 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 114.023 -1.444 . . . . 0.0 108.856 -177.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -79.32 135.27 36.68 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 178.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -114.13 -28.26 7.38 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 113.804 -1.544 . . . . 0.0 107.293 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -114.77 178.61 4.22 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 179.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 58.8 t -90.78 149.9 3.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 104.003 -2.591 . . . . 0.0 104.003 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 110.53 -42.7 1.89 Allowed Glycine 0 N--CA 1.487 2.059 0 C-N-CA 118.407 -1.854 . . . . 0.0 108.703 -178.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.464 ' HA ' ' H ' ' A' ' 201' ' ' LEU . 3.0 m-20 -78.28 168.37 19.94 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 113.079 -1.561 . . . . 0.0 113.239 -179.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.539 ' HG ' ' CA ' ' A' ' 200' ' ' GLY . 76.6 mt -123.22 179.05 4.84 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 114.506 -1.225 . . . . 0.0 110.28 178.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 37.0 m -120.78 98.41 6.0 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 113.392 -1.731 . . . . 0.0 108.372 177.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.421 ' CZ ' ' HB3' ' A' ' 163' ' ' PHE . 17.4 p90 -113.23 165.31 12.54 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 118.73 -1.188 . . . . 0.0 111.379 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -122.59 152.84 40.03 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 117.736 2.495 . . . . 0.0 117.736 -177.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -37.11 76.66 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 108.575 -3.92 . . . . 0.0 114.923 173.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 159' ' ' ALA . . . 106.86 54.69 0.67 Allowed Glycine 0 N--CA 1.491 2.35 0 CA-C-N 114.986 -1.007 . . . . 0.0 112.973 175.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.47 ' O ' ' HA ' ' A' ' 158' ' ' ILE . 5.0 pt-20 -124.17 175.46 7.01 Favored 'General case' 0 N--CA 1.504 2.273 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 176.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.434 HD12 ' CE2' ' A' ' 210' ' ' TYR . 14.2 mm -112.46 131.9 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 119.068 -1.053 . . . . 0.0 111.607 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.507 HD23 ' N ' ' A' ' 179' ' ' LEU . 0.7 OUTLIER -140.26 174.87 10.08 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 114.653 -1.158 . . . . 0.0 113.69 177.826 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 83.6 mt -114.5 154.1 28.83 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.858 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.507 HG21 ' CD1' ' A' ' 157' ' ' TYR . 57.3 t -116.33 104.94 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 114.83 1.419 . . . . 0.0 114.83 -177.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.475 ' O ' ' HB ' ' A' ' 191' ' ' ILE . 13.3 mt -117.1 77.34 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-O 122.94 1.352 . . . . 0.0 108.178 -176.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . 0.462 ' HB3' ' H ' ' A' ' 191' ' ' ILE . 42.4 tt0 146.39 157.15 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.12 0 CA-C-N 109.715 -3.402 . . . . 0.0 108.262 173.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . 0.438 ' N ' ' HG2' ' A' ' 183' ' ' GLU . 64.1 mttp -117.37 102.21 9.05 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 114.655 -1.157 . . . . 0.0 112.233 -177.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.524 ' HB2' ' HE1' ' A' ' 190' ' ' TRP . 38.5 tttm -5.76 76.03 0.03 OUTLIER Pre-proline 0 N--CA 1.507 2.392 0 O-C-N 126.798 2.561 . . . . 0.0 115.005 178.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -66.81 -57.42 0.2 Allowed 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 123.565 2.843 . . . . 0.0 105.88 178.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 27.7 p-10 -121.01 20.36 11.54 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 111.329 -2.669 . . . . 0.0 112.992 -177.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 116.52 -27.49 7.97 Favored Glycine 0 N--CA 1.48 1.578 0 C-N-CA 117.424 -2.322 . . . . 0.0 108.93 -179.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 8.0 m-90 -118.02 148.65 42.04 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 118.332 -1.347 . . . . 0.0 114.474 -177.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' TRP . . . . . 0.524 ' HE1' ' HB2' ' A' ' 185' ' ' LYS . 3.0 m0 -112.39 173.45 6.36 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 102.684 -3.08 . . . . 0.0 102.684 178.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.511 ' HA ' ' O ' ' A' ' 200' ' ' GLY . 12.9 mt -115.58 114.34 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 N-CA-C 103.209 -2.886 . . . . 0.0 103.209 175.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -113.92 173.63 6.34 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 116.249 1.944 . . . . 0.0 116.249 -170.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 26.0 mmmt -121.37 141.1 51.28 Favored 'General case' 0 C--N 1.298 -1.638 1 N-CA-C 99.769 -4.159 . . . . 0.0 99.769 173.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -110.4 -160.1 0.7 Allowed 'General case' 0 N--CA 1.502 2.145 0 C-N-CA 117.433 -1.707 . . . . 0.0 112.089 -177.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -88.87 31.93 0.83 Allowed 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.245 -0.982 . . . . 0.0 111.077 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -123.99 -43.31 2.11 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 175.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 132.43 -40.3 1.64 Allowed Glycine 0 N--CA 1.485 1.939 0 N-CA-C 107.984 -2.046 . . . . 0.0 107.984 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . 0.428 ' OD1' HD22 ' A' ' 171' ' ' LEU . 15.1 p30 -56.79 167.35 0.78 Allowed 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 115.162 1.541 . . . . 0.0 115.162 -178.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -98.01 150.72 21.08 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 112.737 -2.029 . . . . 0.0 115.746 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . 0.539 ' CA ' ' HG ' ' A' ' 171' ' ' LEU . . . -133.18 -177.16 14.75 Favored Glycine 0 N--CA 1.48 1.568 0 CA-C-N 112.827 -1.988 . . . . 0.0 114.522 -176.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.464 ' H ' ' HA ' ' A' ' 170' ' ' ASP . 19.6 mt -131.77 76.82 1.73 Allowed 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 101.492 -3.521 . . . . 0.0 101.492 175.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 5.0 m -107.08 140.14 21.13 Favored Pre-proline 0 N--CA 1.494 1.749 0 C-N-CA 117.997 -1.481 . . . . 0.0 110.207 -172.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 0.4 OUTLIER -90.93 177.77 2.02 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 C-N-CA 122.725 2.283 . . . . 0.0 115.287 -175.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . 0.481 ' HB2' ' HD2' ' A' ' 185' ' ' LYS . 41.6 ttt-85 -89.16 -35.7 16.1 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 174.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 72.9 p -33.46 -41.31 0.08 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 125.527 1.767 . . . . 0.0 113.3 174.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -113.68 5.12 16.34 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 114.522 1.305 . . . . 0.0 114.522 -178.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.411 HD23 ' HB3' ' A' ' 157' ' ' TYR . 0.3 OUTLIER -118.68 161.01 20.8 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 178.374 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -132.57 157.65 77.76 Favored Pre-proline 0 N--CA 1.487 1.383 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 174.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -69.98 173.32 11.34 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.223 1.949 . . . . 0.0 109.47 178.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . 0.526 ' CD1' HG21 ' A' ' 158' ' ' ILE . 2.4 t80 -127.66 -177.15 3.99 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 30.5 t -116.85 44.73 1.99 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 178.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 115.052 -2.404 . . . . 0.0 107.491 179.123 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 10.2 t . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 108.8 171.38 21.05 Favored Glycine 0 N--CA 1.486 2.021 0 C-N-CA 120.113 -1.042 . . . . 0.0 113.67 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -132.16 148.29 52.46 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 103.921 -2.622 . . . . 0.0 103.921 177.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -107.49 142.36 37.48 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 116.82 -1.952 . . . . 0.0 111.577 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.408 ' CE1' HG21 ' A' ' 181' ' ' VAL . 11.2 m-85 -125.29 -179.51 4.63 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 100.91 -3.737 . . . . 0.0 100.91 -179.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.479 HG21 ' CD1' ' A' ' 210' ' ' TYR . 1.5 pt -125.92 147.69 30.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 101.295 -3.594 . . . . 0.0 101.295 174.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.447 ' O ' ' N ' ' A' ' 176' ' ' GLY . . . -86.29 154.44 21.25 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 103.45 -2.796 . . . . 0.0 103.45 178.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.0 m -124.8 -0.93 5.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 126.089 2.118 . . . . 0.0 107.655 177.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -133.2 165.28 24.08 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 177.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -105.27 145.77 30.23 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 178.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -137.77 177.59 7.76 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 117.978 -1.489 . . . . 0.0 109.119 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 87.9 m -132.28 160.7 35.44 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -100.52 130.51 46.61 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 175.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -106.82 -30.51 8.87 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 -178.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -119.44 -177.82 3.46 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 113.253 -1.794 . . . . 0.0 108.22 -179.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 61.1 t -92.77 150.97 3.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 101.899 -3.371 . . . . 0.0 101.899 176.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 110.39 -48.44 0.94 Allowed Glycine 0 N--CA 1.488 2.142 0 N-CA-C 106.057 -2.817 . . . . 0.0 106.057 -176.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.434 ' HA ' ' HB2' ' A' ' 201' ' ' LEU . 0.3 OUTLIER -73.29 169.6 16.77 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 123.879 1.8 . . . . 0.0 114.189 179.911 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.452 ' HG ' ' HA3' ' A' ' 200' ' ' GLY . 9.7 mt -121.04 -178.05 3.65 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 109.404 -3.544 . . . . 0.0 110.243 177.203 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 18.4 m -115.09 -65.15 1.22 Allowed 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 113.955 -1.475 . . . . 0.0 107.967 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 21.7 p90 42.64 166.26 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 116.867 2.173 . . . . 0.0 116.867 -178.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -113.82 -166.84 1.13 Allowed 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 113.562 -1.653 . . . . 0.0 112.728 179.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.415 ' CG ' ' N ' ' A' ' 176' ' ' GLY . 37.2 tttp -98.39 161.56 13.62 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 110.924 -2.853 . . . . 0.0 112.826 -178.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 159' ' ' ALA . . . 37.39 46.45 1.44 Allowed Glycine 0 N--CA 1.492 2.399 0 CA-C-N 112.665 -2.061 . . . . 0.0 110.172 179.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.451 ' O ' ' HA ' ' A' ' 158' ' ' ILE . 5.0 pt-20 -123.35 176.41 6.15 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-N 111.045 -2.578 . . . . 0.0 106.875 177.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 13.9 mm -108.24 125.67 64.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 C-N-CA 119.392 -0.923 . . . . 0.0 111.338 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 24.2 mt -119.78 165.59 14.36 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 114.575 -1.193 . . . . 0.0 108.37 177.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.403 ' HG ' ' N ' ' A' ' 181' ' ' VAL . 45.7 tp -118.11 163.24 16.93 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 178.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.408 HG21 ' CE1' ' A' ' 157' ' ' TYR . 69.0 t -113.24 142.25 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 178.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.554 ' O ' ' HB ' ' A' ' 191' ' ' ILE . 3.2 mm -141.86 75.41 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 104.551 -2.389 . . . . 0.0 104.551 173.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . 0.51 ' HG2' ' N ' ' A' ' 184' ' ' LYS . 38.8 tt0 127.47 148.39 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.539 0 C-N-CA 127.255 2.222 . . . . 0.0 108.794 178.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . 0.51 ' N ' ' HG2' ' A' ' 183' ' ' GLU . 92.6 mttt -126.4 133.06 51.38 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.117 -1.033 . . . . 0.0 111.787 177.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.51 ' CG ' ' HE1' ' A' ' 190' ' ' TRP . 3.5 tttm -7.98 80.86 0.03 OUTLIER Pre-proline 0 N--CA 1.501 2.081 0 O-C-N 126.683 2.489 . . . . 0.0 116.972 177.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 185' ' ' LYS . 58.3 Cg_endo -72.59 -56.57 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.732 0 N-CA-C 104.136 -3.063 . . . . 0.0 104.136 175.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -134.14 23.2 3.82 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 113.604 -1.635 . . . . 0.0 107.999 178.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.474 ' HA2' ' HG2' ' A' ' 185' ' ' LYS . . . 127.65 -21.46 5.64 Favored Glycine 0 N--CA 1.489 2.223 0 CA-C-O 117.902 -1.499 . . . . 0.0 113.258 -178.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -105.05 156.14 18.34 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 118.018 2.599 . . . . 0.0 118.018 -176.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' TRP . . . . . 0.524 ' NE1' ' HB2' ' A' ' 204' ' ' ARG . 20.4 m95 -130.12 147.47 51.86 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 100.344 -3.947 . . . . 0.0 100.344 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.554 ' HB ' ' O ' ' A' ' 182' ' ' ILE . 12.4 mm -109.22 87.27 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 N-CA-C 102.998 -2.964 . . . . 0.0 102.998 178.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -80.02 175.04 10.99 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 113.247 -1.797 . . . . 0.0 113.848 -173.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -130.4 166.45 20.44 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 174.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -126.34 -161.89 1.09 Allowed 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 118.869 -1.132 . . . . 0.0 110.416 178.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -101.44 32.77 3.18 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.711 -178.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -129.1 -33.8 1.94 Allowed 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.092 176.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 138.07 -39.03 1.64 Allowed Glycine 0 N--CA 1.486 1.967 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.525 -179.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 21.3 p30 -56.84 159.84 3.81 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 118.536 -1.266 . . . . 0.0 114.267 -178.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.457 ' HG3' ' N ' ' A' ' 200' ' ' GLY . 0.1 OUTLIER -140.69 166.12 25.62 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 112.008 -2.36 . . . . 0.0 109.573 179.175 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . 0.457 ' N ' ' HG3' ' A' ' 199' ' ' GLU . . . 159.41 174.01 28.59 Favored Glycine 0 N--CA 1.486 2.013 0 C-N-CA 118.148 -1.977 . . . . 0.0 114.684 177.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.434 ' HB2' ' HA ' ' A' ' 170' ' ' ASP . 9.8 mp -59.45 91.82 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 117.052 2.241 . . . . 0.0 117.052 -179.078 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 5.5 m -107.41 149.62 39.02 Favored Pre-proline 0 C--N 1.302 -1.495 0 N-CA-C 100.417 -3.92 . . . . 0.0 100.417 174.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -86.17 167.41 9.33 Favored 'Trans proline' 0 C--N 1.299 -2.033 0 N-CA-C 107.437 -1.794 . . . . 0.0 107.437 178.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . 0.524 ' HB2' ' NE1' ' A' ' 190' ' ' TRP . 12.2 ttp85 -80.22 -36.88 34.13 Favored 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 115.856 -2.338 . . . . 0.0 107.458 176.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 40.8 p -23.73 -54.82 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -110.52 47.4 0.97 Allowed 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.539 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -134.33 101.1 4.88 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 179.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -102.52 151.41 38.22 Favored Pre-proline 0 C--N 1.298 -1.654 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -57.61 164.78 6.96 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.176 1.918 . . . . 0.0 111.757 -178.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . 0.479 ' CD1' HG21 ' A' ' 158' ' ' ILE . 9.7 t80 -121.69 179.23 4.54 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.544 -0.862 . . . . 0.0 109.592 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 48.8 m -111.77 24.5 12.64 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.596 -0.842 . . . . 0.0 110.277 -179.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 . . . . . 0 N--CA 1.487 1.414 0 CA-C-O 115.103 -2.38 . . . . 0.0 106.256 177.212 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 91.7 m . . . . . 0 N--CA 1.492 1.626 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 40.62 -168.68 0.01 OUTLIER Glycine 0 N--CA 1.497 2.717 0 N-CA-C 116.64 1.416 . . . . 0.0 116.64 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -123.46 168.31 12.73 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 178.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -112.32 135.21 53.29 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 124.216 1.96 . . . . 0.0 110.782 -178.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.485 ' CE1' HG21 ' A' ' 181' ' ' VAL . 16.9 m-85 -133.57 175.12 9.71 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 109.28 -3.6 . . . . 0.0 106.251 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.485 ' HA ' ' HA ' ' A' ' 178' ' ' ILE . 1.3 pt -132.03 152.54 36.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 101.475 -3.528 . . . . 0.0 101.475 171.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.48 ' O ' ' N ' ' A' ' 176' ' ' GLY . . . -90.33 152.89 20.82 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 102.287 -3.227 . . . . 0.0 102.287 177.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.444 ' C ' ' HB2' ' A' ' 175' ' ' LYS . 29.1 m -129.41 10.96 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 125.864 1.978 . . . . 0.0 107.765 177.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.401 ' N ' ' HB2' ' A' ' 175' ' ' LYS . . . -137.82 161.05 25.43 Favored Glycine 0 N--CA 1.478 1.474 0 N-CA-C 106.751 -2.54 . . . . 0.0 106.751 173.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -101.18 150.2 23.2 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 104.061 -2.57 . . . . 0.0 104.061 176.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -132.7 177.33 7.71 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 117.816 -1.554 . . . . 0.0 109.145 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 96.8 m -128.65 157.95 39.89 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 177.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -100.09 145.03 28.43 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 178.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 55.3 tp60 -111.21 -37.24 5.37 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -125.56 171.66 10.36 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 113.312 -1.767 . . . . 0.0 108.098 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 67.9 t -60.42 -48.63 87.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 103.873 -2.64 . . . . 0.0 103.873 177.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -30.29 -50.73 0.18 Allowed Glycine 0 N--CA 1.491 2.306 0 CA-C-N 112.308 -2.223 . . . . 0.0 113.399 174.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.536 ' HA ' ' H ' ' A' ' 201' ' ' LEU . 28.7 m-20 -79.83 164.15 23.84 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 113.738 -1.231 . . . . 0.0 113.339 -178.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.434 HD11 ' C ' ' A' ' 199' ' ' GLU . 16.6 mt -114.92 177.95 4.46 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 104.345 -2.465 . . . . 0.0 104.345 175.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 31.4 m -107.66 -57.46 2.09 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 33.1 p90 33.76 164.38 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 118.811 2.893 . . . . 0.0 118.811 -178.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -109.25 -166.55 1.12 Allowed 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 113.749 -1.569 . . . . 0.0 112.476 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.444 ' HB2' ' C ' ' A' ' 160' ' ' VAL . 10.4 ptpt -107.51 176.83 5.02 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 111.222 -2.717 . . . . 0.0 113.73 -176.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 159' ' ' ALA . . . 34.72 44.21 0.45 Allowed Glycine 0 N--CA 1.491 2.351 0 O-C-N 126.327 2.267 . . . . 0.0 109.097 -177.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.421 ' O ' ' HA ' ' A' ' 158' ' ' ILE . 16.7 pt-20 -130.0 175.6 8.75 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-N 110.758 -2.721 . . . . 0.0 106.555 177.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.485 ' HA ' ' HA ' ' A' ' 158' ' ' ILE . 17.9 mm -101.6 123.19 54.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -175.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 6.8 mp -116.89 156.27 27.64 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.568 177.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.496 HD13 ' H ' ' A' ' 181' ' ' VAL . 0.6 OUTLIER -114.77 152.05 32.73 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 -177.181 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.496 ' H ' HD13 ' A' ' 180' ' ' LEU . 59.6 t -111.6 132.91 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 -179.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.569 ' O ' ' HB ' ' A' ' 191' ' ' ILE . 9.9 mt -142.59 78.88 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 CA-C-N 114.177 -1.374 . . . . 0.0 108.758 179.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . 0.484 ' HG2' ' N ' ' A' ' 184' ' ' LYS . 33.6 tt0 122.0 165.13 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 C-N-CA 128.081 2.552 . . . . 0.0 109.616 173.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . 0.484 ' N ' ' HG2' ' A' ' 183' ' ' GLU . 98.4 mttt -110.37 167.03 10.51 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.206 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.708 ' HB3' ' CD1' ' A' ' 190' ' ' TRP . 17.8 pttp -95.85 68.4 0.03 OUTLIER Pre-proline 0 N--CA 1.508 2.469 0 N-CA-C 120.623 3.564 . . . . 0.0 120.623 -179.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -35.1 -56.5 0.5 Allowed 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 123.288 2.659 . . . . 0.0 108.938 171.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -121.16 23.77 10.39 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 112.95 -1.932 . . . . 0.0 114.069 179.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.602 ' CA ' ' HB2' ' A' ' 185' ' ' LYS . . . 110.7 17.46 9.14 Favored Glycine 0 N--CA 1.5 2.962 0 C-N-CA 119.644 -1.265 . . . . 0.0 112.658 178.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 2.0 m-90 -129.81 111.99 13.16 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 119.41 3.115 . . . . 0.0 119.41 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' TRP . . . . . 0.708 ' CD1' ' HB3' ' A' ' 185' ' ' LYS . 28.7 m0 -106.54 160.4 15.45 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 101.856 -3.387 . . . . 0.0 101.856 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.569 ' HB ' ' O ' ' A' ' 182' ' ' ILE . 1.5 mp -115.43 114.21 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 N-CA-C 103.359 -2.83 . . . . 0.0 103.359 173.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -116.26 176.84 4.92 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -171.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 199' ' ' GLU . 27.3 mtpp -126.84 161.03 29.2 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 173.041 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 17.9 p30 -120.59 -165.85 1.25 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 124.254 0.971 . . . . 0.0 111.64 178.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -99.9 39.12 1.36 Allowed 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 40.8 mmtm -118.66 -37.37 3.29 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 179.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 134.62 -35.87 2.15 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 120.142 -1.028 . . . . 0.0 111.47 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . 0.477 ' ND2' ' H ' ' A' ' 198' ' ' ASN . 0.1 OUTLIER -90.96 174.78 7.24 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 116.153 1.909 . . . . 0.0 116.153 -178.469 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.434 ' C ' HD11 ' A' ' 171' ' ' LEU . 0.3 OUTLIER -117.74 161.27 19.97 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 111.964 -2.38 . . . . 0.0 110.08 -179.383 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . 0.423 ' N ' ' HG3' ' A' ' 199' ' ' GLU . . . -144.97 -170.21 13.9 Favored Glycine 0 N--CA 1.477 1.411 0 C-N-CA 119.326 -1.416 . . . . 0.0 111.453 -179.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.536 ' H ' ' HA ' ' A' ' 170' ' ' ASP . 14.4 mt -113.92 88.01 2.75 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 110.645 -2.777 . . . . 0.0 103.914 177.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 4.8 m -115.27 156.65 45.35 Favored Pre-proline 0 N--CA 1.489 1.493 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 -174.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -90.02 -179.82 1.87 Allowed 'Trans proline' 0 C--N 1.298 -2.087 0 C-N-CA 122.299 2.0 . . . . 0.0 106.976 178.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . 0.554 ' HB2' ' CE2' ' A' ' 190' ' ' TRP . 0.7 OUTLIER -102.9 -41.93 5.99 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 102.503 -3.147 . . . . 0.0 102.503 175.849 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 77.9 p -17.76 -46.28 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 O-C-N 126.616 2.447 . . . . 0.0 116.515 176.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . 0.403 ' N ' ' O ' ' A' ' 204' ' ' ARG . 36.4 m-85 -110.27 42.1 1.62 Allowed 'General case' 0 N--CA 1.503 2.205 0 CA-C-N 118.85 0.75 . . . . 0.0 112.643 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 6.1 mp -131.06 162.21 30.32 Favored 'General case' 0 N--CA 1.499 1.979 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.014 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -134.5 156.81 78.49 Favored Pre-proline 0 C--N 1.303 -1.433 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 172.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -72.26 170.69 18.54 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 N-CA-C 106.995 -1.964 . . . . 0.0 106.995 178.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . 0.451 ' CD1' HG21 ' A' ' 158' ' ' ILE . 5.2 t80 -122.91 173.16 7.97 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 118.483 -1.287 . . . . 0.0 110.004 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 32.8 t -123.49 62.19 1.04 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 123.87 0.732 . . . . 0.0 111.448 -179.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 . . . . . 0 N--CA 1.494 1.756 0 CA-C-O 115.68 -2.105 . . . . 0.0 108.861 177.838 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 35.6 m . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -46.22 170.18 0.03 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 116.377 1.311 . . . . 0.0 116.377 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -122.15 156.07 34.43 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 113.196 -1.502 . . . . 0.0 107.977 -179.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -104.61 128.04 52.52 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 117.897 -1.521 . . . . 0.0 111.373 -178.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.461 ' CE1' HG21 ' A' ' 181' ' ' VAL . 15.9 m-85 -122.1 174.8 6.71 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 104.678 -2.341 . . . . 0.0 104.678 178.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.48 HG21 ' CD1' ' A' ' 210' ' ' TYR . 1.7 pt -125.53 146.32 31.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 102.694 -3.076 . . . . 0.0 102.694 172.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.41 156.47 20.15 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 101.361 -3.57 . . . . 0.0 101.361 176.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 33.2 m -122.52 2.53 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 126.106 2.129 . . . . 0.0 108.274 178.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -125.92 167.73 18.24 Favored Glycine 0 N--CA 1.482 1.76 0 N-CA-C 106.504 -2.638 . . . . 0.0 106.504 177.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.413 ' HA ' ' HA ' ' A' ' 174' ' ' LYS . 23.2 t70 -105.53 114.36 28.49 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.271 -0.972 . . . . 0.0 109.913 179.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.445 ' HB3' ' CZ ' ' A' ' 173' ' ' PHE . 46.2 t80 -112.3 154.63 25.37 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.409 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 99.9 m -130.16 159.78 35.78 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 178.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -96.7 103.54 15.46 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 118.31 -1.356 . . . . 0.0 109.404 178.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -117.75 -0.72 11.72 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.009 -178.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.402 ' O ' ' C ' ' A' ' 168' ' ' VAL . 78.3 mm-40 -121.43 179.14 4.53 Favored 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 118.418 -1.313 . . . . 0.0 109.639 -177.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.402 ' C ' ' O ' ' A' ' 167' ' ' GLN . 96.0 t -25.25 -73.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 126.112 2.132 . . . . 0.0 111.06 179.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -133.55 141.13 12.45 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 107.489 -2.244 . . . . 0.0 107.489 174.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -167.64 -179.24 4.24 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 110.372 -2.914 . . . . 0.0 108.181 -179.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.499 ' HG ' ' CA ' ' A' ' 200' ' ' GLY . 16.5 mt -132.34 175.23 9.46 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 169.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 55.1 m -122.05 96.21 4.96 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.282 178.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.445 ' CZ ' ' HB3' ' A' ' 163' ' ' PHE . 17.6 p90 -118.6 168.47 10.67 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.944 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 162' ' ' ASP . 13.2 ptpt -126.1 151.25 47.47 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 116.299 1.963 . . . . 0.0 116.299 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 60.1 tttt -27.11 79.1 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.665 1 CA-C-N 108.337 -4.028 . . . . 0.0 116.14 171.22 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 109.61 48.21 0.81 Allowed Glycine 0 N--CA 1.491 2.309 0 CA-C-N 114.775 -1.102 . . . . 0.0 112.611 176.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' A' ' 158' ' ' ILE . 9.5 pt-20 -138.49 151.81 47.72 Favored 'General case' 0 N--CA 1.507 2.38 0 C-N-CA 117.35 -1.74 . . . . 0.0 109.135 178.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.465 ' N ' HD12 ' A' ' 178' ' ' ILE . 1.3 mp -82.95 137.59 20.74 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 117.765 2.505 . . . . 0.0 117.765 -177.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.413 ' N ' HD22 ' A' ' 179' ' ' LEU . 2.4 mm? -125.63 173.37 9.03 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 104.2 -2.518 . . . . 0.0 104.2 175.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.5 ' HB2' ' HB2' ' A' ' 193' ' ' LYS . 9.8 mt -117.75 161.34 19.86 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 176.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.461 HG21 ' CE1' ' A' ' 157' ' ' TYR . 78.1 t -113.49 124.43 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 N-CA-C 117.674 2.472 . . . . 0.0 117.674 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.566 ' O ' ' HB ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -135.45 77.53 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 CA-C-N 111.371 -2.65 . . . . 0.0 108.257 176.406 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . 0.55 ' HG2' ' N ' ' A' ' 184' ' ' LYS . 35.7 tt0 117.13 164.28 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 128.214 2.606 . . . . 0.0 110.129 173.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . 0.55 ' N ' ' HG2' ' A' ' 183' ' ' GLU . 99.5 mttt -108.87 -177.45 3.31 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.368 178.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.69 ' HD2' ' HB3' ' A' ' 204' ' ' ARG . 8.2 ptmm? -91.43 73.34 0.01 OUTLIER Pre-proline 0 N--CA 1.515 2.782 0 C-N-CA 130.326 3.45 . . . . 0.0 118.018 -177.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.505 ' HD2' ' O ' ' A' ' 184' ' ' LYS . 9.2 Cg_endo -44.31 -56.57 2.46 Favored 'Trans proline' 0 C--N 1.3 -1.981 0 C-N-CA 123.251 2.634 . . . . 0.0 106.802 174.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -126.24 24.2 6.88 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 112.582 -2.099 . . . . 0.0 110.665 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.498 ' CA ' ' HB2' ' A' ' 185' ' ' LYS . . . 110.22 15.78 11.19 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -128.13 102.78 6.86 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 119.933 3.309 . . . . 0.0 119.933 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' TRP . . . . . 0.675 ' CD1' ' HB3' ' A' ' 185' ' ' LYS . 10.7 m0 -95.93 157.05 16.07 Favored 'General case' 0 N--CA 1.498 1.933 1 N-CA-C 99.685 -4.191 . . . . 0.0 99.685 -177.926 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.566 ' HB ' ' O ' ' A' ' 182' ' ' ILE . 1.4 mp -112.54 140.99 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 1 N-CA-C 99.893 -4.114 . . . . 0.0 99.893 173.698 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -132.87 -177.95 4.73 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 119.319 -0.952 . . . . 0.0 113.542 -174.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.5 ' HB2' ' HB2' ' A' ' 180' ' ' LEU . 62.6 mmtt -128.22 169.25 14.37 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 172.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -125.03 -158.0 0.81 Allowed 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.34 -0.944 . . . . 0.0 109.548 178.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -104.71 39.06 1.76 Allowed 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 121.33 0.586 . . . . 0.0 109.967 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -132.26 -37.39 1.1 Allowed 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.56 177.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 134.72 -22.24 3.69 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 -178.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -78.08 164.6 24.87 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.005 -1.078 . . . . 0.0 112.934 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.76 158.17 30.76 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 112.203 -2.271 . . . . 0.0 109.74 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . 0.499 ' CA ' ' HG ' ' A' ' 171' ' ' LEU . . . -135.46 -172.22 12.63 Favored Glycine 0 N--CA 1.479 1.501 0 CA-C-O 123.985 1.881 . . . . 0.0 115.115 -177.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.455 HD23 ' HA ' ' A' ' 201' ' ' LEU . 9.5 mt -126.2 87.06 2.61 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 108.568 -3.816 . . . . 0.0 103.684 177.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 4.9 m -116.79 156.5 47.86 Favored Pre-proline 0 C--N 1.303 -1.45 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 -173.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 0.6 OUTLIER -92.0 174.7 2.18 Favored 'Trans proline' 0 C--N 1.299 -2.061 0 N-CA-C 105.564 -2.514 . . . . 0.0 105.564 178.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . 0.69 ' HB3' ' HD2' ' A' ' 185' ' ' LYS . 0.4 OUTLIER -108.85 -31.06 7.83 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 175.502 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 82.5 p -23.68 -47.16 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.173 0 O-C-N 125.742 1.901 . . . . 0.0 113.875 171.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -112.53 49.49 0.92 Allowed 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 119.745 -0.782 . . . . 0.0 111.77 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -132.68 156.89 46.15 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.332 -179.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -132.02 157.6 77.78 Favored Pre-proline 0 N--CA 1.495 1.791 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 174.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -73.24 158.61 48.56 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 121.283 1.322 . . . . 0.0 108.708 178.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . 0.48 ' CD1' HG21 ' A' ' 158' ' ' ILE . 6.8 t80 -137.18 58.79 1.7 Allowed 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.4 -0.92 . . . . 0.0 109.066 179.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 49.2 m -100.51 61.51 1.03 Allowed 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 -178.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.303 -1.455 0 CA-C-N 112.297 -2.229 . . . . 0.0 109.952 -179.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 10.1 t . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -115.73 -175.22 18.09 Favored Glycine 0 N--CA 1.485 1.907 0 C-N-CA 120.399 -0.905 . . . . 0.0 113.707 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -119.29 166.59 12.82 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 104.907 -2.257 . . . . 0.0 104.907 -179.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -103.48 117.01 33.47 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 117.704 -1.598 . . . . 0.0 113.492 -178.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.462 ' CD1' HG21 ' A' ' 181' ' ' VAL . 5.5 m-85 -123.59 174.91 7.13 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 102.623 -3.103 . . . . 0.0 102.623 177.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.511 HG22 HG13 ' A' ' 178' ' ' ILE . 5.7 pt -131.62 150.76 34.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 103.312 -2.847 . . . . 0.0 103.312 172.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -81.71 151.45 27.51 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 102.848 -3.019 . . . . 0.0 102.848 176.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 26.8 m -129.69 10.72 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 125.866 1.978 . . . . 0.0 107.75 177.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -126.89 164.18 20.55 Favored Glycine 0 N--CA 1.484 1.852 0 N-CA-C 105.17 -3.172 . . . . 0.0 105.17 176.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -105.83 83.91 1.99 Allowed 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 118.709 -1.196 . . . . 0.0 109.277 -179.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -104.43 115.96 31.28 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 122.605 1.193 . . . . 0.0 108.425 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 18.2 m -101.01 154.35 18.77 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 111.944 -2.389 . . . . 0.0 106.379 -179.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.39 129.71 34.75 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 117.168 -1.813 . . . . 0.0 106.447 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -107.42 -29.31 9.32 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 -178.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -119.2 -175.67 2.97 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 113.586 -1.643 . . . . 0.0 106.616 179.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 61.4 t -88.76 151.76 3.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 179.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 114.33 -53.04 0.62 Allowed Glycine 0 N--CA 1.487 2.074 0 N-CA-C 108.644 -1.782 . . . . 0.0 108.644 -178.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.5 ' HA ' ' H ' ' A' ' 201' ' ' LEU . 39.8 m-20 -78.58 169.52 18.11 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 113.951 -1.125 . . . . 0.0 111.668 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.428 ' HG ' ' HA3' ' A' ' 200' ' ' GLY . 15.4 mt -121.01 176.02 5.77 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.182 177.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 31.3 m -116.92 93.09 4.06 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 114.12 -1.4 . . . . 0.0 112.273 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -128.17 166.85 17.73 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 113.512 -1.676 . . . . 0.0 109.274 177.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -125.39 159.82 30.9 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 117.001 2.223 . . . . 0.0 117.001 -178.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 44.4 tttm -35.97 77.45 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.659 1 CA-C-N 108.008 -4.178 . . . . 0.0 116.655 173.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 114.9 47.86 0.55 Allowed Glycine 0 N--CA 1.494 2.504 0 CA-C-N 114.866 -1.061 . . . . 0.0 115.126 174.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -137.51 158.66 43.92 Favored 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 117.472 -1.691 . . . . 0.0 107.576 175.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.511 HG13 HG22 ' A' ' 158' ' ' ILE . 1.1 mp -84.57 134.26 27.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 -176.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.7 mp -135.62 168.83 18.54 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 113.158 -1.837 . . . . 0.0 108.7 175.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.429 ' O ' ' HB1' ' A' ' 192' ' ' ALA . 27.9 mt -107.09 154.09 21.66 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 176.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.465 HG12 ' HB3' ' A' ' 190' ' ' TRP . 2.3 t -122.52 132.69 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 118.367 -1.333 . . . . 0.0 108.502 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.473 ' O ' ' CB ' ' A' ' 183' ' ' GLU . 16.6 mt -139.77 79.99 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 120.264 -0.575 . . . . 0.0 111.658 -173.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . 0.506 ' O ' ' CE3' ' A' ' 190' ' ' TRP . 3.7 tm-20 136.34 147.56 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.976 0 C-N-CA 127.63 2.372 . . . . 0.0 108.816 173.249 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . 0.439 ' HG2' ' CZ3' ' A' ' 190' ' ' TRP . 62.0 mttp -105.54 104.19 13.87 Favored 'General case' 0 N--CA 1.509 2.504 0 N-CA-C 119.727 3.232 . . . . 0.0 119.727 -171.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.523 ' HA ' ' HD2' ' A' ' 186' ' ' PRO . 21.8 pttp -15.09 79.25 0.02 OUTLIER Pre-proline 0 N--CA 1.5 2.074 1 N-CA-C 122.407 4.225 . . . . 0.0 122.407 179.249 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.523 ' HD2' ' HA ' ' A' ' 185' ' ' LYS . 11.0 Cg_endo -45.35 -59.93 1.01 Allowed 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 123.886 3.057 . . . . 0.0 107.321 171.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -121.86 20.75 10.82 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 111.399 -2.637 . . . . 0.0 110.638 -178.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.513 ' CA ' ' HB2' ' A' ' 185' ' ' LYS . . . 114.71 12.18 10.64 Favored Glycine 0 N--CA 1.488 2.154 0 C-N-CA 119.717 -1.23 . . . . 0.0 110.876 179.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . 0.402 ' O ' ' HD2' ' A' ' 186' ' ' PRO . 2.5 m-90 -127.49 134.3 49.82 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 120.318 3.451 . . . . 0.0 120.318 179.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' TRP . . . . . 0.506 ' CE3' ' O ' ' A' ' 183' ' ' GLU . 10.2 m95 -120.11 163.06 18.27 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 104.824 -2.287 . . . . 0.0 104.824 178.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.457 ' HB ' ' O ' ' A' ' 182' ' ' ILE . 1.7 mp -107.45 113.0 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 104.179 -2.526 . . . . 0.0 104.179 177.048 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . 0.442 ' HB2' HG22 ' A' ' 202' ' ' VAL . . . -108.2 -179.81 3.99 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -173.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 199' ' ' GLU . 96.5 mttt -133.6 165.31 25.21 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 172.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -115.62 -160.0 0.73 Allowed 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 118.822 -1.151 . . . . 0.0 109.658 -179.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -97.18 38.67 1.23 Allowed 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.874 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -133.36 -38.38 0.94 Allowed 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.45 177.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 136.87 -39.71 1.6 Allowed Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -178.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 21.5 p30 -52.78 164.27 0.39 Allowed 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.411 ' C ' HD11 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -122.95 157.69 32.07 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 113.049 -1.887 . . . . 0.0 110.552 179.83 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . 0.428 ' HA3' ' HG ' ' A' ' 171' ' ' LEU . . . -142.58 -165.48 10.6 Favored Glycine 0 N--CA 1.482 1.709 0 CA-C-O 122.671 1.151 . . . . 0.0 112.387 -177.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.5 ' H ' ' HA ' ' A' ' 170' ' ' ASP . 33.7 mt -125.2 89.98 3.15 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 111.242 -2.479 . . . . 0.0 106.547 177.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.442 HG22 ' HB2' ' A' ' 192' ' ' ALA . 2.1 m -116.74 154.82 49.45 Favored Pre-proline 0 N--CA 1.496 1.871 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -177.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -89.59 176.26 2.99 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 C-N-CA 123.177 2.585 . . . . 0.0 111.391 -177.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . 0.476 ' HB2' ' CE2' ' A' ' 190' ' ' TRP . 29.3 ttm180 -97.97 -40.09 8.64 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 102.637 -3.097 . . . . 0.0 102.637 174.04 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 73.8 p -25.14 -55.24 0.05 OUTLIER 'General case' 0 N--CA 1.503 2.202 0 O-C-N 125.512 1.758 . . . . 0.0 115.54 176.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -113.66 45.65 1.41 Allowed 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 122.62 1.2 . . . . 0.0 109.387 -178.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -135.75 128.73 31.41 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 112.361 -2.2 . . . . 0.0 105.369 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -114.2 156.09 44.71 Favored Pre-proline 0 N--CA 1.494 1.744 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 178.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -63.21 166.11 15.53 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 121.693 1.595 . . . . 0.0 110.122 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . 0.428 ' CG ' ' N ' ' A' ' 211' ' ' SER . 35.6 t80 -124.33 172.69 8.92 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.688 -0.805 . . . . 0.0 109.511 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . 0.428 ' N ' ' CG ' ' A' ' 210' ' ' TYR . 56.1 m -116.11 50.52 1.03 Allowed 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.004 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 . . . . . 0 N--CA 1.494 1.753 0 CA-C-O 115.121 -2.371 . . . . 0.0 115.495 178.9 . . . . . . . . 0 0 . 1 stop_ save_